Hits from PDB |
Structure Title |
EC number |
1O2U | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O2V | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O2W | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O2X | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O2Y | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O2Z | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O30 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O31 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O32 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O33 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O34 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O35 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O36 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O37 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O38 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O39 | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3A | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3B | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3C | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3D | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3E | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3F | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3G | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3H | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3I | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3J | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3K | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3L | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3M | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3N | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3O | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1O3P | ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS | 3.4.21.73 |
1O3W | STRUCTURE OF THE INHIBITOR FREE TRIPLE MUTANT (K53,56,120M) OF PHOSPHOLIPASE A2 | 3.1.1.4 |
1O4W | CRYSTAL STRUCTURE OF A PIN (PILT N-TERMINUS) DOMAIN CONTAINING PROTEIN (AF0591) FROM ARCHAEOGLOBUS FULGIDUS AT 1.90 A RESOLUTION | 3.1 |
1O4Y | THE THREE-DIMENSIONAL STRUCTURE OF BETA-AGARASE A FROM ZOBELLIA GALACTANIVORANS | 3.2.1.81 |
1O4Z | THE THREE-DIMENSIONAL STRUCTURE OF BETA-AGARASE B FROM ZOBELLIA GALACTANIVORANS | 3.2.1.81 |
1O59 | CRYSTAL STRUCTURE OF ALLANTOICASE (YIR029W) FROM SACCHAROMYCES CEREVISIAE AT 2.40 A RESOLUTION | 3.5.3.4 |
1O5A | DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) | 3.4.21.73 |
1O5B | DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) | 3.4.21.73 |
1O5C | DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) | 3.4.21.73 |
1O5D | DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) | 3.4.21.21 |
1O5E | DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) | 3.4.21 3.4.21.106 |
1O5F | DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) | 3.4.21 3.4.21.106 |
1O5G | DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) | 3.4.21.5 |
1O5R | CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH A POTENT INHIBITOR | 3.5.4.4 |
1O6E | EPSTEIN-BARR VIRUS PROTEASE | 3.4.21.97 |
1O6F | PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, D641A MUTANT WITH BOUND PEPTIDE LIGAND SUC-GLY-PRO | 3.4.21.26 |
1O6G | PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, D641N MUTANT WITH BOUND PEPTIDE LIGAND SUC-GLY-PRO | 3.4.21.26 |
1O6I | CHITINASE B FROM SERRATIA MARCESCENS COMPLEXED WITH THE CATALYTIC INTERMEDIATE MIMIC CYCLIC DIPEPTIDE CI4. | 3.2.1.14 |
1O6X | NMR SOLUTION STRUCTURE OF THE ACTIVATION DOMAIN OF HUMAN PROCARBOXYPEPTIDASE A2 | 3.4.17.15 |
1O75 | TP47, THE 47-KILODALTON LIPOPROTEIN OF TREPONEMA PALLIDUM | 3.4 |
1O77 | CRYSTAL STRUCTURE OF THE C713S MUTANT OF THE TIR DOMAIN OF HUMAN TLR2 | 3.2.2.6 |
1O7A | HUMAN BETA-HEXOSAMINIDASE B | 3.2.1.52 |
1O7D | THE STRUCTURE OF THE BOVINE LYSOSOMAL A-MANNOSIDASE SUGGESTS A NOVEL MECHANISM FOR LOW PH ACTIVATION | 3.2.1.24 |
1O7E | CRYSTAL STRUCTURE OF THE CLASS A BETA-LACTAMSE L2 FROM STENOTROPHOMONAS MALTOPHILIA AT 1.51 ANGSTROM | 3.5.2.6 |
1O7J | ATOMIC RESOLUTION STRUCTURE OF ERWINIA CHRYSANTHEMI L-ASPARAGINASE | 3.5.1.1 |
1O86 | CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH LISINOPRIL. | 3.4.15.1 3.2.1 |
1O8A | CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERTING ENZYME (NATIVE). | 3.4.15.1 3.2.1 |
1O8P | UNBOUND STRUCTURE OF CSCBM6-3 FROM CLOSTRIDIUM STERCORARIUM | 3.2.1.8 |
1O8S | STRUCTURE OF CSCBM6-3 FROM CLOSTRIDIUM STERCORARIUM IN COMPLEX WITH CELLOBIOSE | 3.2.1.8 |
1O8U | THE 2 ANGSTROM STRUCTURE OF 6-OXO CAMPHOR HYDROLASE: NEW STRUCTURAL DIVERSITY IN THE CROTONASE SUPERFAMILY | 3.7.1.18 |
1OA2 | COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY | 3.2.1.4 |
1OA3 | COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY | 3.2.1.4 |
1OA4 | COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY | 3.2.1.4 |
1OA7 | STRUCTURE OF MELANOCARPUS ALBOMYCES ENDOGLUCANASE IN COMPLEX WITH CELLOBIOSE | 3.2.1.4 |
1OA9 | STRUCTURE OF MELANOCARPUS ALBOMYCES ENDOGLUCANASE | 3.2.1.4 |
1OAN | CRYSTAL STRUCTURE OF THE DENGUE 2 VIRUS ENVELOPE PROTEIN | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1OB0 | KINETIC STABILIZATION OF BACILLUS LICHENIFORMIS ALPHA-AMYLASE THROUGH INTRODUCTION OF HYDROPHOBIC RESIDUES AT THE SURFACE | 3.2.1.1 |
1OB2 | E. COLI ELONGATION FACTOR EF-TU COMPLEXED WITH THE ANTIBIOTIC KIRROMYCIN, A GTP ANALOG, AND PHE-TRNA | 3.6.1.48 |
1OB5 | T. AQUATICUS ELONGATION FACTOR EF-TU COMPLEXED WITH THE ANTIBIOTIC ENACYLOXIN IIA, A GTP ANALOG, AND PHE-TRNA | 3.6.1.48 |
1OB8 | HOLLIDAY JUNCTION RESOLVING ENZYME | 3.1.22.4 |
1OB9 | HOLLIDAY JUNCTION RESOLVING ENZYME | 3.1.22.4 |
1OBA | MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN FROM PHAGE CP-1 COMPLEXED WITH CHOLINE | 3.2.1.17 |
1OBB | ALPHA-GLUCOSIDASE A, AGLA, FROM THERMOTOGA MARITIMA IN COMPLEX WITH MALTOSE AND NAD+ | 3.2.1.20 |
1OBR | CARBOXYPEPTIDASE T | 3.4.17.18 |
1OBS | STRUCTURE OF RICIN A CHAIN MUTANT | 3.2.2.22 |
1OBT | STRUCTURE OF RICIN A CHAIN MUTANT, COMPLEX WITH AMP | 3.2.2.22 |
1OBW | STRUCTURE OF INORGANIC PYROPHOSPHATASE | 3.6.1.1 |
1OC5 | D405N MUTANT OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS IN COMPLEX WITH METHYL-CELLOBIOSYL-4-DEOXY-4-THIO-BETA-D-CELLOBIOSIDE | 3.2.1.91 |
1OC6 | STRUCTURE NATIVE OF THE D405N MUTANT OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS AT 1.5 ANGSTROM RESOLUTION | 3.2.1.91 |
1OC7 | D405N MUTANT OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS IN COMPLEX WITH METHYL-TETRATHIO-ALPHA-D-CELLOPENTOSIDE AT 1.1 ANGSTROM RESOLUTION | 3.2.1.91 |
1OCB | STRUCTURE OF THE WILD-TYPE CELLOBIOHYDROLASE CEL6A FROM HUMICOLAS INSOLENS IN COMPLEX WITH A FLUORESCENT SUBSTRATE | 3.2.1.91 |
1OCE | ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH MF268 | 3.1.1.7 |
1OCJ | MUTANT D416A OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS IN COMPLEX WITH A THIOPENTASACCHARIDE AT 1.3 ANGSTROM RESOLUTION | 3.2.1.91 |
1OCN | MUTANT D416A OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS IN COMPLEX WITH A CELLOBIO-DERIVED ISOFAGOMINE AT 1.3 ANGSTROM RESOLUTION | 3.2.1.91 |
1OCQ | COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHEARANS AT 1.08 ANGSTROM RESOLUTION WITH CELLOBIO-DERIVED ISOFAGOMINE | 3.2.1.4 |
1OD0 | FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA | 3.2.1.21 |
1OD1 | ENDOTHIAPEPSIN PD135,040 COMPLEX | 3.4.23.22 |
1OD3 | STRUCTURE OF CSCBM6-3 FROM CLOSTRIDIUM STERCORARIUM IN COMPLEX WITH LAMINARIBIOSE | 3.2.1.8 |
1OD8 | XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO-ISOFAGOMINE LACTAM | 3.2.1.8 |
1ODG | VERY-SHORT-PATCH DNA REPAIR ENDONUCLEASE BOUND TO ITS REACTION PRODUCT SITE | 3.1 |
1ODS | CEPHALOSPORIN C DEACETYLASE FROM BACILLUS SUBTILIS | 3.1.1.41 3.1.1.72 |
1ODT | CEPHALOSPORIN C DEACETYLASE MUTATED, IN COMPLEX WITH ACETATE | 3.1.1.41 3.1.1.72 |
1ODU | CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA ALPHA-FUCOSIDASE IN COMPLEX WITH FUCOSE | 3.2.1.51 |
1ODW | NATIVE HIV-1 PROTEINASE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ODX | HIV-1 PROTEINASE MUTANT A71T, V82A | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ODY | HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ODZ | EXPANSION OF THE GLYCOSYNTHASE REPERTOIRE TO PRODUCE DEFINED MANNO-OLIGOSACCHARIDES | 3.2.1.78 |
1OE4 | XENOPUS SMUG1, AN ANTI-MUTATOR URACIL-DNA GLYCOSYLASE | 3.2.2 |
1OE5 | XENOPUS SMUG1, AN ANTI-MUTATOR URACIL-DNA GLYCOSYLASE | 3.2.2 |
1OE6 | XENOPUS SMUG1, AN ANTI-MUTATOR URACIL-DNA GLYCOSYLASE | 3.2.2 |
1OEM | PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO A SULFENYL-AMIDE BOND | 3.1.3.48 |
1OEO | PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO SULFONIC ACID | 3.1.3.48 |
1OES | OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
1OET | OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
1OEU | OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
1OEV | OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
1OEW | ATOMIC RESOLUTION STRUCTURE OF NATIVE ENDOTHIAPEPSIN | 3.4.23.22 |
1OEX | ATOMIC RESOLUTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A HYDROXYETHYLENE TRANSITION STATE ANALOGUE INHIBITOR H261 | 3.4.23.22 |
1OFC | NUCLEOSOME RECOGNITION MODULE OF ISWI ATPASE | 3.6.4 |
1OG1 | CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2 IN COMPLEX WITH TAD | 2.4.2.31 3.2.2.5 |
1OG3 | CRYSTAL STRUCTURE OF THE EUKARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2 MUTANT E189I IN COMPLEX WITH NAD | 2.4.2.31 3.2.2.5 |
1OG4 | CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2 MUTANT E189A IN COMPLEX WITH NADH | 2.4.2.31 3.2.2.5 |
1OGB | CHITINASE B FROM SERRATIA MARCESCENS MUTANT D142N | 3.2.1.14 |
1OGG | CHITINASE B FROM SERRATIA MARCESCENS MUTANT D142N IN COMPLEX WITH INHIBITOR ALLOSAMIDIN | 3.2.1.14 |
1OGH | STRUCTURE OF THE BIFUNCTIONAL DCTP DEAMINASE-DUTPASE FROM METHANOCALDOCOCCUS JANNASCHII | 3.5.4.13 3.6.1.23 3.5.4.30 |
1OGK | THE CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI DUTPASE IN COMPLEX WITH DUDP | 3.6.1.23 |
1OGL | THE CRYSTAL STRUCTURE OF NATIVE TRYPANOSOMA CRUZI DUTPASE | 3.6.1.23 |
1OGM | DEX49A FROM PENICILLIUM MINIOLUTEUM | 3.2.1.11 |
1OGO | DEX49A FROM PENICILLIUM MINIOLUTEUM COMPLEX WITH ISOMALTOSE | 3.2.1.11 |
1OGS | HUMAN ACID-BETA-GLUCOSIDASE | 3.2.1.45 2.4.1 3.2.1.104 3.2.1 |
1OHC | STRUCTURE OF THE PROLINE DIRECTED PHOSPHATASE CDC14 | 3.1.3.16 3.1.3.48 |
1OHD | STRUCTURE OF CDC14 IN COMPLEX WITH TUNGSTATE | 3.1.3.16 3.1.3.48 |
1OHE | STRUCTURE OF CDC14B PHOSPHATASE WITH A PEPTIDE LIGAND | 3.1.3.16 3.1.3.48 |
1OHT | PEPTIDOGLYCAN RECOGNITION PROTEIN LB | 3.5.1.28 |
1OI4 | CRYSTAL STRUCTURE OF YHBO FROM ESCHERICHIA COLI | 3.1.2 3.5.1 3.5.1.124 |
1OI8 | 5'-NUCLEOTIDASE (E. COLI) WITH AN ENGINEERED DISULFIDE BRIDGE (P90C, L424C) | 3.1.3.5 3.6.1.45 |
1OIE | 5'-NUCLEOTIDASE (E. COLI) WITH AN ENGINEERED DISULFIDE BRIDGE (S228C, P513C) | 3.1.3.5 3.6.1.45 |
1OIF | FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA | 3.2.1.21 |
1OIL | STRUCTURE OF LIPASE | 3.1.1.3 |
1OIM | FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA | 3.2.1.21 |
1OIN | FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA | 3.2.1.21 |
1OJI | ANATOMY OF GLYCOSYNTHESIS: STRUCTURE AND KINETICS OF THE HUMICOLA INSOLENS CEL7B E197A AND E197S GLYCOSYNTHASE MUTANTS | 3.2.1.4 |
1OJJ | ANATOMY OF GLYCOSYNTHESIS: STRUCTURE AND KINETICS OF THE HUMICOLA INSOLENS CEL7BE197A AND E197S GLYCOSYNTHASE MUTANTS | 3.2.1.4 |
1OJK | ANATOMY OF GLYCOSYNTHESIS: STRUCTURE AND KINETICS OF THE HUMICOLA INSOLENS CEL7BE197A AND E197S GLYCOSYNTHASE MUTANTS | 3.2.1.4 |
1OK8 | CRYSTAL STRUCTURE OF THE DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN THE POSTFUSION CONFORMATION | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1OKB | CRYSTAL STRUCTURE OF URACIL-DNA GLYCOSYLASE FROM ATLANTIC COD (GADUS MORHUA) | 3.2.2.3 3.2.2.27 |
1OKE | CRYSTAL STRUCTURE OF THE DENGUE 2 VIRUS ENVELOPE PROTEIN IN COMPLEX WITH N-OCTYL-BETA-D-GLUCOSIDE | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1OKJ | CRYSTAL STRUCTURE OF THE ESSENTIAL E. COLI YEAZ PROTEIN BY MAD METHOD USING THE GADOLINIUM COMPLEX DOTMA"" | 3.4 |
1OKX | BINDING STRUCTURE OF ELASTASE INHIBITOR SCYPTOLIN A | 3.4.21.36 |
1OLP | ALPHA TOXIN FROM CLOSTRIDIUM ABSONUM | 3.1.4.3 |
1OLQ | THE TRICHODERMA REESEI CEL12A P201C MUTANT, STRUCTURE AT 1.7 A RESOLUTION | 3.2.1.4 |
1OLR | THE HUMICOLA GRISEA CEL12A ENZYME STRUCTURE AT 1.2 A RESOLUTION | 3.2.1.4 |
1OM6 | CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 5MM EDTA (2 MONTHS) | 3.4.24.40 |
1OM7 | CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, SOAKED IN 85 MM EDTA | 3.4.24.40 |
1OM8 | CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLYZED WITH 10 MM EDTA | 3.4.24.40 |
1OME | CRYSTAL STRUCTURE OF THE OMEGA LOOP DELETION MUTANT (RESIDUES 163-178 DELETED) OF BETA-LACTAMASE FROM STAPHYLOCOCCUS AUREUS PC1 | 3.5.2.6 |
1OMJ | CRYSTAL STRUCTURE OF A PSYCHROPHILIC ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18 | 3.4.24.40 |
1ONB | SOLUTION STRUCTURE OF AN ENGINEERED ARGININE-RICH SUBDOMAIN 2 OF THE HEPATITIS C VIRUS NS3 RNA HELICASE | 3.4.21.98 3.4.22 3.6.1.15 3.6.4.13 2.7.7.48 |
1ONC | THE REFINED 1.7 ANGSTROMS X-RAY CRYSTALLOGRAPHIC STRUCTURE OF P-30, AN AMPHIBIAN RIBONUCLEASE WITH ANTI-TUMOR ACTIVITY | 3.1.27 |
1ONG | SHV-1 BETA-LACTAMASE WITH A PENEM INHIBITOR | 3.5.2.6 |
1ONH | GC1 BETA-LACTAMASE WITH A PENEM INHIBITOR | 3.5.2.6 |
1ONI | CRYSTAL STRUCTURE OF A HUMAN P14.5, A TRANSLATIONAL INHIBITOR REVEALS DIFFERENT MODE OF LIGAND BINDING NEAR THE INVARIANT RESIDUES OF THE YJGF/UK114 PROTEIN FAMILY | 3.5.99.10 |
1ONK | MISTLETOE LECTIN I FROM VISCUM ALBUM | 3.2.2.22 |
1ONS | CRYSTAL STRUCTURE OF ESCHERICHIA COLI HEAT SHOCK PROTEIN YEDU | 3.1.2 3.5.1 3.5.1.124 4.2.1.130 |
1ONW | CRYSTAL STRUCTURE OF ISOASPARTYL DIPEPTIDASE FROM E. COLI | 3.4.19 |
1ONX | CRYSTAL STRUCTURE OF ISOASPARTYL DIPEPTIDASE FROM ESCHERICHIA COLI COMPLEXED WITH ASPARTATE | 3.4.19 |
1ONY | OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B, COMPOUND 17 | 3.1.3.48 |
1ONZ | OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B, COMPOUND 8B | 3.1.3.48 |
1OO9 | ORIENTATION IN SOLUTION OF MMP-3 CATALYTIC DOMAIN AND N-TIMP-1 FROM RESIDUAL DIPOLAR COUPLINGS | 3.4.24.17 |
1OOK | CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND HUMAN ALPHA-THROMBIN | 3.4.21.5 |
1OOP | THE CRYSTAL STRUCTURE OF SWINE VESICULAR DISEASE VIRUS | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1OP0 | CRYSTAL STRUCTURE OF AAV-SP-I, A GLYCOSYLATED SNAKE VENOM SERINE PROTEINASE FROM AGKISTRODON ACUTUS | 3.4.21 |
1OP2 | CRYSTAL STRUCTURE OF AAV-SP-II, A GLYCOSYLATED SNAKE VENOM SERINE PROTEINASE FROM AGKISTRODON ACUTUS | 3.4.21 |
1OP8 | CRYSTAL STRUCTURE OF HUMAN GRANZYME A | 3.4.21.78 |
1OPZ | A CORE MUTATION AFFECTING THE FOLDING PROPERTIES OF A SOLUBLE DOMAIN OF THE ATPASE PROTEIN COPA FROM BACILLUS SUBTILIS | 3.6.3.4 7.2.2.8 |
1OQ3 | A CORE MUTATION AFFECTING THE FOLDING PROPERTIES OF A SOLUBLE DOMAIN OF THE ATPASE PROTEIN COPA FROM BACILLUS SUBTILIS | 3.6.3.4 7.2.2.8 |
1OQ6 | SOLUTION STRUCTURE OF COPPER-S46V COPA FROM BACILLUS SUBTILIS | 3.6.3.4 7.2.2.8 |
1OQK | STRUCTURE OF MTH11: A HOMOLOGUE OF HUMAN RNASE P PROTEIN RPP29 | 3.1.26.5 |
1OQL | MISTLETOE LECTIN I FROM VISCUM ALBUM COMPLEXED WITH GALACTOSE | 3.2.2.22 |
1OQS | CRYSTAL STRUCTURE OF RV4/RV7 COMPLEX | 3.1.1.4 |
1OR0 | CRYSTAL STRUCTURES OF GLUTARYL 7-AMINOCEPHALOSPORANIC ACID ACYLASE: INSIGHT INTO AUTOPROTEOLYTIC ACTIVATION | 3.5.1 3.5.1.93 |
1ORF | THE OLIGOMERIC STRUCTURE OF HUMAN GRANZYME A REVEALS THE MOLECULAR DETERMINANTS OF SUBSTRATE SPECIFICITY | 3.4.21.78 |
1OS0 | THERMOLYSIN WITH AN ALPHA-AMINO PHOSPHINIC INHIBITOR | 3.4.24.27 |
1OS2 | TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12 | 3.4.24.65 |
1OS5 | CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE COMPLEXED WITH A NOVEL NON-COMPETITIVE INHIBITOR. | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
1OS8 | RECOMBINANT STREPTOMYCES GRISEUS TRYPSIN | 3.4.21.4 |
1OS9 | BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12 | 3.4.24.65 |
1OSE | PORCINE PANCREATIC ALPHA-AMYLASE COMPLEXED WITH ACARBOSE | 3.2.1.1 |
1OSS | T190P STREPTOMYCES GRISEUS TRYPSIN IN COMPLEX WITH BENZAMIDINE | 3.4.21.4 |
1OT5 | THE 2.4 ANGSTROM CRYSTAL STRUCTURE OF KEX2 IN COMPLEX WITH A PEPTIDYL-BORONIC ACID INHIBITOR | 3.4.21.61 |
1OUA | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE I56T MUTANT | 3.2.1.17 |
1OUB | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V100A MUTANT | 3.2.1.17 |
1OUC | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V110A MUTANT | 3.2.1.17 |
1OUD | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V121A MUTANT | 3.2.1.17 |
1OUE | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V125A MUTANT | 3.2.1.17 |
1OUF | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V130A MUTANT | 3.2.1.17 |
1OUG | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V2A MUTANT | 3.2.1.17 |
1OUH | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V74A MUTANT | 3.2.1.17 |
1OUI | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V93A MUTANT | 3.2.1.17 |
1OUJ | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V99A MUTANT | 3.2.1.17 |
1OUO | CRYSTAL STRUCTURE OF THE PERIPLASMIC ENDONUCLEASE VVN | 3.1 |
1OUP | CRYSTAL STRUCTURE OF THE PERIPLASMIC ENDONUCLEASE VVN COMPLEXED WITH OCTAMER DOUBLE STRANDED DNA | 3.1 |
1OUV | HELICOBACTER CYSTEINE RICH PROTEIN C (HCPC) | 3.5.2.6 |
1OV5 | T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 2-ALLYLPHENOL | 3.2.1.17 |
1OV7 | T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 2-ALLYL-6-METHYL-PHENOL | 3.2.1.17 |
1OVH | T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 2-CHLORO-6-METHYL-ANILINE | 3.2.1.17 |
1OVJ | T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 3-FLUORO-2-METHYL_ANILINE | 3.2.1.17 |
1OVK | T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH N-ALLYL-ANILINE | 3.2.1.17 |
1OVQ | SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN YQGF FROM ESCHERICHIA COLI | 3.1 |
1OVW | ENDOGLUCANASE I COMPLEXED WITH NON-HYDROLYSABLE SUBSTRATE ANALOGUE | 3.2.1.4 |
1OWD | SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | 3.4.21.73 |
1OWE | SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | 3.4.21.73 |
1OWH | SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | 3.4.21.73 |
1OWI | SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | 3.4.21.73 |
1OWJ | SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | 3.4.21.73 |
1OWK | SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | 3.4.21.73 |
1OWS | CRYSTAL STRUCTURE OF A C49 PHOSPHOLIPASE A2 FROM INDIAN COBRA REVEALS CARBOHYDRATE BINDING IN THE HYDROPHOBIC CHANNEL | 3.1.1.4 |
1OWY | T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 2-PROPYL-ANILINE | 3.2.1.17 |
1OWZ | T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 4-FLUOROPHENETHYL ALCOHOL | 3.2.1.17 |
1OX1 | CRYSTAL STRUCTURE OF THE BOVINE TRYPSIN COMPLEX WITH A SYNTHETIC 11 PEPTIDE INHIBITOR | 3.4.21.4 |
1OX4 | TOWARDS UNDERSTANDING THE MECHANISM OF THE COMPLEX CYCLIZATION REACTION CATALYZED BY IMIDAZOLE GLYCEROPHOSPHATE SYNTHASE | 2.4.2 4.1.3 4.3.2.10 3.5.1.2 |
1OX5 | TOWARDS UNDERSTANDING THE MECHANISM OF THE COMPLEX CYCLIZATION REACTION CATALYZED BY IMIDAZOLE GLYCEROPHOSPHATE SYNTHASE | 2.4.2 4.1.3 4.3.2.10 3.5.1.2 |
1OX6 | TOWARDS UNDERSTANDING THE MECHANISM OF THE COMPLEX CYCLIZATION REACTION CATALYZED BY IMIDAZOLE GLYCEROPHOSPHATE SYNTHASE | 2.4.2 4.1.3 4.3.2.10 3.5.1.2 |
1OX7 | CRYSTAL STRUCTURE OF YEAST CYTOSINE DEAMINASE APO-ENZYME: INORGANIC ZINC BOUND | 3.5.4.1 |
1OXG | CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN ORGANIC SOLVENT TREATED BOVINE ALPHA-CHYMOTRYPSIN AND ITS AUTOCATALYTICALLY PRODUCED HIGHLY POTENT 14-RESIDUE PEPTIDE AT 2.2 RESOLUTION | 3.4.21.1 |
1OXL | INHIBITION OF PHOSPHOLIPASE A2 (PLA2) BY (2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)-ACETIC ACID (INDOLE): CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PLA2 FROM RUSSELL'S VIPER AND INDOLE AT 1.8 RESOLUTION | 3.1.1.4 |
1OXM | STRUCTURE OF CUTINASE | 3.1.1 3.1.1.74 |
1OXR | ASPIRIN INDUCES ITS ANTI-INFLAMMATORY EFFECTS THROUGH ITS SPECIFIC BINDING TO PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND ASPIRIN AT 1.9A RESOLUTION | 3.1.1.4 |
1OXW | THE CRYSTAL STRUCTURE OF SEMET PATATIN | 3.1.1 |
1OYF | CRYSTAL STRUCTURE OF RUSSELLES VIPER (DABOIA RUSSELLII PULCHELLA) PHOSPHOLIPASE A2 IN A COMPLEX WITH VENOM 6-METHYL HEPTANOL | 3.1.1.4 |
1OYN | CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH (R,S)-ROLIPRAM | 3.1.4.17 3.1.4.53 |
1OYO | REGULATION OF PROTEASE ACTIVITY BY MELANIN: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PROTEINASE K AND MELANIN MONOMERS AT 2.0 RESOLUTION | 3.4.21.64 |
1OYQ | TRYPSIN INHIBITOR COMPLEX | 3.4.21.4 |
1OYT | COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED FLUORINATED INHIBITOR | 3.4.21.5 |
1OYU | LONG-DISTANCE CONFORMATIONAL CHANGES IN A PROTEIN ENGINEERED BY MODULATED SEQUENCE DUPLICATION | 3.2.1.17 |
1OYV | CRYSTAL STRUCTURE OF TOMATO INHIBITOR-II IN A TERNARY COMPLEX WITH SUBTILISIN CARLSBERG | 3.4.21.62 |
1OYW | STRUCTURE OF THE RECQ CATALYTIC CORE | 3.6.1 3.6.4.12 |
1OYY | STRUCTURE OF THE RECQ CATALYTIC CORE BOUND TO ATP-GAMMA-S | 3.6.1 3.6.4.12 |
1OZ0 | CRYSTAL STRUCTURE OF THE HOMODIMERIC BIFUNCTIONAL TRANSFORMYLASE AND CYCLOHYDROLASE ENZYME AVIAN ATIC IN COMPLEX WITH A MULTISUBSTRATE ADDUCT INHIBITOR BETA-DADF. | 2.1.2.3 3.5.4.10 |
1OZ6 | X-RAY STRUCTURE OF ACIDIC PHOSPHOLIPASE A2 FROM INDIAN SAW-SCALED VIPER (ECHIS CARINATUS) WITH A POTENT PLATELET AGGREGATION INHIBITORY ACTIVITY | 3.1.1.4 |
1OZ9 | CRYSTAL STRUCTURE OF AQ_1354, A HYPOTHETICAL PROTEIN FROM AQUIFEX AEOLICUS | 3.1 |
1OZI | THE ALTERNATIVELY SPLICED PDZ2 DOMAIN OF PTP-BL | 3.1.3.48 |
1OZY | CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 (MIPLA3) FROM MICROPECHIS IKAHEKA | 3.1.1.4 |
1P01 | SERINE PROTEASE MECHANISM. STRUCTURE OF AN INHIBITORY COMPLEX OF ALPHA-LYTIC PROTEASE AND A TIGHTLY BOUND PEPTIDE BORONIC ACID | 3.4.21.12 |
1P02 | STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES | 3.4.21.12 |
1P03 | STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES | 3.4.21.12 |
1P04 | STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES | 3.4.21.12 |
1P05 | STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES | 3.4.21.12 |
1P06 | STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES | 3.4.21.12 |
1P09 | STRUCTURAL PLASTICITY AS A DETERMINANT OF ENZYME SPECIFICITY. CREATING BROADLY SPECIFIC PROTEASES | 3.4.21.12 |
1P0I | CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE | 3.1.1.8 |
1P0M | CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE IN COMPLEX WITH A CHOLINE MOLECULE | 3.1.1.8 |
1P0P | CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE IN COMPLEX WITH THE SUBSTRATE ANALOG BUTYRYLTHIOCHOLINE | 3.1.1.8 |
1P0Q | CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE | 3.1.1.8 |
1P10 | STRUCTURAL PLASTICITY AS A DETERMINANT OF ENZYME SPECIFICITY. CREATING BROADLY SPECIFIC PROTEASES | 3.4.21.12 |
1P11 | CRYSTAL STRUCTURES OF ALPHA-LYTIC PROTEASE COMPLEXES WITH IRREVERSIBLY BOUND PHOSPHONATE ESTERS | 3.4.21.12 |
1P12 | CRYSTAL STRUCTURES OF ALPHA-LYTIC PROTEASE COMPLEXES WITH IRREVERSIBLY BOUND PHOSPHONATE ESTERS | 3.4.21.12 |
1P15 | CRYSTAL STRUCTURE OF THE D2 DOMAIN OF RPTPA | 3.1.3.48 |
1P1M | STRUCTURE OF THERMOTOGA MARITIMA AMIDOHYDROLASE TM0936 BOUND TO NI AND METHIONINE | 3.5.4.28 3.5.4.31 |
1P2I | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN | 3.4.21.4 |
1P2J | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN | 3.4.21.4 |
1P2K | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN | 3.4.21.4 |
1P2L | T4 LYSOZYME CORE REPACKING MUTANT V87I/TA | 3.2.1.17 |
1P2M | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN | 3.4.21.1 |
1P2N | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN | 3.4.21.1 |
1P2O | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN | 3.4.21.1 |
1P2P | STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 AT 2.6 ANGSTROMS RESOLUTION AND COMPARISON WITH BOVINE PHOSPHOLIPASE A2 | 3.1.1.4 |
1P2Q | STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN | 3.4.21.1 |
1P2R | T4 LYSOZYME CORE REPACKING MUTANT I78V/TA | 3.2.1.17 |
1P2S | H-RAS 166 IN 50% 2,2,2 TRIFLOUROETHANOL | 3.6.5.2 |
1P2T | H-RAS 166 IN AQUEOUS MOTHER LIQOUR, RT | 3.6.5.2 |
1P2U | H-RAS IN 50% ISOPROPANOL | 3.6.5.2 |
1P36 | T4 LYOSZYME CORE REPACKING MUTANT I100V/TA | 3.2.1.17 |
1P37 | T4 LYSOZYME CORE REPACKING BACK-REVERTANT L102M/CORE10 | 3.2.1.17 |
1P3C | GLUTAMYL ENDOPEPTIDASE FROM BACILLUS INTERMEDIUS | 3.4.21 |
1P3E | STRUCTURE OF GLU ENDOPEPTIDASE IN COMPLEX WITH MPD | 3.4.21 |
1P3N | CORE REDESIGN BACK-REVERTANT I103V/CORE10 | 3.2.1.17 |
1P42 | CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS LPXC DEACETYLASE (ZINC-INHIBITED FORM) | 3.5.1 3.5.1.108 |
1P46 | T4 LYSOZYME CORE REPACKING MUTANT M106I/TA | 3.2.1.17 |
1P49 | STRUCTURE OF HUMAN PLACENTAL ESTRONE/DHEA SULFATASE | 3.1.6.2 |
1P4D | F FACTOR TRAI RELAXASE DOMAIN | 3.6.1 5.6.2.1 3.6.4.12 |
1P4K | CRYSTAL STRUCTURE OF THE GLYCOSYLASPARAGINASE PRECURSOR D151N MUTANT | 3.5.1.26 |
1P4R | CRYSTAL STRUCTURE OF HUMAN ATIC IN COMPLEX WITH FOLATE-BASED INHIBITOR BW1540U88UD | 2.1.2.3 3.5.4.10 |
1P4V | CRYSTAL STRUCTURE OF THE GLYCOSYLASPARAGINASE PRECURSOR D151N MUTANT WITH GLYCINE | 3.5.1.26 |
1P56 | DUPLICATION-EXTENSION OF HELIX A OF T4 LYSOZYME | 3.2.1.17 |
1P57 | EXTRACELLULAR DOMAIN OF HUMAN HEPSIN | 3.4.21 3.4.21.106 |
1P58 | COMPLEX ORGANIZATION OF DENGUE VIRUS MEMBRANE PROTEINS AS REVEALED BY 9.5 ANGSTROM CRYO-EM RECONSTRUCTION | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1P5C | CIRCULAR PERMUTATION OF HELIX A IN T4 LYSOZYME | 3.2.1.17 |
1P5F | CRYSTAL STRUCTURE OF HUMAN DJ-1 | 3.1.2 3.5.1 3.5.1.124 |
1P5X | STRUCTURE OF THE D55N MUTANT OF PHOSPHOLIPASE C FROM BACILLUS CEREUS | 3.1.4.3 |
1P64 | T4 LYSOZYME CORE REPACKING MUTANT L133F/TA | 3.2.1.17 |
1P6B | X-RAY STRUCTURE OF PHOSPHOTRIESTERASE, TRIPLE MUTANT H254G/H257W/L303T | 3.1.8.1 |
1P6C | CRYSTAL STRUCTURE OF PHOSPHOTRIESTERASE TRIPLE MUTANT H254G/H257W/L303T COMPLEXED WITH DIISOPROPYLMETHYLPHOSPHONATE | 3.1.8.1 |
1P6D | STRUCTURE OF THE D55N MUTANT OF PHOSPHOLIPASE C FROM BACILLUS CEREUS IN COMPLEX WITH (3S)-3,4,DI-N-HEXANOYLOXYBUTYL-1-PHOSPHOCHOLINE | 3.1.4.3 |
1P6E | STRUCTURE OF THE D55N MUTANT OF PHOSPHOLIPASE C FROM BACILLUS CEREUS IN COMPLEX WITH 1,2-DI-N-PENTANOYL-SN-GLYCERO-3-DITHIOPHOSPHOCHOLINE | 3.1.4.3 |
1P6O | THE CRYSTAL STRUCTURE OF YEAST CYTOSINE DEAMINASE BOUND TO 4(R)-HYDROXYL-3,4-DIHYDROPYRIMIDINE AT 1.14 ANGSTROMS. | 3.5.4.1 |
1P6T | STRUCTURE CHARACTERIZATION OF THE WATER SOLUBLE REGION OF P-TYPE ATPASE COPA FROM BACILLUS SUBTILIS | 3.6.3.4 7.2.2.8 |
1P6W | CRYSTAL STRUCTURE OF BARLEY ALPHA-AMYLASE ISOZYME 1 (AMY1) IN COMPLEX WITH THE SUBSTRATE ANALOGUE, METHYL 4I,4II,4III-TRI-THIOMALTOTETRAOSIDE (THIO-DP4) | 3.2.1.1 |
1P6Y | T4 LYSOZYME CORE REPACKING MUTANT M120Y/TA | 3.2.1.17 |
1P7D | CRYSTAL STRUCTURE OF THE LAMBDA INTEGRASE (RESIDUES 75-356) BOUND TO DNA | 2.7.7 3.1 |
1P7M | SOLUTION STRUCTURE AND BASE PERTURBATION STUDIES REVEAL A NOVEL MODE OF ALKYLATED BASE RECOGNITION BY 3-METHYLADENINE DNA GLYCOSYLASE I | 3.2.2.20 |
1P7N | DIMERIC ROUS SARCOMA VIRUS CAPSID PROTEIN STRUCTURE WITH AN UPSTREAM 25-AMINO ACID RESIDUE EXTENSION OF C-TERMINAL OF GAG P10 PROTEIN | 3.4.23 |
1P7O | CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 (MIPLA4) FROM MICROPECHIS IKAHEKA | 3.1.1.4 |
1P7S | T4 LYSOZYME CORE REPACKING MUTANT V103I/TA | 3.2.1.17 |
1P7V | STRUCTURE OF A COMPLEX FORMED BETWEEN PROTEINASE K AND A DESIGNED HEPTAPEPTIDE INHIBITOR PRO-ALA-PRO-PHE-ALA-ALA-ALA AT ATOMIC RESOLUTION | 3.4.21.64 |
1P7W | CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEINASE K WITH A DESIGNED HEPTAPEPTIDE INHIBITOR PRO-ALA-PRO-PHE-ALA-SER-ALA AT ATOMIC RESOLUTION | 3.4.21.64 |
1P8A | SOLUTION STRUCTURE OF THE LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE FROM TRITRICHOMONAS FOETUS | 3.1.3.48 3.1.3.2 |
1P8M | STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. | 3.5.3.1 |
1P8N | STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. | 3.5.3.1 |
1P8O | STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. | 3.5.3.1 |
1P8P | STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. | 3.5.3.1 |
1P8Q | STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR CLUSTER OF ARGINASE I. | 3.5.3.1 |
1P8R | STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. | 3.5.3.1 |
1P8S | STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. | 3.5.3.1 |
1P9E | CRYSTAL STRUCTURE ANALYSIS OF METHYL PARATHION HYDROLASE FROM PSEUDOMONAS SP WBC-3 | 3.1.8.1 |
1P9S | CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS | 3.4.24 3.4.19.12 3.4.22 |
1P9U | CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS | 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
1PA0 | CRYSTAL STRUCTURE OF BNSP-7, A LYS49-PHOSPHOLIPASE A2 | 3.1.1.4 |
1PA1 | CRYSTAL STRUCTURE OF THE C215D MUTANT OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
1PA9 | YERSINIA PROTEIN-TYROSINE PHOSPHATASE COMPLEXED WITH PNCS (YOP51,PASTEURELLA X,PTPASE,YOP51DELTA162) (CATALYTIC DOMAIN, RESIDUES 163-468) MUTANT WITH CYS 235 REPLACED BY ARG (C235R) | 3.1.3.48 |
1PAD | BINDING OF CHLOROMETHYL KETONE SUBSTRATE ANALOGUES TO CRYSTALLINE PAPAIN | 3.4.22.2 |
1PAF | THE 2.5 ANGSTROMS STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN | 3.2.2.22 |
1PAG | THE 2.5 ANGSTROMS STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN | 3.2.2.22 |
1PAU | CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE ALDEHYDE INHIBITOR AC-DEVD-CHO | 3.4.22 3.4.22.56 |
1PB0 | YCDX PROTEIN IN AUTOINHIBITED STATE | 3.1.3 |
1PBA | THE NMR STRUCTURE OF THE ACTIVATION DOMAIN ISOLATED FROM PORCINE PROCARBOXYPEPTIDASE B | 3.4.17.2 |
1PBG | THE THREE-DIMENSIONAL STRUCTURE OF 6-PHOSPHO-BETA GALACTOSIDASE FROM LACTOCOCCUS LACTIS | 3.2.1.85 |
1PBH | CRYSTAL STRUCTURE OF HUMAN RECOMBINANT PROCATHEPSIN B AT 3.2 ANGSTROM RESOLUTION | 3.4.22.1 |
1PBT | THE CRYSTAL STRUCTURE OF TM1154, OXIDOREDUCTASE, SOL/DEVB FAMILY FROM THERMOTOGA MARITIMA | 3.1.1.31 |
1PC0 | NMR STRUCTURE OF THE ARCHAEAL HOMOLOGUE OF RNASE P PROTEIN RPP29 | 3.1.26.5 |
1PC8 | CRYSTAL STRUCTURE OF A NOVEL FORM OF MISTLETOE LECTIN FROM HIMALAYAN VISCUM ALBUM L. AT 3.8A RESOLUTION | 3.2.2.22 |
1PC9 | CRYSTAL STRUCTURE OF BNSP-6, A LYS49-PHOSPHOLIPASE A2 | 3.1.1.4 |
1PCA | THREE DIMENSIONAL STRUCTURE OF PORCINE PANCREATIC PROCARBOXYPEPTIDASE A. A COMPARISON OF THE A AND B ZYMOGENS AND THEIR DETERMINANTS FOR INHIBITION AND ACTIVATION | 3.4.17.1 |
1PCI | PROCARICAIN | 3.4.22.6 3.4.22.30 |
1PDV | CRYSTAL STRUCTURE OF HUMAN DJ-1, P 31 2 1 SPACE GROUP | 3.1.2 3.5.1 3.5.1.124 |
1PDW | CRYSTAL STRUCTURE OF HUMAN DJ-1, P 1 21 1 SPACE GROUP | 3.1.2 3.5.1 3.5.1.124 |
1PE0 | CRYSTAL STRUCTURE OF THE K130R MUTANT OF HUMAN DJ-1 | 3.1.2 3.5.1 3.5.1.124 |
1PE5 | THERMOLYSIN WITH TRICYCLIC INHIBITOR | 3.4.24.27 |
1PE6 | REFINED X-RAY STRUCTURE OF PAPAIN(DOT)E-64-C COMPLEX AT 2.1-ANGSTROMS RESOLUTION | 3.4.22.2 |
1PE7 | THERMOLYSIN WITH BICYCLIC INHIBITOR | 3.4.24.27 |
1PE8 | THERMOLYSIN WITH MONOCYCLIC INHIBITOR | 3.4.24.27 |
1PEX | COLLAGENASE-3 (MMP-13) C-TERMINAL HEMOPEXIN-LIKE DOMAIN | 3.4.24 |
1PFG | STRATEGY TO DESIGN INHIBITORS: STRUCTURE OF A COMPLEX OF PROTEINASE K WITH A DESIGNED OCTAPEPTIDE INHIBITOR N-AC-PRO-ALA-PRO-PHE-DALA-ALA-ALA-ALA-NH2 AT 2.5A RESOLUTION | 3.4.21.64 |
1PFQ | CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV / CD26 | 3.4.14.5 |
1PFX | PORCINE FACTOR IXA | 3.4.21.22 |
1PFZ | PROPLASMEPSIN II FROM PLASMODIUM FALCIPARUM | 3.4.23.39 |
1PGS | THE THREE-DIMENSIONAL STRUCTURE OF PNGASE F, A GLYCOSYLASPARAGINASE FROM FLAVOBACTERIUM MENINGOSEPTICUM | 3.5.1.52 |
1PH0 | NON-CARBOXYLIC ACID-CONTAINING INHIBITOR OF PTP1B TARGETING THE SECOND PHOSPHOTYROSINE SITE | 3.1.3.48 |
1PHR | THE CRYSTAL STRUCTURE OF A LOW MOLECULAR PHOSPHOTYROSINE PROTEIN PHOSPHATASE | 3.1.3.48 3.1.3.2 |
1PI4 | STRUCTURE OF N289A MUTANT OF AMPC IN COMPLEX WITH SM3, A PHENYLGLYCLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN | 3.5.2.6 |
1PI5 | STRUCTURE OF N289A MUTANT OF AMPC IN COMPLEX WITH SM2, CARBOXYPHENYLGLYCYLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN | 3.5.2.6 |
1PIF | PIG ALPHA-AMYLASE | 3.2.1.1 |
1PIG | PIG PANCREATIC ALPHA-AMYLASE COMPLEXED WITH THE OLIGOSACCHARIDE V-1532 | 3.2.1.1 |
1PIO | AN ENGINEERED STAPHYLOCOCCUS AUREUS PC1 BETA-LACTAMASE THAT HYDROLYSES THIRD GENERATION CEPHALOSPORINS | 3.5.2.6 |
1PIP | CRYSTAL STRUCTURE OF PAPAIN-SUCCINYL-GLN-VAL-VAL-ALA-ALA-P-NITROANILIDE COMPLEX AT 1.7 ANGSTROMS RESOLUTION: NONCOVALENT BINDING MODE OF A COMMON SEQUENCE OF ENDOGENOUS THIOL PROTEASE INHIBITORS | 3.4.22.2 |
1PIR | SOLUTION STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 | 3.1.1.4 |
1PIS | SOLUTION STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 | 3.1.1.4 |
1PJ8 | STRUCTURE OF A TERNARY COMPLEX OF PROTEINASE K, MERCURY AND A SUBSTRATE-ANALOGUE HEXAPEPTIDE AT 2.2 A RESOLUTION | 3.4.21.64 |
1PJA | THE CRYSTAL STRUCTURE OF PALMITOYL PROTEIN THIOESTERASE-2 REVEALS THE BASIS FOR DIVERGENT SUBSTRATE SPECIFICITIES OF THE TWO LYSOSOMAL THIOESTERASES (PPT1 AND PPT2) | 3.1.2.22 3.1.2 |
1PJI | CRYSTAL STRUCTURE OF WILD TYPE LACTOCOCCUS LACTIS FPG COMPLEXED TO A 1,3 PROPANEDIOL CONTAINING DNA | 3.2.2.23 4.2.99.18 |
1PJJ | COMPLEX BETWEEN THE LACTOCOCCUS LACTIS FPG AND AN ABASIC SITE CONTAINING DNA. | 3.2.2.23 4.2.99.18 |
1PJP | THE 2.2 A CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH SUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE | 3.4.21.39 |
1PJR | STRUCTURE OF DNA HELICASE | 3.6.4.12 |
1PJW | SOLUTION STRUCTURE OF THE DOMAIN III OF THE JAPAN ENCEPHALITIS VIRUS ENVELOPE PROTEIN | 3.4.21.91 3.6.1.15 3.6.4.13 |
1PJX | 0.85 ANGSTROM STRUCTURE OF SQUID GANGLION DFPASE | 3.1.8.2 |
1PK2 | SOLUTION STRUCTURE OF THE TISSUE-TYPE PLASMINOGEN ACTIVATOR KRINGLE 2 DOMAIN COMPLEXED TO 6-AMINOHEXANOIC ACID AN ANTIFIBRINOLYTIC DRUG | 3.4.21.68 |
1PK4 | CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN PLASMINOGEN KRINGLE 4 REFINED AT 1.9-ANGSTROMS RESOLUTION | 3.4.21.7 |
1PKH | STRUCTURAL BASIS FOR RECOGNITION AND CATALYSIS BY THE BIFUNCTIONAL DCTP DEAMINASE AND DUTPASE FROM METHANOCOCCUS JANNASCHII | 3.5.4.13 3.6.1.23 3.5.4.30 |
1PKJ | STRUCTURAL BASIS FOR RECOGNITION AND CATALYSIS BY THE BIFUNCTIONAL DCTP DEAMINASE AND DUTPASE FROM METHANOCOCCUS JANNASCHII | 3.5.4.13 3.6.1.23 3.5.4.30 |
1PKK | STRUCTURAL BASIS FOR RECOGNITION AND CATALYSIS BY THE BIFUNCTIONAL DCTP DEAMINASE AND DUTPASE FROM METHANOCOCCUS JANNASCHII | 3.5.4.13 3.6.1.23 3.5.4.30 |
1PKR | THE STRUCTURE OF RECOMBINANT PLASMINOGEN KRINGLE 1 AND THE FIBRIN BINDING SITE | 3.4.21.7 |
1PKX | CRYSTAL STRUCTURE OF HUMAN ATIC IN COMPLEX WITH XMP | 2.1.2.3 3.5.4.10 |
1PL0 | CRYSTAL STRUCTURE OF HUMAN ATIC IN COMPLEX WITH FOLATE-BASED INHIBITOR, BW2315U89UC | 2.1.2.3 3.5.4.10 |
1PLJ | CRYSTALLOGRAPHIC STUDIES ON P21H-RAS USING SYNCHROTRON LAUE METHOD: IMPROVEMENT OF CRYSTAL QUALITY AND MONITORING OF THE GTPASE REACTION AT DIFFERENT TIME POINTS | 3.6.5.2 |
1PLK | CRYSTALLOGRAPHIC STUDIES ON P21H-RAS USING SYNCHROTRON LAUE METHOD: IMPROVEMENT OF CRYSTAL QUALITY AND MONITORING OF THE GTPASE REACTION AT DIFFERENT TIME POINTS | 3.6.5.2 |
1PLL | CRYSTALLOGRAPHIC STUDIES ON P21H-RAS USING SYNCHROTRON LAUE METHOD: IMPROVEMENT OF CRYSTAL QUALITY AND MONITORING OF THE GTPASE REACTION AT DIFFERENT TIME POINTS | 3.6.5.2 |
1PM5 | CRYSTAL STRUCTURE OF WILD TYPE LACTOCOCCUS LACTIS FPG COMPLEXED TO A TETRAHYDROFURAN CONTAINING DNA | 3.2.2.23 4.2.99.18 |
1PMH | CRYSTAL STRUCTURE OF CALDICELLULOSIRUPTOR SACCHAROLYTICUS CBM27-1 IN COMPLEX WITH MANNOHEXAOSE | 3.2.1.78 |
1PMJ | CRYSTAL STRUCTURE OF CALDICELLULOSIRUPTOR SACCHAROLYTICUS CBM27-1 | 3.2.1.78 |
1PMK | KRINGLE-KRINGLE INTERACTIONS IN MULTIMER KRINGLE STRUCTURES | 3.4.21.7 |
1PML | KRINGLE-KRINGLE INTERACTIONS IN MULTIMER KRINGLE STRUCTURES | 3.4.21.68 |
1PNF | PNGASE F COMPLEX WITH DI-N-ACETYLCHITOBIOSE | 3.5.1.52 |
1PNG | CRYSTAL STRUCTURE OF PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSAMINYL) ASPARAGINE AMIDASE AT 2.2 ANGSTROMS RESOLUTION | 3.5.1.52 |
1PNK | PENICILLIN ACYLASE HAS A SINGLE-AMINO-ACID CATALYTIC CENTRE | 3.5.1.11 |
1PNL | PENICILLIN ACYLASE HAS A SINGLE-AMINO-ACID CATALYTIC CENTRE | 3.5.1.11 |
1PNM | PENICILLIN ACYLASE HAS A SINGLE-AMINO-ACID CATALYTIC CENTRE | 3.5.1.11 |
1PNT | CRYSTAL STRUCTURE OF BOVINE HEART PHOSPHOTYROSYL PHOSPHATASE AT 2.2 ANGSTROMS RESOLUTION | 3.1.3.2 3.1.3.48 |
1PO8 | CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN KRAIT VENOM PHOSPHOLIPASE A2 AND HEPTANOIC ACID AT 2.7 A RESOLUTION. | 3.1.1.4 |
1PO9 | CRYTSAL STRUCTURE OF ISOASPARTYL DIPEPTIDASE | 3.4.19 |
1POA | INTERFACIAL CATALYSIS: THE MECHANISM OF PHOSPHOLIPASE A2 | 3.1.1.4 |
1POB | CRYSTAL STRUCTURE OF COBRA-VENOM PHOSPHOLIPASE A2 IN A COMPLEX WITH A TRANSITION-STATE ANALOGUE | 3.1.1.4 |
1POC | CRYSTAL STRUCTURE OF BEE-VENOM PHOSPHOLIPASE A2 IN A COMPLEX WITH A TRANSITION-STATE ANALOGUE | 3.1.1.4 |
1POD | STRUCTURES OF FREE AND INHIBITED HUMAN SECRETORY PHOSPHOLIPASE A2 FROM INFLAMMATORY EXUDATE | 3.1.1.4 |
1POE | STRUCTURES OF FREE AND INHIBITED HUMAN SECRETORY PHOSPHOLIPASE A2 FROM INFLAMMATORY EXUDATE | 3.1.1.4 |
1POJ | ISOASPARTYL DIPEPTIDASE WITH BOUND INHIBITOR | 3.4.19 |
1POK | CRYSTAL STRUCTURE OF ISOASPARTYL DIPEPTIDASE | 3.4.19 |
1POO | THERMOSTABLE PHYTASE FROM BACILLUS SP | 3.1.3.8 |
1POP | X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A PAPAIN-LEUPEPTIN COMPLEX | 3.4.22.2 |
1POV | ROLE AND MECHANISM OF THE MATURATION CLEAVAGE OF VP0 IN POLIOVIRUS ASSEMBLY: STRUCTURE OF THE EMPTY CAPSID ASSEMBLY INTERMEDIATE AT 2.9 ANGSTROMS RESOLUTION | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1PP2 | THE REFINED CRYSTAL STRUCTURE OF DIMERIC PHOSPHOLIPASE A2 AT 2.5 ANGSTROMS. ACCESS TO A SHIELDED CATALYTIC CENTER | 3.1.1.4 |
1PP4 | THE CRYSTAL STRUCTURE OF RHAMNOGALACTURONAN ACETYLESTERASE IN SPACE GROUP P3121 | 3.1.1 3.1.1.86 |
1PPA | THE CRYSTAL STRUCTURE OF A LYSINE 49 PHOSPHOLIPASE A2 FROM THE VENOM OF THE COTTONMOUTH SNAKE AT 2.0 ANGSTROMS RESOLUTION | 3.1.1.4 |
1PPB | THE REFINED 1.9 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN: INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT | 3.4.21.5 |
1PPC | GEOMETRY OF BINDING OF THE BENZAMIDINE-AND ARGININE-BASED INHIBITORS N-ALPHA-(2-NAPHTHYL-SULPHONYL-GLYCYL)-DL-P-AMIDINOPHENYLALANYL-PIPERIDINE (NAPAP) AND (2R,4R)-4-METHYL-1-[N-ALPHA-(3-METHYL-1,2,3,4-TETRAHYDRO-8-QUINOLINESULPHONYL)-L-ARGINYL]-2-PIPERIDINE CARBOXYLIC ACID (MQPA) TO HUMAN ALPHA-THROMBIN: X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE NAPAP-TRYPSIN COMPLEX AND MODELING OF NAPAP-THROMBIN AND MQPA-THROMBIN | 3.4.21.4 |
1PPD | RESTRAINED LEAST-SQUARES REFINEMENT OF THE SULFHYDRYL PROTEASE PAPAIN TO 2.0 ANGSTROMS | 3.4.22.2 |
1PPE | THE REFINED 2.0 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA-TRYPSIN AND CMTI-I, A TRYPSIN INHIBITOR FROM SQUASH SEEDS (CUCURBITA MAXIMA): TOPOLOGICAL SIMILARITY OF THE SQUASH SEED INHIBITORS WITH THE CARBOXYPEPTIDASE A INHIBITOR FROM POTATOES | 3.4.21.4 |
1PPF | X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR | 3.4.21.37 |
1PPG | THE REFINED 2.3 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ELASTASE IN A COMPLEX WITH A VALINE CHLOROMETHYL KETONE INHIBITOR | 3.4.21.37 |
1PPH | GEOMETRY OF BINDING OF THE NALPHA-TOSYLATED PIPERIDIDES OF M-AMIDINO-, P-AMIDINO-AND P-GUANIDINO PHENYLALANINE TO THROMBIN AND TRYPSIN: X-RAY CRYSTAL STRUCTURES OF THEIR TRYPSIN COMPLEXES AND MODELING OF THEIR THROMBIN COMPLEXES | 3.4.21.4 |
1PPI | THE ACTIVE CENTER OF A MAMMALIAN ALPHA-AMYLASE. THE STRUCTURE OF THE COMPLEX OF A PANCREATIC ALPHA-AMYLASE WITH A CARBOHYDRATE INHIBITOR REFINED TO 2.2 ANGSTROMS RESOLUTION | 3.2.1.1 |
1PPK | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHOROUS-CONTAINING PEPTIDE ANALOGUES | 3.4.23.20 |
1PPL | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES | 3.4.23.20 |
1PPM | CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES | 3.4.23.20 |
1PPN | STRUCTURE OF MONOCLINIC PAPAIN AT 1.60 ANGSTROMS RESOLUTION | 3.4.22.2 |
1PPO | DETERMINATION OF THE STRUCTURE OF PAPAYA PROTEASE OMEGA | 3.4.22.30 |
1PPP | CRYSTAL STRUCTURE OF PAPAIN-E64-C COMPLEX. BINDING DIVERSITY OF E64-C TO PAPAIN S2 AND S3 SUBSITES | 3.4.22.2 |
1PPX | SOLUTION STRUCTURE OF THE MUTT PYROPHOSPHOHYDROLASE COMPLEXED WITH MG(2+) AND 8-OXO-DGMP, A TIGHTLY-BOUND PRODUCT | 3.6.1 3.6.1.55 |
1PPZ | TRYPSIN COMPLEXES AT ATOMIC AND ULTRA-HIGH RESOLUTION | 3.4.21.4 |
1PQ3 | HUMAN ARGINASE II: CRYSTAL STRUCTURE AND PHYSIOLOGICAL ROLE IN MALE AND FEMALE SEXUAL AROUSAL | 3.5.3.1 |
1PQ5 | TRYPSIN AT PH 5, 0.85 A | 3.4.21.4 |
1PQ7 | TRYPSIN AT 0.8 A, PH5 / BORAX | 3.4.21.4 |
1PQ8 | TRYPSIN AT PH 4 AT ATOMIC RESOLUTION | 3.4.21.4 |
1PQA | TRYPSIN WITH PMSF AT ATOMIC RESOLUTION | 3.4.21.4 |
1PQD | T4 LYSOZYME CORE REPACKING MUTANT CORE10/TA | 3.2.1.17 |
1PQI | T4 LYSOZYME CORE REPACKING MUTANT I118L/CORE7/TA | 3.2.1.17 |
1PQJ | T4 LYSOZYME CORE REPACKING MUTANT A111V/CORE10/TA | 3.2.1.17 |
1PQK | REPACKING OF THE CORE OF T4 LYSOZYME BY AUTOMATED DESIGN | 3.2.1.17 |
1PQM | T4 LYSOZYME CORE REPACKING MUTANT V149I/T152V/TA | 3.2.1.17 |
1PQO | T4 LYSOZYME CORE REPACKING MUTANT L118I/TA | 3.2.1.17 |
1PRO | HIV-1 PROTEASE DIMER COMPLEXED WITH A-98881 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1PRX | HORF6 A NOVEL HUMAN PEROXIDASE ENZYME | 1.11.1.27 3.1.1.4 2.3.1.23 |
1PS3 | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH KIFUNENSINE | 3.2.1.114 |
1PS5 | STRUCTURE OF THE MONOCLINIC C2 FORM OF HEN EGG-WHITE LYSOZYME AT 2.0 ANGSTROMS RESOLUTION | 3.2.1.17 |
1PSA | STRUCTURE OF A PEPSIN(SLASH)RENIN INHIBITOR COMPLEX REVEALS A NOVEL CRYSTAL PACKING INDUCED BY MINOR CHEMICAL ALTERATIONS IN THE INHIBITOR | 3.4.23.1 |
1PSC | PHOSPHOTRIESTERASE FROM PSEUDOMONAS DIMINUTA | 3.1.8.1 |
1PSH | CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 FROM INDIAN COBRA REVEALS A TRIMERIC ASSOCIATION | 3.1.1.4 |
1PSJ | ACIDIC PHOSPHOLIPASE A2 FROM AGKISTRODON HALYS PALLAS | 3.1.1.4 |
1PSN | THE CRYSTAL STRUCTURE OF HUMAN PEPSIN AND ITS COMPLEX WITH PEPSTATIN | 3.4.23.1 |
1PSO | THE CRYSTAL STRUCTURE OF HUMAN PEPSIN AND ITS COMPLEX WITH PEPSTATIN | 3.4.23.1 |
1PSU | STRUCTURE OF THE E. COLI PAAI PROTEIN FROM THE PHYENYLACETIC ACID DEGRADATION OPERON | 3.1.2 |
1PT3 | CRYSTAL STRUCTURES OF NUCLEASE-COLE7 COMPLEXED WITH OCTAMER DNA | 3.1 |
1PTA | THREE-DIMENSIONAL STRUCTURE OF PHOSPHOTRIESTERASE: AN ENZYME CAPABLE OF DETOXIFYING ORGANOPHOSPHATE NERVE AGENTS | 3.5 3.1.8.1 |
1PTD | PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C | 3.1.4.10 4.6.1.13 |
1PTG | PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C IN COMPLEX WITH MYO-INOSITOL | 3.1.4.10 4.6.1.13 |
1PTK | STUDIES ON THE INHIBITORY ACTION OF MERCURY UPON PROTEINASE K | 3.4.21.64 |
1PTT | CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE-CONTAINING TETRA-PEPTIDE (AC-DEPYL-NH2) | 3.1.3.48 |
1PTU | CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE-CONTAINING HEXA-PEPTIDE (DADEPYL-NH2) | 3.1.3.48 |
1PTV | CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE | 3.1.3.48 |
1PTW | THE CRYSTAL STRUCTURE OF AMP-BOUND PDE4 SUGGESTS A MECHANISM FOR PHOSPHODIESTERASE CATALYSIS | 3.1.4.17 3.1.4.53 |
1PTY | CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH TWO PHOSPHOTYROSINE MOLECULES | 3.1.3.48 |
1PU3 | THE SOLUTION NMR STRUCTURE AND DYNAMICS OF A RECOMBINANT ONCONASE WITH ALTERED N-TERMINAL AND MET23 RESIDUES | 3.1.27 |
1PUM | MISTLETOE LECTIN I IN COMPLEX WITH GALACTOSE | 3.2.2.22 |
1PUN | SOLUTION STRUCTURE OF THE MUTT PYROPHOSPHOHYDROLASE COMPLEXED WITH MG(2+) AND 8-OXO-DGMP, A TIGHTLY-BOUND PRODUCT | 3.6.1 3.6.1.55 |
1PUQ | SOLUTION STRUCTURE OF THE MUTT PYROPHOSPHOHYDROLASE COMPLEXED WITH MG(2+) AND 8-OXO-DGMP, A TIGHTLY-BOUND PRODUCT | 3.6.1 3.6.1.55 |
1PUS | SOLUTION STRUCTURE OF THE MUTT PYROPHOSPHOHYDROLASE COMPLEXED WITH MG(2+) AND 8-OXO-DGMP, A TIGHTLY-BOUND PRODUCT | 3.6.1 3.6.1.55 |
1PUU | MISTLETOE LECTIN I IN COMPLEX WITH LACTOSE | 3.2.2.22 |
1PV1 | CRYSTAL STRUCTURE ANALYSIS OF YEAST HYPOTHETICAL PROTEIN: YJG8_YEAST | 3.1.1 3.1.2.12 |
1PV2 | NATIVE FORM 2 E.COLI CHAPERONE HSP31 | 3.1.2 3.5.1 3.5.1.124 4.2.1.130 |
1PV9 | PROLIDASE FROM PYROCOCCUS FURIOSUS | 3.4.13.9 |
1PVI | STRUCTURE OF PVUII ENDONUCLEASE WITH COGNATE DNA | 3.1.21.4 |
1PVJ | CRYSTAL STRUCTURE OF THE STREPTOCOCCAL PYROGENIC EXOTOXIN B (SPEB)- INHIBITOR COMPLEX | 3.4.22.10 |
1PVS | 3-METHYLADENINE GLCOSYLASE II(ALKA) HYPOXANTHINE COMPLEX | 3.2.2.21 |
1PVU | THE CRYSTAL STRUCTURE OF PVUII ENDONUCLEASE REVEALS EXTENSIVE STRUCTURAL HOMOLOGIES TO ECORV | 3.1.21.4 |
1PVX | DO-1,4-BETA-XYLANASE, ROOM TEMPERATURE, PH 4.5 | 3.2.1.8 |
1PW1 | NON-COVALENT COMPLEX OF STREPTOMYCES R61 DD-PEPTIDASE WITH A HIGHLY SPECIFIC PENICILLIN | 3.4.16.4 |
1PW8 | COVALENT ACYL ENZYME COMPLEX OF THE R61 DD-PEPTIDASE WITH A HIGHLY SPECIFIC CEPHALOSPORIN | 3.4.16.4 |
1PWC | PENICILLOYL ACYL ENZYME COMPLEX OF THE STREPTOMYCES R61 DD-PEPTIDASE WITH PENICILLIN G | 3.4.16.4 |
1PWD | COVALENT ACYL ENZYME COMPLEX OF THE STREPTOMYCES R61 DD-PEPTIDASE WITH CEPHALOSPORIN C | 3.4.16.4 |
1PWG | COVALENT PENICILLOYL ACYL ENZYME COMPLEX OF THE STREPTOMYCES R61 DD-PEPTIDASE WITH A HIGHLY SPECIFIC PENICILLIN | 3.4.16.4 |
1PWO | CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 (MIPLA2) FROM MICROPECHIS IKAHEKA | 3.1.1.4 |
1PWP | CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR COMPLEXED WITH SMALL MOLECULE INHIBITOR NSC 12155 | 3.4.24.83 |
1PWQ | CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH THIOACETYL-TYR-PRO-MET-AMIDE, A METAL-CHELATING PEPTIDYL SMALL MOLECULE INHIBITOR | 3.4.24.83 |
1PWU | CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH (3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP-METHYLAMIDE), A KNOWN SMALL MOLECULE INHIBITOR OF MATRIX METALLOPROTEASES. | 3.4.24 3.4.24.83 |
1PWV | CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR WILD-TYPE PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE. | 3.4.24 3.4.24.83 |
1PWW | CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR ACTIVE SITE MUTANT PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE IN THE PRESENCE OF ZINC. | 3.4.24 3.4.24.83 |
1PX8 | CRYSTAL STRUCTURE OF BETA-D-XYLOSIDASE FROM THERMOANAEROBACTERIUM SACCHAROLYTICUM, A FAMILY 39 GLYCOSIDE HYDROLASE | 3.2.1.37 |
1PXH | CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B WITH POTENT AND SELECTIVE BIDENTATE INHIBITOR COMPOUND 2 | 3.1.3.48 |
1PXV | THE STAPHOSTATIN-STAPHOPAIN COMPLEX: A FORWARD BINDING INHIBITOR IN COMPLEX WITH ITS TARGET CYSTEINE PROTEASE | 3.4.22 |
1PYN | DUAL-SITE POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR USING A LINKED FRAGMENT STRATEGY AND A MALONATE HEAD ON THE FIRST SITE | 3.1.3.48 |
1PYO | CRYSTAL STRUCTURE OF HUMAN CASPASE-2 IN COMPLEX WITH ACETYL-LEU-ASP-GLU-SER-ASP-CHO | 3.4.22 3.4.22.55 |
1PYP | X-RAY DIFFRACTION STUDY OF INORGANIC PYROPHOSPHATASE FROM BAKER,S YEAST AT THE 3 ANGSTROMS RESOLUTION (RUSSIAN) | 3.6.1.1 |
1PYT | TERNARY COMPLEX OF PROCARBOXYPEPTIDASE A, PROPROTEINASE E, AND CHYMOTRYPSINOGEN C | 3.4.17.1 |
1PYV | NMR SOLUTION STRUCTURE OF THE MITOCHONDRIAL F1B PRESEQUENCE PEPTIDE FROM NICOTIANA PLUMBAGINIFOLIA | 3.6.3.14 7.1.2.2 |
1PZ2 | CRYSTAL STRUCTURE OF A TRANSIENT COVALENT REACTION INTERMEDIATE OF A FAMILY 51 ALPHA-L-ARABINOFURANOSIDASE | 3.2.1.55 |
1PZ3 | CRYSTAL STRUCTURE OF A FAMILY 51 (GH51) ALPHA-L-ARABINOFURANOSIDASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 | 3.2.1.55 |
1PZO | TEM-1 BETA-LACTAMASE IN COMPLEX WITH A NOVEL, CORE-DISRUPTING, ALLOSTERIC INHIBITOR | 3.5.2.6 |
1PZP | TEM-1 BETA-LACTAMASE IN COMPLEX WITH A NOVEL, CORE-DISRUPTING, ALLOSTERIC INHIBITOR | 3.5.2.6 |
1Q0P | A DOMAIN OF FACTOR B | 3.4.21.47 |
1Q0R | CRYSTAL STRUCTURE OF ACLACINOMYCIN METHYLESTERASE (RDMC) WITH BOUND PRODUCT ANALOGUE, 10-DECARBOXYMETHYLACLACINOMYCIN T (DCMAT) | 3.1.1.95 |
1Q0Z | CRYSTAL STRUCTURE OF ACLACINOMYCIN METHYLESTERASE (RDMC) WITH BOUND PRODUCT ANALOGUE, 10-DECARBOXYMETHYLACLACINOMYCIN A (DCMA) | 3.1.1.95 |
1Q1M | A HIGHLY EFFICIENT APPROACH TO A SELECTIVE AND CELL ACTIVE PTP1B INHIBITORS | 3.1.3.48 |
1Q1Y | CRYSTAL STRUCTURES OF PEPTIDE DEFORMYLASE FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH ACTINONIN | 3.5.1.88 |
1Q21 | CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF THE CATALYTIC DOMAINS OF NORMAL RAS PROTEIN AND AN ONCOGENIC MUTANT COMPLEXED WITH GSP | 3.6.5.2 |
1Q27 | NMR SOLUTION STRUCTURE OF DR0079: AN HYPOTHETICAL NUDIX PROTEIN FROM D. RADIODURANS | 3.6.1 |
1Q2B | CELLOBIOHYDROLASE CEL7A WITH DISULPHIDE BRIDGE ADDED ACROSS EXO-LOOP BY MUTATIONS D241C AND D249C | 3.2.1.91 |
1Q2E | CELLOBIOHYDROLASE CEL7A WITH LOOP DELETION 245-252 AND BOUND NON-HYDROLYSABLE CELLOTETRAOSE | 3.2.1.91 |
1Q2L | CRYSTAL STRUCTURE OF PITRILYSIN | 3.4.24.55 |
1Q2P | SHV-1 CLASS A BETA-LACTAMASE COMPLEXED WITH PENEM WAY185229 | 3.5.2.6 |
1Q2Q | ENTEROBACTER CLOACAE GC1 CLASS C BETA-LACTAMASE COMPLEXED WITH PENEM WAY185229 | 3.5.2.6 |
1Q2U | CRYSTAL STRUCTURE OF DJ-1/RS AND IMPLICATION ON FAMILIAL PARKINSON'S DISEASE | 3.1.2 3.5.1 3.5.1.124 |
1Q2V | CRYSTAL STRUCTURE OF THE CHAPERONIN FROM THERMOCOCCUS STRAIN KS-1 (NUCLEOTIDE-FREE FORM) | 3.6.4.9 |
1Q2W | X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS MAIN PROTEASE | 3.4.22 3.4.19.12 3.4.22.69 |
1Q2Z | THE 3D SOLUTION STRUCTURE OF THE C-TERMINAL REGION OF KU86 | 3.6.4 |
1Q31 | CRYSTAL STRUCTURE OF THE TOBACCO ETCH VIRUS PROTEASE C151A MUTANT | 3.4.22.44 3.4 3.4.22.45 3.6.4 2.7.7.48 |
1Q33 | CRYSTAL STRUCTURE OF HUMAN ADP-RIBOSE PYROPHOSPHATASE NUDT9 | 3.6.1.13 |
1Q39 | CRYSTAL STRUCTURE OF THE DNA REPAIR ENZYME ENDONUCLEASE-VIII (NEI) FROM E. COLI: THE WT ENZYME AT 2.8 RESOLUTION. | 3.2.2 4.2.99.18 |
1Q3A | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 10 | 3.4.24.22 |
1Q3B | CRYSTAL STRUCTURE OF THE DNA REPAIR ENZYME ENDONUCLEASE-VIII (NEI) FROM E. COLI: THE R252A MUTANT AT 2.05 RESOLUTION. | 3.2.2 4.2.99.18 |
1Q3C | CRYSTAL STRUCTURE OF THE DNA REPAIR ENZYME ENDONUCLEASE-VIII (NEI) FROM E. COLI: THE E2A MUTANT AT 2.3 RESOLUTION. | 3.2.2 4.2.99.18 |
1Q3F | URACIL DNA GLYCOSYLASE BOUND TO A CATIONIC 1-AZA-2'-DEOXYRIBOSE-CONTAINING DNA | 3.2.2 3.2.2.27 |
1Q3I | CRYSTAL STRUCTURE OF NA,K-ATPASE N-DOMAIN | 3.6.3.9 7.2.2.13 |
1Q3K | CRYSTAL STRUCTURE OF CREATININE AMIDOHYDROLASE (CREATININASE) | 3.5.2.10 |
1Q3Q | CRYSTAL STRUCTURE OF THE CHAPERONIN FROM THERMOCOCCUS STRAIN KS-1 (TWO-POINT MUTANT COMPLEXED WITH AMP-PNP) | 3.6.4.9 |
1Q3R | CRYSTAL STRUCTURE OF THE CHAPERONIN FROM THERMOCOCCUS STRAIN KS-1 (NUCLEOTIDE-FREE FORM OF SINGLE MUTANT) | 3.6.4.9 |
1Q3X | CRYSTAL STRUCTURE OF THE CATALYTIC REGION OF HUMAN MASP-2 | 3.4.21 3.4.21.104 |
1Q4N | STRUCTURAL STUDIES OF PHE256TRP OF HUMAN SALIVARY ALPHA-AMYLASE: IMPLICATIONS FOR THE ROLE OF A CONSERVED WATER MOLECULE AND ITS ASSOCIATED CHAIN IN ENZYME ACTIVITY | 3.2.1.1 |
1Q4S | CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4-HYDROXYBENZOYL COA THIOESTERASE COMPLEXED WITH COA AND 4-HYDROXYBENZOIC ACID | 3.1.2.23 |
1Q4T | CRYSTAL STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE FROM ARTHROBACTER SP. STRAIN SU COMPLEXED WITH 4-HYDROXYPHENYL COA | 3.1.2.23 |
1Q4U | CRYSTAL STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE FROM ARTHROBACTER SP. STRAIN SU COMPLEXED WITH 4-HYDROXYBENZYL COA | 3.1.2.23 |
1Q57 | THE CRYSTAL STRUCTURE OF THE BIFUNCTIONAL PRIMASE-HELICASE OF BACTERIOPHAGE T7 | 2.7.7 3.6.4.12 |
1Q5H | HUMAN DUTP PYROPHOSPHATASE COMPLEX WITH DUDP | 3.6.1.23 |
1Q5P | S156E/S166D VARIANT OF BACILLUS LENTUS SUBTILISIN | 3.4.21.62 |
1Q5Q | THE RHODOCOCCUS 20S PROTEASOME | 3.4.25.1 |
1Q5U | HUMAN DUTP PYROPHOSPHATASE | 3.6.1.23 |
1Q6C | CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE COMPLEXED WITH MALTOSE | 3.2.1.2 |
1Q6D | CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT (M51T) WITH INCREASED PH OPTIMUM | 3.2.1.2 |
1Q6E | CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT (E178Y) WITH INCREASED PH OPTIMUM AT PH 5.4 | 3.2.1.2 |
1Q6F | CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT (E178Y) WITH INCREASED PH OPTIMUM AT PH 7.1 | 3.2.1.2 |
1Q6G | CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT (N340T) WITH INCREASED PH OPTIMUM | 3.2.1.2 |
1Q6J | THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2 | 3.1.3.48 |
1Q6K | CATHEPSIN K COMPLEXED WITH T-BUTYL(1S)-1-CYCLOHEXYL-2-OXOETHYLCARBAMATE | 3.4.22.38 |
1Q6M | THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 3 | 3.1.3.48 |
1Q6N | THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 4 | 3.1.3.48 |
1Q6P | THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 6 | 3.1.3.48 |
1Q6S | THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 9 | 3.1.3.48 |
1Q6T | THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 11 | 3.1.3.48 |
1Q6V | FIRST CRYSTAL STRUCTURE OF A C49 MONOMER PLA2 FROM THE VENOM OF DABOIA RUSSELLI PULCHELLA AT 1.8 A RESOLUTION | 3.1.1.4 |
1Q74 | THE CRYSTAL STRUCTURE OF 1D-MYO-INOSITOL 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE DEACETYLASE (MSHB) | 3.5.1.103 |
1Q7A | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELL'S VIPER PHOSPHOLIPASE A2 AND AN ANTIINFLAMMATORY AGENT OXYPHENBUTAZONE AT 1.6A RESOLUTION | 3.1.1.4 |
1Q7I | STRUCTURAL ANALYSIS OF INTEGRIN ALPHA IIB BETA 3- DISINTEGRIN WITH THE AKGDWN MOTIF | 3.4.24 |
1Q7J | STRUCTURAL ANALYSIS OF INTEGRIN ALPHA IIB BETA 3- DISINTEGRIN WITH THE AKGDWN MOTIF | 3.4.24 |
1Q7L | ZN-BINDING DOMAIN OF THE T347G MUTANT OF HUMAN AMINOACYLASE-I | 3.5.1.14 |
1Q7R | X-RAY CRYSTALLOGRAPHIC ANALYSIS OF A PREDICTED AMIDOTRANSFERASE FROM B. STEAROTHERMOPHILUS AT 1.9 A RESOLUTION | 4.3.3.6 3.5.1.2 |
1Q7S | CRYSTAL STRUCTURE OF BIT1 | 3.1.1.29 |
1Q7T | RV1170 (MSHB) FROM MYCOBACTERIUM TUBERCULOSIS | 3.5.1.103 |
1Q7X | SOLUTION STRUCTURE OF THE ALTERNATIVELY SPLICED PDZ2 DOMAIN (PDZ2B) OF PTP-BAS (HPTP1E) | 3.1.3.48 |
1Q83 | CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-TZ2PA6 SYN COMPLEX | 3.1.1.7 |
1Q84 | CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-TZ2PA6 ANTI COMPLEX | 3.1.1.7 |
1Q8F | CRYSTAL STRUCTURE OF THE E.COLI PYRIMIDINE NUCLEOSIDE HYDROLASE YEIK | 3.2.2.8 |
1Q8R | STRUCTURE OF E.COLI RUSA HOLLIDAY JUNCTION RESOLVASE | 3.1.22 3.1.22.4 |
1Q91 | CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR DPB-T | 3.1.3.5 3.1.3 |
1Q92 | CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR PMCP-U | 3.1.3.5 3.1.3 |
1Q9D | FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH A NEW ALLOSTERIC SITE INHIBITOR (I-STATE) | 3.1.3.11 |
1Q9E | RNASE T1 VARIANT WITH ADENINE SPECIFICITY | 3.1.27.3 4.6.1.24 |
1Q9H | 3-DIMENSIONAL STRUCTURE OF NATIVE CEL7A FROM TALAROMYCES EMERSONII | 3.2.1.91 3.2.1 |
1Q9M | THREE DIMENSIONAL STRUCTURES OF PDE4D IN COMPLEX WITH ROLIPRAMS AND IMPLICATION ON INHIBITOR SELECTIVITY | 3.1.4.17 3.1.4.53 |
1Q9P | SOLUTION STRUCTURE OF THE MATURE HIV-1 PROTEASE MONOMER | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1Q9X | CRYSTAL STRUCTURE OF ENTEROBACTERIA PHAGE RB69 GP43 DNA POLYMERASE COMPLEXED WITH TETRAHYDROFURAN CONTAINING DNA | 2.7.7.7 3.1.11 |
1Q9Y | CRYSTAL STRUCTURE OF ENTEROBACTERIA PHAGE RB69 GP43 DNA POLYMERASE COMPLEXED WITH 8-OXOGUANOSINE CONTAINING DNA | 2.7.7.7 3.1.11 |
1QA0 | BOVINE TRYPSIN 2-AMINOBENZIMIDAZOLE COMPLEX | 3.4.21.4 |
1QA1 | TAILSPIKE PROTEIN, MUTANT V331G | 3.2.1 |
1QA2 | TAILSPIKE PROTEIN, MUTANT A334V | 3.2.1 |
1QA3 | TAILSPIKE PROTEIN, MUTANT A334I | 3.2.1 |
1QA7 | CRYSTAL COMPLEX OF THE 3C PROTEINASE FROM HEPATITIS A VIRUS WITH ITS INHIBITOR AND IMPLICATIONS FOR THE POLYPROTEIN PROCESSING IN HAV | 3.6.1.15 3.4.22.28 2.7.7.48 |
1QAE | THE ACTIVE SITE OF SERRATIA ENDONUCLEASE CONTAINS A CONSERVED MAGNESIUM-WATER CLUSTER | 3.1.30.2 |
1QAH | CRYSTAL STRUCTURE OF PERCHLORIC ACID SOLUBLE PROTEIN-A TRANSLATIONAL INHIBITOR | 3.5.99.10 |
1QAI | CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN | 2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1QAJ | CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN | 2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1QAS | 1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1 | 3.1.4.11 |
1QAT | 1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE DELTA COMPLEX WITH SAMARIUM (III) CHLORIDE | 3.1.4.11 |
1QAZ | CRYSTAL STRUCTURE OF ALGINATE LYASE A1-III FROM SPHINGOMONAS SPECIES A1 AT 1.78A RESOLUTION | 3.5.1.45 |
1QB0 | HUMAN CDC25B CATALYTIC DOMAIN | 3.1.3.48 |
1QB1 | BOVINE TRYPSIN WITH 1-[2-[5-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-6-[3-(4,5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL)PHENOXY]PYRIDIN-4-YL]PIPERIDINE-3-CARBOXYLIC ACID (ZK-806974) | 3.4.21.4 |
1QB2 | CRYSTAL STRUCTURE OF THE CONSERVED SUBDOMAIN OF HUMAN PROTEIN SRP54M AT 2.1A RESOLUTION: EVIDENCE FOR THE MECHANISM OF SIGNAL PEPTIDE BINDING | 3.6.5 |
1QB6 | BOVINE TRYPSIN 3,3'-[3,5-DIFLUORO-4-METHYL-2, 6-PYRIDINEDIYLBIS(OXY)]BIS(BENZENECARBOXIMIDAMIDE) (ZK-805623) COMPLEX | 3.4.21.4 |
1QB9 | BOVINE TRYPSIN 7-[[2-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]-9H-CARBOZOL-9-YL] METHYL]NAPHTHALENE-2-CARBOXIMIDAMIDE (ZK-806450) COMPLEX | 3.4.21.4 |
1QBA | BACTERIAL CHITOBIASE, GLYCOSYL HYDROLASE FAMILY 20 | 3.2.1.52 |
1QBB | BACTERIAL CHITOBIASE COMPLEXED WITH CHITOBIOSE (DINAG) | 3.2.1.52 |
1QBJ | CRYSTAL STRUCTURE OF THE ZALPHA Z-DNA COMPLEX | 3.5.4.37 |
1QBN | BOVINE TRYPSIN 2-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-6-[3-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)PHENOXY]PYRIDINE-4-CARBOXYLIC ACID (ZK-806688) COMPLEX | 3.4.21.4 |
1QBO | BOVINE TRYPSIN 7-[[6-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]-2-METHYL-BENZIMIDAZOL-1-YL]METHYL]NAPHTHALENE-2-CARBOXIMIDAMID ZK-806711 INHIBITOR COMPLEX | 3.4.21.4 |
1QBR | HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1QBS | HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1QBT | HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1QBU | HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1QC9 | THE CRYSTALLOGRAPHIC STRUCTURE OF RESTRICTION ENDONUCLEASE ECO RI AT 3.3 A IN THE ABSENSE OF DNA | 3.1.21.4 |
1QCG | LOW TEMPERATURE STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN | 3.2.2.22 |
1QCI | LOW TEMPERATURE STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN COMPLEXED WITH ADENINE | 3.2.2.22 |
1QCJ | LOW TEMPERATURE COMPLEX OF POKEWEED ANTIVIRAL PROTEIN WITH PTEORIC ACID | 3.2.2.22 |
1QCN | CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE | 3.7.1.2 |
1QCO | CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH FUMARATE AND ACETOACETATE | 3.7.1.2 |
1QCP | CRYSTAL STRUCTURE OF THE RWJ-51084 BOVINE PANCREATIC BETA-TRYPSIN AT 1.8 A | 3.4.21.4 |
1QCS | N-TERMINAL DOMAIN OF N-ETHYLMALEIMIDE SENSITIVE FACTOR (NSF) | 3.6.4.6 |
1QD2 | CRYSTAL STRUCTURE OF THE COMPLEX OF TRICHOSANTHIN WITH ADENINE, OBTAINED FROM TRICHOSANTHIN COMPLEXED WITH THE DINUCLEOTIDE APG | 3.2.2.22 |
1QD5 | OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI | 3.1.1.32 3.1.1.4 |
1QD9 | BACILLUS SUBTILIS YABJ | 3.5.99.10 |
1QDE | CRYSTAL STRUCTURE OF THE ATPASE DOMAIN OF TRANSLATION INITIATION FACTOR 4A FROM SACCHAROMYCES CEREVISIAE-THE PROTOTYPE OF THE DEAD BOX PROTEIN FAMILY | 3.6.4.13 |
1QDM | CRYSTAL STRUCTURE OF PROPHYTEPSIN, A ZYMOGEN OF A BARLEY VACUOLAR ASPARTIC PROTEINASE. | 3.4.23.40 |
1QDN | AMINO TERMINAL DOMAIN OF THE N-ETHYLMALEIMIDE SENSITIVE FUSION PROTEIN (NSF) | 3.6.4.6 |
1QDQ | X-RAY CRYSTAL STRUCTURE OF BOVINE CATHEPSIN B-CA074 COMPLEX | 3.4.22.1 |
1QDR | 2.1 A RESOLUTION STRUCTURE OF ESCHERICHIA COLI LYTIC TRANSGLYCOSYLASE SLT35 | 3.2.1 4.2.2 |
1QDU | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK | 3.4.22 3.4.22.61 |
1QE1 | CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1QE3 | PNB ESTERASE | 3.1.1 |
1QEZ | SULFOLOBUS ACIDOCALDARIUS INORGANIC PYROPHOSPHATASE: AN ARCHAEL PYROPHOSPHATASE. | 3.6.1.1 |
1QF0 | THERMOLYSIN (E.C.3.4.24.27) COMPLEXED WITH (2-SULPHANYL-3-PHENYLPROPANOYL)-PHE-TYR. PARAMETERS FOR ZN-BIDENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE | 3.4.24.27 |
1QF1 | THERMOLYSIN (E.C.3.4.24.27) COMPLEXED WITH (2-SULPHANYLHEPTANOYL)-PHE-ALA. PARAMETERS FOR ZN-BIDENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE | 3.4.24.27 |
1QF2 | THERMOLYSIN (E.C.3.4.24.27) COMPLEXED WITH (2-SULPHANYL-3-PHENYLPROPANOYL)-GLY-(5-PHENYLPROLINE). PARAMETERS FOR ZN-MONODENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE | 3.4.24.27 |
1QFC | STRUCTURE OF RAT PURPLE ACID PHOSPHATASE | 3.1.3.2 |
1QFK | STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION | 3.4.21.21 |
1QFM | PROLYL OLIGOPEPTIDASE FROM PORCINE MUSCLE | 3.4.21.26 |
1QFS | PROLYL OLIGOPEPTIDASE FROM PORCINE MUSCLE WITH COVALENTLY BOUND INHIBITOR Z-PRO-PROLINAL | 3.4.21.26 |
1QFX | PH 2.5 ACID PHOSPHATASE FROM ASPERGILLUS NIGER | 3.1.3.8 |
1QGC | STRUCTURE OF THE COMPLEX OF A FAB FRAGMENT OF A NEUTRALIZING ANTIBODY WITH FOOT AND MOUTH DISEASE VIRUS | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
1QGE | NEW CRYSTAL FORM OF PSEUDOMONAS GLUMAE (FORMERLY CHROMOBACTERIUM VISCOSUM ATCC 6918) LIPASE | 3.1.1.3 |
1QGF | PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3R, 4S)N-PARA-TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE | 3.4.21.36 |
1QGI | CHITOSANASE FROM BACILLUS CIRCULANS | 3.2.1.132 |
1QGP | NMR STRUCTURE OF THE Z-ALPHA DOMAIN OF ADAR1, 15 STRUCTURES | 3.5.4.37 |
1QGX | X-RAY STRUCTURE OF YEAST HAL2P | 3.1.3.7 |
1QH3 | HUMAN GLYOXALASE II WITH CACODYLATE AND ACETATE IONS PRESENT IN THE ACTIVE SITE | 3.1.2.6 |
1QH5 | HUMAN GLYOXALASE II WITH S-(N-HYDROXY-N-BROMOPHENYLCARBAMOYL)GLUTATHIONE | 3.1.2.6 |
1QH6 | CATALYSIS AND SPECIFICITY IN ENZYMATIC GLYCOSIDE HYDROLASES: A 2,5B CONFORMATION FOR THE GLYCOSYL-ENZYME INTERMIDIATE REVEALED BY THE STRUCTURE OF THE BACILLUS AGARADHAERENS FAMILY 11 XYLANASE | 3.2.1.8 |
1QH7 | CATALYSIS AND SPECIFICITY IN ENZYMATIC GLYCOSIDE HYDROLASES: A 2,5B CONFORMATION FOR THE GLYCOSYL-ENZYME INTERMIDIATE REVEALED BY THE STRUCTURE OF THE BACILLUS AGARADHAERENS FAMILY 11 XYLANASE | 3.2.1.8 |
1QH9 | ENZYME-PRODUCT COMPLEX OF L-2-HALOACID DEHALOGENASE | 3.8.1.2 |
1QHC | CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 5'-PHOSPHO-2'-DEOXYURIDINE-3'-PYROPHOSPHATE ADENOSINE-3'-PHOSPHATE | 3.1.27.5 4.6.1.18 |
1QHG | STRUCTURE OF DNA HELICASE MUTANT WITH ADPNP | 3.6.4.12 |
1QHH | STRUCTURE OF DNA HELICASE WITH ADPNP | 3.6.4.12 |
1QHK | N-TERMINAL DOMAIN OF SACCHAROMYCES CEREVISIAE RNASE HI REVEALS A FOLD WITH A RESEMBLANCE TO THE N-TERMINAL DOMAIN OF RIBOSOMAL PROTEIN L9 | 3.1.26.4 |
1QHO | FIVE-DOMAIN ALPHA-AMYLASE FROM BACILLUS STEAROTHERMOPHILUS, MALTOSE/ACARBOSE COMPLEX | 3.2.1.133 |
1QHP | FIVE-DOMAIN ALPHA-AMYLASE FROM BACILLUS STEAROTHERMOPHILUS, MALTOSE COMPLEX | 3.2.1.133 |
1QHR | NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS | 3.4.21.5 |
1QHW | PURPLE ACID PHOSPHATASE FROM RAT BONE | 3.1.3.2 |
1QHZ | NATIVE TETRAGONAL STRUCTURE OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS | 3.2.1.4 |
1QI0 | ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE TETRAGONAL CRYSTAL FORM IN COMPLEX WITH CELLOBIOSE | 3.2.1.4 |
1QI2 | ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE TETRAGONAL CRYSTAL FORM IN COMPLEX WITH 2',4'-DINITROPHENYL 2-DEOXY-2-FLUORO-B-D-CELLOTRIOSIDE | 3.2.1.4 |
1QI3 | MUTANT (D193N) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE | 3.2.1.60 |
1QI4 | MUTANT (E219G) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE | 3.2.1.60 |
1QI5 | MUTANT (D294N) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE | 3.2.1.60 |
1QI7 | THE CRYSTAL STRUCTURE AT 2.0 A OF SAPORIN SO6, A RIBOSOME INACTIVATING PROTEIN FROM SAPONARIA OFFICINALIS | 3.2.2.22 |
1QIA | CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN | 3.4.24.17 |
1QIB | CRYSTAL STRUCTURE OF GELATINASE A CATALYTIC DOMAIN | 3.4.24.24 |
1QIC | CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN | 3.4.24.17 |
1QID | SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT A) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE | 3.1.1.7 |
1QIE | SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT B) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE | 3.1.1.7 |
1QIF | SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT C) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE | 3.1.1.7 |
1QIG | SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT D) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE | 3.1.1.7 |
1QIH | SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT E) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE | 3.1.1.7 |
1QII | SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT F) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE | 3.1.1.7 |
1QIJ | SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT G) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE | 3.1.1.7 |
1QIK | SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT H) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE | 3.1.1.7 |
1QIM | SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT I) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE | 3.1.1.7 |
1QIO | SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE CAUSED BY INTENSE SYNCHROTRON RADIATION TO HEN EGG WHITE LYSOZYME | 3.2.1.17 |
1QJ1 | NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS | 3.4.21.5 |
1QJ6 | NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS | 3.4.21.5 |
1QJ7 | NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS | 3.4.21.5 |
1QJI | STRUCTURE OF ASTACIN WITH A TRANSITION-STATE ANALOGUE INHIBITOR | 3.4.24.21 |
1QJJ | STRUCTURE OF ASTACIN WITH A HYDROXAMIC ACID INHIBITOR | 3.4.24.21 |
1QJM | CRYSTAL STRUCTURE OF A COMPLEX OF LACTOFERRIN WITH A LANTHANIDE ION (SM3+) AT 3.4 ANGSTROM RESOLUTION | 3.4.21 |
1QJV | PECTIN METHYLESTERASE PEMA FROM ERWINIA CHRYSANTHEMI | 3.1.1.11 |
1QJW | CEL6A (Y169F) WITH A NON-HYDROLYSABLE CELLOTETRAOSE | 3.2.1.91 |
1QK0 | CEL6A WITH A NON-HYDROLYSABLE CELLOTETRAOSE | 3.2.1.91 |
1QK2 | WILD TYPE CEL6A WITH A NON-HYDROLYSABLE CELLOTETRAOSE | 3.2.1.91 |
1QKQ | CHARCOT-LEYDEN CRYSTAL PROTEIN - MANNOSE COMPLEX | 3.1.1.5 |
1QL0 | SM ENDONUCLEASE FROM SERATIA MARCENSCENS AT ATOMIC RESOLUTION | 3.1.30.2 |
1QL7 | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN | 3.4.21.4 |
1QL8 | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN | 3.4.21.4 |
1QL9 | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH RAT TRYPSIN MUTANT X99RT | 3.4.21.4 |
1QLD | SOLUTION STRUCTURE OF TYPE X CBM | 3.2.1.8 |
1QLG | CRYSTAL STRUCTURE OF PHYTASE WITH MAGNESIUM FROM BACILLUS AMYLOLIQUEFACIENS | 3.1.3.8 |
1QLL | PIRATOXIN-II (PRTX-II) - A K49 PLA2 FROM BOTHROPS PIRAJAI | 3.1.1.4 |
1QLM | THE CRYSTAL STRUCTURE OF METHENYLTETRAHYDROMETHANOPTERIN CYCLOHYDROLASE FROM THE HYPERTHERMOPHILIC ARCHAEON METHANOPYRUS KANDLERI | 3.5.4.27 |
1QM6 | CLOSED FORM OF CLOSTRIDIUM PERFRINGENS ALPHA-TOXIN STRAIN NCTC8237 | 3.1.4.3 |
1QMC | C-TERMINAL DNA-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1QMD | CALCIUM BOUND CLOSED FORM ALPHA-TOXIN FROM CLOSTRIDIUM PERFRINGENS | 3.1.4.3 |
1QMT | RECOMBINANT HUMAN EOSINOPHIL CATIONIC PROTEIN | 3.1.27 |
1QMU | DUCK CARBOXYPEPTIDASE D DOMAIN II | 3.4.17.22 |
1QMY | FMDV LEADER PROTEASE (LBSHORT-C51A-C133S) | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
1QNJ | THE STRUCTURE OF NATIVE PORCINE PANCREATIC ELASTASE AT ATOMIC RESOLUTION (1.1 A) | 3.4.21.36 |
1QNO | THE 3-D STRUCTURE OF A TRICHODERMA REESEI B-MANNANASE FROM GLYCOSIDE HYDROLASE FAMILY 5 | 3.2.1.78 |
1QNP | THE 3-D STRUCTURE OF A TRICHODERMA REESEI B-MANNANASE FROM GLYCOSIDE HYDROLASE FAMILY 5 | 3.2.1.78 |
1QNQ | THE 3-D STRUCTURE OF A TRICHODERMA REESEI B-MANNANASE FROM GLYCOSIDE HYDROLASE FAMILY 5 | 3.2.1.78 |
1QNR | THE 3-D STRUCTURE OF A TRICHODERMA REESEI B-MANNANASE FROM GLYCOSIDE HYDROLASE FAMILY 5 | 3.2.1.78 |
1QNS | THE 3-D STRUCTURE OF A TRICHODERMA REESEI B-MANNANASE FROM GLYCOSIDE HYDROLASE FAMILY 5 | 3.2.1.78 |
1QO7 | STRUCTURE OF ASPERGILLUS NIGER EPOXIDE HYDROLASE | 3.3.2.3 |
1QO9 | NATIVE ACETYLCHOLINESTERASE FROM DROSOPHILA MELANOGASTER | 3.1.1.7 |
1QOL | STRUCTURE OF THE FMDV LEADER PROTEASE | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
1QON | ACHE FROM DROSOPHILA MELANOGASTER COMPLEX WITH TACRINE DERIVATIVE 9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE | 3.1.1.7 |
1QOZ | CATALYTIC CORE DOMAIN OF ACETYL XYLAN ESTERASE FROM TRICHODERMA REESEI | 3.1.1.72 |
1QPK | MUTANT (D193G) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE | 3.2.1.60 |
1QPS | THE CRYSTAL STRUCTURE OF A POST-REACTIVE COGNATE DNA-ECO RI COMPLEX AT 2.50 A IN THE PRESENCE OF MN2+ ION | 3.1.21.4 |
1QQ1 | TAILSPIKE PROTEIN, MUTANT E359G | 3.2.1 |
1QQ4 | CRYSTAL STRUCTURE OF AN ALPHA-LYTIC PROTEASE MUTANT WITH ACCELERATED FOLDING KINETICS, R102H/G134S | 3.4.21.12 |
1QQ5 | STRUCTURE OF L-2-HALOACID DEHALOGENASE FROM XANTHOBACTER AUTOTROPHICUS | 3.8.1.2 |
1QQ6 | STRUCTURE OF L-2-HALOACID DEHALOGENASE FROM XANTHOBACTER AUTOTROPHICUS WITH CHLOROACETIC ACID COVALENTLY BOUND | 3.8.1.2 |
1QQ7 | STRUCTURE OF L-2-HALOACID DEHALOGENASE FROM XANTHOBACTER AUTOTROPHICUS WITH CHLOROPROPIONIC ACID COVALENTLY BOUND | 3.8.1.2 |
1QQ9 | STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH METHIONINE | 3.4.11 3.4.11.24 |
1QQJ | CRYSTAL STRUCTURE OF MOUSE FUMARYLACETOACETATE HYDROLASE REFINED AT 1.55 ANGSTROM RESOLUTION | 3.7.1.2 |
1QQP | FOOT-AND-MOUTH DISEASE VIRUS/ OLIGOSACCHARIDE RECEPTOR COMPLEX. | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
1QQU | CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH BOUND ACETATE ION | 3.4.21.4 |
1QQY | X-RAY CRYSTAL STRUCTURE ANALYSIS OF CANINE MILK LYSOZYME (APO-TYPE) | 3.2.1.17 |
1QR3 | STRUCTURE OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH FR901277, A NOVEL MACROCYCLIC INHIBITOR OF ELASTASES AT 1.6 ANGSTROM RESOLUTION | 3.4.21.36 |
1QRA | STRUCTURE OF P21RAS IN COMPLEX WITH GTP AT 100 K | 3.6.5.2 |
1QRB | PLASTICITY AND STERIC STRAIN IN A PARALLEL BETA-HELIX: RATIONAL MUTATIONS IN P22 TAILSPIKE PROTEIN | 3.2.1 |
1QRC | TAILSPIKE PROTEIN, MUTANT W391A | 3.2.1 |
1QRH | X-RAY STRUCTURE OF THE DNA-ECO RI ENDONUCLEASE COMPLEXES WITH AN R145K MUTATION AT 2.7 A | 3.1.21.4 |
1QRI | X-RAY STRUCTURE OF THE DNA-ECO RI ENDONUCLEASE COMPLEXES WITH AN E144D MUTATION AT 2.7 A | 3.1.21.4 |
1QRP | HUMAN PEPSIN 3A IN COMPLEX WITH A PHOSPHONATE INHIBITOR IVA-VAL-VAL-LEU(P)-(O)PHE-ALA-ALA-OME | 3.4.23.1 |
1QRR | CRYSTAL STRUCTURE OF SQD1 PROTEIN COMPLEX WITH NAD AND UDP-GLUCOSE | 3.13.1.1 |
1QRW | CRYSTAL STRUCTURE OF AN ALPHA-LYTIC PROTEASE MUTANT WITH ACCELERATED FOLDING KINETICS, R102H/G134S, PH 8 | 3.4.21.12 |
1QRX | CRYSTAL STRUCTURE OF WILD-TYPE ALPHA-LYTIC PROTEASE AT 1.6 A, PH 5.14 | 3.4.21.12 |
1QRZ | CATALYTIC DOMAIN OF PLASMINOGEN | 3.4.21.7 |
1QS4 | CORE DOMAIN OF HIV-1 INTEGRASE COMPLEXED WITH MG++ AND 1-(5-CHLOROINDOL-3-YL)-3-HYDROXY-3-(2H-TETRAZOL-5-YL)-PROPENONE | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1QS5 | THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | 3.2.1.17 |
1QS9 | THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | 3.2.1.17 |
1QSA | CRYSTAL STRUCTURE OF THE 70 KDA SOLUBLE LYTIC TRANSGLYCOSYLASE SLT70 FROM ESCHERICHIA COLI AT 1.65 ANGSTROMS RESOLUTION | 3.2.1 4.2.2 |
1QSB | THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | 3.2.1.17 |
1QSQ | CAVITY CREATING MUTATION | 3.2.1.17 |
1QSW | CRYSTAL STRUCTURE ANALYSIS OF A HUMAN LYSOZYME MUTANT W64C C65A | 3.2.1.17 |
1QT3 | T26D MUTANT OF T4 LYSOZYME | 3.2.1.17 |
1QT4 | T26Q MUTANT OF T4 LYSOZYME | 3.2.1.17 |
1QT5 | D20E MUTANT STRUCTURE OF T4 LYSOZYME | 3.2.1.17 |
1QT6 | E11H MUTANT OF T4 LYSOZYME | 3.2.1.17 |
1QT7 | E11N MUTANT OF T4 LYSOZYME | 3.2.1.17 |
1QT8 | T26H MUTANT OF T4 LYSOZYME | 3.2.1.17 |
1QTB | THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | 3.2.1.17 |
1QTC | THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | 3.2.1.17 |
1QTD | THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | 3.2.1.17 |
1QTE | CRYSTAL STRUCTURE OF THE 70 KDA SOLUBLE LYTIC TRANSGLYCOSYLASE SLT70 FROM ESCHERICHIA COLI AT 1.90 A RESOLUTION IN COMPLEX WITH A 1,6-ANHYDROMUROTRIPEPTIDE | 3.2.1 4.2.2 |
1QTF | CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN B | 3.4.21 |
1QTH | THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME | 3.2.1.17 |
1QTI | ACETYLCHOLINESTERASE (E.C.3.1.1.7) | 3.1.1.7 |
1QTK | CRYSTAL STRUCTURE OF HEW LYSOZYME UNDER PRESSURE OF KRYPTON (55 BAR) | 3.2.1.17 |
1QTN | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TETRAPEPTIDE INHIBITOR ACE-IETD-ALDEHYDE | 3.4.22 3.4.22.61 |
1QTR | CRYSTAL STRUCTURE ANALYSIS OF THE PROLYL AMINOPEPTIDASE FROM SERRATIA MARCESCENS | 3.4.11.5 |
1QTV | T26E APO STRUCTURE OF T4 LYSOZYME | 3.2.1.17 |
1QTW | HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI DNA REPAIR ENZYME ENDONUCLEASE IV | 3.1.21.2 |
1QTZ | D20C MUTANT OF T4 LYSOZYME | 3.2.1.17 |
1QU9 | 1.2 A CRYSTAL STRUCTURE OF YJGF GENE PRODUCT FROM E. COLI | 3.5.99.10 |
1QUA | CRYSTAL STRUCTURE OF ACUTOLYSIN-C, A HEMORRHAGIC TOXIN FROM THE SNAKE VENOM OF AGKISTRODON ACUTUS, AT 2.2 A RESOLUTION | 3.4.24 |
1QUD | L99G MUTANT OF T4 LYSOZYME | 3.2.1.17 |
1QUG | E108V MUTANT OF T4 LYSOZYME | 3.2.1.17 |
1QUH | L99G/E108V MUTANT OF T4 LYSOZYME | 3.2.1.17 |
1QUM | CRYSTAL STRUCTURE OF ESCHERICHIA COLI ENDONUCLEASE IV IN COMPLEX WITH DAMAGED DNA | 3.1.21.2 |
1QUO | L99A/E108V MUTANT OF T4 LYSOZYME | 3.2.1.17 |
1QUR | HUMAN ALPHA-THROMBIN IN COMPLEX WITH BIVALENT, BENZAMIDINE-BASED SYNTHETIC INHIBITOR | 3.4.21.5 |
1QUS | 1.7 A RESOLUTION STRUCTURE OF THE SOLUBLE LYTIC TRANSGLYCOSYLASE SLT35 FROM ESCHERICHIA COLI | 3.2.1 4.2.2 |
1QUT | THE SOLUBLE LYTIC TRANSGLYCOSYLASE SLT35 FROM ESCHERICHIA COLI IN COMPLEX WITH N-ACETYLGLUCOSAMINE | 3.2.1 4.2.2 |
1QUV | CRYSTAL STRUCTURE OF THE RNA DIRECTED RNA POLYMERASE OF HEPATITIS C VIRUS | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
1QVA | YEAST INITIATION FACTOR 4A N-TERMINAL DOMAIN | 3.6.4.13 |
1QVJ | STRUCTURE OF NUDT9 COMPLEXED WITH RIBOSE-5-PHOSPHATE | 3.6.1.13 |
1QW7 | STRUCTURE OF AN ENGINEERED ORGANOPHOSPHOROUS HYDROLASE WITH INCREASED ACTIVITY TOWARD HYDROLYSIS OF PHOSPHOTHIOLATE BONDS | 3.1.8.1 |
1QW8 | CRYSTAL STRUCTURE OF A FAMILY 51 ALPHA-L-ARABINOFURANOSIDASE IN COMPLEX WITH ARA-ALPHA(1,3)-XYL | 3.2.1.55 |
1QW9 | CRYSTAL STRUCTURE OF A FAMILY 51 ALPHA-L-ARABINOFURANOSIDASE IN COMPLEX WITH 4-NITROPHENYL-ARA | 3.2.1.55 |
1QWN | GOLGI ALPHA-MANNOSIDASE II COVALENT INTERMEDIATE COMPLEX WITH 5-FLUORO-GULOSYL-FLUORIDE | 3.2.1.114 |
1QWO | CRYSTAL STRUCTURE OF A PHOSPHORYLATED PHYTASE FROM ASPERGILLUS FUMIGATUS, REVEALING THE STRUCTURAL BASIS FOR ITS HEAT RESILIENCE AND CATALYTIC PATHWAY | 3.1.3.8 |
1QWQ | SOLUTION STRUCTURE OF THE MONOMERIC N67D MUTANT OF BOVINE SEMINAL RIBONUCLEASE | 3.1.27.5 4.6.1.18 |
1QWU | GOLGI ALPHA-MANNOSIDASE II D341N MUTANT COMPLEX WITH 5-F-GULOSIDE | 3.2.1.114 |
1QWY | LATENT LYTM AT 1.3 A RESOLUTION | 3.4.24.75 |
1QWZ | CRYSTAL STRUCTURE OF SORTASE B FROM S. AUREUS COMPLEXED WITH MTSET | 3.4.22.71 |
1QX1 | GOLGI ALPHA-MANNOSIDASE II D341N MUTANT COMPLEX WITH 2-F-MANNOSYL-F | 3.2.1.114 |
1QX3 | CONFORMATIONAL RESTRICTIONS IN THE ACTIVE SITE OF UNLIGANDED HUMAN CASPASE-3 | 3.4.22 3.4.22.56 |
1QX6 | CRYSTAL STRUCTURE OF SORTASE B COMPLEXED WITH E-64 | 3.4.22.71 |
1QXA | CRYSTAL STRUCTURE OF SORTASE B COMPLEXED WITH GLY3 | 3.4.22.71 |
1QXK | MONOACID-BASED, CELL PERMEABLE, SELECTIVE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
1QXL | CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH FR235380 | 3.5.4.4 |
1QXP | CRYSTAL STRUCTURE OF A MU-LIKE CALPAIN | 3.4.22.52 3.4.22.53 |
1QXW | CRYSTAL STRUCTURE OF STAPHYLOCCOCUS AUREUS IN COMPLEX WITH AN AMINOKETONE INHIBITOR 54135. | 3.4.11.18 |
1QXY | CRYSTAL STRUCTURE OF S. AUREUS METHIONINE AMINOPEPTIDASE IN COMPLEX WITH A KETOHETEROCYCLE 618 | 3.4.11.18 |
1QXZ | CRYSTAL STRUCTURE OF S. AUREUS METHIONINE AMINOPEPTIDASE IN COMPLEX WITH A KETOHETEROCYCLE INHIBITOR 119 | 3.4.11.18 |
1QY6 | STRUCTUE OF V8 PROTEASE FROM STAPHYLOCOCCUS AUREUS | 3.4.21.19 |
1QZ0 | CRYSTAL STRUCTURE OF THE YERSINIA PESTIS PHOSPHATASE YOPH IN COMPLEX WITH A PHOSPHOTYROSYL MIMETIC-CONTAINING HEXAPEPTIDE | 3.1.3.48 |
1QZ8 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS NSP9 | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
1QZ9 | THE THREE DIMENSIONAL STRUCTURE OF KYNURENINASE FROM PSEUDOMONAS FLUORESCENS | 3.7.1.3 |
1QZM | ALPHA-DOMAIN OF ATPASE | 3.4.21.53 |
1QZQ | HUMAN TYROSYL DNA PHOSPHODIESTERASE | 3.1.4 |
1QZY | HUMAN METHIONINE AMINOPEPTIDASE IN COMPLEX WITH BENGAMIDE INHIBITOR LAF153 AND COBALT | 3.4.11.18 |
1R08 | STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1R09 | HUMAN RHINOVIRUS 14 COMPLEXED WITH ANTIVIRAL COMPOUND R 61837 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1R0A | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1R0R | 1.1 ANGSTROM RESOLUTION STRUCTURE OF THE COMPLEX BETWEEN THE PROTEIN INHIBITOR, OMTKY3, AND THE SERINE PROTEASE, SUBTILISIN CARLSBERG | 3.4.21.62 |
1R0S | CRYSTAL STRUCTURE OF ADP-RIBOSYL CYCLASE GLU179ALA MUTANT | 3.2.2.5 3.2.2.6 2.4.99.20 |
1R0V | STRUCTURE DETERMINATION OF THE DIMERIC ENDONUCLEASE IN A PSEUDO-FACE-CENTERD P21212 SPACE GROUP | 3.1.27.9 4.6.1.16 |
1R11 | STRUCTURE DETERMINATION OF THE DIMERIC ENDONUCLEASE IN A PSEUDO-FACE-CENTERD P21 SPACE GROUP | 3.1.27.9 4.6.1.16 |
1R12 | NATIVE APLYSIA ADP RIBOSYL CYCLASE | 3.2.2.5 3.2.2.6 2.4.99.20 |
1R15 | APLYSIA ADP RIBOSYL CYCLASE WITH BOUND NICOTINAMIDE AND R5P | 3.2.2.5 3.2.2.6 2.4.99.20 |
1R16 | APLYSIA ADP RIBOSYL CYCLASE WITH BOUND PYRIDYLCARBINOL AND R5P | 3.2.2.5 3.2.2.6 2.4.99.20 |
1R1A | CRYSTAL STRUCTURE OF HUMAN RHINOVIRUS SEROTYPE 1A (HRV1A) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1R1D | STRUCTURE OF A CARBOXYLESTERASE FROM BACILLUS STEAROTHERMOPHILUS | 3.1.1.1 |
1R1H | STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS | 3.4.24.11 |
1R1I | STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS | 3.4.24.11 |
1R1J | STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS | 3.4.24.11 |
1R1O | AMINO ACID SULFONAMIDES AS TRANSITION-STATE ANALOGUE INHIBITORS OF ARGINASE | 3.5.3.1 |
1R2Q | CRYSTAL STRUCTURE OF HUMAN RAB5A GTPASE DOMAIN AT 1.05 A RESOLUTION | 3.6.5.2 |
1R2Y | MUTM (FPG) BOUND TO 8-OXOGUANINE (OXOG) CONTAINING DNA | 3.2.2.23 4.2.99.18 |
1R2Z | MUTM (FPG) BOUND TO 5,6-DIHYDROURACIL (DHU) CONTAINING DNA | 3.2.2.23 4.2.99.18 |
1R33 | GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH 5-THIO-D-MANNOPYRANOSYLAMINE | 3.2.1.114 |
1R34 | GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH 5-THIO-D-MANNOPYRANOSYLAMIDINIUM SALT | 3.2.1.114 |
1R3M | CRYSTAL STRUCTURE OF THE DIMERIC UNSWAPPED FORM OF BOVINE SEMINAL RIBONUCLEASE | 3.1.27.5 4.6.1.18 |
1R3N | CRYSTAL STRUCTURE OF BETA-ALANINE SYNTHASE FROM SACCHAROMYCES KLUYVERI | 3.5.1.6 |
1R42 | NATIVE HUMAN ANGIOTENSIN CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE (ACE2) | 3.4.17.23 3.4.17 |
1R43 | CRYSTAL STRUCTURE OF BETA-ALANINE SYNTHASE FROM SACCHAROMYCES KLUYVERI (SELENOMETHIONINE SUBSTITUTED PROTEIN) | 3.5.1.6 |
1R44 | CRYSTAL STRUCTURE OF VANX | 3.4.13 3.4.13.22 |
1R46 | STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE | 3.2.1.22 3.2.1.47 |
1R47 | STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE | 3.2.1.22 3.2.1.47 |
1R4F | INOSINE-ADENOSINE-GUANOSINE PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX: TRP260ALA MUTANT IN COMPLEX WITH 3-DEAZA-ADENOSINE | 3.2.2.1 |
1R4L | INHIBITOR BOUND HUMAN ANGIOTENSIN CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE (ACE2) | 3.4.17.23 3.4.17 |
1R4P | SHIGA TOXIN TYPE 2 | 3.2.2.22 |
1R4Q | SHIGA TOXIN | 3.2.2.22 |
1R4Y | SOLUTION STRUCTURE OF THE DELETION MUTANT DELTA(7-22) OF THE CYTOTOXIC RIBONUCLEASE ALPHA-SARCIN | 3.1.27.10 4.6.1.23 |
1R4Z | BACILLUS SUBTILIS LIPASE A WITH COVALENTLY BOUND RC-IPG-PHOSPHONATE-INHIBITOR | 3.1.1.3 |
1R50 | BACILLUS SUBTILIS LIPASE A WITH COVALENTLY BOUND SC-IPG-PHOSPHONATE-INHIBITOR | 3.1.1.3 |
1R54 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM33 | 3.4.24 |
1R55 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM 33 | 3.4.24 |
1R58 | CRYSTAL STRUCTURE OF METAP2 COMPLEXED WITH A357300 | 3.4.11.18 |
1R5C | X-RAY STRUCTURE OF THE COMPLEX OF BOVINE SEMINAL RIBONUCLEASE SWAPPING DIMER WITH D(CPA) | 3.1.27.5 4.6.1.18 |
1R5D | X-RAY STRUCTURE OF BOVINE SEMINAL RIBONUCLEASE SWAPPING DIMER FROM A NEW CRYSTAL FORM | 3.1.27.5 4.6.1.18 |
1R5G | CRYSTAL STRUCTURE OF METAP2 COMPLEXED WITH A311263 | 3.4.11.18 |
1R5H | CRYSTAL STRUCTURE OF METAP2 COMPLEXED WITH A320282 | 3.4.11.18 |
1R5T | THE CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE CDD1, AN ORPHAN C TO U EDITASE FROM YEAST | 3.5.4.5 |
1R5Z | CRYSTAL STRUCTURE OF SUBUNIT C OF V-ATPASE | 3.6.3.14 |
1R62 | CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE TWO-COMPONENT SYSTEM TRANSMITTER PROTEIN NRII (NTRB) | 2.7.3 2.7.13.3 3.1.3 |
1R64 | THE 2.2 A CRYSTAL STRUCTURE OF KEX2 PROTEASE IN COMPLEX WITH AC-ARG-GLU-LYS-BOROARG PEPTIDYL BORONIC ACID INHIBITOR | 3.4.21.61 |
1R6A | STRUCTURE OF THE DENGUE VIRUS 2'O METHYLTRANSFERASE IN COMPLEX WITH S-ADENOSYL HOMOCYSTEINE AND RIBAVIRIN 5' TRIPHOSPHATE | 2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 |
1R6H | SOLUTION STRUCTURE OF HUMAN PRL-3 | 3.1.3.48 |
1R6R | SOLUTION STRUCTURE OF DENGUE VIRUS CAPSID PROTEIN REVEALS A NEW FOLD | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1R6V | CRYSTAL STRUCTURE OF FERVIDOLYSIN FROM FERVIDOBACTERIUM PENNIVORANS, A KERATINOLYTIC ENZYME RELATED TO SUBTILISIN | 3.4.21 |
1R77 | CRYSTAL STRUCTURE OF THE CELL WALL TARGETING DOMAIN OF PEPTIDYLGLYCAN HYDROLASE ALE-1 | 3.4.24.7 3.4.24.75 |
1R7M | THE HOMING ENDONUCLEASE I-SCEI BOUND TO ITS DNA RECOGNITION REGION | 3.1 |
1R7O | CRYSTAL STRUCTURE OF APO-MANNANASE 26A FROM PSUDOMONAS CELLULOSA | 3.2.1.78 |
1R7R | THE CRYSTAL STRUCTURE OF MURINE P97/VCP AT 3.6A | 3.6.4.6 |
1R8L | THE STRUCTURE OF ENDO-BETA-1,4-GALACTANASE FROM BACILLUS LICHENIFORMIS | 3.2.1.89 |
1R9G | THREE-DIMENSIONAL STRUCTURE OF YAAE FROM BACILLUS SUBTILIS | 4.3.3.6 3.5.1.2 |
1R9M | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV AT 2.1 ANG. RESOLUTION. | 3.4.14.5 |
1R9W | CRYSTAL STRUCTURE OF THE DNA-BINDING DOMAIN OF THE HUMAN PAPILLOMAVIRUS TYPE 18 (HPV-18) REPLICATION INITIATION PROTEIN E1 | 3.6.4.12 |
1R9X | BACTERIAL CYTOSINE DEAMINASE D314G MUTANT. | 3.5.4.1 3.5.4 |
1R9Y | BACTERIAL CYTOSINE DEAMINASE D314A MUTANT. | 3.5.4.1 3.5.4 |
1R9Z | BACTERIAL CYTOSINE DEAMINASE D314S MUTANT. | 3.5.4.1 3.5.4 |
1RA0 | BACTERIAL CYTOSINE DEAMINASE D314G MUTANT BOUND TO 5-FLUORO-4-(S)-HYDROXY-3,4-DIHYDROPYRIMIDINE. | 3.5.4.1 3.5.4 |
1RA5 | BACTERIAL CYTOSINE DEAMINASE D314A MUTANT BOUND TO 5-FLUORO-4-(S)-HYDROXYL-3,4-DIHYDROPYRIMIDINE. | 3.5.4.1 3.5.4 |
1RA6 | POLIOVIRUS POLYMERASE FULL LENGTH APO STRUCTURE | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
1RA7 | POLIOVIRUS POLYMERASE WITH GTP | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
1RAK | BACTERIAL CYTOSINE DEAMINASE D314S MUTANT BOUND TO 5-FLUORO-4-(S)-HYDROXYL-3,4-DIHYDROPYRIMIDINE. | 3.5.4.1 3.5.4 |
1RAR | CRYSTAL STRUCTURE OF A FLUORESCENT DERIVATIVE OF RNASE A | 3.1.27.5 4.6.1.18 |
1RAS | CRYSTAL STRUCTURE OF A FLUORESCENT DERIVATIVE OF RNASE A | 3.1.27.5 4.6.1.18 |
1RAT | EFFECTS OF TEMPERATURE ON PROTEIN STRUCTURE AND DYNAMICS: X-RAY CRYSTALLOGRAPHIC STUDIES OF THE PROTEIN RIBONUCLEASE-A AT NINE DIFFERENT TEMPERATURES FROM 98 TO 320 K | 3.1.27.5 4.6.1.18 |
1RB7 | YEAST CYTOSINE DEAMINASE CRYSTAL FORM P212121 WITH SODIUM ACETATE. | 3.5.4.1 |
1RBB | THE CRYSTAL STRUCTURE OF RIBONUCLEASE B AT 2.5-ANGSTROMS RESOLUTION | 3.1.27.5 4.6.1.18 |
1RBC | CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES | 3.1.27.5 4.6.1.18 |
1RBD | CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES | 3.1.27.5 4.6.1.18 |
1RBE | CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES | 3.1.27.5 4.6.1.18 |
1RBF | CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES | 3.1.27.5 4.6.1.18 |
1RBG | CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES | 3.1.27.5 4.6.1.18 |
1RBH | CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES | 3.1.27.5 4.6.1.18 |
1RBI | CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES | 3.1.27.5 4.6.1.18 |
1RBJ | RIBONUCLEASE B COMPLEX WITH D(TETRA-(DEOXY-ADENYLATE)) | 3.1.27.5 4.6.1.18 |
1RBN | THE STRUCTURE OF RIBONUCLEASE A DERIVATIVE II AT 2.1 ANGSTROMS RESOLUTION | 3.1.27.5 4.6.1.18 |
1RBR | STRUCTURAL STUDY OF MUTANTS OF ESCHERICHIA COLI RIBONUCLEASE HI WITH ENHANCED THERMOSTABILITY | 3.1.26.4 |
1RBS | STRUCTURAL STUDY OF MUTANTS OF ESCHERICHIA COLI RIBONUCLEASE HI WITH ENHANCED THERMOSTABILITY | 3.1.26.4 |
1RBT | STRUCTURAL STUDY OF MUTANTS OF ESCHERICHIA COLI RIBONUCLEASE HI WITH ENHANCED THERMOSTABILITY | 3.1.26.4 |
1RBU | STRUCTURAL STUDY OF MUTANTS OF ESCHERICHIA COLI RIBONUCLEASE HI WITH ENHANCED THERMOSTABILITY | 3.1.26.4 |
1RBV | STRUCTURAL STUDY OF MUTANTS OF ESCHERICHIA COLI RIBONUCLEASE HI WITH ENHANCED THERMOSTABILITY | 3.1.26.4 |
1RBW | RIBONUCLEASE A (E.C.3.1.27.5) WITH GUANIDINIUM | 3.1.27.5 4.6.1.18 |
1RBX | RIBONUCLEASE A (E.C.3.1.27.5) CONTROL | 3.1.27.5 4.6.1.18 |
1RC5 | CRYSTAL STRUCTURE OF MG(II)-COMPLEX OF RNASE III ENDONUCLEASE DOMAIN FROM AQUIFEX AEOLICUS AT 2.30 ANGSTROM RESOLUTION | 3.1.26.3 |
1RC6 | CRYSTAL STRUCTURE OF PROTEIN YLBA FROM E. COLI, PFAM DUF861 | 3.5.3.26 |
1RC7 | CRYSTAL STRUCTURE OF RNASE III MUTANT E110K FROM AQUIFEX AEOLICUS COMPLEXED WITH DS-RNA AT 2.15 ANGSTROM RESOLUTION | 3.1.26.3 |
1RC8 | T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-GTCAC-3' SSDNA | 2.7.1.78 3.1.3.34 |
1RCA | STRUCTURE OF THE CRYSTALLINE COMPLEX OF DEOXYCYTIDYLYL-3',5'-GUANOSINE (3',5'-DCPDG) CO-CRYSTALISED WITH RIBONUCLEASE AT 1.9 ANGSTROMS RESOLUTION. RETROBINDING IN PANCREATIC RNASEA IS INDEPENDENT OF MODE OF INHIBITOR INTROMISSION | 3.1.27.5 4.6.1.18 |
1RCH | SOLUTION NMR STRUCTURE OF RIBONUCLEASE HI FROM ESCHERICHIA COLI, 8 STRUCTURES | 3.1.26.4 |
1RCJ | CRYSTAL STRUCTURE OF E166A MUTANT OF SHV-1 BETA-LACTAMASE WITH THE TRANS-ENAMINE INTERMEDIATE OF TAZOBACTAM | 3.5.2.6 |
1RCK | THE THREE DIMENSIONAL STRUCTURE OF GUANINE-SPECIFIC RIBONUCLEASE F1 IN SOLUTION DETERMINED BY NMR SPECTROSCOPY AND DISTANCE GEOMETRY | 3.1.27.3 4.6.1.24 |
1RCL | THE THREE DIMENSIONAL STRUCTURE OF GUANINE-SPECIFIC RIBONUCLEASE F1 IN SOLUTION DETERMINED BY NMR SPECTROSCOPY AND DISTANCE GEOMETRY | 3.1.27.3 4.6.1.24 |
1RCM | CRYSTAL STRUCTURE OF A UBIQUITIN-DEPENDENT DEGRADATION SUBSTRATE: A THREE-DISULFIDE FORM OF LYSOZYME | 3.2.1.17 |
1RD3 | 2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K | 3.4.21.5 |
1RD6 | CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE A MUTANT W167A | 3.2.1.14 |
1RDA | CRYSTAL STRUCTURES OF RIBONUCLEASE HI ACTIVE SITE MUTANTS FROM ESCHERICHIA COLI | 3.1.26.4 |
1RDB | CRYSTAL STRUCTURES OF RIBONUCLEASE HI ACTIVE SITE MUTANTS FROM ESCHERICHIA COLI | 3.1.26.4 |
1RDC | CRYSTAL STRUCTURES OF RIBONUCLEASE HI ACTIVE SITE MUTANTS FROM ESCHERICHIA COLI | 3.1.26.4 |
1RDD | CRYSTAL STRUCTURE OF ESCHERICHIA COLI RNASE HI IN COMPLEX WITH MG2+ AT 2.8 ANGSTROMS RESOLUTION: PROOF FOR A SINGLE MG2+ SITE | 3.1.26.4 |
1RDF | G50P MUTANT OF PHOSPHONOACETALDEHYDE HYDROLASE IN COMPLEX WITH SUBSTRATE ANALOGUE VINYL SULFONATE | 3.11.1.1 |
1RDR | POLIOVIRUS 3D POLYMERASE | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
1RDS | CRYSTAL STRUCTURE OF RIBONUCLEASE MS (AS RIBONUCLEASE T1 HOMOLOGUE) COMPLEXED WITH A GUANYLYL-3',5'-CYTIDINE ANALOGUE | 3.1.27.3 4.6.1.24 |
1RDX | R-STATE STRUCTURE OF THE ARG 243 TO ALA MUTANT OF PIG KIDNEY FRUCTOSE 1,6-BISPHOSPHATASE EXPRESSED IN E. COLI | 3.1.3.11 |
1RDY | T-STATE STRUCTURE OF THE ARG 243 TO ALA MUTANT OF PIG KIDNEY FRUCTOSE 1,6-BISPHOSPHATASE EXPRESSED IN E. COLI | 3.1.3.11 |
1RDZ | T-STATE STRUCTURE OF THE ARG 243 TO ALA MUTANT OF PIG KIDNEY FRUCTOSE 1,6-BISPHOSPHATASE EXPRESSED IN E. COLI | 3.1.3.11 |
1RE1 | CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR | 3.4.22 3.4.22.56 |
1RE2 | HUMAN LYSOZYME LABELLED WITH TWO 2',3'-EPOXYPROPYL BETA-GLYCOSIDE OF N-ACETYLLACTOSAMINE | 3.2.1.17 |
1RED | ENDO-1,4-BETA-XYLANASE II COMPLEX WITH 4,5-EPOXYPENTYL-BETA-D-XYLOSIDE | 3.2.1.8 |
1REE | ENDO-1,4-BETA-XYLANASE II COMPLEX WITH 3,4-EPOXYBUTYL-BETA-D-XYLOSIDE | 3.2.1.8 |
1REF | ENDO-1,4-BETA-XYLANASE II COMPLEX WITH 2,3-EPOXYPROPYL-BETA-D-XYLOSIDE | 3.2.1.8 |
1REM | HUMAN LYSOZYME WITH MAN-B1,4-GLCNAC COVALENTLY ATTACHED TO ASP53 | 3.2.1.17 |
1RER | CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SEMLIKI FOREST VIRUS. | 3.4.21.90 |
1REV | HIV-1 REVERSE TRANSCRIPTASE | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1REX | NATIVE HUMAN LYSOZYME | 3.2.1.17 |
1REY | HUMAN LYSOZYME-N,N'-DIACETYLCHITOBIOSE COMPLEX | 3.2.1.17 |
1REZ | HUMAN LYSOZYME-N-ACETYLLACTOSAMINE COMPLEX | 3.2.1.17 |
1RFF | CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTAPEPTIDE KLNYYDPR, AND TETRANUCLEOTIDE AGTT. | 3.1.4 |
1RFI | CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE COMPLEXED WITH VANADATE, PENTAPEPTIDE KLNYK, AND TETRANUCLEOTIDE AGTC | 3.1.4 |
1RFL | NMR DATA DRIVEN STRUCTURAL MODEL OF G-DOMAIN OF MNME PROTEIN | 3.6 |
1RFN | HUMAN COAGULATION FACTOR IXA IN COMPLEX WITH P-AMINO BENZAMIDINE | 3.4.21.22 |
1RFP | ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS | 3.2.1.17 |
1RG1 | CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTOPAMINE, AND TETRANUCLEOTIDE AGTT | 3.1.4 |
1RG2 | CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTOPAMINE, AND TETRANUCLEOTIDE AGTA | 3.1.4 |
1RGA | CRYSTAL STRUCTURE OF RNASE T1 WITH 3'-GMP AND GUANOSINE: A PRODUCT COMPLEX | 3.1.27.3 4.6.1.24 |
1RGB | PHOSPHOLIPASE A2 FROM VIPERA AMMODYTES MERIDIONALIS | 3.1.1.4 |
1RGC | THE COMPLEX BETWEEN RIBONUCLEASE T1 AND 3'-GUANYLIC ACID SUGGESTS GEOMETRY OF ENZYMATIC REACTION PATH. AN X-RAY STUDY | 3.1.27.3 4.6.1.24 |
1RGE | HYDROLASE, GUANYLORIBONUCLEASE | 3.1.27.3 4.6.1.24 |
1RGF | HYDROLASE, GUANYLORIBONUCLEASE | 3.1.27.3 4.6.1.24 |
1RGG | HYDROLASE, GUANYLORIBONUCLEASE | 3.1.27.3 4.6.1.24 |
1RGH | HYDROLASE, GUANYLORIBONUCLEASE | 3.1.27.3 4.6.1.24 |
1RGK | RNASE T1 MUTANT GLU46GLN BINDS THE INHIBITORS 2'GMP AND 2'AMP AT THE 3' SUBSITE | 3.1.27.3 4.6.1.24 |
1RGL | RNASE T1 MUTANT GLU46GLN BINDS THE INHIBITORS 2'GMP AND 2'AMP AT THE 3' SUBSITE | 3.1.27.3 4.6.1.24 |
1RGQ | M9A HCV PROTEASE COMPLEX WITH PENTAPEPTIDE KETO-AMIDE INHIBITOR | 3.4.21.98 3.4.22 3.6.1.15 3.6.4.13 2.7.7.48 |
1RGT | CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTOPAMINE, AND TETRANUCLEOTIDE AGTC | 3.1.4 |
1RGU | THE CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTOPAMINE, AND TETRANUCLEOTIDE AGTG | 3.1.4 |
1RGY | CITROBACTER FREUNDII GN346 CLASS C BETA-LACTAMASE COMPLEXED WITH TRANSITION-STATE ANALOG OF CEFOTAXIME | 3.5.2.6 |
1RGZ | ENTEROBACTER CLOACAE GC1 CLASS C BETA-LACTAMASE COMPLEXED WITH TRANSITION-STATE ANALOG OF CEFOTAXIME | 3.5.2.6 |
1RH0 | CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTOPAMINE AND TRINUCLEOTIDE GTT | 3.1.4 |
1RH9 | FAMILY GH5 ENDO-BETA-MANNANASE FROM LYCOPERSICON ESCULENTUM (TOMATO) | 3.2.1.78 |
1RHA | WATER DEPENDENT DOMAIN MOTION AND FLEXIBILITY IN RIBONUCLEASE A AND THE INVARIANT FEATURES IN ITS HYDRATION SHELL. AN X-RAY STUDY OF TWO LOW HUMIDITY CRYSTAL FORMS OF THE ENZYME | 3.1.27.5 4.6.1.18 |
1RHB | WATER DEPENDENT DOMAIN MOTION AND FLEXIBILITY IN RIBONUCLEASE A AND THE INVARIANT FEATURES IN ITS HYDRATION SHELL. AN X-RAY STUDY OF TWO LOW HUMIDITY CRYSTAL FORMS OF THE ENZYME | 3.1.27.5 4.6.1.18 |
1RHI | HUMAN RHINOVIRUS 3 COAT PROTEIN | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RHJ | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR | 3.4.22 3.4.22.56 |
1RHK | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PHENYL-PROPYL-KETONE INHIBITOR | 3.4.22 3.4.22.56 |
1RHL | RIBONUCLEASE T1 COMPLEXED WITH 2'GMP/G23A MUTANT | 3.1.27.3 4.6.1.24 |
1RHM | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR | 3.4.22 3.4.22.56 |
1RHQ | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR | 3.4.22 3.4.22.56 |
1RHR | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A CINNAMIC ACID METHYL ESTER INHIBITOR | 3.4.22 3.4.22.56 |
1RHU | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A 5,6,7 TRICYCLIC PEPTIDOMIMETIC INHIBITOR | 3.4.22 3.4.22.56 |
1RI6 | STRUCTURE OF A PUTATIVE ISOMERASE FROM E. COLI | 3.1.1.31 |
1RIF | CRYSTAL STRUCTURE OF THE UVSW HELICASE FROM BACTERIOPHAGE T4 | 3.6.4.12 |
1RIL | CRYSTAL STRUCTURE OF RIBONUCLEASE H FROM THERMUS THERMOPHILUS HB8 REFINED AT 2.8 ANGSTROMS RESOLUTION | 3.1.26.4 |
1RIW | THROMBIN IN COMPLEX WITH NATURAL PRODUCT INHIBITOR OSCILLARIN | 3.4.21.5 |
1RJP | CRYSTAL STRUCTURE OF D-AMINOACYLASE IN COMPLEX WITH 100MM CUCL2 | 3.5.1.81 |
1RJQ | THE CRYSTAL STRUCTURE OF THE D-AMINOACYLASE MUTANT D366A | 3.5.1.81 |
1RJR | THE CRYSTAL STRUCTURE OF THE D-AMINOACYLASE D366A MUTANT IN COMPLEX WITH 100MM ZNCL2 | 3.5.1.81 |
1RJX | HUMAN PLASMINOGEN CATALYTIC DOMAIN, K698M MUTANT | 3.4.21.7 |
1RK5 | THE D-AMINOACYLASE MUTANT D366A IN COMPLEX WITH 100MM CUCL2 | 3.5.1.81 |
1RK6 | THE ENZYME IN COMPLEX WITH 50MM CDCL2 | 3.5.1.81 |
1RKN | SOLUTION STRUCTURE OF 1-110 FRAGMENT OF STAPHYLOCOCCAL NUCLEASE WITH G88W MUTATION | 3.1.31.1 |
1RKP | CRYSTAL STRUCTURE OF PDE5A1-IBMX | 3.1.4.17 3.1.4.35 |
1RKQ | CRYSTAL STRUCTURE OF HAD-LIKE PHOSPHATASE YIDA FROM E. COLI | 3.1.3.23 |
1RKU | CRYSTAL STRUCTURE OF THRH GENE PRODUCT OF PSEUDOMONAS AERUGINOSA | 3.1.3.3 |
1RKV | STRUCTURE OF PHOSPHATE COMPLEX OF THRH FROM PSEUDOMONAS AERUGINOSA | 3.1.3.3 |
1RL0 | CRYSTAL STRUCTURE OF A NEW RIBOSOME-INACTIVATING PROTEIN (RIP): DIANTHIN 30 | 3.2.2.22 |
1RL4 | PLASMODIUM FALCIPARUM PEPTIDE DEFORMYLASE COMPLEX WITH INHIBITOR | 3.5.1.31 3.5.1.88 |
1RL8 | CRYSTAL STRUCTURE OF THE COMPLEX OF RESISTANT STRAIN OF HIV-1 PROTEASE(V82A MUTANT) WITH RITONAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RLA | THREE-DIMENSIONAL STRUCTURE OF RAT LIVER ARGINASE, THE BINUCLEAR MANGANESE METALLOENZYME OF THE UREA CYCLE | 3.5.3.1 |
1RLK | STRUCTURE OF CONSERVED PROTEIN OF UNKNOWN FUNCTION TA0108 FROM THERMOPLASMA ACIDOPHILUM | 3.1.1.29 |
1RLM | CRYSTAL STRUCTURE OF YBIV FROM ESCHERICHIA COLI K12 | 3.1.3 3.1.3.23 |
1RLO | PHOSPHO-ASPARTYL INTERMEDIATE ANALOGUE OF YBIV FROM E. COLI K12 | 3.1.3 3.1.3.23 |
1RLS | CRYSTAL STRUCTURE OF RNASE T1 COMPLEXED WITH THE PRODUCT NUCLEOTIDE 3'-GMP. STRUCTURAL EVIDENCE FOR DIRECT INTERACTION OF HISTIDINE 40 AND GLUTAMIC ACID 58 WITH THE 2'-HYDROXYL GROUP OF RIBOSE | 3.1.27.3 4.6.1.24 |
1RLT | TRANSITION STATE ANALOGUE OF YBIV FROM E. COLI K12 | 3.1.3 3.1.3.23 |
1RLV | CRYSTAL STRUCTURE OF A DIMERIC ARCHAEAL SPLICING ENDONUCLEASE | 3.1.27.9 4.6.1.16 |
1RLW | CALCIUM-PHOSPHOLIPID BINDING DOMAIN FROM CYTOSOLIC PHOSPHOLIPASE A2 | 3.1.1.4 3.1.1.5 |
1RM8 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-16/MT3-MMP: CHARACTERIZATION OF MT-MMP SPECIFIC FEATURES | 3.4.24 |
1RMD | RAG1 DIMERIZATION DOMAIN | 3.1 2.3.2.27 |
1RMG | RHAMNOGALACTURONASE A FROM ASPERGILLUS ACULEATUS | 3.2.1 3.2.1.171 |
1RMQ | CRYSTAL STRUCTURE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE WITH OSMIATE MIMICKING THE CATALYTIC INTERMEDIATE | 3.1.3.2 |
1RMS | CRYSTAL STRUCTURES OF RIBONUCLEASE MS COMPLEXED WITH 3'-GUANYLIC ACID A GP*C ANALOGUE, 2'-DEOXY-2'-FLUOROGUANYLYL-3',5'-CYTIDINE | 3.1.4.23 4.6.1.24 |
1RMT | CRYSTAL STRUCTURE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE COMPLEXED WITH ADENOSINE. | 3.1.3.2 |
1RMU | THREE-DIMENSIONAL STRUCTURES OF DRUG-RESISTANT MUTANTS OF HUMAN RHINOVIRUS 14 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RMY | CRYSTAL STRUCTURE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE TERNARY COMPLEX WITH DEOXYCYTOSINE AND PHOSPHATE BOUND TO THE CATALYTIC METAL | 3.1.3.2 |
1RMZ | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR NNGH AT 1.3 A RESOLUTION | 3.4.24.65 |
1RN1 | THREE-DIMENSIONAL STRUCTURE OF GLN 25-RIBONUCLEASE T1 AT 1.84 ANGSTROMS RESOLUTION: STRUCTURAL VARIATIONS AT THE BASE RECOGNITION AND CATALYTIC SITES | 3.1.27.3 4.6.1.24 |
1RN4 | HIS92ALA MUTATION IN RIBONUCLEASE T1 INDUCES SEGMENTAL FLEXIBILITY. AN X-RAY STUDY | 3.1.27.3 4.6.1.24 |
1RN8 | CRYSTAL STRUCTURE OF DUTPASE COMPLEXED WITH SUBSTRATE ANALOGUE IMIDO-DUTP | 3.6.1.23 |
1RNB | CRYSTAL STRUCTURE OF A BARNASE-D(*GP*C) COMPLEX AT 1.9 ANGSTROMS RESOLUTION | 3.1.27 |
1RNC | NEWLY OBSERVED BINDING MODE IN PANCREATIC RIBONUCLEASE | 3.1.27.5 4.6.1.18 |
1RND | NEWLY OBSERVED BINDING MODE IN PANCREATIC RIBONUCLEASE | 3.1.27.5 4.6.1.18 |
1RNE | THE CRYSTAL STRUCTURE OF RECOMBINANT GLYCOSYLATED HUMAN RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG INHIBITOR | 3.4.23.15 |
1RNF | X-RAY CRYSTAL STRUCTURE OF UNLIGANDED HUMAN RIBONUCLEASE 4 | 3.1.27 |
1RNH | STRUCTURE OF RIBONUCLEASE H PHASED AT 2 ANGSTROMS RESOLUTION BY MAD ANALYSIS OF THE SELENOMETHIONYL PROTEIN | 3.1.26.4 |
1RNJ | CRYSTAL STRUCTURE OF INACTIVE MUTANT DUTPASE COMPLEXED WITH SUBSTRATE ANALOGUE IMIDO-DUTP | 3.6.1.23 |
1RNM | RIBONUCLEASE A COMPLEX WITH CYTIDYLIC ACID (5'CMP) CRYSTALLIZED FROM 80% AMMONIUM SULPHATE | 3.1.27.5 4.6.1.18 |
1RNN | RIBONUCLEASE A COMPLEX WITH CYTIDYLIC ACID (5'CMP) CRYSTALLIZED FROM 8M SODIUM FORMATE | 3.1.27.5 4.6.1.18 |
1RNO | RIBONUCLEASE A CRYSTALLIZED FROM 80% AMMONIUM SULPHATE | 3.1.27.5 4.6.1.18 |
1RNQ | RIBONUCLEASE A CRYSTALLIZED FROM 8M SODIUM FORMATE | 3.1.27.5 4.6.1.18 |
1RNT | RESTRAINED LEAST-SQUARES REFINEMENT OF THE CRYSTAL STRUCTURE OF THE RIBONUCLEASE T1(ASTERISK)2(PRIME)-GUANYLIC ACID COMPLEX AT 1.9 ANGSTROMS RESOLUTION | 3.1.27.3 4.6.1.24 |
1RNU | REFINEMENT OF THE CRYSTAL STRUCTURE OF RIBONUCLEASE S. COMPARISON WITH AND BETWEEN THE VARIOUS RIBONUCLEASE A STRUCTURES | 3.1.27.5 4.6.1.18 |
1RNV | REFINEMENT OF THE CRYSTAL STRUCTURE OF RIBONUCLEASE S. COMPARISON WITH AND BETWEEN THE VARIOUS RIBONUCLEASE A STRUCTURES | 3.1.27.5 4.6.1.18 |
1RNW | RECOMBINANT RIBONUCLEASE A CRYSTALLIZED FROM 80% AMMONIUM SULPHATE | 3.1.27.5 4.6.1.18 |
1RNX | RIBONUCLEASE A CRYSTALLIZED FROM 3M SODIUM CHLORIDE, 30% AMMONIUM SULFATE | 3.1.27.5 4.6.1.18 |
1RNY | RIBONUCLEASE A CRYSTALLIZED FROM 3M CESIUM CHLORIDE, 30% AMMONIUM SULFATE | 3.1.27.5 4.6.1.18 |
1RNZ | RIBONUCLEASE A CRYSTALLIZED FROM 2.5M SODIUM CHLORIDE, 3.3M SODIUM FORMATE | 3.1.27.5 4.6.1.18 |
1RO6 | CRYSTAL STRUCTURE OF PDE4B2B COMPLEXED WITH ROLIPRAM (R & S) | 3.1.4.17 3.1.4.53 |
1RO9 | CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH 8-BR-AMP | 3.1.4.17 3.1.4.53 |
1ROB | STRUCTURE OF THE CRYSTALLINE COMPLEX OF CYTIDYLIC ACID (2'-CMP) WITH RIBONUCLEASE AT 1.6 ANGSTROMS RESOLUTION | 3.1.27.5 4.6.1.18 |
1ROR | CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH AMP | 3.1.4.17 3.1.4.53 |
1ROS | CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[1,1-BIPHENYL]-4-YL)-4-OXOBUTANOIC ACID | 3.4.24.65 |
1RP1 | DOG PANCREATIC LIPASE RELATED PROTEIN 1 | 3.1.1.3 |
1RP5 | PBP2X FROM STREPTOCOCCUS PNEUMONIAE STRAIN 5259 WITH REDUCED SUSCEPTIBILITY TO BETA-LACTAM ANTIBIOTICS | 3.4 |
1RP8 | CRYSTAL STRUCTURE OF BARLEY ALPHA-AMYLASE ISOZYME 1 (AMY1) INACTIVE MUTANT D180A IN COMPLEX WITH MALTOHEPTAOSE | 3.2.1.1 |
1RP9 | CRYSTAL STRUCTURE OF BARLEY ALPHA-AMYLASE ISOZYME 1 (AMY1) INACTIVE MUTANT D180A IN COMPLEX WITH ACARBOSE | 3.2.1.1 |
1RPA | THREE-DIMENSIONAL STRUCTURE OF RAT ACID PHOSPHATASE IN COMPLEX WITH L(+) TARTRATE | 3.1.3.2 3.1.3.5 |
1RPF | THE STRUCTURES OF RNASE COMPLEXED WITH 3'-CMP AND D(CPA): ACTIVE SITE CONFORMATION AND CONSERVED WATER MOLECULES | 3.1.27.5 4.6.1.18 |
1RPG | STRUCTURES OF RNASE A COMPLEXED WITH 3'-CMP AND D(CPA): ACTIVE SITE CONFORMATION AND CONSERVED WATER MOLECULES | 3.1.27.5 4.6.1.18 |
1RPH | STRUCTURES OF RNASE A COMPLEXED WITH 3'-CMP AND D(CPA): ACTIVE SITE CONFORMATION AND CONSERVED WATER MOLECULES | 3.1.27.5 4.6.1.18 |
1RPI | CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY | 3.4.23.16 |
1RPK | CRYSTAL STRUCTURE OF BARLEY ALPHA-AMYLASE ISOZYME 1 (AMY1) IN COMPLEX WITH ACARBOSE | 3.2.1.1 |
1RPM | HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU, DOMAIN 1 | 3.1.3.48 |
1RPT | CRYSTAL STRUCTURES OF RAT ACID PHOSPHATASE COMPLEXED WITH THE TRANSITIONS STATE ANALOGS VANADATE AND MOLYBDATE: IMPLICATIONS FOR THE REACTION MECHANISM | 3.1.3.2 3.1.3.5 |
1RPZ | T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-TGCAC-3' SSDNA | 2.7.1.78 3.1.3.34 |
1RQ5 | STRUCTURAL BASIS FOR THE EXOCELLULASE ACTIVITY OF THE CELLOBIOHYDROLASE CBHA FROM C. THERMOCELLUM | 3.2.1.91 3.2.1 |
1RQ9 | CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY | 3.4.23.16 |
1RQC | CRYSTALS OF PEPTIDE DEFORMYLASE FROM PLASMODIUM FALCIPARUM WITH TEN SUBUNITS PER ASYMMETRIC UNIT REVEAL CRITICAL CHARACTERISTICS OF THE ACTIVE SITE FOR DRUG DESIGN | 3.5.1.88 |
1RQL | CRYSTAL STRUCTURE OF PHOSPONOACETALDEHYDE HYDROLASE COMPLEXED WITH MAGNESIUM AND THE INHIBITOR VINYL SULFONATE | 3.11.1.1 |
1RQN | PHOSPHONOACETALDEHYDE HYDROLASE COMPLEXED WITH MAGNESIUM | 3.11.1.1 |
1RQX | CRYSTAL STRUCTURE OF ACC DEAMINASE COMPLEXED WITH INHIBITOR | 3.5.99.7 |
1RR9 | CATALYTIC DOMAIN OF E.COLI LON PROTEASE | 3.4.21.53 |
1RRA | RIBONUCLEASE A FROM RATTUS NORVEGICUS (COMMON RAT) | 3.1.27.5 4.6.1.18 |
1RRC | T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-GTC-3' SSDNA | 2.7.1.78 3.1.3.34 |
1RRE | CRYSTAL STRUCTURE OF E.COLI LON PROTEOLYTIC DOMAIN | 3.4.21.53 |
1RRK | CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B | 3.4.21.47 |
1RRQ | MUTY ADENINE GLYCOSYLASE IN COMPLEX WITH DNA CONTAINING AN A:OXOG PAIR | 3.2.2 3.2.2.31 |
1RRS | MUTY ADENINE GLYCOSYLASE IN COMPLEX WITH DNA CONTAINING AN ABASIC SITE | 3.2.2 3.2.2.31 |
1RS0 | CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH DI-ISOPROPYL-PHOSPHATE (DIP) | 3.4.21.47 |
1RSM | THE 2-ANGSTROMS RESOLUTION STRUCTURE OF A THERMOSTABLE RIBONUCLEASE A CHEMICALLY CROSS-LINKED BETWEEN LYSINE RESIDUES 7 AND 41 | 3.1.27.5 4.6.1.18 |
1RSN | RIBONUCLEASE (RNASE SA) (E.C.3.1.4.8) COMPLEXED WITH EXO-2',3'-CYCLOPHOSPHOROTHIOATE | 3.1.27.3 4.6.1.24 |
1RT1 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RT2 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RT3 | AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RT4 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RT5 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RT6 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RT7 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RTB | CRYSTAL STRUCTURE DISPOSITION OF THYMIDYLIC ACID TETRAMER IN COMPLEX WITH RIBONUCLEASE A | 3.1.27.5 4.6.1.18 |
1RTC | THE STRUCTURE OF RECOMBINANT RICIN A CHAIN AT 2.3 ANGSTROMS | 3.2.2.22 |
1RTD | STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RTF | COMPLEX OF BENZAMIDINE WITH THE CATALYTIC DOMAIN OF HUMAN TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR [(TC)-T-PA] | 3.4.21.68 |
1RTG | C-TERMINAL DOMAIN (HAEMOPEXIN-LIKE DOMAIN) OF HUMAN MATRIX METALLOPROTEINASE-2 | 3.4.24.24 |
1RTH | HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RTI | HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RTJ | MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1RTK | CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH 4-GUANIDINOBENZOIC ACID | 3.4.21.47 |
1RTL | CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN: NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND PYRROLIDINE-5,5-TRANSLACTAM INHIBITOR | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
1RTQ | THE 0.95 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE AMINOPEPTIDASE FROM AEROMONAS PROTEOLYTICA | 3.4.11.10 |
1RUC | RHINOVIRUS 14 MUTANT N1105S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52035 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RUD | RHINOVIRUS 14 MUTANT N1105S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52084 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RUE | RHINOVIRUS 14 SITE DIRECTED MUTANT N1219A COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52035 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RUF | RHINOVIRUS 14 (HRV14) (MUTANT WITH ASN 1 219 REPLACED BY ALA (N219A IN CHAIN 1) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RUG | RHINOVIRUS 14 MUTANT N1219S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52035 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RUH | RHINOVIRUS 14 MUTANT N1219S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52084 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RUI | RHINOVIRUS 14 MUTANT S1223G COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52084 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RUJ | RHINOVIRUS 14 MUTANT WITH SER 1 223 REPLACED BY GLY (S1223G) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RUV | RIBONUCLEASE A-URIDINE VANADATE COMPLEX: HIGH RESOLUTION RESOLUTION X-RAY STRUCTURE (1.3 A) | 3.1.27.5 4.6.1.18 |
1RV5 | COMPLEX OF ECORV ENDONUCLEASE WITH D(AAAGAT)/D(ATCTT) | 3.1.21.4 |
1RV7 | CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY | 3.4.23.16 |
1RVA | MG2+ BINDING TO THE ACTIVE SITE OF ECO RV ENDONUCLEASE: A CRYSTALLOGRAPHIC STUDY OF COMPLEXES WITH SUBSTRATE AND PRODUCT DNA AT 2 ANGSTROMS RESOLUTION | 3.1.21.4 |
1RVB | MG2+ BINDING TO THE ACTIVE SITE OF ECO RV ENDONUCLEASE: A CRYSTALLOGRAPHIC STUDY OF COMPLEXES WITH SUBSTRATE AND PRODUCT DNA AT 2 ANGSTROMS RESOLUTION | 3.1.21.4 |
1RVC | MG2+ BINDING TO THE ACTIVE SITE OF ECO RV ENDONUCLEASE: A CRYSTALLOGRAPHIC STUDY OF COMPLEXES WITH SUBSTRATE AND PRODUCT DNA AT 2 ANGSTROMS RESOLUTION | 3.1.21.4 |
1RVD | H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA,GAMMA-IMIDO-GTP | 3.6.5.2 |
1RVE | THE CRYSTAL STRUCTURE OF ECORV ENDONUCLEASE AND OF ITS COMPLEXES WITH COGNATE AND NON-COGNATE DNA FRAGMENTS | 3.1.21.4 |
1RVF | FAB COMPLEXED WITH INTACT HUMAN RHINOVIRUS | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1RW2 | THREE-DIMENSIONAL STRUCTURE OF KU80 CTD | 3.6.4 |
1RWK | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-(2-MERCAPTO-ACETYLAMINO)-4-OXO-PENTANOIC ACID | 3.4.22.36 |
1RWM | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-[2-(5-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-THIOPHEN-2-YL)-ACETYLAMINO]-PENTANOIC ACID | 3.4.22.36 |
1RWN | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID | 3.4.22.36 |
1RWO | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-{6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-PENTANOIC ACID | 3.4.22.36 |
1RWP | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID | 3.4.22.36 |
1RWQ | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH 5-AMINOMETHYL-6-(2,4-DICHLORO-PHENYL)-2-(3,5-DIMETHOXY-PHENYL)-PYRIMIDIN-4-YLAMINE | 3.4.14.5 |
1RWV | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 5-[5-(1-CARBOXYMETHYL-2-OXO-PROPYLCARBAMOYL)-5-PHENYL-PENTYLSULFAMOYL]-2-HYDROXY-BENZOIC ACID | 3.4.22.36 |
1RWW | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-PYRIDINE-3-CARBONYL)-AMINO]-BUTYRIC ACID | 3.4.22.36 |
1RWX | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-{6-[4-(QUINOXALIN-2-YLOXY)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-BUTYRIC ACID | 3.4.22.36 |
1RXD | CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE 4A1 | 3.1.3.48 |
1RXP | STRUCTURE OF TRYPSIN (ORTHORHOMBIC) WITH 1-(4-TERT-BUTYLCARBAMOYL- PIPERAZINE-1-CARBONYL)-3-(3-GUANIDINO-PROPYL)-4-OXO-AZETIDINE-2-CARBOXYLIC ACID | 3.4.21.4 |
1RXQ | YFIT FROM BACILLUS SUBTILIS IS A PROBABLE METAL-DEPENDENT HYDROLASE WITH AN UNUSUAL FOUR-HELIX BUNDLE TOPOLOGY | 3 |
1RXV | CRYSTAL STRUCTURE OF A. FULGIDUS FEN-1 BOUND TO DNA | 3.1 |
1RXW | CRYSTAL STRUCTURE OF A. FULGIDUS FEN-1 BOUND TO DNA | 3.1 |
1RXX | STRUCTURE OF ARGININE DEIMINASE | 3.5.3.6 |
1RYA | CRYSTAL STRUCTURE OF THE E. COLI GDP-MANNOSE MANNOSYL HYDROLASE IN COMPLEX WITH GDP AND MG | 3.6.1 |
1RYB | CRYSTAL STRUCTURE OF THE CHLOROPLAST GROUP II INTRON SPLICING FACTOR CRS2 | 3.1.1.29 |
1RYF | ALTERNATIVE SPLICING OF RAC1 GENERATES RAC1B, A SELF-ACTIVATING GTPASE | 3.6.5.2 |
1RYH | ALTERNATIVE SPLICING OF RAC1 GENERATES RAC1B, A SELF-ACTIVATING GTPASE | 3.6.5.2 |
1RZ2 | 1.6A CRYSTAL STRUCTURE OF THE PROTEIN BA4783/Q81L49 (SIMILAR TO SORTASE B) FROM BACILLUS ANTHRACIS. | 3.4.22.71 |
1RZN | CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN-RELATED FACTOR A FROM BACILLUS SUBTILIS. | 3.1.22.4 |
1RZO | AGGLUTININ FROM RICINUS COMMUNIS WITH GALACTOAZA | 3.2.2.22 |
1RZW | THE SOLUTION STRUCTURE OF THE ARCHAEGLOBUS FULGIDIS PROTEIN AF2095. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET GR4 | 3.1.1.29 |
1RZY | CRYSTAL STRUCTURE OF RABBIT HINT COMPLEXED WITH N-ETHYLSULFAMOYLADENOSINE | 3 |
1S01 | LARGE INCREASES IN GENERAL STABILITY FOR SUBTILISIN BPN(PRIME) THROUGH INCREMENTAL CHANGES IN THE FREE ENERGY OF UNFOLDING | 3.4.21.62 |
1S02 | EFFECTS OF ENGINEERED SALT BRIDGES ON THE STABILITY OF SUBTILISIN BPN' | 3.4.21.14 3.4.21.62 |
1S0B | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0 | 3.4.24.69 |
1S0C | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0 | 3.4.24.69 |
1S0D | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5 | 3.4.24.69 |
1S0E | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0 | 3.4.24.69 |
1S0F | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0 | 3.4.24.69 |
1S0G | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B APO FORM | 3.4.24.69 |
1S0I | TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH SIALYL-LACTOSE (MICHAELIS COMPLEX) | 3.2.1.18 |
1S0J | TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH MUNANA (MICHAELIS COMPLEX) | 3.2.1.18 |
1S0Q | NATIVE BOVINE PANCREATIC TRYPSIN | 3.4.21.4 |
1S0R | BOVINE PANCREATIC TRYPSIN INHIBITED WITH BENZAMIDINE AT ATOMIC RESOLUTION | 3.4.21.4 |
1S0U | EIF2GAMMA APO | 3.6.5.3 |
1S0W | 1B LACTAMSE/ B LACTAMASE INHIBITOR | 3.5.2.6 |
1S17 | IDENTIFICATION OF NOVEL POTENT BICYCLIC PEPTIDE DEFORMYLASE INHIBITORS | 3.5.1.88 |
1S18 | STRUCTURE AND PROTEIN DESIGN OF HUMAN APYRASE | 3.6.1.5 3.6.1.6 |
1S1C | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE HUMAN RHOA AND RHO-BINDING DOMAIN OF HUMAN ROCKI | 3.6.5.2 |
1S1D | STRUCTURE AND PROTEIN DESIGN OF HUMAN APYRASE | 3.6.1.5 3.6.1.6 |
1S1T | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1S1U | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1S1V | CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1S1W | CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1S1X | CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1S2B | STRUCTURE OF SCP-B THE FIRST MEMBER OF THE EQOLISIN FAMILY OF PEPTIDASES TO HAVE ITS STRUCTURE DETERMINED | 3.4.23.32 |
1S2J | CRYSTAL STRUCTURE OF THE DROSOPHILA PATTERN-RECOGNITION RECEPTOR PGRP-SA | 3.4.17.13 |
1S2K | STRUCTURE OF SCP-B A MEMBER OF THE EQOLISIN FAMILY OF PEPTIDASES IN A COMPLEX WITH A TRIPEPTIDE ALA-ILE-HIS | 3.4.23.32 |
1S2M | CRYSTAL STRUCTURE OF THE DEAD BOX PROTEIN DHH1P | 3.6.4.13 |
1S2N | CRYSTAL STRUCTURE OF A COLD ADAPTED SUBTILISIN-LIKE SERINE PROTEINASE | 3.4.21 |
1S2O | X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 AT 1.40 A RESOLUTION | 3.1.3.24 |
1S3L | STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A NOVEL ARCHAEAL PHOSPHODIESTERASE | 3.1.4 |
1S3M | STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A NOVEL ARCHAEAL PHOSPHODIESTERASE | 3.1.4 |
1S3N | STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A NOVEL ARCHAEAL PHOSPHODIESTERASE | 3.1.4 |
1S3T | BORATE INHIBITED BACILLUS PASTEURII UREASE CRYSTAL STRUCTURE | 3.5.1.5 |
1S48 | CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE CONSTRUCT 1 (RESIDUES 71-679) FROM BVDV | 3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48 |
1S49 | CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE CONSTRUCT 1 (RESIDUES 71-679) FROM BOVINE VIRAL DIARRHEA VIRUS COMPLEXED WITH GTP | 3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 2.7.7.48 |
1S4B | CRYSTAL STRUCTURE OF HUMAN THIMET OLIGOPEPTIDASE. | 3.4.24.15 |
1S4V | THE 2.0 A CRYSTAL STRUCTURE OF THE KDEL-TAILED CYSTEINE ENDOPEPTIDASE FUNCTIONING IN PROGRAMMED CELL DEATH OF RICINUS COMMUNIS ENDOSPERM | 3.4.22 |
1S58 | THE STRUCTURE OF B19 PARVOVIRUS CAPSID | 3.1.1.4 |
1S5P | STRUCTURE AND SUBSTRATE BINDING PROPERTIES OF COBB, A SIR2 HOMOLOG PROTEIN DEACETYLASE FROM ESCHERICIA COLI. | 3.5.1 2.3.1.286 |
1S5S | PORCINE TRYPSIN COMPLEXED WITH GUANIDINE-3-PROPANOL INHIBITOR | 3.4.21.4 |
1S5U | CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN EC709 FROM ESCHERICHIA COLI | 3.1.2 |
1S66 | CRYSTAL STRUCTURE OF HEME DOMAIN OF DIRECT OXYGEN SENSOR FROM E. COLI | 3.1.4.52 |
1S67 | CRYSTAL STRUCTURE OF HEME DOMAIN OF DIRECT OXYGEN SENSOR FROM E. COLI | 3.1.4.52 |
1S6B | X-RAY CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN TWO HOMOLOGOUS ISOFORMS OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA: PRINCIPLE OF MOLECULAR ASSOCIATION AND INACTIVATION | 3.1.1.4 |
1S6F | PORCINE TRYPSIN COVALENT COMPLEX WITH BORATE AND GUANIDINE-3 INHIBITOR | 3.4.21.4 |
1S6H | PORCINE TRYPSIN COMPLEXED WITH GUANIDINE-3-PROPANOL INHIBITOR | 3.4.21.4 |
1S6O | SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF THE APO-FORM OF THE SECOND METAL-BINDING DOMAIN OF THE MENKES PROTEIN ATP7A | 3.6.3.4 7.2.2.8 |
1S6P | CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1S6Q | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1S6R | 908R CLASS C BETA-LACTAMASE BOUND TO IODO-ACETAMIDO-PHENYL BORONIC ACID | 3.5.2.6 |
1S6U | SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF THE CU(I) FORM OF THE SECOND METAL-BINDING DOMAIN OF THE MENKES PROTEIN ATP7A | 3.6.3.4 7.2.2.8 |
1S6Y | 2.3A CRYSTAL STRUCTURE OF PHOSPHO-BETA-GLUCOSIDASE | 3.2.1.86 |
1S70 | COMPLEX BETWEEN PROTEIN SER/THR PHOSPHATASE-1 (DELTA) AND THE MYOSIN PHOSPHATASE TARGETING SUBUNIT 1 (MYPT1) | 3.1.3.16 3.1.3.53 |
1S7G | STRUCTURAL BASIS FOR THE MECHANISM AND REGULATION OF SIR2 ENZYMES | 3.5.1 2.3.1.286 |
1S81 | PORCINE TRYPSIN WITH NO INHIBITOR BOUND | 3.4.21.4 |
1S82 | PORCINE TRYPSIN COMPLEXED WITH BORATE AND ETHYLENE GLYCOL | 3.4.21.4 |
1S83 | PORCINE TRYPSIN COMPLEXED WITH 4-AMINO PROPANOL | 3.4.21.4 |
1S84 | PORCINE TRYPSIN COVALENT COMPLEX WITH 4-AMINO BUTANOL, BORATE AND ETHYLENE GLYCOL | 3.4.21.4 |
1S85 | PORCINE TRYPSIN COMPLEXED WITH P-HYDROXYMETHYL BENZAMIDINE AND BORATE | 3.4.21.4 |
1S8E | CRYSTAL STRUCTURE OF MRE11-3 | 3.1 |
1S8G | CRYSTAL STRUCTURE OF LYS49-PHOSPHOLIPASE A2 FROM AGKISTRODON CONTORTRIX LATICINCTUS, FATTY ACID BOUND FORM | 3.1.1.4 |
1S8H | CRYSTAL STRUCTURE OF LYS49-PHOSPHOLIPASE A2 FROM AGKISTRODON CONTORTRIX LATICINCTUS, FIRST FATTY ACID FREE FORM | 3.1.1.4 |
1S8I | CRYSTAL STRUCTURE OF LYS49-PHOSPHOLIPASE A2 FROM AGKISTRODON CONTORTRIX LATICINCTUS, SECOND FATTY ACID FREE FORM | 3.1.1.4 |
1S8O | HUMAN SOLUBLE EPOXIDE HYDROLASE | 3.3.2.3 3.3.2.10 3.1.3.76 |
1S95 | STRUCTURE OF SERINE/THREONINE PROTEIN PHOSPHATASE 5 | 3.1.3.16 |
1S9E | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1S9G | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394. | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1S9H | CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS TYPE 2 REP40 | 3.6.4.12 |
1S9R | CRYSTAL STRUCTURE OF ARGININE DEIMINASE COVALENTLY LINKED WITH A REACTION INTERMEDIATE | 3.5.3.6 |
1SA3 | AN ASYMMETRIC COMPLEX OF RESTRICTION ENDONUCLEASE MSPI ON ITS PALINDROMIC DNA RECOGNITION SITE | 3.1.21.4 |
1SAT | CRYSTAL STRUCTURE OF THE 50 KDA METALLO PROTEASE FROM S. MARCESCENS | 3.4.24.40 |
1SAW | X-RAY STRUCTURE OF HOMO SAPIENS PROTEIN FLJ36880 | 3.7.1.5 4.1.1.112 |
1SB1 | NOVEL NON-COVALENT THROMBIN INHIBITORS INCORPORATING P1 4,5,6,7-TETRAHYDROBENZOTHIAZOLE ARGININE SIDE CHAIN MIMETICS | 3.4.21.5 |
1SBC | THE REFINED CRYSTAL STRUCTURE OF SUBTILISIN CARLSBERG AT 2.5 ANGSTROMS RESOLUTION | 3.4.21.62 |
1SBG | AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1SBH | SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) MUTANT (M50F, N76D, G169A, Q206C, N218S, K256Y) | 3.4.21.62 |
1SBI | SUBTILISIN BPN' 8397 (E.C. 3.4.21.14) MUTANT (M50F, N76D, G169A, Q206C, N218S) | 3.4.21.62 |
1SBK | X-RAY STRUCTURE OF YDII_ECOLI NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER29. | 3.1.2.28 |
1SBN | REFINED CRYSTAL STRUCTURES OF SUBTILISIN NOVO IN COMPLEX WITH WILD-TYPE AND TWO MUTANT EGLINS. COMPARISON WITH OTHER SERINE PROTEINASE INHIBITOR COMPLEXES | 3.4.21.62 |
1SBT | ATOMIC COORDINATES FOR SUBTILISIN BPN (OR NOVO) | 3.4.21.14 3.4.21.62 |
1SBW | CRYSTAL STRUCTURE OF MUNG BEAN INHIBITOR LYSINE ACTIVE FRAGMENT COMPLEX WITH BOVINE BETA-TRYPSIN AT 1.8A RESOLUTION | 3.4.21.4 |
1SC0 | X-RAY STRUCTURE OF YB61_HAEIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET IR63 | 3.1.2 |
1SC1 | CRYSTAL STRUCTURE OF AN ACTIVE-SITE LIGAND-FREE FORM OF THE HUMAN CASPASE-1 C285A MUTANT | 3.4.22.36 |
1SC3 | CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT IN COMPLEX WITH MALONATE | 3.4.22.36 |
1SC4 | CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT AFTER REMOVAL OF MALONATE | 3.4.22.36 |
1SC8 | UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-J435 COMPLEX | 3.4.21.73 |
1SCA | ENZYME CRYSTAL STRUCTURE IN A NEAT ORGANIC SOLVENT | 3.4.21.62 |
1SCB | ENZYME CRYSTAL STRUCTURE IN A NEAT ORGANIC SOLVENT | 3.4.21.62 |
1SCD | X-RAY CRYSTAL STRUCTURE OF CROSS-LINKED SUBTILISM CARLSBERG IN WATER VS. ACETONITRILE | 3.4.21.62 |
1SCJ | CRYSTAL STRUCTURE OF SUBTILISIN-PROPEPTIDE COMPLEX | 3.4.21.62 |
1SCN | INACTIVATION OF SUBTILISIN CARLSBERG BY N-(TERT-BUTOXYCARBONYL-ALANYL-PROLYL-PHENYLALANYL)-O-BENZOL HYDROXYLAMINE: FORMATION OF COVALENT ENZYME-INHIBITOR LINKAGE IN THE FORM OF A CARBAMATE DERIVATIVE | 3.4.21.62 |
1SCW | TOWARD BETTER ANTIBIOTICS: CRYSTAL STRUCTURE OF R61 DD-PEPTIDASE INHIBITED BY A NOVEL MONOCYCLIC PHOSPHATE INHIBITOR | 3.4.16.4 |
1SDE | TOWARD BETTER ANTIBIOTICS: CRYSTAL STRUCTURE OF D-ALA-D-ALA PEPTIDASE INHIBITED BY A NOVEL BICYCLIC PHOSPHATE INHIBITOR | 3.4.16.4 |
1SDN | CRYSTAL STRUCTURE OF A DEACYLATION-DEFECTIVE MUTANT OF PENICILLIN-BINDING PROTEIN 5 MODIFIED BY MERCURY | 3.4.16.4 3.5.2.6 |
1SDO | CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE BSTYI | 3.1.21.4 |
1SDT | CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1SDU | CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1SDV | CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1SDX | CRYSTAL STRUCTURE OF THE ZINC SATURATED C-TERMINAL HALF OF BOVINE LACTOFERRIN AT 2.0 A RESOLUTION REVEALS TWO ADDITIONAL ZINC BINDING SITES | 3.4.21 |
1SEH | CRYSTAL STRUCTURE OF E. COLI DUTPASE COMPLEXED WITH THE PRODUCT DUMP | 3.6.1.23 |
1SEL | CRYSTAL STRUCTURE OF SELENOSUBTILISIN AT 2.0-ANGSTROMS RESOLUTION | 3.4.21.62 |
1SF4 | BINDING OF N,N'-DIACETYLCHITOBIOSE TO HEW LYSOZYME: A POWDER DIFFRACTION STUDY | 3.2.1.17 |
1SF6 | BINDING OF N,N',N-TRIACETYLCHITOTRIOSE TO HEW LYSOZYME: A POWDER DIFFRACTION STUDY" | 3.2.1.17 |
1SF7 | BINDING OF TETRA-N-ACETYLCHITOTETRAOSE TO HEW LYSOZYME: A POWDER DIFFRACTION STUDY | 3.2.1.17 |
1SFB | BINDING OF PENTA-N-ACETYLCHITOPENTAOSE TO HEW LYSOZYME: A POWDER DIFFRACTION STUDY | 3.2.1.17 |
1SFG | BINDING OF HEXA-N-ACETYLCHITOHEXAOSE: A POWDER DIFFRACTION STUDY | 3.2.1.17 |
1SFI | HIGH RESOLUTION STRUCTURE OF A POTENT, CYCLIC PROTEASE INHIBITOR FROM SUNFLOWER SEEDS | 3.4.21.4 |
1SFK | CORE (C) PROTEIN FROM WEST NILE VIRUS, SUBTYPE KUNJIN | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1SFQ | FAST FORM OF THROMBIN MUTANT R(77A)A BOUND TO PPACK | 3.4.21.5 |
1SFV | PORCINE PANCREAS PHOSPHOLIPASE A2, NMR, MINIMIZED AVERAGE STRUCTURE | 3.1.1.4 |
1SFW | PORCINE PANCREAS PHOSPHOLIPASE A2, NMR, 18 STRUCTURES | 3.1.1.4 |
1SG3 | STRUCTURE OF ALLANTOICASE | 3.5.3.4 |
1SG8 | CRYSTAL STRUCTURE OF THE PROCOAGULANT FAST FORM OF THROMBIN | 3.4.21.5 |
1SGC | THE 1.8 ANGSTROMS STRUCTURE OF THE COMPLEX BETWEEN CHYMOSTATIN AND STREPTOMYCES GRISEUS PROTEASE A. A MODEL FOR SERINE PROTEASE CATALYTIC TETRAHEDRAL INTERMEDIATES | 3.4.21.80 |
1SGD | ASP 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5 | 3.4.21.81 |
1SGE | GLU 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5 | 3.4.21.81 |
1SGF | CRYSTAL STRUCTURE OF 7S NGF: A COMPLEX OF NERVE GROWTH FACTOR WITH FOUR BINDING PROTEINS (SERINE PROTEINASES) | 3.4.21.35 |
1SGI | CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN | 3.4.21.5 |
1SGL | THE THREE-DIMENSIONAL STRUCTURE AND X-RAY SEQUENCE REVEAL THAT TRICHOMAGLIN IS A NOVEL S-LIKE RIBONUCLEASE | 3.1 |
1SGN | ASN 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B | 3.4.21.81 |
1SGP | ALA 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B | 3.4.21.81 |
1SGQ | GLY 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B | 3.4.21.81 |
1SGR | LEU 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B | 3.4.21.81 |
1SGT | REFINED CRYSTAL STRUCTURE OF STREPTOMYCES GRISEUS TRYPSIN AT 1.7 ANGSTROMS RESOLUTION | 3.4.21.4 |
1SGU | COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1SGY | TYR 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5 | 3.4.21.81 |
1SGZ | CRYSTAL STRUCTURE OF UNBOUND BETA-SECRETASE CATALYTIC DOMAIN. | 3.4.23.46 |
1SH0 | CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (TRICLINIC) | 2.7.7.48 3.4.22.66 3.6.1.15 |
1SH2 | CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (METAL-FREE, CENTERED ORTHORHOMBIC) | 2.7.7.48 3.4.22.66 3.6.1.15 |
1SH3 | CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (MGSO4 CRYSTAL FORM) | 2.7.7.48 3.4.22.66 3.6.1.15 |
1SH7 | CRYSTAL STRUCTURE OF A COLD ADAPTED SUBTILISIN-LIKE SERINE PROTEINASE | 3.4.21 |
1SH9 | COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1SHH | SLOW FORM OF THROMBIN BOUND WITH PPACK | 3.4.21.5 |
1SHJ | CASPASE-7 IN COMPLEX WITH DICA ALLOSTERIC INHIBITOR | 3.4.22 3.4.22.60 |
1SHL | CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR | 3.4.22 3.4.22.60 |
1SHN | CRYSTAL STRUCTURE OF SHRIMP ALKALINE PHOSPHATASE WITH PHOSPHATE BOUND | 3.1.3.1 |
1SHQ | CRYSTAL STRUCTURE OF SHRIMP ALKALINE PHOSPHATASE WITH MAGNESIUM IN M3 | 3.1.3.1 |
1SHV | STRUCTURE OF SHV-1 BETA-LACTAMASE | 3.5.2.6 |
1SIB | REFINED CRYSTAL STRUCTURES OF SUBTILISIN NOVO IN COMPLEX WITH WILD-TYPE AND TWO MUTANT EGLINS. COMPARISON WITH OTHER SERINE PROTEINASE INHIBITOR COMPLEXES | 3.4.21.62 |
1SIP | ALTERNATIVE NATIVE FLAP CONFORMATION REVEALED BY 2.3 ANGSTROMS RESOLUTION STRUCTURE OF SIV PROTEINASE | 3.4.23 2.7.7.49 3.1.13.2 3.1.26.13 |
1SIV | THREE-DIMENSIONAL STRUCTURE OF A SIV PROTEASE(SLASH)INHIBITOR COMPLEX. IMPLICATIONS FOR THE DESIGN OF HIV-1 AND HIV-2 PROTEASE INHIBITORS | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1SIX | MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH MAGNESIUM AND ALPHA,BETA-IMIDO-DUTP | 3.6.1.23 |
1SJN | MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH MAGNESIUM AND ALPHA,BETA-IMIDO-DUTP | 3.6.1.23 |
1SJY | CRYSTAL STRUCTURE OF NUDIX HYDROLASE DR1025 FROM DEINOCOCCUS RADIODURANS | 3.6.1 |
1SK8 | CRYSTALLOGRAPHIC SNAPSHOTS OF ASPERGILLUS FUMIGATUS PHYTASE REVEALING ITS ENZYMATIC DYNAMICS | 3.1.3.8 |
1SK9 | CRYSTALLOGRAPHIC SNAPSHOTS OF ASPERGILLUS FUMIGATUS PHYTASE REVEALING ITS ENZYMATIC DYNAMICS | 3.1.3.8 |
1SKA | CRYSTALLOGRAPHIC SNAPSHOTS OF ASPERGILLUS FUMIGATUS PHYTASE REVEALING ITS ENZYMATIC DYNAMICS | 3.1.3.8 |
1SKB | CRYSTALLOGRAPHIC SNAPSHOTS OF ASPERGILLUS FUMIGATUS PHYTASE REVEALING ITS ENZYMATIC DYNAMICS | 3.1.3.8 |
1SKF | CRYSTAL STRUCTURE OF THE STREPTOMYCES K15 DD-TRANSPEPTIDASE | 3.4.16.4 |
1SKG | STRUCTURE-BASED RATIONAL DRUG DESIGN: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND A PENTAPEPTIDE VAL-ALA-PHE-ARG-SER | 3.1.1.4 |
1SKR | T7 DNA POLYMERASE COMPLEXED TO DNA PRIMER/TEMPLATE AND DDATP | 2.7.7.7 3.1.11 |
1SKS | BINARY 3' COMPLEX OF T7 DNA POLYMERASE WITH A DNA PRIMER/TEMPLATE CONTAINING A CIS-SYN THYMINE DIMER ON THE TEMPLATE | 2.7.7.7 3.1.11 |
1SKW | BINARY 3' COMPLEX OF T7 DNA POLYMERASE WITH A DNA PRIMER/TEMPLATE CONTAINING A DISORDERED CIS-SYN THYMINE DIMER ON THE TEMPLATE | 2.7.7.7 3.1.11 |
1SL0 | TERNARY 3' COMPLEX OF T7 DNA POLYMERASE WITH A DNA PRIMER/TEMPLATE CONTAINING A DISORDERED CIS-SYN THYMINE DIMER ON THE TEMPLATE AND AN INCOMING NUCLEOTIDE | 2.7.7.7 3.1.11 |
1SL1 | BINARY 5' COMPLEX OF T7 DNA POLYMERASE WITH A DNA PRIMER/TEMPLATE CONTAINING A CIS-SYN THYMINE DIMER ON THE TEMPLATE | 2.7.7.7 3.1.11 |
1SL2 | TERNARY 5' COMPLEX OF T7 DNA POLYMERASE WITH A DNA PRIMER/TEMPLATE CONTAINING A CIS-SYN THYMINE DIMER ON THE TEMPLATE AND AN INCOMING NUCLEOTIDE | 2.7.7.7 3.1.11 |
1SL3 | CRYSTAL STRUCTUE OF THROMBIN IN COMPLEX WITH A POTENT P1 HETEROCYCLE-ARYL BASED INHIBITOR | 3.4.21.5 |
1SLH | MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH MAGNESIUM AND DUDP | 3.6.1.23 |
1SLI | LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH DANA | 3.2.1.18 4.2.2.15 |
1SLJ | SOLUTION STRUCTURE OF THE S1 DOMAIN OF RNASE E FROM E. COLI | 3.1.4 3.1.26.12 |
1SLL | SIALIDASE L FROM LEECH MACROBDELLA DECORA | 3.2.1.18 4.2.2.15 |
1SLM | CRYSTAL STRUCTURE OF FIBROBLAST STROMELYSIN-1: THE C-TRUNCATED HUMAN PROENZYME | 3.4.24.17 |
1SLN | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-702,842 | 3.4.24.17 |
1SLY | COMPLEX OF THE 70-KDA SOLUBLE LYTIC TRANSGLYCOSYLASE WITH BULGECIN A | 3.2.1 4.2.2 |
1SM8 | M. TUBERCULOSIS DUTPASE COMPLEXED WITH CHROMIUM AND DUTP | 3.6.1.23 |
1SMC | MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH DUTP IN THE ABSENCE OF METAL ION. | 3.6.1.23 |
1SMD | HUMAN SALIVARY AMYLASE | 3.2.1.1 |
1SME | PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH PEPSTATIN A | 3.4.23.39 |
1SMF | STUDIES ON AN ARTIFICIAL TRYPSIN INHIBITOR PEPTIDE DERIVED FROM THE MUNG BEAN INHIBITOR | 3.4.21.4 |
1SML | METALLO BETA LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA | 3.5.2.6 |
1SMN | IDENTIFICATION OF THE SERRATIA ENDONUCLEASE DIMER: STRUCTURAL BASIS AND IMPLICATIONS FOR CATALYSIS | 3.1.30.2 |
1SMP | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN SERRATIA MARCESCENS METALLO-PROTEASE AND AN INHIBITOR FROM ERWINIA CHRYSANTHEMI | 3.4.24.40 |
1SMR | THE 3-D STRUCTURE OF MOUSE SUBMAXILLARY RENIN COMPLEXED WITH A DECAPEPTIDE INHIBITOR CH-66 BASED ON THE 4-16 FRAGMENT OF RAT ANGIOTENSINOGEN | 3.4.23.15 |
1SMX | CRYSTAL STRUCTURE OF THE S1 DOMAIN OF RNASE E FROM E. COLI (NATIVE) | 3.1.4 3.1.26.12 |
1SN8 | CRYSTAL STRUCTURE OF THE S1 DOMAIN OF RNASE E FROM E. COLI (PB DERIVATIVE) | 3.1.4 3.1.26.12 |
1SNC | THE CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF STAPHYLOCOCCAL NUCLEASE, CA2+, AND THE INHIBITOR PD*TP, REFINED AT 1.65 ANGSTROMS | 3.1.31.1 |
1SND | STAPHYLOCOCCAL NUCLEASE DIMER CONTAINING A DELETION OF RESIDUES 114-119 COMPLEXED WITH CALCIUM CHLORIDE AND THE COMPETITIVE INHIBITOR DEOXYTHYMIDINE-3',5'-DIPHOSPHATE | 3.1.31.1 |
1SNF | MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH MAGNESIUM AND DEOXYURIDINE 5'-MONOPHOSPHATE | 3.6.1.23 |
1SNK | CATHEPSIN K COMPLEXED WITH CARBAMATE DERIVATIZED NORLEUCINE ALDEHYDE | 3.4.22.38 |
1SNM | ACTIVE SITE MUTANT GLU-43 (RIGHT ARROW) ASP IN STAPHYLOCOCCAL NUCLEASE DISPLAYS NONLOCAL STRUCTURAL CHANGES | 3.1.31.1 |
1SNO | PROTEIN STABILITY IN STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1SNP | PROTEIN STABILITY IN STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1SNQ | PROTEIN STABILITY IN STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1SNT | STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2 | 3.2.1.18 |
1SO2 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3B IN COMPLEX WITH A DIHYDROPYRIDAZINE INHIBITOR | 3.1.4.17 |
1SO7 | MALTOSE-INDUCED STRUCTURE OF THE HUMAN CYTOLSOLIC SIALIDASE NEU2 | 3.2.1.18 |
1SOA | HUMAN DJ-1 WITH SULFINIC ACID | 3.1.2 3.5.1 3.5.1.124 |
1SOJ | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3B IN COMPLEX WITH IBMX | 3.1.4.17 |
1SOM | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED BY NERVE AGENT GD (SOMAN). | 3.1.1.7 |
1SOT | CRYSTAL STRUCTURE OF THE DEGS STRESS SENSOR | 3.4.21 3.4.21.107 |
1SOZ | CRYSTAL STRUCTURE OF DEGS PROTEASE IN COMPLEX WITH AN ACTIVATING PEPTIDE | 3.4.21 3.4.21.107 |
1SP4 | CRYSTAL STRUCTURE OF NS-134 IN COMPLEX WITH BOVINE CATHEPSIN B: A TWO HEADED EPOXYSUCCINYL INHIBITOR EXTENDS ALONG THE WHOLE ACTIVE SITE CLEFT | 3.4.22.1 |
1SP5 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A PRODUCT OF AUTOPROTEOLYSIS | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1SPB | SUBTILISIN BPN' PROSEGMENT (77 RESIDUES) COMPLEXED WITH A MUTANT SUBTILISIN BPN' (266 RESIDUES). CRYSTAL PH 4.6. CRYSTALLIZATION TEMPERATURE 20 C DIFFRACTION TEMPERATURE-160 C | 3.4.21.62 |
1SPI | CRYSTAL STRUCTURE OF SPINACH CHLOROPLAST FRUCTOSE-1,6-BISPHOSPHATASE AT 2.8 ANGSTROMS RESOLUTION | 3.1.3.11 |
1SPJ | STRUCTURE OF MATURE HUMAN TISSUE KALLIKREIN (HUMAN KALLIKREIN 1 OR KLK1) AT 1.70 ANGSTROM RESOLUTION WITH VACANT ACTIVE SITE | 3.4.21.35 |
1SPV | CRYSTAL STRUCTURE OF THE PUTATIVE PHOSPHATASE OF ESCHERICHIA COLI, NORTHEAST STRUCTURAL GENOMOICS TARGET ER58 | 3.1.1.106 |
1SQ2 | CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR (NAR) VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME | 3.2.1.17 |
1SQA | SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | 3.4.21.73 |
1SQJ | CRYSTAL STRUCTURE ANALYSIS OF OLIGOXYLOGLUCAN REDUCING-END-SPECIFIC CELLOBIOHYDROLASE (OXG-RCBH) | 3.2.1.150 |
1SQM | STRUCTURE OF [R563A] LEUKOTRIENE A4 HYDROLASE | 3.3.2.6 3.4.11.4 |
1SQO | SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | 3.4.21.73 |
1SQT | SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE | 3.4.21.73 |
1SQU | STRUCTURAL GENOMICS, CRYSTAL STRUCTURE OF THE CHEX PROTEIN FROM THERMOTOGA MARITIMA | 3 |
1SQY | STRUCTURE OF HUMAN DIFERRIC LACTOFERRIN AT 2.5A RESOLUTION USING CRYSTALS GROWN AT PH 6.5 | 3.4.21 |
1SQZ | DESIGN OF SPECIFIC INHIBITORS OF PHOPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP II PHOPHOLIPASE A2 AND A DESIGNED PEPTIDE DEHYDRO-ILE-ALA-ARG-SER AT 1.2A RESOLUTION | 3.1.1.4 |
1SRN | THE REFINED CRYSTAL STRUCTURE OF A FULLY ACTIVE SEMISYNTHETIC RIBONUCLEASE AT 1.8 ANGSTROMS RESOLUTION | 3.1.27.5 4.6.1.18 |
1SRP | STRUCTURAL ANALYSIS OF SERRATIA PROTEASE | 3.4.24.40 |
1SSO | SOLUTION STRUCTURE AND DNA-BINDING PROPERTIES OF A THERMOSTABLE PROTEIN FROM THE ARCHAEON SULFOLOBUS SOLFATARICUS | 3.1.27 |
1SSW | CRYSTAL STRUCTURE OF PHAGE T4 LYSOZYME MUTANT Y24A/Y25A/T26A/I27A/C54T/C97A | 3.2.1.17 |
1SSX | 0.83A RESOLUTION CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE AT PH 8 | 3.4.21.12 |
1SSY | CRYSTAL STRUCTURE OF PHAGE T4 LYSOZYME MUTANT G28A/I29A/G30A/C54T/C97A | 3.2.1.17 |
1ST0 | STRUCTURE OF DCPS BOUND TO M7GPPPG | 3.6.1.59 |
1ST2 | THE THREE-DIMENSIONAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS SUBTILISIN AT 1.8 ANGSTROMS AND AN ANALYSIS OF THE STRUCTURAL CONSEQUENCES OF PEROXIDE INACTIVATION | 3.4.21.14 3.4.21.62 |
1ST3 | THE CRYSTAL STRUCTURE OF THE BACILLUS LENTUS ALKALINE PROTEASE, SUBTILISIN BL, AT 1.4 ANGSTROMS RESOLUTION | 3.4.21.62 |
1ST4 | STRUCTURE OF DCPS BOUND TO M7GPPPA | 3.6.1.59 |
1ST8 | CRYSTAL STRUCTURE OF FRUCTAN 1-EXOHYDROLASE IIA FROM CICHORIUM INTYBUS | 3.2.1.80 |
1STA | ACCOMMODATION OF INSERTION MUTATIONS ON THE SURFACE AND IN THE INTERIOR OF STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1STB | ACCOMMODATION OF INSERTION MUTATIONS ON THE SURFACE AND IN THE INTERIOR OF STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1STF | THE REFINED 2.4 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF RECOMBINANT HUMAN STEFIN B IN COMPLEX WITH THE CYSTEINE PROTEINASE PAPAIN: A NOVEL TYPE OF PROTEINASE INHIBITOR INTERACTION | 3.4.22.2 |
1STG | TWO DISTINCTLY DIFFERENT METAL BINDING MODES ARE SEEN IN X-RAY CRYSTAL STRUCTURES OF STAPHYLOCOCCAL NUCLEASE-COBALT(II)-NUCLEOTIDE COMPLEXES | 3.1.31.1 |
1STH | TWO DISTINCTLY DIFFERENT METAL BINDING MODES ARE SEEN IN X-RAY CRYSTAL STRUCTURES OF STAPHYLOCOCCAL NUCLEASE-COBALT(II)-NUCLEOTIDE COMPLEXES | 3.1.31.1 |
1STN | THE CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE REFINED AT 1.7 ANGSTROMS RESOLUTION | 3.1.31.1 |
1STX | STRUCTURE OF THE K38A MUTANT OF ECORV BOUND TO COGNATE DNA AND MN2+ | 3.1.21.4 |
1STY | THE ALPHA ANEURISM: A STRUCTURAL MOTIF REVEALED IN AN INSERTION MUTANT OF STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1SU1 | STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF YFCE, A PHOSPHOESTERASE FROM E. COLI | 3.1.4 |
1SU4 | CRYSTAL STRUCTURE OF CALCIUM ATPASE WITH TWO BOUND CALCIUM IONS | 3.6.3.8 7.2.2.10 |
1SUA | SUBTILISIN BPN' | 3.4.21.62 |
1SUB | CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN | 3.4.21.62 |
1SUC | CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN | 3.4.21.62 |
1SUD | CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN | 3.4.21.62 |
1SUE | SUBTILISIN BPN' FROM BACILLUS AMYLOLIQUEFACIENS, MUTANT | 3.4.21.62 |
1SUG | 1.95 A STRUCTURE OF APO PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
1SUP | SUBTILISIN BPN' AT 1.6 ANGSTROMS RESOLUTION: ANALYSIS OF DISCRETE DISORDER AND COMPARISON OF CRYSTAL FORMS | 3.4.21.62 |
1SUQ | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1SUZ | THE STRUCTURE OF K92A ECORV BOUND TO COGNATE DNA AND MG2+ | 3.1.21.4 |
1SV2 | CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM LEPTOSPIRA INTERROGANS (LIPDF) AT PH7.5 | 3.5.1.88 |
1SV3 | STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND 4-METHOXYBENZOIC ACID AT 1.3A RESOLUTION. | 3.1.1.4 |
1SV5 | CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1SV9 | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUPII PHOSPHOLIPASE A2 AND ANTI-INFLAMMATORY AGENT 2-[(2,6-DICHLOROPHENYL)AMINO] BENZENEACETIC ACID AT 2.7A RESOLUTION | 3.1.1.4 |
1SVB | ENVELOPE GLYCOPROTEIN FROM TICK-BORNE ENCEPHALITIS VIRUS | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1SVJ | THE SOLUTION STRUCTURE OF THE NUCLEOTIDE BINDING DOMAIN OF KDPB | 3.6.3.12 7.2.2.6 |
1SVK | STRUCTURE OF THE K180P MUTANT OF GI ALPHA SUBUNIT BOUND TO ALF4 AND GDP | 3.6.1.46 |
1SVL | CO-CRYSTAL STRUCTURE OF SV40 LARGE T ANTIGEN HELICASE DOMAIN AND ADP | 3.6.4 |
1SVM | CO-CRYSTAL STRUCTURE OF SV40 LARGE T ANTIGEN HELICASE DOMAIN AND ATP | 3.6.4 |
1SVN | SAVINASE | 3.4.21.62 |
1SVO | STRUCTURE OF SV40 LARGE T ANTIGEN HELICASE DOMAIN | 3.6.4 |
1SVP | SINDBIS VIRUS CAPSID PROTEIN | 3.4.21 3.4.21.90 |
1SVS | STRUCTURE OF THE K180P MUTANT OF GI ALPHA SUBUNIT BOUND TO GPPNHP. | 3.6.1.46 |
1SWV | CRYSTAL STRUCTURE OF THE D12A MUTANT OF PHOSPHONOACETALDEHYDE HYDROLASE COMPLEXED WITH MAGNESIUM | 3.11.1.1 |
1SWW | CRYSTAL STRUCTURE OF THE PHOSPHONOACETALDEHYDE HYDROLASE D12A MUTANT COMPLEXED WITH MAGNESIUM AND SUBSTRATE PHOSPHONOACETALDEHYDE | 3.11.1.1 |
1SWY | USE OF A HALIDE BINDING SITE TO BYPASS THE 1000-ATOM LIMIT TO AB INITIO STRUCTURE DETERMINATION | 3.2.1.17 |
1SWZ | USE OF AN ION-BINDING SITE TO BYPASS THE 1000-ATOM LIMIT TO AB INITIO STRUCTURE DETERMINATION BY DIRECT METHODS | 3.2.1.17 |
1SX2 | USE OF A HALIDE BINDING SITE TO BYPASS THE 1000-ATOM LIMIT TO STRUCTURE DETERMINATION BY DIRECT METHODS | 3.2.1.17 |
1SX5 | K38A ECORV BOUND TO CLEAVED DNA AND MN2+: P1 CRYSTAL FORM | 3.1.21.4 |
1SX7 | USE OF AN ION-BINDING SITE TO BYPASS THE 1000-ATOM LIMIT TO AB INITIO STRUCTURE DETERMINATION BY DIRECT METHODS | 3.2.1.17 |
1SX8 | ECORV BOUND TO COGNATE DNA AND MN2+ | 3.1.21.4 |
1SXK | CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND A NON-SPECIFIC ANTI-INFLAMMATORY AMINO SALICYLIC ACID AT 1.2 A RESOLUTION | 3.1.1.4 |
1SXR | DROSOPHILA PEPTIDOGLYCAN RECOGNITION PROTEIN (PGRP)-SA | 3.4.17.13 |
1SXV | 1.3A CRYSTAL STRUCTURE OF RV3628, MYCOBACTERIUM TUBERCULOSIS INORGANIC PYROPHOSPHATASE (PPASE) AT PH5.0 | 3.6.1.1 |
1SYB | TRANSFER OF A BETA-TURN STRUCTURE TO A NEW PROTEIN CONTEXT | 3.1.31.1 |
1SYC | ENGINEERING ALTERNATIVE BETA-TURN TYPES IN STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1SYD | ENGINEERING ALTERNATIVE BETA-TURN TYPES IN STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1SYE | ENGINEERING ALTERNATIVE BETA-TURN TYPES IN STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1SYF | ENGINEERING ALTERNATIVE BETA-TURN TYPES IN STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1SYG | ENGINEERING ALTERNATIVE BETA-TURN TYPES IN STAPHYLOCOCCAL NUCLEASE | 3.1.31.1 |
1SYL | CRYSTAL STRUCTURE OF INACTIVE MUTANT DUTPASE COMPLEXED WITH SUBSTRATE DUTP | 3.6.1.23 |
1SZ3 | CRYSTAL STRUCTURE OF NUDIX HYDROLASE DR1025 IN COMPLEXED WITH GNP AND MG+2 | 3.6.1 |
1SZ6 | MISTLETOE LECTIN I FROM VISCUM ALBUM. CRYSTAL STRUCTURE AT 2.05 A RESOLUTION | 3.2.2.22 |
1SZ8 | CRYSTAL STRUCTURE OF AN ACIDIC PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 1.5 A RESOLUTION | 3.1.1.4 |
1SZB | CRYSTAL STRUCTURE OF THE HUMAN MBL-ASSOCIATED PROTEIN 19 (MAP19) | 3.4.21.104 |
1SZC | STRUCTURAL BASIS FOR NICOTINAMIDE CLEAVAGE AND ADP-RIBOSE TRANSFER BY NAD+-DEPENDENT SIR2 HISTONE/PROTEIN DEACETYLASES | 3.5.1 2.3.1.286 |
1SZD | STRUCTURAL BASIS FOR NICOTINAMIDE CLEAVAGE AND ADP-RIBOSE TRANSFER BY NAD+-DEPENDENT SIR2 HISTONE/PROTEIN DEACETYLASES | 3.5.1 2.3.1.286 |
1SZN | THE STRUCTURE OF ALPHA-GALACTOSIDASE | 3.2.1.22 |
1SZO | CRYSTAL STRUCTURE ANALYSIS OF THE 6-OXO CAMPHOR HYDROLASE HIS122ALA MUTANT BOUND TO ITS NATURAL PRODUCT (2S,4S)-ALPHA-CAMPHOLINIC ACID | 3.7.1.18 |
1SZZ | CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM LEPTOSPIRA INTERROGANS COMPLEXED WITH INHIBITOR ACTINONIN | 3.5.1.88 |
1T03 | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P) | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1T05 | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1T0O | THE STRUCTURE OF ALPHA-GALACTOSIDASE FROM TRICHODERMA REESEI COMPLEXED WITH BETA-D-GALACTOSE | 3.2.1.22 |
1T2H | Y81W MUTANT OF RNASE SA FROM STREPTOMYCES AUREOFACIENS | 3.1.27.3 4.6.1.24 |
1T2I | T76W MUTANT OF RNASE SA FROM STREPTOMYCES AUREOFACIENS | 3.1.27.3 4.6.1.24 |
1T2N | STRUCTURE OF A THERMOSTABLE TRIPLE MUTANT OF BACILLUS SUBTILIS LIPASE OBTAINED THROUGH DIRECTED EVOLUTION | 3.1.1.3 |
1T2T | CRYSTAL STRUCTURE OF THE DNA-BINDING DOMAIN OF INTRON ENDONUCLEASE I-TEVI WITH OPERATOR SITE | 3.1 |
1T31 | A DUAL INHIBITOR OF THE LEUKOCYTE PROTEASES CATHEPSIN G AND CHYMASE WITH THERAPEUTIC EFFICACY IN ANIMALS MODELS OF INFLAMMATION | 3.4.21.39 |
1T32 | A DUAL INHIBITOR OF THE LEUKOCYTE PROTEASES CATHEPSIN G AND CHYMASE WITH THERAPEUTIC EFFICACY IN ANIMALS MODELS OF INFLAMMATION | 3.4.21.20 |
1T37 | DESIGN OF SPECIFIC INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP I PHOSPHOLIPASE A2 AND A DESIGNED PENTAPEPTIDE LEU-ALA-ILE-TYR-SER AT 2.6A RESOLUTION | 3.1.1.4 |
1T3A | CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE E CATALYTIC DOMAIN | 3.4.24.69 |
1T3C | CLOSTRIDIUM BOTULINUM TYPE E CATALYTIC DOMAIN E212Q MUTANT | 3.4.24.69 |
1T3G | CRYSTAL STRUCTURE OF THE TOLL/INTERLEUKIN-1 RECEPTOR (TIR) DOMAIN OF HUMAN IL-1RAPL | 3.2.2.6 |
1T3J | MITOFUSIN DOMAIN HR2 V686M/I708M MUTANT | 3.6.5 |
1T3K | NMR STRUCTURE OF A CDC25-LIKE DUAL-SPECIFICITY TYROSINE PHOSPHATASE OF ARABIDOPSIS THALIANA | 3.1.3.48 1.20.4.1 |
1T3M | STRUCTURE OF THE ISOASPARTYL PEPTIDASE WITH L-ASPARAGINASE ACTIVITY FROM E. COLI | 3.5.1.1 3.4.19.5 |
1T3P | HALF-SANDWICH ARENE RUTHENIUM(II)-ENZYME COMPLEX | 3.2.1.17 |
1T3R | HIV PROTEASE WILD-TYPE IN COMPLEX WITH TMC114 INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1T48 | ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
1T49 | ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
1T4J | ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
1T4M | STRUCTURE OF A THERMOSTABLE DOUBLE MUTANT OF BACILLUS SUBTILIS LIPASE OBTAINED THROUGH DIRECTED EVOLUTION | 3.1.1.3 |
1T4N | SOLUTION STRUCTURE OF RNT1P DSRBD | 3.1.26.3 |
1T4O | CRYSTAL STRUCTURE OF RNT1P DSRBD | 3.1.26.3 |
1T4P | ARGINASE-DEHYDRO-ABH COMPLEX | 3.5.3.1 |
1T4R | ARGINASE-DESCARBOXY-NOR-NOHA COMPLEX | 3.5.3.1 |
1T4S | ARGINASE-L-VALINE COMPLEX | 3.5.3.1 |
1T4T | ARGINASE-DINOR-NOHA COMPLEX | 3.5.3.1 |
1T4U | CRYSTAL STRUCTURE ANALYSIS OF A NOVEL OXYGUANIDINE BOUND TO THROMBIN | 3.4.21.5 |
1T4V | CRYSTAL STRUCTURE ANALYSIS OF A NOVEL OXYGUANIDINE BOUND TO THROMBIN | 3.4.21.5 |
1T5B | STRUCTURAL GENOMICS, A PROTEIN FROM SALMONELLA TYPHIMURIUM SIMILAR TO E. COLI ACYL CARRIER PROTEIN PHOSPHODIESTERASE | 3.1.4.14 1.7.1.17 |
1T5F | ARGINASE I-AOH COMPLEX | 3.5.3.1 |
1T5G | ARGINASE-F2-L-ARGININE COMPLEX | 3.5.3.1 |
1T5I | CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF UAP56 | 3.6.4.13 |
1T5J | CRYSTAL STRUCTURE OF RIBOSYLGLYCOHYDROLASE MJ1187 FROM METHANOCOCCUS JANNASCHII | 3.2.2 |
1T5S | STRUCTURE OF THE (SR)CA2+-ATPASE CA2-E1-AMPPCP FORM | 3.6.3.8 7.2.2.10 |
1T5T | STRUCTURE OF THE (SR)CA2+-ATPASE CA2-E1-ADP:ALF4- FORM | 3.6.3.8 7.2.2.10 |
1T64 | CRYSTAL STRUCTURE OF HUMAN HDAC8 COMPLEXED WITH TRICHOSTATIN A | 3.5.1.98 |
1T67 | CRYSTAL STRUCTURE OF HUMAN HDAC8 COMPLEXED WITH MS-344 | 3.5.1.98 |
1T69 | CRYSTAL STRUCTURE OF HUMAN HDAC8 COMPLEXED WITH SAHA | 3.5.1.98 |
1T6C | STRUCTURAL CHARACTERIZATION OF THE PPX/GPPA PROTEIN FAMILY: CRYSTAL STRUCTURE OF THE AQUIFEX AEOLICUS FAMILY MEMBER | 3.6.1.11 3.6.1.40 |
1T6D | MIRAS PHASING OF THE AQUIFEX AEOLICUS PPX/GPPA PHOSPHATASE: CRYSTAL STRUCTURE OF THE TYPE II VARIANT | 3.6.1.11 3.6.1.40 |
1T6E | CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR I | 3.2.1.8 |
1T6G | CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR-I IN COMPLEX WITH ASPERGILLUS NIGER XYLANASE-I | 3.2.1.8 |
1T6H | CRYSTAL STRUCTURE T4 LYSOZYME INCORPORATING AN UNNATURAL AMINO ACID P-IODO-L-PHENYLALANINE AT POSITION 153 | 3.2.1.17 |
1T6N | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN UAP56 | 3.6.4.13 |
1T6V | CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR (NAR) VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME | 3.2.1.17 |
1T70 | CRYSTAL STRUCTURE OF A NOVEL PHOSPHATASE FROM DEINOCOCCUS RADIODURANS | 3.1.4.16 3.1.3.60 |
1T71 | CRYSTAL STRUCTURE OF A NOVEL PHOSPHATASE MYCOPLASMA PNEUMONIAEFROM | 3.1 |
1T7C | CRYSTAL STRUCTURE OF THE P1 GLU BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX | 3.4.21.1 |
1T7D | CRYSTAL STRUCTURE OF ESCHERICHIA COLI TYPE I SIGNAL PEPTIDASE IN COMPLEX WITH A LIPOPEPTIDE INHIBITOR | 3.4.21.89 |
1T7I | THE STRUCTURAL AND THERMODYNAMIC BASIS FOR THE BINDING OF TMC114, A NEXT-GENERATION HIV-1 PROTEASE INHIBITOR. | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1T7J | CRYSTAL STRUCTURE OF INHIBITOR AMPRENAVIR IN COMPLEX WITH A MULTI-DRUG RESISTANT VARIANT OF HIV-1 PROTEASE (L63P/V82T/I84V) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1T7K | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH ARYLSULFONAMIDE AZACYCLIC UREA | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1T7P | T7 DNA POLYMERASE COMPLEXED TO DNA PRIMER/TEMPLATE,A NUCLEOSIDE TRIPHOSPHATE, AND ITS PROCESSIVITY FACTOR THIOREDOXIN | 2.7.7.7 3.1.11 |
1T8A | USE OF SEQUENCE DUPLICATION TO ENGINEER A LIGAND-TRIGGERED LONG-DISTANCE MOLECULAR SWITCH IN T4 LYSOZYME | 3.2.1.17 |
1T8E | T7 DNA POLYMERASE TERNARY COMPLEX WITH DCTP AT THE INSERTION SITE. | 2.7.7.7 3.1.11 |
1T8F | CRYSTAL STRUCTURE OF PHAGE T4 LYSOZYME MUTANT R14A/K16A/I17A/K19A/T21A/E22A/C54T/C97A | 3.2.1.17 |
1T8G | CRYSTAL STRUCTURE OF PHAGE T4 LYSOZYME MUTANT L32A/L33A/T34A/C54T/C97A/E108V | 3.2.1.17 |
1T8H | 1.8 A CRYSTAL STRUCTURE OF AN UNCHARACTERIZED B. STEAROTHERMOPHILUS PROTEIN | 2.4.2.1 3.5.4.4 2.4.2.28 |
1T8L | CRYSTAL STRUCTURE OF THE P1 MET BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX | 3.4.21.1 |
1T8M | CRYSTAL STRUCTURE OF THE P1 HIS BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX | 3.4.21.1 |
1T8N | CRYSTAL STRUCTURE OF THE P1 THR BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX | 3.4.21.1 |
1T8O | CRYSTAL STRUCTURE OF THE P1 TRP BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX | 3.4.21.1 |
1T8Q | STRUCTURAL GENOMICS, CRYSTAL STRUCTURE OF GLYCEROPHOSPHORYL DIESTER PHOSPHODIESTERASE FROM E. COLI | 3.1.4.46 |
1T8W | CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE | 3.2.2.4 |
1T97 | USE OF SEQUENCE DUPLICATION TO ENGINEER A LIGAND-TRIGGERED LONG-DISTANCE MOLECULAR SWITCH IN T4 LYSOZYME | 3.2.1.17 |
1T9H | THE CRYSTAL STRUCTURE OF YLOQ, A CIRCULARLY PERMUTED GTPASE. | 3.6.1 |
1T9I | I-CREI(D20N)/DNA COMPLEX | 3.1 |
1T9J | I-CREI(Q47E)/DNA COMPLEX | 3.1 |
1T9R | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A | 3.1.4.17 3.1.4.35 |
1T9S | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH GMP | 3.1.4.17 3.1.4.35 |
1T9Z | THREE-DIMENSIONAL STRUCTURE OF A RNA-POLYMERASE II BINDING PROTEIN. | 3.1.3.16 |
1TA0 | THREE-DIMENSIONAL STRUCTURE OF A RNA-POLYMERASE II BINDING PROTEIN WITH ASSOCIATED LIGAND. | 3.1.3.16 |
1TA1 | H141C MUTANT OF RAT LIVER ARGINASE I | 3.5.3.1 |
1TA2 | CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 1 | 3.4.21.5 |
1TA6 | CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 14B | 3.4.21.5 |
1TAB | STRUCTURE OF THE TRYPSIN-BINDING DOMAIN OF BOWMAN-BIRK TYPE PROTEASE INHIBITOR AND ITS INTERACTION WITH TRYPSIN | 3.4.21.4 |
1TAL | ALPHA-LYTIC PROTEASE AT 120 K (SINGLE STRUCTURE MODEL) | 3.4.21.12 |
1TAM | HUMAN IMMUNODEFICIENCY VIRUS, NMR, MINIMIZED AVERAGE STRUCTURE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1TAW | BOVINE TRYPSIN COMPLEXED TO APPI | 3.4.21.4 |
1TAY | DISSECTION OF THE FUNCTIONAL ROLE OF STRUCTURAL ELEMENTS OF TYROSINE-63 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME | 3.2.1.17 |
1TAZ | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 1B | 3.1.4.17 |
1TB5 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH AMP | 3.1.4.17 3.1.4.53 |
1TB6 | 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX | 3.4.21.5 |
1TB7 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH AMP | 3.1.4.17 3.1.4.53 |
1TBB | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ROLIPRAM | 3.1.4.17 3.1.4.53 |
1TBD | SOLUTION STRUCTURE OF THE ORIGIN DNA BINDING DOMAIN OF SV40 T-ANTIGEN, NMR, MINIMIZED AVERAGE STRUCTURE | 3.6.4 |
1TBF | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH SILDENAFIL | 3.1.4.17 3.1.4.35 |
1TBH | H141D MUTANT OF RAT LIVER ARGINASE I | 3.5.3.1 |
1TBJ | H141A MUTANT OF RAT LIVER ARGINASE I | 3.5.3.1 |
1TBL | H141N MUTANT OF RAT LIVER ARGINASE I | 3.5.3.1 |
1TBQ | CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN | 3.4.21.5 |
1TBR | CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN | 3.4.21.5 |
1TBU | CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF YEAST PEROXISOMAL THIOESTERASE-1 | 3.1.2.2 |
1TBY | DISSECTION OF THE FUNCTIONAL ROLE OF STRUCTURAL ELEMENTS OF TYROSINE-63 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME | 3.2.1.17 |
1TBZ | HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N-[5-(AMINOIMINOMETHYL)AMINO]-1-{{BENZOTHIAZOLYL)CARBONYL] BUTYL]-L-PROLINAMIDE TRIFLUROACETATE AND EXOSITE-HIRUGEN | 3.4.21.5 |
1TC5 | STRUCTURAL ANALYSIS OF A PROBABLE EUKARYOTIC D-AMINO ACID TRNA DEACYLASE | 3.1 |
1TC8 | CRYSTAL STRUCTURE OF KRAIT-VENOM PHOSPHOLIPASE A2 IN A COMPLEX WITH A NATURAL FATTY ACID TRIDECANOIC ACID | 3.1.1.4 |
1TCA | THE SEQUENCE, CRYSTAL STRUCTURE DETERMINATION AND REFINEMENT OF TWO CRYSTAL FORMS OF LIPASE B FROM CANDIDA ANTARCTICA | 3.1.1.3 |
1TCB | THE SEQUENCE, CRYSTAL STRUCTURE DETERMINATION AND REFINEMENT OF TWO CRYSTAL FORMS OF LIPASE B FROM CANDIDA ANTARCTICA | 3.1.1.3 |
1TCC | THE SEQUENCE, CRYSTAL STRUCTURE DETERMINATION AND REFINEMENT OF TWO CRYSTAL FORMS OF LIPASE B FROM CANDIDA ANTARCTICA | 3.1.1.3 |
1TCO | TERNARY COMPLEX OF A CALCINEURIN A FRAGMENT, CALCINEURIN B, FKBP12 AND THE IMMUNOSUPPRESSANT DRUG FK506 (TACROLIMUS) | 3.1.3.16 |
1TCS | CRYSTAL STRUCTURE OF TRICHOSANTHIN-NADPH COMPLEX AT 1.7 ANGSTROMS RESOLUTION REVEALS ACTIVE-SITE ARCHITECTURE | 3.2.2.22 |
1TCW | SIV PROTEASE COMPLEXED WITH INHIBITOR SB203386 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1TCX | HIV TRIPLE MUTANT PROTEASE COMPLEXED WITH INHIBITOR SB203386 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1TCY | DISSECTION OF THE FUNCTIONAL ROLE OF STRUCTURAL ELEMENTS OF TYROSINE-63 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME | 3.2.1.17 |
1TD7 | INTERACTIONS OF A SPECIFIC NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) WITH GROUP I PHOSPHOLIPASE A2 (PLA2): CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PLA2 AND NIFLUMIC ACID AT 2.5 A RESOLUTION | 3.1.1.4 |
1TDG | COMPLEX OF S130G SHV-1 BETA-LACTAMASE WITH TAZOBACTAM | 3.5.2.6 |
1TDH | CRYSTAL STRUCTURE OF HUMAN ENDONUCLEASE VIII-LIKE 1 (NEIL1) | 3.2.2 4.2.99.18 |
1TDL | STRUCTURE OF SER130GLY SHV-1 BETA-LACTAMASE | 3.5.2.6 |
1TDV | NON-SPECIFIC BINDING TO PHOSPHOLIPASE A2:CRYSTAL STRUCTURE OF THE COMPLEX OF PLA2 WITH A DESIGNED PEPTIDE TYR-TRP-ALA-ALA-ALA-ALA AT 1.7A RESOLUTION | 3.1.1.4 |
1TDY | DISSECTION OF THE FUNCTIONAL ROLE OF STRUCTURAL ELEMENTS OF TYROSINE-63 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME | 3.2.1.17 |
1TDZ | CRYSTAL STRUCTURE COMPLEX BETWEEN THE LACTOCOCCUS LACTIS FPG (MUTM) AND A FAPY-DG CONTAINING DNA | 3.2.2.23 4.2.99.18 |
1TE0 | STRUCTURAL ANALYSIS OF DEGS, A STRESS SENSOR OF THE BACTERIAL PERIPLASM | 3.4.21 3.4.21.107 |
1TE2 | PUTATIVE PHOSPHATASE YNIC FROM ESCHERICHIA COLI K12 | 3.1.3.18 3.1.3.68 3.1.3.22 3.1.3.50 3.1.3.23 |
1TE7 | SOLUTION NMR STRUCTURE OF PROTEIN YQFB FROM ESCHERICHIA COLI. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET99 | 3.5.1.135 |
1TEC | CRYSTALLOGRAPHIC REFINEMENT BY INCORPORATION OF MOLECULAR DYNAMICS. THE THERMOSTABLE SERINE PROTEASE THERMITASE COMPLEXED WITH EGLIN-C | 3.4.21.66 |
1TEM | 6 ALPHA HYDROXYMETHYL PENICILLOIC ACID ACYLATED ON THE TEM-1 BETA-LACTAMASE FROM ESCHERICHIA COLI | 3.5.2.6 |
1TEW | STRUCTURE OF HEXAGONAL TURKEY EGG WHITE LYSOZYME AT 1.65 ANGSTROMS RESOLUTION | 3.2.1.17 |
1TF4 | ENDO/EXOCELLULASE FROM THERMOMONOSPORA | 3.2.1.4 |
1TF8 | STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH L-TRYPTOPHAN | 3.4.11 3.4.11.24 |
1TF9 | STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH P-IODO-L-PHENYLALANINE | 3.4.11 3.4.11.24 |
1TFF | STRUCTURE OF OTUBAIN-2 | 3.4 3.4.19.12 |
1TFM | CRYSTAL STRUCTURE OF A RIBOSOME INACTIVATING PROTEIN IN ITS NATURALLY INHIBITED FORM | 3.2.2.22 |
1TFR | RNASE H FROM BACTERIOPHAGE T4 | 3.1.26.4 |
1TFX | COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR WITH PORCINE TRYPSIN | 3.4.21.4 |
1TG1 | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELLS VIPER PHOSPHOLIPASE A2 AND A DESIGNED PEPTIDE INHIBITOR PHQ-LEU-VAL-ARG-TYR AT 1.2A RESOLUTION | 3.1.1.4 |
1TG4 | DESIGN OF SPECIFIC INHIBITORS OF GROUPII PHOSPHOLIPASE A2(PLA2): CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELLS VIPER PLA2 AND DESIGNED PEPTIDE PHE-LEU-ALA-TYR-LYS AT 1.7A RESOLUTION | 3.1.1.4 |
1TG6 | CRYSTALLOGRAPHY AND MUTAGENESIS POINT TO AN ESSENTIAL ROLE FOR THE N-TERMINUS OF HUMAN MITOCHONDRIAL CLPP | 3.4.21.92 |
1TG7 | NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP. | 3.2.1.23 |
1TG8 | THE STRUCTURE OF DENGUE VIRUS E GLYCOPROTEIN | 3.4.21.91 3.6.1.15 3.6.4.13 |
1TGB | CRYSTAL STRUCTURE OF BOVINE TRYPSINOGEN AT 1.8 ANGSTROMS RESOLUTION. II. CRYSTALLOGRAPHIC REFINEMENT, REFINED CRYSTAL STRUCTURE AND COMPARISON WITH BOVINE TRYPSIN | 3.4.21.4 |
1TGC | ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY | 3.4.21.4 |
1TGM | CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 AND ASPIRIN AT 1.86 A RESOLUTION | 3.1.1.4 |
1TGN | STRUCTURE OF BOVINE TRYPSINOGEN AT 1.9 ANGSTROMS RESOLUTION | 3.4.21.4 |
1TGT | ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY | 3.4.21.4 |
1TGZ | STRUCTURE OF HUMAN SENP2 IN COMPLEX WITH SUMO-1 | 3.4.22 |
1TH0 | STRUCTURE OF HUMAN SENP2 | 3.4.22 |
1TH6 | CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 IN COMPLEX WITH ATROPINE AT 1.23A RESOLUTION | 3.1.1.4 |
1THD | COMPLEX ORGANIZATION OF DENGUE VIRUS E PROTEIN AS REVEALED BY 9.5 ANGSTROM CRYO-EM RECONSTRUCTION | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1THE | CRYSTAL STRUCTURES OF RECOMBINANT RAT CATHEPSIN B AND A CATHEPSIN B-INHIBITOR COMPLEX: IMPLICATIONS FOR STRUCTURE-BASED INHIBITOR DESIGN | 3.4.22.1 |
1THG | 1.8 ANGSTROMS REFINED STRUCTURE OF THE LIPASE FROM GEOTRICHUM CANDIDUM | 3.1.1.3 |
1THL | THERMOLYSIN COMPLEXED WITH A NOVEL GLUTARAMIDE DERIVATIVE, N-(1-(2(R,S)-CARBOXY-4-PHENYLBUTYL) CYCLOPENTYLCARBONYL)-(S)-TRYPTOPHAN | 3.4.24.27 |
1THM | CRYSTAL STRUCTURE OF THERMITASE AT 1.4 ANGSTROMS RESOLUTION | 3.4.21.66 |
1THP | STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE | 3.4.21.5 |
1THR | STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A NATURAL EXOSITE INHIBITOR | 3.4.21.5 |
1THS | STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A NATURAL EXOSITE INHIBITOR | 3.4.21.5 |
1THZ | CRYSTAL STRUCTURE OF AVIAN AICAR TRANSFORMYLASE IN COMPLEX WITH A NOVEL INHIBITOR IDENTIFIED BY VIRTUAL LIGAND SCREENING | 2.1.2.3 3.5.4.10 |
1TIB | CONFORMATIONAL LABILITY OF LIPASES OBSERVED IN THE ABSENCE OF AN OIL-WATER INTERFACE: CRYSTALLOGRAPHIC STUDIES OF ENZYMES FROM THE FUNGI HUMICOLA LANUGINOSA AND RHIZOPUS DELEMAR | 3.1.1.3 |
1TIC | CONFORMATIONAL LABILITY OF LIPASES OBSERVED IN THE ABSENCE OF AN OIL-WATER INTERFACE: CRYSTALLOGRAPHIC STUDIES OF ENZYMES FROM THE FUNGI HUMICOLA LANUGINOSA AND RHIZOPUS DELEMAR | 3.1.1.3 |
1TIK | CRYSTAL STRUCTURE OF ACYL CARRIER PROTEIN PHOSPHODIESTERASE | 3.1.4.14 1.7.1.17 |
1TIO | HIGH PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE | 3.4.21.4 |
1TIP | THE BISPHOSPHATASE DOMAIN OF THE BIFUNCTIONAL RAT LIVER 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE | 3.1.3.46 2.7.1.105 |
1TIY | X-RAY STRUCTURE OF GUANINE DEAMINASE FROM BACILLUS SUBTILIS NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR160 | 3.5.4.3 |
1TJ3 | X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 IN A CLOSED CONFORMATION | 3.1.3.24 |
1TJ4 | X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 IN COMPLEX WITH SUCROSE | 3.1.3.24 |
1TJ5 | X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 IN COMPLEX WITH SUCROSE AND PHOSPHATE | 3.1.3.24 |
1TJ9 | STRUCTURE OF THE COMPLEXED FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 AND A RATIONALLY DESIGNED TETRA PEPTIDE,VAL-ALA-ARG-SER AT 1.1A RESOLUTION | 3.1.1.4 |
1TJK | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 WITH A DESIGNED PENTAPEPTIDE, PHE- LEU- SER- THR- LYS AT 1.2 A RESOLUTION | 3.1.1.4 |
1TK0 | T7 DNA POLYMERASE TERNARY COMPLEX WITH 8 OXO GUANOSINE AND DDCTP AT THE INSERTION SITE | 2.7.7.7 3.1.11 |
1TK2 | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN ALKALINE PROTEINASE SAVINASE AND GRAMICIDIN S AT 1.5A RESOLUTION | 3.4.21.62 |
1TK3 | CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV/CD26 | 3.4.14.5 |
1TK4 | CRYSTAL STRUCTURE OF RUSSELLS VIPER PHOSPHOLIPASE A2 IN COMPLEX WITH A SPECIFICALLY DESIGNED TETRAPEPTIDE ALA-ILE-ARG-SER AT 1.1 A RESOLUTION | 3.1.1.4 |
1TK5 | T7 DNA POLYMERASE BINARY COMPLEX WITH 8 OXO GUANOSINE IN THE TEMPLATING STRAND | 2.7.7.7 3.1.11 |
1TK8 | T7 DNA POLYMERASE TERNARY COMPLEX WITH 8 OXO GUANOSINE AND DAMP AT THE ELONGATION SITE | 2.7.7.7 3.1.11 |
1TKD | T7 DNA POLYMERASE TERNARY COMPLEX WITH 8 OXO GUANOSINE AND DCMP AT THE ELONGATION SITE | 2.7.7.7 3.1.11 |
1TKF | STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH D-TRYPTOPHAN | 3.4.11 3.4.11.24 |
1TKH | STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH D-PHENYLALANINE | 3.4.11 3.4.11.24 |
1TKJ | STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH D-METHIONINE | 3.4.11 3.4.11.24 |
1TKR | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 INHIBITED WITH DIISOPROPYL FLUOROPHOSPHATE | 3.4.14.5 |
1TKT | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1TKX | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1TKZ | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW429576 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1TL1 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1TL3 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1TL9 | HIGH RESOLUTION CRYSTAL STRUCTURE OF CALPAIN I PROTEASE CORE IN COMPLEX WITH LEUPEPTIN | 3.4.22.52 |
1TLA | HYDROPHOBIC CORE REPACKING AND AROMATIC-AROMATIC INTERACTION IN THE THERMOSTABLE MUTANT OF T4 LYSOZYME SER 117 (RIGHT ARROW) PHE | 3.2.1.17 |
1TLD | CRYSTAL STRUCTURE OF BOVINE BETA-TRYPSIN AT 1.5 ANGSTROMS RESOLUTION IN A CRYSTAL FORM WITH LOW MOLECULAR PACKING DENSITY. ACTIVE SITE GEOMETRY, ION PAIRS AND SOLVENT STRUCTURE | 3.4.21.4 |
1TLI | THERMOLYSIN (2% ISOPROPANOL SOAKED CRYSTALS) | 3.4.24.27 |
1TLO | HIGH RESOLUTION CRYSTAL STRUCTURE OF CALPAIN I PROTEASE CORE IN COMPLEX WITH E64 | 3.4.22.52 |
1TLP | CRYSTALLOGRAPHIC STRUCTURAL ANALYSIS OF PHOSPHORAMIDATES AS INHIBITORS AND TRANSITION-STATE ANALOGS OF THERMOLYSIN | 3.4.24.27 |
1TLX | THERMOLYSIN (NATIVE) | 3.4.24.27 |
1TM1 | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 | 3.4.21.62 |
1TM3 | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59K MUTANT | 3.4.21.62 |
1TM4 | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILSIN BPN'WITH CHYMOTRYPSIN INHIBITOR 2 M59G MUTANT | 3.4.21.62 |
1TM5 | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59A MUTANT | 3.4.21.62 |
1TM7 | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59Y MUTANT | 3.4.21.62 |
1TMB | MOLECULAR BASIS FOR THE INHIBITION OF HUMAN ALPHA-THROMBIN BY THE MACROCYCLIC PEPTIDE CYCLOTHEONAMIDE A | 3.4.21.5 |
1TME | THREE-DIMENSIONAL STRUCTURE OF THEILER VIRUS | 3.6.4.13 3.4.22.28 2.7.7.48 |
1TMF | THREE-DIMENSIONAL STRUCTURE OF THEILER MURINE ENCEPHALOMYELITIS VIRUS (BEAN STRAIN) | 3.6.4.13 3.4.22.28 2.7.7.48 |
1TMG | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59F MUTANT | 3.4.21.62 |
1TML | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF A THERMOPHILIC ENDOCELLULASE | 3.2.1.4 |
1TMN | BINDING OF N-CARBOXYMETHYL DIPEPTIDE INHIBITORS TO THERMOLYSIN DETERMINED BY X-RAY CRYSTALLOGRAPHY. A NOVEL CLASS OF TRANSITION-STATE ANALOGUES FOR ZINC PEPTIDASES | 3.4.24.27 |
1TMQ | STRUCTURE OF TENEBRIO MOLITOR LARVAL ALPHA-AMYLASE IN COMPLEX WITH RAGI BIFUNCTIONAL INHIBITOR | 3.2.1.1 |
1TMT | CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS | 3.4.21.5 |
1TMU | CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS | 3.4.21.5 |
1TNG | PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1TNH | PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1TNI | PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1TNJ | PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1TNK | PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1TNL | PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1TNS | A NOVEL CLASS OF WINGED HELIX-TURN-HELIX PROTEIN: THE DNA-BINDING DOMAIN OF MU TRANSPOSASE | 3.1.22 6.5.1 |
1TNT | A NOVEL CLASS OF WINGED HELIX-TURN-HELIX PROTEIN: THE DNA-BINDING DOMAIN OF MU TRANSPOSASE | 3.1.22 6.5.1 |
1TO1 | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 Y61A MUTANT | 3.4.21.62 |
1TO2 | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59K, IN PH 9 CRYOSOAK | 3.4.21.62 |
1TO9 | CRYSTAL STRUCTURE OF THI-4 PROTEIN FROM BACILLUS SUBTILIS | 3.5.99.2 |
1TOC | STRUCTURE OF SERINE PROTEINASE | 3.4.21.5 |
1TOM | ALPHA-THROMBIN COMPLEXED WITH HIRUGEN | 3.4.21.5 |
1TON | RAT SUBMAXILLARY GLAND SERINE PROTEASE, TONIN. STRUCTURE SOLUTION AND REFINEMENT AT 1.8 ANGSTROMS RESOLUTION | 3.4.21.35 |
1TP2 | CRYSTAL STRUCTURE OF THE COMPLEX OF GROUP II PHOSPHOLIPASEA2 DIMER WITH A FATTY ACID TRIDECANOIC ACID AT 2.4 A RESOLUTION | 3.1.1.4 |
1TPA | THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS | 3.4.21.4 |
1TPG | F1-G MODULE PAIR RESIDUES 1-91 (C83S) OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) (NMR, 298K, PH2.95, REPRESENTATIVE STRUCTURE) | 3.4.21.68 |
1TPK | CRYSTAL STRUCTURE OF THE KRINGLE-2 DOMAIN OF TISSUE PLASMINOGEN ACTIVATOR AT 2.4-ANGSTROMS RESOLUTION | 3.4.21.31 3.4.21.68 |
1TPM | SOLUTION STRUCTURE OF THE FIBRIN BINDING FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN ACTIVATOR DETERMINED BY 1H NUCLEAR MAGNETIC RESONANCE | 3.4.21.68 |
1TPN | SOLUTION STRUCTURE OF THE FIBRIN BINDING FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN ACTIVATOR DETERMINED BY 1H NUCLEAR MAGNETIC RESONANCE | 3.4.21.68 |
1TPO | THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS | 3.4.21.4 |
1TPP | THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS | 3.4.21.4 |
1TPS | ATOMIC STRUCTURE OF THE TRYPSIN-A90720A COMPLEX: A UNIFIED APPROACH TO STRUCTURE AND FUNCTION | 3.4.21.4 |
1TPZ | CRYSTAL STRUCTURE OF IIGP1: A PARADIGM FOR INTERFERON INDUCIBLE P47 RESISTANCE GTPASES | 3.6.5 |
1TQ2 | CRYSTAL STRUCTURE OF IIGP1: A PARADIGM FOR INTERFERON INDUCIBLE P47 RESISTANCE GTPASES | 3.6.5 |
1TQ4 | CRYSTAL STRUCTURE OF IIGP1: A PARADIGM FOR INTERFERON INDUCIBLE P47 RESISTANCE GTPASES | 3.6.5 |
1TQ6 | CRYSTAL STRUCTURE OF IIGP1: A PARADIGM FOR INTERFERON INDUCIBLE P47 RESISTANCE GTPASES | 3.6.5 |
1TQ7 | CRYSTAL STRUCTURE OF THE ANTICOAGULANT THROMBIN MUTANT W215A/E217A BOUND TO PPACK | 3.4.21.5 |
1TQ9 | NON-COVALENT SWAPPED DIMER OF BOVINE SEMINAL RIBONUCLEASE IN COMPLEX WITH 2'-DEOXYCYTIDINE-2'-DEOXYADENOSINE-3',5'-MONOPHOSPHATE | 3.1.27.5 4.6.1.18 |
1TQD | CRYSTAL STRUCTURE OF IIGP1: A PARADIGM FOR INTERFERON INDUCIBLE P47 RESISTANCE GTPASES | 3.6.5 |
1TQF | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR | 3.4.23.46 |
1TQH | COVALENT REACTION INTERMEDIATE REVEALED IN CRYSTAL STRUCTURE OF THE GEOBACILLUS STEAROTHERMOPHILUS CARBOXYLESTERASE EST30 | 3.1.1.1 |
1TQO | CRYOGENIC CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT TRUNCATED DELTA+PHS I92E | 3.1.31.1 |
1TQS | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH SALACINOL | 3.2.1.114 |
1TQT | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH A DIASTEREOMER OF SALACINOL | 3.2.1.114 |
1TQU | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH THE SALACINOL ANALOG GHAVAMIOL | 3.2.1.114 |
1TQV | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH SELENO-SALACINOL (BLINTOL) | 3.2.1.114 |
1TQW | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH A DIASTEREOMER OF SELENO-SALACINOL | 3.2.1.114 |
1TR1 | CRYSTAL STRUCTURE OF E96K MUTATED BETA-GLUCOSIDASE A FROM BACILLUS POLYMYXA, AN ENZYME WITH INCREASED THERMORESISTANCE | 3.2.1.21 |
1TR5 | ROOM TEMPERATURE STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT TRUNCATED DELTA+PHS I92E | 3.1.31.1 |
1TR9 | STRUCTURE OF BETA-HEXOSAMINIDASE FROM VIBRIO CHOLERAE | 3.2.1.52 |
1TRH | TWO CONFORMATIONAL STATES OF CANDIDA RUGOSA LIPASE | 3.1.1.3 |
1TRL | NMR SOLUTION STRUCTURE OF THE C-TERMINAL FRAGMENT 255-316 OF THERMOLYSIN: A DIMER FORMED BY SUBUNITS HAVING THE NATIVE STRUCTURE | 3.4.24.27 |
1TRM | THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS | 3.4.21.4 |
1TRN | CRYSTAL STRUCTURE OF HUMAN TRYPSIN 1: UNEXPECTED PHOSPHORYLATION OF TYROSINE 151 | 3.4.21.4 |
1TRP | X-RAY CRYSTALLOGRAPHIC AND CALORIMERIC STUDIES OF THE EFFECTS OF THE MUTATION TRP 59 TYR IN RIBONUCLEASE T1 | 3.1.27.3 4.6.1.24 |
1TRQ | X-RAY CRYSTALLOGRAPHIC AND CALORIMERIC STUDIES OF THE EFFECTS OF THE MUTATION TRP 59 TYR IN RIBONUCLEASE T1 | 3.1.27.3 4.6.1.24 |
1TRY | STRUCTURE OF INHIBITED TRYPSIN FROM FUSARIUM OXYSPORUM AT 1.55 ANGSTROMS | 3.4.21.4 |
1TS9 | CRYSTAL STRUCTURE OF THE ARCHAEAL HOMOLOG OF HUMAN RNASE P PROTEIN RPP29 FROM ARCHAEOGLOBUS FULGIDUS | 3.1.26.5 |
1TSF | CRYSTAL STRUCTURE OF THE ARCHAEAL HOMOLOG OF HUMAN RNASE P PROTEIN RPP29 FROM ARCHAEOGLOBUS FULGIDUS | 3.1.26.5 |
1TSP | CRYSTAL STRUCTURE OF P22 TAILSPIKE PROTEIN: INTERDIGITATED SUBUNITS IN A THERMOSTABLE TRIMER | 3.2.1 |
1TSQ | CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT | 3.4.23.16 |
1TSU | CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT | 3.4.23.16 |
1TT2 | CRYOGENIC CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT TRUNCATED DELTA+PHS I92K | 3.1.31.1 |
1TTO | CRYSTAL STRUCTURE OF THE RNASE T1 VARIANT R2 | 3.1.27.3 4.6.1.24 |
1TU3 | CRYSTAL STRUCTURE OF RAB5 COMPLEX WITH RABAPTIN5 C-TERMINAL DOMAIN | 3.6.5.2 |
1TU4 | CRYSTAL STRUCTURE OF RAB5-GDP COMPLEX | 3.6.5.2 |
1TUM | MUTT PYROPHOSPHOHYDROLASE-METAL-NUCLEOTIDE-METAL COMPLEX, NMR, 16 STRUCTURES | 3.6.1 3.6.1.55 |
1TUX | HIGH RESOLUTION CRYSTAL STRUCTURE OF A THERMOSTABLE XYLANASE FROM THERMOASCUS AURANTIACUS | 3.2.1.8 |
1TV6 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707 | 2.7.7.4 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1TVI | SOLUTION STRUCTURE OF TM1509 FROM THERMOTOGA MARITIMA: VT1, A NESGC TARGET PROTEIN | 3.1 |
1TVN | CELLULASE CEL5G FROM PSEUDOALTEROMONAS HALOPLANKTIS, A FAMILY GH 5-2 ENZYME | 3.2.1.4 |
1TVP | ENDOGLUCANASE CEL5G FROM PSEUDOALTEROMONAS HALOPLANKTIS IN COMPLEX WITH CELLOBIOSE | 3.2.1.4 |
1TVR | HIV-1 RT/9-CL TIBO | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1TW7 | WIDE OPEN 1.3A STRUCTURE OF A MULTI-DRUG RESISTANT HIV-1 PROTEASE REPRESENTS A NOVEL DRUG TARGET | 3.4.23.16 |
1TW8 | HINCII BOUND TO CA2+ AND COGNATE DNA GTCGAC | 3.1.21.4 |
1TWL | INORGANIC PYROPHOSPHATASE FROM PYROCOCCUS FURIOSUS PFU-264096-001 | 3.6.1.1 |
1TWX | CRYSTAL STRUCTURE OF THE THROMBIN MUTANT D221A/D222K | 3.4.21.5 |
1TX3 | HINCII BOUND TO COGNATE DNA | 3.1.21.4 |
1TX6 | TRYPSIN:BBI COMPLEX | 3.4.21.4 |
1TX7 | BOVINE TRYPSIN COMPLEXED WITH P-AMIDINOPHENYLMETHYLPHOSPHINIC ACID (AMPA) | 3.4.21.4 |
1TX8 | BOVINE TRYPSIN COMPLEXED WITH AMSO | 3.4.21.4 |
1TXO | CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS SERINE/THREONINE PHOSPHATASE PSTP/PPP AT 1.95 A. | 3.1.3.16 |
1TXR | X-RAY CRYSTAL STRUCTURE OF BESTATIN BOUND TO AAP | 3.4.11.10 |
1TXZ | CRYSTAL STRUCTURE OF YEAST YMX7, AN ADP-RIBOSE-1''-MONOPHOSPHATASE, COMPLEXED WITH ADP-RIBOSE | 3.1.3.84 |
1TY8 | CRYSTAL STRUCTURE OF YEAST YMX7, AN ADP-RIBOSE-1''-MONOPHOSPHATASE, COMPLEXED WITH ADP | 3.1.3.84 |
1TYF | THE STRUCTURE OF CLPP AT 2.3 ANGSTROM RESOLUTION SUGGESTS A MODEL FOR ATP-DEPENDENT PROTEOLYSIS | 3.4.21.92 |
1TYH | CRYSTAL STRUCTURE OF TRANSCRIPTIONAL ACTIVATOR TENA FROM BACILLUS SUBTILIS | 3.5.99.2 |
1TYN | ATOMIC STRUCTURE OF THE TRYPSIN-CYCLOTHEONAMIDE A COMPLEX: LESSONS FOR THE DESIGN OF SERINE PROTEASE INHIBITORS | 3.4.21.4 |
1TYU | STRUCTURE OF TAILSPIKE-PROTEIN | 3.2.1 |
1TYV | STRUCTURE OF TAILSPIKE-PROTEIN | 3.2.1 |
1TYW | STRUCTURE OF TAILSPIKE-PROTEIN | 3.2.1 |
1TYX | TITLE OF TAILSPIKE-PROTEIN | 3.2.1 |
1TYY | CRYSTAL STRUCTURE OF AMINOIMIDAZOLE RIBOSIDE KINASE FROM SALMONELLA ENTERICA | 2.7.1.4 3.6.1.26 |
1TYZ | CRYSTAL STRUCTURE OF 1-AMINOCYCLOPROPANE-1-CARBOYXLATE DEAMINASE FROM PSEUDOMONAS | 3.5.99.7 |
1TZ2 | CRYSTAL STRUCTURE OF 1-AMINOCYCLOPROPANE-1-CARBOYXLATE DEAMINASE COMPLEXED WITH ACC | 3.5.99.7 |
1TZ3 | CRYSTAL STRUCTURE OF AMINOIMIDAZOLE RIBOSIDE KINASE COMPLEXED WITH AMINOIMIDAZOLE RIBOSIDE | 2.7.1.4 3.6.1.26 |
1TZ6 | CRYSTAL STRUCTURE OF AMINOIMIDAZOLE RIBOSIDE KINASE FROM SALMONELLA ENTERICA COMPLEXED WITH AMINOIMIDAZOLE RIBOSIDE AND ATP ANALOG | 2.7.1.4 3.6.1.26 |
1TZJ | CRYSTAL STRUCTURE OF 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE COMPLEXED WITH D-VINYL GLYCINE | 3.5.99.7 |
1TZK | CRYSTAL STRUCTURE OF 1-AMINOCYCLOPROPANE-1-CARBOXYLATE-DEAMINASE COMPLEXED WITH ALPHA-KETO-BUTYRATE | 3.5.99.7 |
1TZM | CRYSTAL STRUCTURE OF ACC DEAMINASE COMPLEXED WITH SUBSTRATE ANALOG B-CHLORO-D-ALANINE | 3.5.99.7 |
1TZP | MEPA, INACTIVE FORM WITHOUT ZN IN P21 | 3.4.99 3.4.24 |
1TZS | CRYSTAL STRUCTURE OF AN ACTIVATION INTERMEDIATE OF CATHEPSIN E | 3.4.23.34 |
1U02 | CRYSTAL STRUCTURE OF TREHALOSE-6-PHOSPHATE PHOSPHATASE RELATED PROTEIN | 3.1.3.12 |
1U05 | CRYSTAL STRUCTURE OF PROTEIN YFIH FROM SHIGELLA FLEXNERI, PFAM DUF152 | 2.4.2.1 3.5.4.4 2.4.2.28 |
1U09 | FOOTAND MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE | 2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15 |
1U0A | CRYSTAL STRUCTURE OF THE ENGINEERED BETA-1,3-1,4-ENDOGLUCANASE H(A16-M) IN COMPLEX WITH BETA-GLUCAN TETRASACCHARIDE | 3.2.1.73 |
1U0C | Y33C MUTANT OF HOMING ENDONUCLEASE I-CREI | 3.1 |
1U0D | Y33H MUTANT OF HOMING ENDONUCLEASE I-CREI | 3.1 |
1U0J | CRYSTAL STRUCTURE OF AAV2 REP40-ADP COMPLEX | 3.6.4.12 |
1U0L | CRYSTAL STRUCTURE OF YJEQ FROM THERMOTOGA MARITIMA | 3.6.1 |
1U10 | MEPA, ACTIVE FORM WITH ZN IN P1 | 3.4.99 3.4.24 |
1U14 | THE CRYSTAL STRUCTURE OF HYPOTHETICAL UPF0244 PROTEIN YJJX AT RESOLUTION 1.68 ANGSTROM | 3.6.1.73 |
1U1B | STRUCTURE OF BOVINE PANCREATIC RIBONUCLEASE A IN COMPLEX WITH 3'-PHOSPHOTHYMIDINE (3'-5')-PYROPHOSPHATE ADENOSINE 3'-PHOSPHATE | 3.1.27.5 4.6.1.18 |
1U20 | CRYSTAL STRUCTURE OF XENOPUS LAEVIS NUDIX HYDROLASE NUCLEAR SNORNA DECAPPING PROTEIN X29 | 3.6.1.62 3.6.1.64 |
1U24 | CRYSTAL STRUCTURE OF SELENOMONAS RUMINANTIUM PHYTASE | 3.1.3.72 |
1U25 | CRYSTAL STRUCTURE OF SELENOMONAS RUMINANTIUM PHYTASE COMPLEXED WITH PERSULFATED PHYTATE IN THE C2221 CRYSTAL FORM | 3.1.3.72 |
1U26 | CRYSTAL STRUCTURE OF SELENOMONAS RUMINANTIUM PHYTASE COMPLEXED WITH PERSULFATED PHYTATE | 3.1.3.72 |
1U2E | CRYSTAL STRUCTURE OF THE C-C BOND HYDROLASE MHPC | 3.7.1 3.7.1.14 |
1U2P | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS LOW MOLECULAR PROTEIN TYROSINE PHOSPHATASE (MPTPA) AT 1.9A RESOLUTION | 3.1.3.48 |
1U2Q | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (MPTPA) AT 2.5A RESOLUTION WITH GLYCEROL IN THE ACTIVE SITE | 3.1.3.48 |
1U2S | X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 IN COMPLEX WITH GLUCOSE | 3.1.3.24 |
1U2T | X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 IN COMPLEX WITH SUCROSE6P | 3.1.3.24 |
1U2Y | IN SITU EXTENSION AS AN APPROACH FOR IDENTIFYING NOVEL ALPHA-AMYLASE INHIBITORS, STRUCTURE CONTAINING D-GLUCONHYDROXIMO-1,5-LACTAM | 3.2.1.1 |
1U30 | IN SITU EXTENSION AS AN APPROACH FOR IDENTIFYING NOVEL ALPHA-AMYLASE INHIBITORS, STRUCTURE CONTAINING MALTOSYL-ALPHA (1,4)-D-GLUCONHYDROXIMO-1,5-LACTAM | 3.2.1.1 |
1U32 | CRYSTAL STRUCTURE OF A PROTEIN PHOSPHATASE-1: CALCINEURIN HYBRID BOUND TO OKADAIC ACID | 3.1.3.16 |
1U33 | IN SITU EXTENSION AS AN APPROACH FOR IDENTIFYING NOVEL ALPHA-AMYLASE INHIBITORS | 3.2.1.1 |
1U4G | ELASTASE OF PSEUDOMONAS AERUGINOSA WITH AN INHIBITOR | 3.4.24.26 |
1U4J | CRYSTAL STRUCTURE OF A CARBOHYDRATE INDUCED DIMER OF GROUP I PHOSPHOLIPASE A2 FROM BUNGARUS CAERULEUS AT 2.1 A RESOLUTION | 3.1.1.4 |
1U5I | CRYSTAL STRUCTURE ANALYSIS OF RAT M-CALPAIN MUTANT LYS10 THR | 3.4.22.53 |
1U5W | CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN YJJX FROM ESCHERICHIA COLI | 3.6.1.73 |
1U60 | MCSG APC5046 PROBABLE GLUTAMINASE YBAS | 3.5.1.2 |
1U61 | CRYSTAL STRUCTURE OF PUTATIVE RIBONUCLEASE III FROM BACILLUS CEREUS | 3.1.26 |
1U62 | NMR STRUCTURE ANALYSIS OF THE LACTOFERRIN-BASED PEPTIDE FQWQRNIRKVR IN COMPLEX WITH LIPOPOLYSACCHARIDE | 3.4.21 |
1U65 | ACHE W. CPT-11 | 3.1.1.7 |
1U6Q | SUBSTITUTED 2-NAPHTHAMADINE INHIBITORS OF UROKINASE | 3.4.21.73 |
1U6Z | STRUCTURE OF AN E. COLI EXOPOLYPHOSPHATASE: INSIGHT INTO THE PROCESSIVE HYDROLYSIS OF POLYPHOSPHATE AND ITS REGULATION | 3.6.1.11 |
1U73 | CRYSTAL STRUCTURE OF A DIMERIC ACIDIC PLATELET AGGREGATION INHIBITOR AND HYPOTENSIVE PHOSPHOLIPASE A2 FROM BOTHROPS JARARACUSSU | 3.1.1.4 |
1U7L | CRYSTAL STRUCTURE OF SUBUNIT C (VMA5P) OF THE YEAST V-ATPASE | 3.6.3.14 |
1U7O | MAGNESIUM DEPENDENT PHOSPHATASE 1 (MDP-1) | 3.1.3 3.1.3.48 |
1U7P | X-RAY CRYSTAL STRUCTURE OF THE HYPOTHETICAL PHOSPHOTYROSINE PHOSPHATASE MDP-1 OF THE HALOACID DEHALOGENASE SUPERFAMILY | 3.1.3 3.1.3.48 |
1U7Q | THE SOLUTION STRUCTURE OF THE NUCLEOTIDE BINDING DOMAIN OF KDPB | 3.6.3.12 7.2.2.6 |
1U8E | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F | 3.4.14.5 |
1U8G | CRYSTAL STRUCTURE OF A HIV-1 PROTEASE IN COMPLEX WITH PEPTIDOMIMETIC INHIBITOR KI2-PHE-GLU-GLU-NH2 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1U8U | E. COLI THIOESTERASE I/PROTEASE I/LYSOPHOSPHOLIASE L1 IN COMPLEXED WITH OCTANOIC ACID | 3.1.1.5 3.1.2 3.1.2.2 3.1.1.2 3.1.2.14 3.4.21 |
1U8X | CRYSTAL STRUCTURE OF GLVA FROM BACILLUS SUBTILIS, A METAL-REQUIRING, NAD-DEPENDENT 6-PHOSPHO-ALPHA-GLUCOSIDASE | 3.2.1.122 |
1U8Y | CRYSTAL STRUCTURES OF RAL-GPPNHP AND RAL-GDP REVEAL TWO NOVEL BINDING SITES THAT ARE ALSO PRESENT IN RAS AND RAP | 3.6.5.2 |
1U8Z | CRYSTAL STRUCTURES OF RAL-GPPNHP AND RAL-GDP REVEAL TWO NOVEL BINDING SITES THAT ARE ALSO PRESENT IN RAS AND RAP | 3.6.5.2 |
1U90 | CRYSTAL STRUCTURES OF RAL-GPPNHP AND RAL-GDP REVEAL TWO NOVEL BINDING SITES THAT ARE ALSO PRESENT IN RAS AND RAP | 3.6.5.2 |
1U9Q | CRYSTAL STRUCTURE OF CRUZAIN BOUND TO AN ALPHA-KETOESTER | 3.4.22.51 |
1U9R | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66E/P117G/H124L/S128A AT ROOM TEMPERATURE | 3.1.31.1 |
1U9V | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABE854 | 3.4.22.38 |
1U9W | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABI491 | 3.4.22.38 |
1U9X | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABJ688 | 3.4.22.38 |
1UA3 | CRYSTAL STRUCTURE OF THE PIG PANCREATIC A-AMYLASE COMPLEXED WITH MALTO-OLIGOSACCHARIDES | 3.2.1.1 |
1UA7 | CRYSTAL STRUCTURE ANALYSIS OF ALPHA-AMYLASE FROM BACILLUS SUBTILIS COMPLEXED WITH ACARBOSE | 3.2.1.1 |
1UAA | E. COLI REP HELICASE/DNA COMPLEX | 3.6.1 |
1UAD | CRYSTAL STRUCTURE OF THE RALA-GPPNHP-SEC5 RAL-BINDING DOMAIN COMPLEX | 3.6.5.2 |
1UAQ | THE CRYSTAL STRUCTURE OF YEAST CYTOSINE DEAMINASE | 3.5.4.1 |
1UAS | CRYSTAL STRUCTURE OF RICE ALPHA-GALACTOSIDASE | 3.2.1.22 |
1UAX | CRYSTAL STRUCTURE OF THE RIBONUCLEASE H2 FROM PYROCOCCUS HORIKOSHII OT3 | 3.1.26.4 |
1UB4 | CRYSTAL STRUCTURE OF MAZEF COMPLEX | 3.1.27 |
1UBN | SELENOSUBTILISIN BPN | 3.4.21.62 |
1UBP | CRYSTAL STRUCTURE OF UREASE FROM BACILLUS PASTEURII INHIBITED WITH BETA-MERCAPTOETHANOL AT 1.65 ANGSTROMS RESOLUTION | 3.5.1.5 |
1UBZ | CRYSTAL STRUCTURE OF GLU102-MUTANT HUMAN LYSOZYME DOUBLY LABELED WITH 2',3'-EPOXYPROPYL BETA-GLYCOSIDE OF N-ACETYLLACTOSAMINE | 3.2.1.17 |
1UC0 | CRYSTAL STRUCTURE OF WILD-TYPE HEN-EGG WHITE LYSOZYME SINGLY LABELED WITH 2',3'-EPOXYPROPYL BETA-GLYCOSIDE OF N-ACETYLLACTOSAMINE | 3.2.1.17 |
1UC2 | HYPOTHETICAL EXTEIN PROTEIN OF PH1602 FROM PYROCOCCUS HORIKOSHII | 6.5.1.8 3.1 |
1UCA | CRYSTAL STRUCTURE OF THE RIBONUCLEASE MC1 FROM BITTER GOURD SEEDS COMPLEXED WITH 2'-UMP | 3.1.27.1 4.6.1.19 |
1UCC | CRYSTAL STRUCTURE OF THE RIBONUCLEASE MC1 FROM BITTER GOURD SEEDS COMPLEXED WITH 3'-UMP. | 3.1.27.1 4.6.1.19 |
1UCD | CRYSTAL STRUCTURE OF RIBONUCLEASE MC1 FROM BITTER GOURD SEEDS COMPLEXED WITH 5'-UMP | 3.1.27.1 4.6.1.19 |
1UCF | THE CRYSTAL STRUCTURE OF DJ-1, A PROTEIN RELATED TO MALE FERTILITY AND PARKINSON'S DISEASE | 3.1.2 3.5.1 3.5.1.124 |
1UCG | CRYSTAL STRUCTURE OF RIBONUCLEASE MC1 N71T MUTANT | 3.1.27.1 4.6.1.19 |
1UCH | DEUBIQUITINATING ENZYME UCH-L3 (HUMAN) AT 1.8 ANGSTROM RESOLUTION | 3.1.2.15 3.4.19.12 |
1UCI | MUTANTS OF RNASE SA | 3.1.27.3 4.6.1.24 |
1UCJ | MUTANTS OF RNASE SA | 3.1.27.3 4.6.1.24 |
1UCK | MUTANTS OF RNASE SA | 3.1.27.3 4.6.1.24 |
1UCL | MUTANTS OF RNASE SA | 3.1.27.3 4.6.1.24 |
1UCO | HEN EGG-WHITE LYSOZYME, LOW HUMIDITY FORM | 3.2.1.17 |
1UCY | THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A ALPHA (RESIDUES 7-19). THREE COMPLEXES, ONE WITH EPSILON-THROMBIN AND TWO WITH ALPHA-THROMBIN | 3.4.21.5 |
1UD2 | CRYSTAL STRUCTURE OF CALCIUM-FREE ALPHA-AMYLASE FROM BACILLUS SP. STRAIN KSM-K38 (AMYK38) | 3.2.1.1 |
1UD3 | CRYSTAL STRUCTURE OF AMYK38 N289H MUTANT | 3.2.1.1 |
1UD4 | CRYSTAL STRUCTURE OF CALCIUM FREE ALPHA AMYLASE FROM BACILLUS SP. STRAIN KSM-K38 (AMYK38, IN CALCIUM CONTAINING SOLUTION) | 3.2.1.1 |
1UD5 | CRYSTAL STRUCTURE OF AMYK38 WITH RUBIDIUM ION | 3.2.1.1 |
1UD6 | CRYSTAL STRUCTURE OF AMYK38 WITH POTASSIUM ION | 3.2.1.1 |
1UD8 | CRYSTAL STRUCTURE OF AMYK38 WITH LITHIUM ION | 3.2.1.1 |
1UDE | CRYSTAL STRUCTURE OF THE INORGANIC PYROPHOSPHATASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS HORIKOSHII OT3 | 3.6.1.1 |
1UDG | THE STRUCTURAL BASIS OF SPECIFIC BASE EXCISION REPAIR BY URACIL-DNA GLYCOSYLASE | 3.2.2.3 3.2.2.27 |
1UDH | THE STRUCTURAL BASIS OF SPECIFIC BASE EXCISION REPAIR BY URACIL-DNA GLYCOSYLASE | 3.2.2.3 3.2.2.27 |
1UDI | NUCLEOTIDE MIMICRY IN THE CRYSTAL STRUCTURE OF THE URACIL-DNA GLYCOSYLASE-URACIL GLYCOSYLASE INHIBITOR PROTEIN COMPLEX | 3.2.2.3 3.2.2.27 |
1UDT | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH SILDENAFIL(VIAGRA) | 3.1.4.17 3.1.4.35 |
1UDU | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH TADALAFIL(CIALIS) | 3.1.4.17 3.1.4.35 |
1UDX | CRYSTAL STRUCTURE OF THE CONSERVED PROTEIN TT1381 FROM THERMUS THERMOPHILUS HB8 | 3.6.5 |
1UEA | MMP-3/TIMP-1 COMPLEX | 3.4.24.17 |
1UF4 | CRYSTAL STRUCTURE OF C171A/V236A MUTANT OF N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE | 3.5.1.77 |
1UF5 | CRYSTAL STRUCTURE OF C171A/V236A MUTANT OF N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE COMPLEXED WITH N-CARBAMYL-D-METHIONINE | 3.5.1.77 |
1UF7 | CRYSTAL STRUCTURE OF C171A/V236A MUTANT OF N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE COMPLEXED WITH N-CARBAMYL-D-VALINE | 3.5.1.77 |
1UF8 | CRYSTAL STRUCTURE OF C171A/V236A MUTANT OF N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE COMPLEXED WITH N-CARBAMYL-D-PHENYLALANINE | 3.5.1.77 |
1UFW | SOLUTION STRUCTURE OF RNP DOMAIN IN SYNAPTOJANIN 2 | 3.1.3.36 |
1UG6 | STRUCTURE OF BETA-GLUCOSIDASE AT ATOMIC RESOLUTION FROM THERMUS THERMOPHILUS HB8 | 3.2.1.21 |
1UG8 | NMR STRUCTURE OF THE R3H DOMAIN FROM POLY(A)-SPECIFIC RIBONUCLEASE | 3.1.13.4 |
1UG9 | CRYSTAL STRUCTURE OF GLUCODEXTRANASE FROM ARTHROBACTER GLOBIFORMIS I42 | 3.2.1.70 3.2.1.3 |
1UGH | CRYSTAL STRUCTURE OF HUMAN URACIL-DNA GLYCOSYLASE IN COMPLEX WITH A PROTEIN INHIBITOR: PROTEIN MIMICRY OF DNA | 3.2.2.3 3.2.2.27 |
1UH2 | THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE/MALTO-HEXAOSE COMPLEX | 3.2.1.1 3.2.1.135 |
1UH3 | THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE/ACARBOSE COMPLEX | 3.2.1.1 3.2.1.135 |
1UH4 | THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1/MALTO-TRIDECAOSE COMPLEX | 3.2.1.1 3.2.1.135 |
1UH7 | CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 4.6 | 3.4.23.6 3.4.23.21 |
1UH8 | CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 8.0 | 3.4.23.6 3.4.23.21 |
1UH9 | CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 7.0 | 3.4.23.6 3.4.23.21 |
1UHB | CRYSTAL STRUCTURE OF PORCINE ALPHA TRYPSIN BOUND WITH AUTO CATALYTICALY PRODUCED NATIVE PEPTIDE AT 2.15 A RESOLUTION | 3.4.21.4 |
1UHO | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH VARDENAFIL(LEVITRA) | 3.1.4.17 3.1.4.35 |
1UHV | CRYSTAL STRUCTURE OF BETA-D-XYLOSIDASE FROM THERMOANAEROBACTERIUM SACCHAROLYTICUM, A FAMILY 39 GLYCOSIDE HYDROLASE | 3.2.1.37 |
1UI0 | CRYSTAL STRUCTURE OF URACIL-DNA GLYCOSYLASE FROM THERMUS THERMOPHILUS HB8 | 3.2.2 3.2.2.27 |
1UI1 | CRYSTAL STRUCTURE OF URACIL-DNA GLYCOSYLASE FROM THERMUS THERMOPHILUS HB8 | 3.2.2 3.2.2.27 |
1UIA | ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS | 3.2.1.17 |
1UIB | ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS | 3.2.1.17 |
1UIC | ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS | 3.2.1.17 |
1UID | ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS | 3.2.1.17 |
1UIE | ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS | 3.2.1.17 |
1UIF | ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS | 3.2.1.17 |
1UIG | ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS | 3.2.1.17 |
1UIH | ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS | 3.2.1.17 |
1UIL | DOUBLE-STRANDED RNA-BINDING MOTIF OF HYPOTHETICAL PROTEIN BAB28848 | 3.6.4.13 |
1UIO | ADENOSINE DEAMINASE (HIS 238 ALA MUTANT) | 3.5.4.4 |
1UIP | ADENOSINE DEAMINASE (HIS 238 GLU MUTANT) | 3.5.4.4 |
1UJ1 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) | 3.4.24 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
1UJB | STRUCTURE OF THE PROTEIN HISTIDINE PHOSPHATASE SIXA | 3.1.3 |
1UJC | STRUCTURE OF THE PROTEIN HISTIDINE PHOSPHATASE SIXA COMPLEXED WITH TUNGSTATE | 3.1.3 |
1UJX | THE FORKHEAD ASSOCIATED (FHA) DOMAIN LIKE STRUCTURE FROM MOUSE POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE | 3.1.3.32 2.7.1.78 |
1UK2 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH8.0 | 3.4.24 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
1UK3 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH7.6 | 3.4.24 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
1UK4 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) COMPLEXED WITH AN INHIBITOR | 3.4.24 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
1UK6 | CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH PROPIONATE | 3.7.1.9 |
1UK7 | CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH N-BUTYRATE | 3.7.1.9 |
1UK8 | CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH N-VALERATE | 3.7.1.9 |
1UK9 | CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH ISOVALERATE | 3.7.1.9 |
1UKA | CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH (S)-2-METHYLBUTYRATE | 3.7.1.9 |
1UKB | CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH BENZOATE | 3.7.1.9 |
1UKC | CRYSTAL STRUCTURE OF ASPERGILLUS NIGER ESTA | 3.1.1 |
1UKF | CRYSTAL STRUCTURE OF PSEUDOMONAS AVIRULENCE PROTEIN AVRPPHB | 3.4.22 |
1UKO | CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT SUBSTITUTED AT SURFACE REGION | 3.2.1.2 |
1UKP | CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT SUBSTITUTED AT SURFACE REGION | 3.2.1.2 |
1UKR | STRUCTURE OF ENDO-1,4-BETA-XYLANASE C | 3.2.1.8 |
1ULO | N-TERMINAL CELLULOSE-BINDING DOMAIN FROM CELLULOMONAS FIMI BETA-1,4-GLUCANASE C, NMR, MINIMIZED AVERAGE STRUCTURE | 3.2.1.4 |
1ULP | N-TERMINAL CELLULOSE-BINDING DOMAIN FROM CELLULOMONAS FIMI BETA-1,4-GLUCANASE C, NMR, 25 STRUCTURES | 3.2.1.4 |
1ULR | CRYSTAL STRUCTURE OF TT0497 FROM THERMUS THERMOPHILUS HB8 | 3.6.1.7 |
1ULV | CRYSTAL STRUCTURE OF GLUCODEXTRANASE COMPLEXED WITH ACARBOSE | 3.2.1.70 3.2.1.3 |
1UM2 | CRYSTAL STRUCTURE OF THE VMA1-DERIVED ENDONUCLEASE WITH THE LIGATED EXTEIN SEGMENT | 3.6.3.14 7.1.2.2 3.1 |
1UMA | ALPHA-THROMBIN (HIRUGEN) COMPLEXED WITH NA-(N,N-DIMETHYLCARBAMOYL)-ALPHA-AZALYSINE | 3.4.21.5 |
1UMG | CRYSTAL STRUCTURE OF FRUCTOSE-1,6-BISPHOSPHATASE | 3.1.3.11 4.1.2.13 |
1UML | CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH A POTENT INHIBITOR FR233624 | 3.5.4.4 |
1UMS | STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR ENSEMBLE OF 20 STRUCTURES | 3.4.24.17 |
1UMT | STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR AVERAGE OF 20 STRUCTURES MINIMIZED WITH RESTRAINTS | 3.4.24.17 |
1UMU | STRUCTURE DETERMINATION OF UMUD' BY MAD PHASING OF THE SELENOMETHIONYL PROTEIN | 3.4.21 |
1UMV | CRYSTAL STRUCTURE OF AN ACIDIC, NON-MYOTOXIC PHOSPHOLIPASE A2 FROM THE VENOM OF BOTHROPS JARARACUSSU | 3.1.1.4 |
1UN3 | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T44D | 3.1.27.5 3.1.27 |
1UN4 | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T80A | 3.1.27.5 3.1.27 |
1UN5 | ARH-II, AN ANGIOGENIN/RNASE A CHIMERA | 3.1.27.5 3.1.27 4.6.1.18 |
1UNE | CARBOXYLIC ESTER HYDROLASE, 1.5 ANGSTROM ORTHORHOMBIC FORM OF THE BOVINE RECOMBINANT PLA2 | 3.1.1.4 |
1UO6 | PORCINE PANCREATIC ELASTASE/XE-COMPLEX | 3.4.21.36 |
1UOC | X-RAY STRUCTURE OF THE RNASE DOMAIN OF THE YEAST POP2 PROTEIN | 3.1.13.4 |
1UOK | CRYSTAL STRUCTURE OF B. CEREUS OLIGO-1,6-GLUCOSIDASE | 3.2.1.10 |
1UOO | PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND GLY-PHE-ARG-PRO | 3.4.21.26 |
1UOP | PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND GLY-PHE-GLU-PRO | 3.4.21.26 |
1UOQ | PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND GLU-PHE-SER-PRO | 3.4.21.26 |
1UOZ | STRUCTURE OF THE ENDOGLUCANASE CEL6 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH THIOCELLOPENTAOSE AT 1.1 ANGSTROM | 3.2.1 |
1UP0 | STRUCTURE OF THE ENDOGLUCANASE CEL6 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH CELLOBIOSE AT 1.75 ANGSTROM | 3.2.1 |
1UP2 | STRUCTURE OF THE ENDOGLUCANASE CEL6 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH GLUCOSE-ISOFAGOMINE AT 1.9 ANGSTROM | 3.2.1 |
1UP3 | STRUCTURE OF THE ENDOGLUCANASE CEL6 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH METHYL-CELLOBIOSYL-4-DEOXY-4-THIO-BETA-D-CELLOBIOSIDE AT 1.6 ANGSTROM | 3.2.1 |
1UPH | HIV-1 MYRISTOYLATED MATRIX | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1UPJ | HIV-1 PROTEASE COMPLEX WITH U095438 [3-[1-(4-BROMOPHENYL) ISOBUTYL]-4-HYDROXYCOUMARIN | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1UPN | COMPLEX OF ECHOVIRUS TYPE 12 WITH DOMAINS 3 AND 4 OF ITS RECEPTOR DECAY ACCELERATING FACTOR (CD55) BY CRYO ELECTRON MICROSCOPY AT 16 A | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1UQ4 | RICIN A-CHAIN (RECOMBINANT) R213D MUTANT | 3.2.2.22 |
1UQ5 | RICIN A-CHAIN (RECOMBINANT) N122A MUTANT | 3.2.2.22 |
1UQY | XYLANASE XYN10B MUTANT (E262S) FROM CELLVIBRIO MIXTUS IN COMPLEX WITH XYLOPENTAOSE | 3.2.1.8 |
1UQZ | XYLANASE XYN10B MUTANT (E262S) FROM CELLVIBRIO MIXTUS IN COMPLEX WITH 4-O-METHYL GLUCURONIC ACID | 3.2.1.8 |
1UR0 | THE STRUCTURE OF ENDO-BETA-1,4-GALACTANASE FROM BACILLUS LICHENIFORMIS IN COMPLEX WITH TWO OLIGOSACCHARIDE PRODUCTS. | 3.2.1.89 |
1UR1 | XYLANASE XYN10B MUTANT (E262S) FROM CELLVIBRIO MIXTUS IN COMPLEX WITH ARABINOFURANOSE ALPHA-1,3 LINKED TO XYLOBIOSE | 3.2.1.8 |
1UR2 | XYLANASE XYN10B MUTANT (E262S) FROM CELLVIBRIO MIXTUS IN COMPLEX WITH ARABINOFURANOSE ALPHA 1,3 LINKED TO XYLOTRIOSE | 3.2.1.8 |
1UR4 | THE STRUCTURE OF ENDO-BETA-1,4-GALACTANASE FROM BACILLUS LICHENIFORMIS IN COMPLEX WITH TWO OLIGOSACCHARIDE PRODUCTS. | 3.2.1.89 |
1UR8 | INTERACTIONS OF A FAMILY 18 CHITINASE WITH THE DESIGNED INHIBITOR HM508, AND ITS DEGRADATION PRODUCT, CHITOBIONO-DELTA-LACTONE | 3.2.1.14 |
1UR9 | INTERACTIONS OF A FAMILY 18 CHITINASE WITH THE DESIGNED INHIBITOR HM508, AND ITS DEGRADATION PRODUCT, CHITOBIONO-DELTA-LACTONE | 3.2.1.14 |
1URA | ALKALINE PHOSPHATASE (D51ZN) | 3.1.3.1 |
1URB | ALKALINE PHOSPHATASE (N51MG) | 3.1.3.1 |
1URK | SOLUTION STRUCTURE OF THE AMINO TERMINAL FRAGMENT OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 3.4.21.73 |
1URR | A NOVEL DROSOPHILA MELANOGASTER ACYLPHOSPHATASE (ACPDRO2) | 3.6.1.7 |
1URX | CRYSTALLOGRAPHIC STRUCTURE OF BETA-AGARASE A IN COMPLEX WITH OLIGOAGAROSE | 3.2.1.81 |
1US2 | XYLANASE10C (MUTANT E385A) FROM CELLVIBRIO JAPONICUS IN COMPLEX WITH XYLOPENTAOSE | 3.2.1.8 |
1US3 | NATIVE XYLANASE10C FROM CELLVIBRIO JAPONICUS | 3.2.1.8 |
1USH | 5'-NUCLEOTIDASE FROM E. COLI | 3.1.3.5 3.6.1.45 |
1USN | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-142372 | 3.4.24.17 |
1USR | NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE: EVIDENCE FOR A SECOND SIALIC ACID BINDING SITE AND IMPLICATIONS FOR FUSION | 3.2.1.18 |
1USW | CRYSTAL STRUCTURE OF FERULIC ACID ESTERASE FROM ASPERGILLUS NIGER | 3.1.1.73 |
1USX | CRYSTAL STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE COMPLEXED WITH THIOSIALOSIDE | 3.2.1.18 |
1UT5 | DIVALENT METAL IONS (MANGANESE) BOUND TO T5 5'-EXONUCLEASE | 3.1.11.3 3.1.11 |
1UT6 | STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH N-9-(1',2',3',4'-TETRAHYDROACRIDINYL)-1,8- DIAMINOOCTANE AT 2.4 ANGSTROMS RESOLUTION. | 3.1.1.7 |
1UT8 | DIVALENT METAL IONS (ZINC) BOUND TO T5 5'-EXONUCLEASE | 3.1.11.3 3.1.11 |
1UT9 | STRUCTURAL BASIS FOR THE EXOCELLULASE ACTIVITY OF THE CELLOBIOHYDROLASE CBHA FROM C. THERMOCELLUM | 3.2.1.4 |
1UTE | PIG PURPLE ACID PHOSPHATASE COMPLEXED WITH PHOSPHATE | 3.1.3.2 |
1UTJ | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS | 3.4.21.4 |
1UTK | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS | 3.4.21.4 |
1UTL | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS | 3.4.21.4 |
1UTM | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS | 3.4.21.4 |
1UTN | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS | 3.4.21.4 |
1UTO | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS | 3.4.21.4 |
1UTP | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS | 3.4.21.4 |
1UTQ | TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS | 3.4.21.4 |
1UTT | CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[1,1-BIPHENYL]-4-YL)-4-OXOBUTANOIC ACID | 3.4.24.65 |
1UTZ | CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO (2R)-3-({[4-[(PYRIDIN-4-YL)PHENYL]-THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID | 3.4.24.65 |
1UU4 | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A IN COMPLEX WITH CELLOBIOSE | 3.2.1.4 |
1UU5 | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A SOAKED WITH CELLOTETRAOSE | 3.2.1.4 |
1UU6 | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A IN COMPLEX WITH A SOAKED CELLOPENTAOSE | 3.2.1.4 |
1UUG | ESCHERICHIA COLI URACIL-DNA GLYCOSYLASE:INHIBITOR COMPLEX WITH WILD-TYPE UDG AND WILD-TYPE UGI | 3.2.2.3 3.2.2.27 |
1UV4 | NATIVE BACILLUS SUBTILIS ARABINANASE ARB43A | 3.2.1.99 |
1UVO | STRUCTURE OF THE COMPLEX OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH CADMIUM REFINED AT 1.85 A RESOLUTION (CRYSTAL A) | 3.4.21.36 |
1UVP | STRUCTURE OF THE COMPLEX OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH CADMIUM REFINED AT 1.85 A RESOLUTION (CRYSTAL B) | 3.4.21.36 |
1UVS | BOVINE THROMBIN--BM51.1011 COMPLEX | 3.4.21.5 |
1UVT | BOVINE THROMBIN--BM14.1248 COMPLEX | 3.4.21.5 |
1UVU | BOVINE THROMBIN--BM12.1700 COMPLEX | 3.4.21.5 |
1UW7 | NSP9 PROTEIN FROM SARS-CORONAVIRUS. | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
1UWB | TYR 181 CYS HIV-1 RT/8-CL TIBO | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1UWC | FERULOYL ESTERASE FROM ASPERGILLUS NIGER | 3.1.1.73 |
1UWI | CRYSTAL STRUCTURE OF MUTATED BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS, WORKING AT MODERATE TEMPERATURE | 3.2.1.23 |
1UWQ | STRUCTURE OF BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS | 3.2.1.23 |
1UWR | STRUCTURE OF BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH 2-DEOXY-2-FLUORO-GALACTOSE | 3.2.1.23 |
1UWS | STRUCTURE OF BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH 2-DEOXY-2-FLUORO-GLUCOSE | 3.2.1.23 |
1UWT | STRUCTURE OF BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH D-GALACTOHYDROXIMO-1,5-LACTAM | 3.2.1.23 |
1UWU | STRUCTURE OF BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH D-GLUCOHYDROXIMO-1,5-LACTAM | 3.2.1.23 |
1UWW | X-RAY CRYSTAL STRUCTURE OF A NON-CRYSTALLINE CELLULOSE SPECIFIC CARBOHYDRATE-BINDING MODULE: CBM28. | 3.2.1.4 |
1UWY | CRYSTAL STRUCTURE OF HUMAN CARBOXYPEPTIDASE M | 3.4.17.12 |
1UWZ | BACILLUS SUBTILIS CYTIDINE DEAMINASE WITH AN ARG56 - ALA SUBSTITUTION | 3.5.4.5 |
1UX0 | BACILLUS SUBTILIS CYTIDINE DEAMINASE WITH AN ARG56 - GLN SUBSTITUTION | 3.5.4.5 |
1UX1 | BACILLUS SUBTILIS CYTIDINE DEAMINASE WITH A CYS53HIS AND AN ARG56GLN SUBSTITUTION | 3.5.4.5 |
1UX7 | CARBOHYDRATE-BINDING MODULE CBM36 IN COMPLEX WITH CALCIUM AND XYLOTRIOSE | 3.2.1.55 |
1UXO | THE CRYSTAL STRUCTURE OF THE YDEN GENE PRODUCT FROM B. SUBTILIS | 3 |
1UXX | CBM6CT FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH XYLOPENTAOSE | 3.2.1.8 |
1UY1 | BINDING SUB-SITE DISSECTION OF A FAMILY 6 CARBOHYDRATE-BINDING MODULE BY X-RAY CRYSTALLOGRAPHY AND ISOTHERMAL TITRATION CALORIMETRY | 3.2.1.8 |
1UY2 | BINDING SUB-SITE DISSECTION OF A FAMILY 6 CARBOHYDRATE-BINDING MODULE BY X-RAY CRYSTALLOGRAPHY AND ISOTHERMAL TITRATION CALORIMETRY | 3.2.1.8 |
1UY3 | BINDING SUB-SITE DISSECTION OF A FAMILY 6 CARBOHYDRATE-BINDING MODULE BY X-RAY CRYSTALLOGRAPHY AND ISOTHERMAL TITRATION CALORIMETRY | 3.2.1.8 |
1UY4 | BINDING SUB-SITE DISSECTION OF A FAMILY 6 CARBOHYDRATE-BINDING MODULE BY X-RAY CRYSTALLOGRAPHY AND ISOTHERMAL TITRATION CALORIMETRY | 3.2.1.8 |
1UYQ | MUTATED B-GLUCOSIDASE A FROM PAENIBACILLUS POLYMYXA SHOWING INCREASED STABILITY | 3.2.1.21 |
1UZ1 | FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH ISOFAGOMINE LACTAM | 3.2.1.21 |
1UZA | CRYSTALLOGRAPHIC STRUCTURE OF A FERULOYL ESTERASE FROM ASPERGILLUS NIGER | 3.1.1.73 |
1UZE | COMPLEX OF THE ANTI-HYPERTENSIVE DRUG ENALAPRILAT AND THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME | 3.2.1 3.4.15.1 |
1UZF | COMPLEX OF THE ANTI-HYPERTENSIVE DRUG CAPTOPRIL AN THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME | 3.2.1 3.4.15.1 |
1UZG | CRYSTAL STRUCTURE OF THE DENGUE TYPE 3 VIRUS ENVELOPE PROTEIN | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1V03 | CRYSTAL STRUCTURE OF THE SORGHUM BICOLOR DHURRINASE 1 | 3.2.1.21 |
1V04 | SERUM PARAOXONASE BY DIRECTED EVOLUTION | 3.1.1.2 3.1.8.1 3.1.1.81 |
1V08 | CRYSTAL STRUCTURE OF THE ZEA MAZE BETA-GLUCOSIDASE-1 IN COMPLEX WITH GLUCO-TETRAZOLE | 3.2.1.21 3.2.1.182 |
1V0A | FAMILY 11 CARBOHYDRATE-BINDING MODULE OF CELLULOSOMAL CELLULASE LIC26A-CEL5E OF CLOSTRIDIUM THERMOCELLUM | 3.2.1.4 |
1V0D | CRYSTAL STRUCTURE OF CASPASE-ACTIVATED DNASE (CAD) | 3 |
1V0K | XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO-DEOXYNOJIRIMYCIN AT PH 5.8 | 3.2.1.8 |
1V0L | XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO-ISOFAGOMINE AT PH 5.8 | 3.2.1.8 |
1V0M | XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO-DEOXYNOJIRIMYCIN AT PH 7.5 | 3.2.1.8 |
1V0N | XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO-ISOFAGOMINE AT PH 7.5 | 3.2.1.8 |
1V0R | TUNGSTATE-INHIBITED PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF | 3.1.4.4 |
1V0S | UNINHIBITED FORM OF PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF | 3.1.4.4 |
1V0T | PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF SOAKED WITH THE PRODUCT GLYCEROPHOSPHATE | 3.1.4.4 |
1V0U | PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF SOAKED WITH THE PRODUCT GLYCEROPHOSPHATE. | 3.1.4.4 |
1V0V | PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF SOAKED WITH THE SUBSTRATE DIBUTYRYLPHOSPHATIDYLCHOLINE. | 3.1.4.4 |
1V0W | PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF SOAKED WITH THE SUBSTRATE DIBUTYRYLPHOSPHATIDYLCHOLINE. | 3.1.4.4 |
1V0Y | PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF SOAKED WITH THE SUBSTRATE DIBUTYRYLPHOSPHATIDYLCHOLINE. | 3.1.4.4 |
1V0Z | STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 | 3.2.1.18 |
1V13 | CRYSTAL STRUCTURE OF THE MUTANT HIS103ALA OF THE COLICIN E9 DNASE DOMAIN IN COMPLEX WITH ZN+2 (2.0 ANGSTROMS) | 3.1 |
1V14 | CRYSTAL STRUCTURE OF THE COLICIN E9, MUTANT HIS103ALA, IN COMPLEX WITH MG+2 AND DSDNA (RESOLUTION 2.9A) | 3.1.21.1 3.1 |
1V15 | CRYSTAL STRUCTURE OF THE COLICIN E9, MUTANT HIS103ALA, IN COMPLEX WITH ZN+2 AND DSDNA (RESOLUTION 2.4A) | 3.1.21.1 3.1 |
1V2G | THE L109P MUTANT OF E. COLI THIOESTERASE I/PROTEASE I/LYSOPHOSPHOLIPASE L1 (TAP) IN COMPLEXED WITH OCTANOIC ACID | 3.1.1.5 3.1.2 3.1.2.2 3.1.1.2 3.1.2.14 3.4.21 |
1V2I | STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III | 3.2.1.18 |
1V2J | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI)BT.C1 | 3.4.21.4 |
1V2K | FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(TRIPLE.GLU)BT.D2 | 3.4.21.4 |
1V2L | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(TRIPLE.GLU)BT.D1 | 3.4.21.4 |
1V2M | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(TRIPLE.GLU)BT.A1 | 3.4.21.4 |
1V2N | POTENT FACTOR XA INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(99/175/190)BT | 3.4.21.4 |
1V2O | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSYI)BT.B4 | 3.4.21.4 |
1V2P | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSYI)BT.A4 | 3.4.21.4 |
1V2Q | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSWI)BT.B4 | 3.4.21.4 |
1V2R | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI)BT.B4 | 3.4.21.4 |
1V2S | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSFI.GLU)BT.D1 | 3.4.21.4 |
1V2T | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSFI.GLU)BT.B4 | 3.4.21.4 |
1V2U | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARINAT X(SSAI)BT.D1 | 3.4.21.4 |
1V2V | BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSAI)BT.C1 | 3.4.21.4 |
1V2W | TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSAI)BT.B4 | 3.4.21.4 |
1V3A | STRUCTURE OF HUMAN PRL-3, THE PHOSPHATASE ASSOCIATED WITH CANCER METASTASIS | 3.1.3.48 |
1V3B | STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III | 3.2.1.18 |
1V3C | STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC | 3.2.1.18 |
1V3D | STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC2EN | 3.2.1.18 |
1V3E | STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH ZANAMAVIR | 3.2.1.18 |
1V3H | THE ROLES OF GLU186 AND GLU380 IN THE CATALYTIC REACTION OF SOYBEAN BETA-AMYLASE | 3.2.1.2 |
1V3I | THE ROLES OF GLU186 AND GLU380 IN THE CATALYTIC REACTION OF SOYBEAN BETA-AMYLASE | 3.2.1.2 |
1V3X | FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE | 3.4.21.6 |
1V3Y | THE CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM THERMUS THERMOPHILUS HB8 | 3.5.1.88 |
1V3Z | CRYSTAL STRUCTURE OF ACYLPHOSPHATASE FROM PYROCOCCUS HORIKOSHII | 3.6.1.7 |
1V4Y | THE FUNCTIONAL ROLE OF THE BINUCLEAR METAL CENTER IN D-AMINOACYLASE. ONE-METAL ACTIVATION AND SECOND-METAL ATTENUATION | 3.5.1.81 |
1V51 | THE FUNCTIONAL ROLE OF THE BINUCLEAR METAL CENTER IN D-AMINOACYLASE. ONE-METAL ACTIVATION AND SECOND-METAL ATTENUATION | 3.5.1.81 |
1V5C | THE CRYSTAL STRUCTURE OF THE INACTIVE FORM CHITOSANASE FROM BACILLUS SP. K17 AT PH3.7 | 3.2.1.132 3.2.1 |
1V5D | THE CRYSTAL STRUCTURE OF THE ACTIVE FORM CHITOSANASE FROM BACILLUS SP. K17 AT PH6.4 | 3.2.1.132 3.2.1 |
1V5I | CRYSTAL STRUCTURE OF SERINE PROTEASE INHIBITOR POIA1 IN COMPLEX WITH SUBTILISIN BPN' | 3.4.21.62 |
1V5O | SOLUTION STRUCTURE OF THE UBIQUITIN-LIKE DOMAIN FROM MOUSE HYPOTHETICAL 1700011N24RIK PROTEIN | 3.4.23 |
1V5T | SOLUTION STRUCTURE OF THE UBIQUITIN-LIKE DOMAIN FROM MOUSE HYPOTHETICAL 8430435I17RIK PROTEIN | 3.1.3.16 |
1V6C | CRYSTAL STRUCTURE OF PSYCHROPHILIC SUBTILISIN-LIKE PROTEASE APA1 FROM ANTARCTIC PSYCHROTROPH PSEUDOALTEROMONAS SP. AS-11 | 3.4.21 |
1V6D | THE CRYSTAL STRUCTURE OF THE TRYPSIN COMPLEX WITH SYNTHETIC HETEROCHIRAL PEPTIDE | 3.4.21.4 |
1V6T | CRYSTAL STRUCTURE OF LACTAM UTILIZATION PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 | 3.5.2.9 |
1V6U | CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-ALPHA-L-ARABINOFURANOSYL-XYLOBIOSE | 3.2.1.8 |
1V6V | CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(2)-ALPHA-L-ARABINOFURANOSYL-XYLOTRIOSE | 3.2.1.8 |
1V6W | CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-4-O-METHYL-ALPHA-D-GLUCURONOSYL-XYLOBIOSE | 3.2.1.8 |
1V6X | CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(3)-4-O-METHYL-ALPHA-D-GLUCURONOSYL-XYLOTRIOSE | 3.2.1.8 |
1V6Y | CRYSTAL STRUCTURE OF CHIMERIC XYLANASE BETWEEN STREPTOMYCES OLIVACEOVIRIDIS E-86 FXYN AND CELLULOMONAS FIMI CEX | 3.2.1.8 3.2.1.91 |
1V73 | CRYSTAL STRUCTURE OF COLD-ACTIVE PROTEIN-TYROSINE PHOSPHATASE OF A PSYCHROPHILE SHEWANELLA SP. | 3.1.3.48 |
1V76 | CRYSTAL STRUCTURE OF ARCHAEAL RIBONUCLEASE P PROTEIN PH1771P FROM PYROCOCCUS HORIKOSHII OT3 | 3.1.26.5 |
1V77 | CRYSTAL STRUCTURE OF THE PH1877 PROTEIN | 3.1.26.5 |
1V79 | CRYSTAL STRUCTURES OF ADENOSINE DEAMINASE COMPLEXED WITH POTENT INHIBITORS | 3.5.4.4 |
1V7A | CRYSTAL STRUCTURES OF ADENOSINE DEAMINASE COMPLEXED WITH POTENT INHIBITORS | 3.5.4.4 |
1V7R | STRUCTURE OF NUCLEOTIDE TRIPHOSPHATE PYROPHOSPHATASE FROM PYROCOCCUS HORIKOSHII OT3 | 3.6.1.19 3.6.1.66 |
1V7S | TRICLINIC HEN LYSOZYME CRYSTALLIZED AT 313K FROM A D2O SOLUTION | 3.2.1.17 |
1V7T | TRICLINIC LYSOZYME WITH LOW SOLVENT CONTENT OBTAINED BY PHASE TRANSITION | 3.2.1.17 |
1V7Z | CREATININASE-PRODUCT COMPLEX | 3.5.2.10 |
1V8B | CRYSTAL STRUCTURE OF A HYDROLASE | 3.3.1.1 |
1V8E | CRYSTAL STRUCTURE OF GLYCEROPHOSPHORYL DIESTER PHOSPHODIESTERASE FROM THERMUS THERMOPHILUS HB8 | 3.1.4.46 |
1V8I | CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE | 3.6.1.13 |
1V8L | STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH ADP-RIBOSE | 3.6.1.13 |
1V8M | CRYSTAL STRUCTURE ANALYSIS OF ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH ADP-RIBOSE AND GD | 3.6.1.13 |
1V8N | CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH ZN | 3.6.1.13 |
1V8O | CRYSTAL STRUCTURE OF PAE2754 FROM PYROBACULUM AEROPHILUM | 3.1 |
1V8P | CRYSTAL STRUCTURE OF PAE2754 FROM PYROBACULUM AEROPHILUM | 3.1 |
1V8R | CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH ADP-RIBOSE AND ZN | 3.6.1.13 |
1V8S | CRYSTAL STRUCTURE ANALUSIS OF THE ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH AMP AND MG | 3.6.1.13 |
1V8T | CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH RIBOSE-5'-PHOSPHATE AND ZN | 3.6.1.13 |
1V8U | CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE OF E82Q MUTANT WITH SO4 AND MG | 3.6.1.13 |
1V8V | CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE OF E86Q MUTANT, COMPLEXED WITH ADP-RIBOSE AND MG | 3.6.1.13 |
1V8W | CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE OF E82Q MUTANT, COMPLEXED WITH SO4 AND ZN | 3.6.1.13 |
1V8Y | CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE OF E86Q MUTANT, COMPLEXED WITH ADP-RIBOSE AND ZN | 3.6.1.13 |
1V96 | CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN OF UNKNOWN FUNCTION FROM PYROCOCCUS HORIKOSHII OT3 | 3.1 |
1V9H | CRYSTAL STRUCTURE OF THE RNASE MC1 MUTANT Y101A IN COMPLEX WITH 5'-UMP | 3.1.27.1 4.6.1.19 |
1V9M | CRYSTAL STRUCTURE OF THE C SUBUNIT OF V-TYPE ATPASE FROM THERMUS THERMOPHILUS | 3.6.3.14 |
1V9Y | CRYSTAL STRUCTURE OF THE HEME PAS SENSOR DOMAIN OF EC DOS (FERRIC FORM) | 3.1.4.52 |
1V9Z | CRYSTAL STRUCTURE OF THE HEME PAS SENSOR DOMAIN OF EC DOS (FERROUS FORM) | 3.1.4.52 |
1VA4 | PSEUDOMONAS FLUORESCENS ARYL ESTERASE | 3.1.1.2 1 |
1VAH | CRYSTAL STRUCTURE OF THE PIG PANCREATIC-AMYLASE COMPLEXED WITH R-NITROPHENYL-A-D-MALTOSIDE | 3.2.1.1 |
1VAP | THE MONOMERIC ASP49 SECRETORY PHOSPHOLIPASE A2 FROM THE VENOM OF AGKISTRIDON PISCIVORUS PISCIVORUS | 3.1.1.4 |
1VAS | ATOMIC MODEL OF A PYRIMIDINE DIMER SPECIFIC EXCISION REPAIR ENZYME COMPLEXED WITH A DNA SUBSTRATE: STRUCTURAL BASIS FOR DAMAGED DNA RECOGNITION | 3.2.2.17 4.2.99.18 |
1VAT | IODINE DERIVATIVE OF HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
1VAU | XENON DERIVATIVE OF HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
1VB6 | CRYSTAL STRUCTURE OF THE HEME PAS SENSOR DOMAIN OF EC DOS (OXYGEN-BOUND FORM) | 3.1.4.52 |
1VB9 | CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) COMPLEXED WITH TRANSGLYCOSYLATED PRODUCT | 3.2.1.1 3.2.1.135 |
1VBR | CRYSTAL STRUCTURE OF COMPLEX XYLANASE 10B FROM THERMOTOGA MARITIMA WITH XYLOBIOSE | 3.2.1.8 |
1VBU | CRYSTAL STRUCTURE OF NATIVE XYLANASE 10B FROM THERMOTOGA MARITIMA | 3.2.1.8 |
1VC8 | CRYSTAL STRUCTURE OF A T.THERMOPHILUS HB8 AP6A HYDROLASE NDX1-AP6A COMPLEX | 3.6.1.61 |
1VC9 | CRYSTAL STRUCTURE OF A T.THERMOPHILUS HB8 AP6A HYDROLASE E50Q MUTANT-MG2+-ATP COMPLEX | 3.6.1.61 |
1VCD | CRYSTAL STRUCTURE OF A T.THERMOPHILUS HB8 AP6A HYDROLASE NDX1 | 3.6.1.61 |
1VCJ | INFLUENZA B VIRUS NEURAMINIDASE COMPLEXED WITH 1-(4-CARBOXY-2-(3-PENTYLAMINO)PHENYL)-5-AMINOMETHYL-5-HYDROXYMETHYL-PYRROLIDIN-2-ONE | 3.2.1.18 |
1VCP | SEMLIKI FOREST VIRUS CAPSID PROTEIN (CRYSTAL FORM I) | 3.4.21.90 |
1VCQ | SEMLIKI FOREST VIRUS CAPSID PROTEIN (CRYSTAL FORM II) | 3.4.21.90 |
1VCU | STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2 IN COMPLEX WITH THE INHIBITOR DANA | 3.2.1.18 |
1VCW | CRYSTAL STRUCTURE OF DEGS AFTER BACKSOAKING THE ACTIVATING PEPTIDE | 3.4.21 3.4.21.107 |
1VCZ | CRYSTAL STRUCTURE OF THE RNASE NT IN COMPLEX WITH 5'-GMP | 3.1.27.1 |
1VD1 | CRYSTAL STRUCTURE OF RNASE NT IN COMPLEX WITH 5'-AMP | 3.1.27.1 |
1VD3 | RIBONUCLEASE NT IN COMPLEX WITH 2'-UMP | 3.1.27.1 |
1VD5 | CRYSTAL STRUCTURE OF UNSATURATED GLUCURONYL HYDROLASE, RESPONSIBLE FOR THE DEGRADATION OF GLYCOSAMINOGLYCAN, FROM BACILLUS SP. GL1 AT 1.8 A RESOLUTION | 3.2.1 3.2.1.179 |
1VD6 | CRYSTAL STRUCTURE OF GLYCEROPHOSPHORYL DIESTER PHOSPHODIESTERASE COMPLEXED WITH GLYCEROL | 3.1.4.46 |
1VDE | PI-SCEI, A HOMING ENDONUCLEASE WITH PROTEIN SPLICING ACTIVITY | 7.1.2.2 3.1 |
1VDL | SOLUTION STRUCTURE OF RSGI RUH-013, A UBA DOMAIN IN MOUSE CDNA | 3.1.2.15 3.4.19.12 |
1VDP | THE CRYSTAL STRUCTURE OF THE MONOCLINIC FORM OF HEN EGG WHITE LYSOZYME AT 1.7 ANGSTROMS RESOLUTION IN SPACE | 3.2.1.17 |
1VDQ | THE CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF HEN EGG WHITE LYSOZYME AT 1.5 ANGSTROMS RESOLUTION | 3.2.1.17 |
1VDS | THE CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF HEN EGG WHITE LYSOZYME AT 1.6 ANGSTROMS RESOLUTION IN SPACE | 3.2.1.17 |
1VDT | THE CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF HEN EGG WHITE LYSOZYME AT 1.7 ANGSTROMS RESOLUTION UNDER BASIC CONDITIONS IN SPACE | 3.2.1.17 |
1VDW | A HYPOTHETICAL PROTEIN PH1897 FROM PYROCOCCUS HORIKOSHII WITH SIMILARITIES FOR INOSITOL-1 MONOPHOSPHATASE | 3.1.3.11 |
1VDX | CRYSTAL STRUCTURE OF A PYROCOCCUS HORIKOSHII PROTEIN WITH SIMILARITIES TO 2'5' RNA-LIGASE | 6.5.1.3 3.1.4.58 |
1VDZ | CRYSTAL STRUCTURE OF A-TYPE ATPASE CATALYTIC SUBUNIT A FROM PYROCOCCUS HORIKOSHII OT3 | 3.6.3.14 7.1.2.2 3.1 |
1VE6 | CRYSTAL STRUCTURE OF AN ACYLPEPTIDE HYDROLASE/ESTERASE FROM AEROPYRUM PERNIX K1 | 3.4.19.1 |
1VE7 | CRYSTAL STRUCTURE OF AN ACYLPEPTIDE HYDROLASE/ESTERASE FROM AEROPYRUM PERNIX K1 IN COMPLEX WITH P-NITROPHENYL PHOSPHATE | 3.4.19.1 |
1VEC | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF RCK/P54, A HUMAN DEAD-BOX PROTEIN | 3.6.4.13 |
1VED | THE CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF HEN EGG WHITE LYSOZYME AT 1.9 ANGSTROMS RESOLUTION IN SPACE | 3.2.1.17 |
1VEK | SOLUTION STRUCTURE OF RSGI RUH-011, A UBA DOMAIN FROM ARABIDOPSIS CDNA | 3.4.19.12 |
1VEM | CRYSTAL STRUCTURE ANALYSIS OF BACILLUS CEREUS BETA-AMYLASE AT THE OPTIMUM PH (6.5) | 3.2.1.2 |
1VEN | CRYSTAL STRUCTURE ANALYSIS OF Y164E/MALTOSE OF BACILUS CEREUS BETA-AMYLASE AT PH 4.6 | 3.2.1.2 |
1VEO | CRYSTAL STRUCTURE ANALYSIS OF Y164F/MALTOSE OF BACILLUS CEREUS BETA-AMYLASE AT PH 4.6 | 3.2.1.2 |
1VEP | CRYSTAL STRUCTURE ANALYSIS OF TRIPLE (T47M/Y164E/T328N)/MALTOSE OF BACILLUS CEREUS BETA-AMYLASE AT PH 6.5 | 3.2.1.2 |
1VEV | CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM LEPTOSPIRA INTERROGANS (LIPDF) AT PH6.5 | 3.5.1.88 |
1VEY | CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM LEPTOSPIRA INTERROGANS (LIPDF) AT PH7.0 | 3.5.1.88 |
1VEZ | CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM LEPTOSPIRA INTERROGANS(LIPDF) AT PH8.0 | 3.5.1.88 |
1VF8 | THE CRYSTAL STRUCTURE OF YM1 AT 1.31 A RESOLUTION | 3.2.1.52 |
1VFD | HUMAN LACTOFERRIN, N-TERMINAL LOBE MUTANT WITH ARG 121 REPLACED BY GLU (R121E) | 3.4.21 |
1VFE | HUMAN LACTOFERRIN, N-TERMINAL LOBE MUTANT WITH ARG 121 REPLACED BY SER (R121S) | 3.4.21 |
1VFF | BETA-GLYCOSIDASE FROM PYROCOCCUS HORIKOSHII | 3.2.1.21 |
1VFL | ADENOSINE DEAMINASE | 3.5.4.4 |
1VFM | CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2/ALPHA-CYCLODEXTRIN COMPLEX | 3.2.1.135 |
1VFO | CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2/BETA-CYCLODEXTRIN COMPLEX | 3.2.1.135 |
1VFP | CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH BOUND AMPPCP | 3.6.3.8 7.2.2.10 |
1VFU | CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 AMYLASE 2/GAMMA-CYCLODEXTRIN COMPLEX | 3.2.1.135 |
1VG5 | SOLUTION STRUCTURE OF RSGI RUH-014, A UBA DOMAIN FROM ARABIDOPSIS CDNA | 3.4.21 |
1VGC | GAMMA-CHYMOTRYPSIN L-PARA-CHLORO-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX | 3.4.21.1 |
1VGJ | CRYSTAL STRUCTURE OF 2'-5' RNA LIGASE FROM PYROCOCCUS HORIKOSHII | 3.1.4.58 |
1VGN | STRUCTURE-BASED DESIGN OF THE IRREVERSIBLE INHIBITORS TO METALLO--LACTAMASE (IMP-1) | 3.5.2.6 |
1VGX | CRYSTAL STRUCTURE OF A AUTOINDUCER-2 SYNTHESIS PROTEIN | 3.13.1 4.4.1.21 |
1VGY | CRYSTAL STRUCTURE OF SUCCINYL DIAMINOPIMELATE DESUCCINYLASE | 3.5.1.18 |
1VH2 | CRYSTAL STRUCTURE OF A AUTOINDUCER-2 SYNTHESIS PROTEIN | 3.13.1 4.4.1.21 |
1VH5 | CRYSTAL STRUCTURE OF A PUTATIVE THIOESTERASE | 3.1.2.28 |
1VH9 | CRYSTAL STRUCTURE OF A PUTATIVE THIOESTERASE | 3.1.2 |
1VHE | CRYSTAL STRUCTURE OF A AMINOPEPTIDASE/GLUCANASE HOMOLOG | 3.4.11 |
1VHG | CRYSTAL STRUCTURE OF ADP COMPOUNDS HYDROLASE | 3.6.1 |
1VHR | HUMAN VH1-RELATED DUAL-SPECIFICITY PHOSPHATASE | 3.1.3.48 3.1.3.16 |
1VHU | CRYSTAL STRUCTURE OF A PUTATIVE PHOSPHOESTERASE | 3.2.2 |
1VHX | CRYSTAL STRUCTURE OF PUTATIVE HOLLIDAY JUNCTION RESOLVASE | 3.1 |
1VHZ | CRYSTAL STRUCTURE OF ADP COMPOUNDS HYDROLASE | 3.6.1 |
1VI8 | CRYSTAL STRUCTURE OF A PUTATIVE THIOESTERASE | 3.1.2.28 |
1VIJ | HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 HEXAGONAL FORM | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1VIK | HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 ORTHORHOMBIC FORM | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1VIP | ANTICOAGULANT CLASS II PHOSPHOLIPASE A2 FROM THE VENOM OF VIPERA RUSSELLI RUSSELLI | 3.1.1.4 |
1VIQ | CRYSTAL STRUCTURE OF PUTATIVE ADP RIBOSE PYROPHOSPHATASE | 3.6.1.13 |
1VIT | THROMBIN:HIRUDIN 51-65 COMPLEX | 3.4.21.5 |
1VIU | CRYSTAL STRUCTURE OF PUTATIVE ADP RIBOSE PYROPHOSPHATASE | 3.6.1 |
1VIW | TENEBRIO MOLITOR ALPHA-AMYLASE-INHIBITOR COMPLEX | 3.2.1.1 |
1VIX | CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDASE T | 3.4.11.14 3.4.11.4 |
1VJ5 | HUMAN SOLUBLE EPOXIDE HYDROLASE- N-CYCLOHEXYL-N'-(4-IODOPHENYL)UREA COMPLEX | 3.3.2.3 3.3.2.10 3.1.3.76 |
1VJ6 | PDZ2 FROM PTP-BL IN COMPLEX WITH THE C-TERMINAL LIGAND FROM THE APC PROTEIN | 3.1.3.48 |
1VJ7 | CRYSTAL STRUCTURE OF THE BIFUNCTIONAL CATALYTIC FRAGMENT OF RELSEQ, THE RELA/SPOT HOMOLOG FROM STREPTOCOCCUS EQUISIMILIS. | 3.1.7.2 2.7.6.5 |
1VJ9 | UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-JT464 COMPLEX | 3.4.21.73 |
1VJA | UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-JT463 COMPLEX | 3.4.21.73 |
1VJE | CRYSTAL STRUCTURE OF A AUTOINDUCER-2 SYNTHESIS PROTEIN WITH BOUND SELENOMETHIONINE | 3.13.1 4.4.1.21 |
1VJR | CRYSTAL STRUCTURE OF 4-NITROPHENYLPHOSPHATASE (TM1742) FROM THERMOTOGA MARITIMA AT 2.40 A RESOLUTION | 3.1.3.41 |
1VJS | STRUCTURE OF ALPHA-AMYLASE PRECURSOR | 3.2.1.1 |
1VJT | CRYSTAL STRUCTURE OF ALPHA-GLUCOSIDASE (TM0752) FROM THERMOTOGA MARITIMA AT 2.50 A RESOLUTION | 3.2.1.139 |
1VJV | CRYSTAL STRUCTURE OF UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 6 (YFR010W) FROM SACCHAROMYCES CEREVISIAE AT 1.74 A RESOLUTION | 3.1.2.15 3.4.19.12 |
1VJZ | CRYSTAL STRUCTURE OF ENDOGLUCANASE (TM1752) FROM THERMOTOGA MARITIMA AT 2.05 A RESOLUTION | 3.2.1.4 |
1VK0 | X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT5G06450 | 3.1.13.1 |
1VK2 | CRYSTAL STRUCTURE OF URACIL-DNA GLYCOSYLASE (TM0511) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION | 3.2.2 3.2.2.27 |
1VK6 | CRYSTAL STRUCTURE OF NADH PYROPHOSPHATASE (1790429) FROM ESCHERICHIA COLI K12 AT 2.20 A RESOLUTION | 3.6.1 3.6.1.22 |
1VKG | CRYSTAL STRUCTURE OF HUMAN HDAC8 COMPLEXED WITH CRA-19156 | 3.5.1.98 |
1VKH | CRYSTAL STRUCTURE OF A PUTATIVE SERINE HYDROLASE (YDR428C) FROM SACCHAROMYCES CEREVISIAE AT 1.85 A RESOLUTION | 3.5.1.9 |
1VKP | X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT5G08170, AGMATINE IMINOHYDROLASE | 3.5.3.12 |
1VKQ | A RE-DETERMINATION OF THE STRUCTURE OF THE TRIPLE MUTANT (K53,56,120M) OF PHOSPHOLIPASE A2 AT 1.6A RESOLUTION USING SULPHUR-SAS AT 1.54A WAVELENGTH | 3.1.1.4 |
1VL1 | CRYSTAL STRUCTURE OF 6-PHOSPHOGLUCONOLACTONASE (TM1154) FROM THERMOTOGA MARITIMA AT 1.70A RESOLUTION | 3.1.1.31 |
1VL9 | ATOMIC RESOLUTION (0.97A) STRUCTURE OF THE TRIPLE MUTANT (K53,56,121M) OF BOVINE PANCREATIC PHOSPHOLIPASE A2 | 3.1.1.4 |
1VLR | CRYSTAL STRUCTURE OF MRNA DECAPPING ENZYME (DCPS) FROM MUS MUSCULUS AT 1.83 A RESOLUTION | 3.6.1.59 |
1VM1 | STRUCTURE OF SHV-1 BETA-LACTAMASE INHIBITED BY TAZOBACTAM | 3.5.2.6 |
1VMG | CRYSTAL STRUCTURE OF MAZG NUCLEOTIDE PYROPHOSPHOHYDROLASE (13816655) FROM SULFOLOBUS SOLFATARICUS AT 1.46 A RESOLUTION | 3.6.1 |
1VOT | ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH HUPERZINE A | 3.1.1.7 |
1VP2 | CRYSTAL STRUCTURE OF A PUTATIVE XANTHOSINE TRIPHOSPHATE PYROPHOSPHATASE/HAM1 PROTEIN HOMOLOG (TM0159) FROM THERMOTOGA MARITIMA AT 1.78 A RESOLUTION | 3.6.1 3.6.1.66 |
1VP7 | CRYSTAL STRUCTURE OF EXODEOXYRIBONUCLEASE VII SMALL SUBUNIT (NP_881400.1) FROM BORDETELLA PERTUSSIS AT 2.40 A RESOLUTION | 3.1.11.6 |
1VPM | CRYSTAL STRUCTURE OF ACYL-COA HYDROLASE (NP_241664.1) FROM BACILLUS HALODURANS AT 1.66 A RESOLUTION | 3.1.2 |
1VQ2 | CRYSTAL STRUCTURE OF T4-BACTERIOPHAGE DEOXYCYTIDYLATE DEAMINASE, MUTANT R115E | 3.5.4.12 |
1VR0 | CRYSTAL STRUCTURE OF PUTATIVE 2-PHOSPHOSULFOLACTATE PHOSPHATASE (15026306) FROM CLOSTRIDIUM ACETOBUTYLICUM AT 2.6 A RESOLUTION | 3.1.3.71 |
1VR1 | SPECIFITY FOR PLASMINOGEN ACTIVATOR INHIBITOR-1 | 3.4.21.5 |
1VRH | HRV14/SDZ 880-061 COMPLEX | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1VRL | MUTY ADENINE GLYCOSYLASE IN COMPLEX WITH DNA AND SOAKED ADENINE FREE BASE | 3.2.2 3.2.2.31 |
1VRR | CRYSTAL STRUCTURE OF THE RESTRICTION ENDONUCLEASE BSTYI COMPLEX WITH DNA | 3.1.21.4 |
1VRT | HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1VRU | HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1VRX | ENDOCELLULASE E1 FROM ACIDOTHERMUS CELLULOLYTICUS MUTANT Y245G | 3.2.1.4 |
1VSB | SUBTILISIN CARLSBERG L-PARA-CHLOROPHENYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX | 3.4.21.62 |
1VSD | ASV INTEGRASE CORE DOMAIN WITH MG(II) COFACTOR AND HEPES LIGAND, HIGH MG CONCENTRATION FORM | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1VSE | ASV INTEGRASE CORE DOMAIN WITH MG(II) COFACTOR AND HEPES LIGAND, LOW MG CONCENTRATION FORM | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1VSF | ASV INTEGRASE CORE DOMAIN WITH MN(II) COFACTOR AND HEPES LIGAND, HIGH MG CONCENTRATION FORM | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1VSH | ASV INTEGRASE CORE DOMAIN WITH ZN(II) COFACTORS | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1VSI | ASV INTEGRASE CORE DOMAIN WITH CA(II) COFACTOR | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1VSJ | ASV INTEGRASE CORE DOMAIN WITH CD(II) COFACTORS | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1VSK | ASV INTEGRASE CORE DOMAIN D64N MUTATION IN CITRATE BUFFER PH 6.0 | 2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1VSL | ASV INTEGRASE CORE DOMAIN D64N MUTATION WITH ZINC CATION | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1VSM | ASV INTEGRASE CORE DOMAIN IN CITRATE BUFFER PH 5.0 | 2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1VSN | CRYSTAL STRUCTURE OF A POTENT SMALL MOLECULE INHIBITOR BOUND TO CATHEPSIN K | 3.4.22.38 |
1VSR | VERY SHORT PATCH REPAIR (VSR) ENDONUCLEASE FROM ESCHERICHIA COLI | 3.1 |
1VXO | METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH O-ETHYL-S-[2-[BIS(1-METHYLETHYL)AMINO]ETHYL] METHYLPHOSPHONOTHIOATE (VX) | 3.1.1.7 |
1VXR | O-ETHYLMETHYLPHOSPHONYLATED ACETYLCHOLINESTERASE OBTAINED BY REACTION WITH O-ETHYL-S-[2-[BIS(1-METHYLETHYL)AMINO]ETHYL] METHYLPHOSPHONOTHIOATE (VX) | 3.1.1.7 |
1VYB | ENDONUCLEASE DOMAIN OF HUMAN LINE1 ORF2P | 2.7.7.49 3.1.21 |
1VYQ | NOVEL INHIBITORS OF PLASMODIUM FALCIPARUM DUTPASE PROVIDE A PLATFORM FOR ANTI-MALARIAL DRUG DESIGN | 3.6.1.23 |
1VZ2 | PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, Y73C/V427C/C255T MUTANT | 3.4.21.26 |
1VZ3 | PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, T597C MUTANT | 3.4.21.26 |
1VZJ | STRUCTURE OF THE TETRAMERIZATION DOMAIN OF ACETYLCHOLINESTERASE: FOUR-FOLD INTERACTION OF A WWW MOTIF WITH A LEFT-HANDED POLYPROLINE HELIX | 3.1.1.7 |
1VZQ | COMPLEX OF THROMBIN WITH DESIGNED INHIBITOR 7165 | 3.4.21.5 |
1VZS | SOLUTION STRUCTURE OF SUBUNIT F6 FROM THE PERIPHERAL STALK REGION OF ATP SYNTHASE FROM BOVINE HEART MITOCHONDRIA | 3.6.3.14 |
1VZV | STRUCTURE OF VARICELLA-ZOSTER VIRUS PROTEASE | 3.4.21 3.4.21.97 |
1W08 | STRUCTURE OF T70N HUMAN LYSOZYME | 3.2.1.17 |
1W0H | CRYSTALLOGRAPHIC STRUCTURE OF THE NUCLEASE DOMAIN OF 3'HEXO, A DEDDH FAMILY MEMBER, BOUND TO RAMP | 3.1 |
1W0J | BERYLLIUM FLUORIDE INHIBITED BOVINE F1-ATPASE | 3.6.3.14 |
1W0N | STRUCTURE OF UNCOMPLEXED CARBOHYDRATE BINDING DOMAIN CBM36 | 3.2.1.8 3.2.1.55 |
1W0O | VIBRIO CHOLERAE SIALIDASE | 3.2.1.18 |
1W0P | VIBRIO CHOLERAE SIALIDASE WITH ALPHA-2,6-SIALYLLACTOSE | 3.2.1.18 |
1W0Y | TF7A_3771 COMPLEX | 3.4.21.21 |
1W0Z | UROKINASE TYPE PLASMINOGEN ACTIVATOR | 3.4.21.73 |
1W10 | UROKINASE TYPE PLASMINOGEN ACTIVATOR | 3.4.21.73 |
1W11 | UROKINASE TYPE PLASMINOGEN ACTIVATOR | 3.4.21.73 |
1W12 | UROKINASE TYPE PLASMINOGEN ACTIVATOR | 3.4.21.73 |
1W13 | UROKINASE TYPE PLASMINOGEN ACTIVATOR | 3.4.21.73 |
1W14 | UROKINASE TYPE PLASMINOGEN ACTIVATOR | 3.4.21.73 |
1W17 | STRUCTURE OF BACILLUS SUBTILIS PDAA, A FAMILY 4 CARBOHYDRATE ESTERASE. | 3 3.5.1 |
1W1A | STRUCTURE OF BACILLUS SUBTILIS PDAA IN COMPLEX WITH NAG, A FAMILY 4 CARBOHYDRATE ESTERASE. | 3.5.1 |
1W1B | STRUCTURE OF BACILLUS SUBTILIS PDAA WITH CADMIUM, A FAMILY 4 CARBOHYDRATE ESTERASE. | 3.5.1 |
1W1P | CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(GLY-L-PRO) AT 2.1 A RESOLUTION | 3.2.1.14 |
1W1T | CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(HIS-L-PRO) AT 1.9 A RESOLUTION | 3.2.1.14 |
1W1V | CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(L-ARG-L-PRO) AT 1.85 A RESOLUTION | 3.2.1.14 |
1W1X | STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA, NEU5AC), CRYSTAL SOAKED FOR 3 HOURS AT 277 K. | 3.2.1.18 |
1W1Y | CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(L-TYR-L-PRO) AT 1.85 A RESOLUTION | 3.2.1.14 |
1W20 | STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA, NEU5AC), CRYSTAL SOAKED FOR 3 HOURS AT 291 K | 3.2.1.18 |
1W21 | STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA, NEU5AC), CRYSTAL SOAKED FOR 43 HOURS AT 291 K. | 3.2.1.18 |
1W22 | CRYSTAL STRUCTURE OF INHIBITED HUMAN HDAC8 | 3.5.1.98 |
1W2I | CRYSTAL STRUCTUORE OF ACYLPHOSPHATASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH FORMATE | 3.6.1.7 |
1W2K | TF7A_4380 COMPLEX | 3.4.21.21 |
1W2P | THE 3-DIMENSIONAL STRUCTURE OF A XYLANASE (XYN10A) FROM CELLVIBRIO JAPONICUS | 3.2.1.8 |
1W2U | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A IN COMPLEX WITH A SOAKED THIO CELLOTETRAOSE | 3.2.1.4 |
1W2V | THE 3-DIMENSIONAL STRUCTURE OF A THERMOSTABLE MUTANT OF A XYLANASE (XYN10A) FROM CELLVIBRIO JAPONICUS | 3.2.1.8 |
1W2Y | THE CRYSTAL STRUCTURE OF A COMPLEX OF CAMPYLOBACTER JEJUNI DUTPASE WITH SUBSTRATE ANALOGUE DUPNHP | 3.6.1.23 |
1W32 | THE 3-DIMENSIONAL STRUCTURE OF A THERMOSTABLE MUTANT OF A XYLANASE (XYN10A) FROM CELLVIBRIO JAPONICUS | 3.2.1.8 |
1W3C | CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS3 PROTEASE IN COMPLEX WITH A PEPTIDOMIMETIC INHIBITOR | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
1W3H | THE 3-DIMENSIONAL STRUCTURE OF A THERMOSTABLE MUTANT OF A XYLANASE (XYN10A) FROM CELLVIBRIO JAPONICUS | 3.2.1.8 |
1W3J | FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH TETRAHYDROOXAZINE | 3.2.1.21 |
1W3K | ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN COMPLEX WITH CELLOBIO DERIVED-TETRAHYDROOXAZINE | 3.2.1.4 |
1W3L | ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN COMPLEX WITH CELLOTRI DERIVED-TETRAHYDROOXAZINE | 3.2.1.4 |
1W4L | COMPLEX OF TCACHE WITH BIS-ACTING GALANTHAMINE DERIVATIVE | 3.1.1.7 |
1W4O | BINDING OF NONNATURAL 3'-NUCLEOTIDES TO RIBONUCLEASE A | 3.1.27.5 4.6.1.18 |
1W4P | BINDING OF NONNATURAL 3'-NUCLEOTIDES TO RIBONUCLEASE A | 3.1.27.5 4.6.1.18 |
1W4Q | BINDING OF NONNATURAL 3'-NUCLEOTIDES TO RIBONUCLEASE A | 3.1.27.5 4.6.1.18 |
1W50 | APO STRUCTURE OF BACE (BETA SECRETASE) | 3.4.23.46 |
1W51 | BACE (BETA SECRETASE) IN COMPLEX WITH A NANOMOLAR NON-PEPTIDIC INHIBITOR | 3.4.23.46 |
1W53 | KINASE RECRUITMENT DOMAIN OF THE STRESS PHOSPHATASE RSBU | 3.1.3.3 |
1W5D | CRYSTAL STRUCTURE OF PBP4A FROM BACILLUS SUBTILIS | 3.4.16.4 |
1W5V | HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2- SYMMETRIC INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1W5W | HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2- SYMMETRIC INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1W5X | HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2- SYMMETRIC INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1W5Y | HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2- SYMMETRIC INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1W6H | NOVEL PLASMEPSIN II-INHIBITOR COMPLEX | 3.4.23.39 |
1W6I | PLASMEPSIN II-PEPSTATIN A COMPLEX | 3.4.23.39 |
1W6R | COMPLEX OF TCACHE WITH GALANTHAMINE DERIVATIVE | 3.1.1.7 |
1W6V | SOLUTION STRUCTURE OF THE DUSP DOMAIN OF HUSP15 | 3.1.2.15 3.4.19.12 |
1W6Z | HIGH ENERGY TETRAGONAL LYSOZYME X-RAY STRUCTURE | 3.2.1.17 |
1W75 | NATIVE ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE (ACHE) | 3.1.1.7 |
1W76 | ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE (ACHE) COMPLEXED WITH BIS-ACTING GALANTHAMINE DERIVATIVE | 3.1.1.7 |
1W79 | CRYSTAL STRUCTURE OF THE DD-TRANSPEPTIDASE-CARBOXYPEPTIDASE FROM ACTINOMADURA R39 | 3.4.16.4 |
1W7F | CRYSTAL STRUCTURE OF THE CLASS A BETA-LACTAMASE BS3 INHIBITED WITH ISOCITRATE | 3.5.2.6 |
1W7G | ALPHA-THROMBIN COMPLEX WITH SULFATED HIRUDIN (RESIDUES 54-65) AND L- ARGININE TEMPLATE INHIBITOR CS107 | 3.4.21.5 |
1W7V | ZNMG SUBSTITUTED AMINOPEPTIDASE P FROM E. COLI | 3.4.11.9 |
1W7X | FACTOR7 - 413 COMPLEX | 3.4.21.21 |
1W8B | FACTOR7 - 413 COMPLEX | 3.4.21.21 |
1W8I | THE STRUCTURE OF GENE PRODUCT AF1683 FROM ARCHAEOGLOBUS FULGIDUS. | 3.1 |
1W8N | CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS. | 3.2.1.18 |
1W8O | CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS | 3.2.1.18 |
1W8Q | CRYSTAL STRUCTURE OF THE DD-TRANSPEPTIDASE-CARBOXYPEPTIDASE FROM ACTINOMADURA R39 | 3.4.16.4 |
1W8Y | CRYSTAL STRUCTURE OF THE NITROCEFIN ACYL-DD-PEPTIDASE FROM ACTINOMADURA R39. | 3.4.16.4 |
1W9B | S. ALBA MYROSINASE IN COMPLEX WITH CARBA-GLUCOTROPAEOLIN | 3.2.3.1 3.2.1.147 |
1W9D | S. ALBA MYROSINASE IN COMPLEX WITH S-ETHYL PHENYLACETOTHIOHYDROXIMATE- O-SULFATE | 3.2.3.1 3.2.1.147 |
1W9I | MYOSIN II DICTYOSTELIUM DISCOIDEUM MOTOR DOMAIN S456Y BOUND WITH MGADP-BEFX | 3.6.4.1 |
1W9J | MYOSIN II DICTYOSTELIUM DISCOIDEUM MOTOR DOMAIN S456Y BOUND WITH MGADP-ALF4 | 3.6.4.1 |
1W9K | DICTYOSTELIUM DISCOIDEUM MYOSIN II MOTOR DOMAIN S456E WITH BOUND MGADP-BEFX | 3.6.4.1 |
1W9L | MYOSIN II DICTYOSTELIUM DISCOIDEUM MOTOR DOMAIN S456E BOUND WITH MGADP-ALF4 | 3.6.4.1 |
1W9P | SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITORS AGAINST ASPERGILLUS FUMIGATUS, HUMAN AND BACTERIAL CHITINASEFRA | 3.2.1.14 |
1W9S | STRUCTURE OF A BETA-1,3-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS | 3.2.1.6 |
1W9T | STRUCTURE OF A BETA-1,3-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS IN COMPLEX WITH XYLOBIOSE | 3.2.1.6 |
1W9U | SPECIFICITY AND AFFNITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR ARGADIN AGAINST ASPERGILLUS FUMIGATUS CHITINASE | 3.2.1.14 |
1W9V | SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGIFIN AGAINST ASPERGILLUS FUMIGATUS | 3.2.1.14 |
1W9W | STRUCTURE OF A BETA-1,3-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS IN COMPLEX WITH LAMINARIHEXAOSE | 3.2.1.6 |
1W9X | BACILLUS HALMAPALUS ALPHA AMYLASE | 3.2.1.1 |
1WAB | PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE | 3.1.1.47 |
1WAF | DNA POLYMERASE FROM BACTERIOPHAGE RB69 | 2.7.7.7 3.1.11 |
1WAJ | DNA POLYMERASE FROM BACTERIOPHAGE RB69 | 2.7.7.7 3.1.11 |
1WAO | PP5 STRUCTURE | 3.1.3.16 |
1WAR | RECOMBINANT HUMAN PURPLE ACID PHOSPHATASE EXPRESSED IN PICHIA PASTORIS | 3.1.3.2 |
1WAW | SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR ARGADIN AGAINST HUMAN CHITINASE | 3.2.1.14 |
1WAX | PROTEIN TYROSINE PHOSPHATASE 1B WITH ACTIVE SITE INHIBITOR | 3.1.3.48 |
1WAY | ACTIVE SITE THROMBIN INHIBITORS | 3.4.21.5 |
1WB0 | SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR ARGIFIN AGAINST HUMAN CHITINASE | 3.2.1.14 |
1WB4 | S954A MUTANT OF THE FERULOYL ESTERASE MODULE FROM CLOSTRIDIUM THERMOCELLUM COMPLEXED WITH SINAPINATE | 3.2.1.8 |
1WB5 | S954A MUTANT OF THE FERULOYL ESTERASE MODULE FROM CLOSTRIDIUM THERMOCELLUM COMPLEXED WITH SYRINGATE | 3.2.1.8 |
1WB6 | S954A MUTANT OF THE FERULOYL ESTERASE MODULE FROM CLOSTRIDIUM THERMOCELLUM COMPLEXED WITH VANILLATE | 3.2.1.8 |
1WBG | ACTIVE SITE THROMBIN INHIBITORS | 3.4.21.5 |
1WBQ | ZNMG SUBSTITUTED AMINOPEPTIDASE P FROM E. COLI | 3.4.11.9 |
1WBU | FRAGMENT BASED LEAD DISCOVERY USING CRYSTALLOGRAPHY | 3.1.27.5 4.6.1.18 |
1WC2 | BETA-1,4-D-ENDOGLUCANASE CEL45A FROM BLUE MUSSEL MYTILUS EDULIS AT 1.2A | 3.2.1.4 |
1WCD | CRYSTAL STRUCTURE OF IBDV T1 VIRUS-LIKE PARTICLE REVEALS A MISSING LINK IN ICOSAHEDRAL VIRUSES EVOLUTION | 3.4.21 |
1WCE | CRYSTAL STRUCTURE OF THE T13 IBDV VIRAL PARTICLE REVEALS A MISSING LINK IN ICOSAHEDRAL VIRUSES EVOLUTION | 3.4.21 |
1WCF | 1.54 A CRYSTAL STRUCTURE OF RV3628, MYCOBACTERIUM TUBERCULOSIS INORGANIC PYROPHOSPHATASE (PPASE) AT PH7.0 | 3.6.1.1 |
1WCG | APHID MYROSINASE | 3.2.3.1 3.2.1.147 |
1WCH | CRYSTAL STRUCTURE OF PTPL1 HUMAN TYROSINE PHOSPHATASE MUTATED IN COLORECTAL CANCER - EVIDENCE FOR A SECOND PHOSPHOTYROSINE SUBSTRATE RECOGNITION POCKET | 3.1.3.48 |
1WCQ | MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE. | 3.2.1.18 |
1WCS | A MUTANT OF TRYPANOSOMA RANGELI SIALIDASE DISPLAYING TRANS-SIALIDASE ACTIVITY | 3.2.1.18 |
1WCV | STRUCTURE OF THE BACTERIAL CHROMOSOME SEGREGATION PROTEIN SOJ | 3.6 |
1WCY | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEX WITH DIPROTIN A | 3.4.14.5 |
1WCZ | CRYSTAL STRUCTURE OF AN ALKALINE FORM OF V8 PROTEASE FROM STAPHYLOCOCCUS AUREUS | 3.4.21.19 |
1WD3 | CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE | 3.2.1.55 |
1WD4 | CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH ARABINOSE | 3.2.1.55 |
1WD8 | CALCIUM FREE FORM OF HUMAN PEPTIDYLARGININE DEIMINASE TYPE4 (PAD4) | 3.5.3.15 |
1WD9 | CALCIUM BOUND FORM OF HUMAN PEPTIDYLARGININE DEIMINASE TYPE4 (PAD4) | 3.5.3.15 |
1WDA | CRYSTAL STRUCTURE OF HUMAN PEPTIDYLARGININE DEIMINASE TYPE4 (PAD4) IN COMPLEX WITH BENZOYL-L-ARGININE AMIDE | 3.5.3.15 |
1WDP | THE ROLE OF AN INNER LOOP IN THE CATALYTIC MECHANISM OF SOYBEAN BETA-AMYLASE | 3.2.1.2 |
1WDQ | THE ROLE OF AN INNER LOOP IN THE CATALYTIC MECHANISM OF SOYBEAN BETA-AMYLASE | 3.2.1.2 |
1WDR | THE ROLE OF AN INNER LOOP IN THE CATALYTIC MECHANISM OF SOYBEAN BETA-AMYLASE | 3.2.1.2 |
1WDS | THE ROLE OF AN INNER LOOP IN THE CATALYTIC MECHANISM OF SOYBEAN BETA-AMYLASE | 3.2.1.2 |
1WDY | CRYSTAL STRUCTURE OF RIBONUCLEASE | 3.1.26 |
1WE4 | CRYSTAL STRUCTURE OF CLASS A BETA-LACTAMASE TOHO-1 G238C MUTANT | 3.5.2.6 |
1WE5 | CRYSTAL STRUCTURE OF ALPHA-XYLOSIDASE FROM ESCHERICHIA COLI | 3.2.1 3.2.1.177 |
1WEF | CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI K20A MUTANT | 3.2.2 3.2.2.31 |
1WEG | CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI K142A MUTANT | 3.2.2 3.2.2.31 |
1WEI | CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI K20A MUTANT COMPLEXED TO ADENINE | 3.2.2 3.2.2.31 |
1WEK | CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN TT1465 FROM THERMUS THERMOPHILUS HB8 | 3.2.2 |
1WGG | SOLUTION STRUCTURE OF THE N-TERMINAL UBIQUITIN-LIKE DOMAIN OF MOUSE UBIQUITIN SPECIFIC PROTEASE 14 (USP14) | 3.1.2.15 3.4.19.12 |
1WGI | STRUCTURE OF INORGANIC PYROPHOSPHATASE | 3.6.1.1 |
1WGJ | STRUCTURE OF INORGANIC PYROPHOSPHATASE | 3.6.1.1 |
1WGW | SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF MOUSE PUTATIVE SIGNAL RECOGNITION PARTICLE 54 (SRP54) | 3.6.5 |
1WH0 | SOLUTION STRUCTURE OF THE CS DOMAIN OF HUMAN USP19 | 3.1.2.15 3.4.19.12 |
1WHB | SOLUTION STRUCTURE OF THE RHODANESE-LIKE DOMAIN IN HUMAN UBIQUITIN SPECIFIC PROTEASE 8 (UBP8) | 3.1.2.15 3.4.19.12 |
1WHE | COAGULATION FACTOR, NMR, 20 STRUCTURES | 3.4.21.6 |
1WHF | COAGULATION FACTOR, NMR, 15 STRUCTURES | 3.4.21.6 |
1WHL | SOLUTION STRUCTURE OF THE 1ST CAP-GLY DOMAIN IN HUMAN CYLINDROMATOSIS TUMOR SUPPRESSOR CYLD | 3.4.19.12 |
1WHM | SOLUTION STRUCTURE OF THE 2ND CAP-GLY DOMAIN IN HUMAN CYLINDROMATOSIS TUMOR SUPPRESSOR CYLD | 3.4.19.12 |
1WHQ | SOLUTION STRUCTURE OF THE N-TERMINAL DSRBD FROM HYPOTHETICAL PROTEIN BAB28848 | 3.6.4.13 |
1WHS | STRUCTURE OF THE COMPLEX OF L-BENZYLSUCCINATE WITH WHEAT SERINE CARBOXYPEPTIDASE II AT 2.0 ANGSTROMS RESOLUTION | 3.4.16.1 3.4.16.6 |
1WHT | STRUCTURE OF THE COMPLEX OF L-BENZYLSUCCINATE WITH WHEAT SERINE CARBOXYPEPTIDASE II AT 2.0 ANGSTROMS RESOLUTION | 3.4.16.1 3.4.16.6 |
1WHV | SOLUTION STRUCTURE OF THE RNA BINDING DOMAIN FROM HYPOTHETICAL PROTEIN BAB23382 | 3.1.13.4 |
1WIV | SOLUTION STRUCTURE OF RSGI RUH-023, A UBA DOMAIN FROM ARABIDOPSIS CDNA | 3.4.19.12 |
1WJ9 | CRYSTAL STRUCTURE OF A CRISPR-ASSOCIATED PROTEIN FROM THERMUS THERMOPHILUS | 3.1 |
1WJA | SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (D FORM), NMR, REGULARIZED MEAN STRUCTURE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1WJB | SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (D FORM), NMR, 40 STRUCTURES | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1WJC | SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (E FORM), NMR, REGULARIZED MEAN STRUCTURE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1WJD | SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (E FORM), NMR, 38 STRUCTURES | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1WJE | SOLUTION STRUCTURE OF H12C MUTANT OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE COMPLEXED TO CADMIUM, NMR, MINIMIZED AVERAGE STRUCTURE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1WJF | SOLUTION STRUCTURE OF H12C MUTANT OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE COMPLEXED TO CADMIUM, NMR, 40 STRUCTURES | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1WKM | THE PRODUCT BOUND FORM OF THE MN(II)LOADED METHIONINE AMINOPEPTIDASE FROM HYPERTHERMOPHILE PYROCOCCUS FURIOSUS | 3.4.11.18 |
1WKQ | CRYSTAL STRUCTURE OF BACILLUS SUBTILIS GUANINE DEAMINASE. THE FIRST DOMAIN-SWAPPED STRUCTURE IN THE CYTIDINE DEAMINASE SUPERFAMILY | 3.5.4.3 |
1WKR | CRYSTAL STRUCTURE OF ASPARTIC PROTEINASE FROM IRPEX LACTEUS | 3.4.23.29 |
1WKY | CRYSTAL STRUCTURE OF ALKALINE MANNANASE FROM BACILLUS SP. STRAIN JAMB-602: CATALYTIC DOMAIN AND ITS CARBOHYDRATE BINDING MODULE | 3.2.1.78 |
1WL6 | MG-SUBSTITUTED FORM OF E. COLI AMINOPEPTIDASE P | 3.4.11.9 |
1WL7 | STRUCTURE OF THE THERMOSTABLE ARABINANASE | 3.2.1.99 |
1WL9 | STRUCTURE OF AMINOPEPTIDASE P FROM E. COLI | 3.4.11.9 |
1WLJ | HUMAN ISG20 | 3.1 3.1.13.1 |
1WLR | APO AMINOPEPTIDASE P FROM E. COLI | 3.4.11.9 |
1WLS | CRYSTAL STRUCTURE OF L-ASPARAGINASE I HOMOLOGUE PROTEIN FROM PYROCOCCUS HORIKOSHII | 3.5.1.1 |
1WM1 | CRYSTAL STRUCTURE OF PROLYL AMINOPEPTIDASE, COMPLEX WITH PRO-TBODA | 3.4.11.5 |
1WM9 | STRUCTURE OF GTP CYCLOHYDROLASE I FROM THERMUS THERMOPHILUS HB8 | 3.5.4.16 |
1WMD | CRYSTAL STRUCTURE OF ALKALINE SERINE PROTEASE KP-43 FROM BACILLUS SP. KSM-KP43 (1.30 ANGSTROM, 100 K) | 3.4.21 |
1WME | CRYSTAL STRUCTURE OF ALKALINE SERINE PROTEASE KP-43 FROM BACILLUS SP. KSM-KP43 (1.50 ANGSTROM, 293 K) | 3.4.21 |
1WMF | CRYSTAL STRUCTURE OF ALKALINE SERINE PROTEASE KP-43 FROM BACILLUS SP. KSM-KP43 (OXIDIZED FORM, 1.73 ANGSTROM) | 3.4.21 |
1WMR | CRYSTAL STRUCTURE OF ISOPULLULANASE FROM ASPERGILLUS NIGER ATCC 9642 | 3.2.1.57 |
1WN1 | CRYSTAL STRUCTURE OF DIPEPTIASE FROM PYROCOCCUS HORIKOSHII OT3 | 3.4 |
1WN2 | CRYSTAL STRUCTURE OF PROJECT ID PH1539 FROM PYROCOCCUS HORIKOSHII OT3 | 3.1.1.29 |
1WN5 | CRYSTAL STRUCTURE OF BLASTICIDIN S DEAMINASE (BSD) COMPLEXED WITH CACODYLIC ACID | 3.5.4.23 |
1WN6 | CRYSTAL STRUCTURE OF BLASTICIDIN S DEAMINASE (BSD) COMPLEXED WITH TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S | 3.5.4.23 |
1WNE | FOOT AND MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH A TEMPLATE-PRIMER RNA | 2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15 |
1WNF | CRYSTAL STRUCTURE OF PH0066 FROM PYROCOCCUS HORIKOSHII | 3.5.1.1 |
1WNI | CRYSTAL STRUCTURE OF H2-PROTEINASE | 3.4.24.53 |
1WNO | CRYSTAL STRUCTURE OF A NATIVE CHITINASE FROM ASPERGILLUS FUMIGATUS YJ-407 | 3.2.1.14 |
1WNS | CRYSTAL STRUCTURE OF FAMILY B DNA POLYMERASE FROM HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS KODAKARAENSIS KOD1 | 2.7.7.7 3.1 |
1WO2 | CRYSTAL STRUCTURE OF THE PIG PANCREATIC ALPHA-AMYLASE COMPLEXED WITH MALTO-OLIGOSAACHARIDES UNDER THE EFFECT OF THE CHLORIDE ION | 3.2.1.1 |
1WOF | CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR N1 | 3.4.24 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
1WOG | CRYSTAL STRUCTURE OF AGMATINASE REVEALS STRUCTURAL CONSERVATION AND INHIBITION MECHANISM OF THE UREOHYDROLASE SUPERFAMILY | 3.5.3.11 |
1WOH | CRYSTAL STRUCTURE OF AGMATINASE REVEALS STRUCTURAL CONSERVATION AND INHIBITION MECHANISM OF THE UREOHYDROLASE SUPERFAMILY | 3.5.3.11 |
1WOI | CRYSTAL STRUCTURE OF AGMATINASE REVEALS STRUCTURAL CONSERVATION AND INHIBITION MECHANISM OF THE UREOHYDROLASE SUPERFAMILY | 3.5.3.11 |
1WOJ | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE | 3.1.4.37 |
1WP6 | CRYSTAL STRUCTURE OF MALTOHEXAOSE-PRODUCING AMYLASE FROM ALKALOPHILIC BACILLUS SP.707. | 3.2.1.98 |
1WPC | CRYSTAL STRUCTURE OF MALTOHEXAOSE-PRODUCING AMYLASE COMPLEXED WITH PSEUDO-MALTONONAOSE | 3.2.1.98 |
1WPG | CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH MGF4 | 3.6.3.8 7.2.2.10 |
1WPM | STRUCTURE OF BACILLUS SUBTILIS INORGANIC PYROPHOSPHATASE | 3.6.1.1 |
1WPN | CRYSTAL STRUCTURE OF THE N-TERMINAL CORE OF BACILLUS SUBTILIS INORGANIC PYROPHOSPHATASE | 3.6.1.1 |
1WPO | HYDROLYTIC ENZYME HUMAN CYTOMEGALOVIRUS PROTEASE | 3.4.21 3.4.21.97 |
1WPP | STRUCTURE OF STREPTOCOCCUS GORDONII INORGANIC PYROPHOSPHATASE | 3.6.1.1 |
1WPX | CRYSTAL STRUCTURE OF CARBOXYPEPTIDASE Y INHIBITOR COMPLEXED WITH THE COGNATE PROTEINASE | 3.4.16.5 |
1WQM | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
1WQN | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
1WQO | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
1WQP | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
1WQQ | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
1WQR | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
1WQS | CRYSTAL STRUCTURE OF NOROVIRUS 3C-LIKE PROTEASE | 2.7.7.48 3.4.22.66 3.6.1.15 |
1WQV | HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH PROPYLSULFONAMIDE-D-THR-MET-P-AMINOBENZAMIDINE | 3.4.21.21 |
1WR0 | STRUCTURAL CHARACTERIZATION OF THE MIT DOMAIN FROM HUMAN VPS4B | 3.6.4.6 |
1WR8 | CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN PH1421 FROM PYROCOCCUS HORIKOSHII. | 3.1.3.18 |
1WRA | CRYSTAL STRUCTURE OF PHOSPHORYLCHOLINE ESTERASE DOMAIN OF THE VIRULENCE FACTOR CHOLINE BINDING PROTEIN E FROM STREPTOCOCCUS PNEUMONIAE | 3.1.4.38 |
1WRB | CRYSTAL STRUCTURE OF THE N-TERMINAL RECA-LIKE DOMAIN OF DJVLGB, A PRANARIAN VASA-LIKE RNA HELICASE | 3.6.4.13 |
1WRM | CRYSTAL STRUCTURE OF JSP-1 | 3.1.3.48 3.1.3.16 |
1WS0 | STRUCTURE ANALYSIS OF PEPTIDE DEFORMYLASE FROM BACILLUS CEREUS | 3.5.1.88 |
1WS1 | STRUCTURE ANALYSIS OF PEPTIDE DEFORMYLASE FROM BACILLUS CEREUS | 3.5.1.88 |
1WSA | STRUCTURE OF L-ASPARAGINASE II PRECURSOR | 3.5.1.1 |
1WSD | ALKALINE M-PROTEASE FORM I CRYSTAL STRUCTURE | 3.4.21 |
1WSE | CO-CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (E48A*) WITH MN2+ | 3.1.26.4 |
1WSF | CO-CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (D134A*) WITH MN2+ | 3.1.26.4 |
1WSG | CO-CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (E48A/D134N*) WITH MN2+ | 3.1.26.4 |
1WSH | CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (E48A/K87A) | 3.1.26.4 |
1WSI | CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (E48A/K87A/D134N) | 3.1.26.4 |
1WSJ | CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (K87A/H124A) | 3.1.26.4 |
1WSS | HUMAN FACTOR VIIA-TISSUE FACTOR IN COMPLEX WITH PEPTIDE-MIMETIC INHIBITOR THAT HAS TWO CHARGED GROUPS IN P2 AND P4 | 3.4.21.21 |
1WTD | CRYSTAL STRUCTURE OF TYPE II RESTRCITION ENDONUCLEASE, ECOO109I DNA-FREE FORM | 3.1.21.4 |
1WTE | CRYSTAL STRUCTURE OF TYPE II RESTRCITION ENDONUCLEASE, ECOO109I COMPLEXED WITH COGNATE DNA | 3.1.21.4 |
1WTG | HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-BIPHENYLALANINE-GLN-P-AMINOBENZAMIDINE | 3.4.21.21 |
1WTH | CRYSTAL STRUCTURE OF GP5-S351L MUTANT AND GP27 COMPLEX | 3.2.1.17 |
1WTM | X-RAY STRUCTURE OF HEW LYSOZYME ORTHORHOMBIC CRYSTAL FORMED IN THE EARTH'S MAGNETIC FIELD | 3.2.1.17 |
1WTN | THE STRUCTURE OF HEW LYSOZYME ORTHORHOMBIC CRYSTAL GROWTH UNDER A HIGH MAGNETIC FIELD | 3.2.1.17 |
1WU0 | SOLUTION STRUCTURE OF SUBUNIT C OF F1FO-ATP SYNTHASE FROM THE THERMOPHILIC BACILLUS PS3 | 3.6.3.14 |
1WU1 | FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | 3.4.21.6 |
1WU4 | CRYSTAL STRUCTURE OF REDUCING-END-XYLOSE RELEASING EXO-OLIGOXYLANASE | 3.2.1.156 |
1WU5 | CRYSTAL STRUCTURE OF REDUCING-END-XYLOSE RELEASING EXO-OLIGOXYLANASE COMPLEXED WITH XYLOSE | 3.2.1.156 |
1WU6 | CRYSTAL STRUCTURE OF REDUCING-END-XYLOSE RELEASING EXO-OLIGOXYLANASE E70A MUTANT COMPLEXED WITH XYLOBIOSE | 3.2.1.156 |
1WUD | E. COLI RECQ HRDC DOMAIN | 3.6.1 3.6.4.12 |
1WUN | HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-TRP-GLN-P-AMINOBENZAMIDINE | 3.4.21.21 |
1WUO | CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81A) | 3.5.2.6 |
1WUP | CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81E) | 3.5.2.6 |
1WUQ | STRUCTURE OF GTP CYCLOHYDROLASE I COMPLEXED WITH 8-OXO-GTP | 3.5.4.16 |
1WUR | STRUCTURE OF GTP CYCLOHYDROLASE I COMPLEXED WITH 8-OXO-DGTP | 3.5.4.16 |
1WV7 | HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5-PROPOXY-TRP-GLN-P-AMINOBENZAMIDINE | 3.4.21.21 |
1WVA | CRYSTAL STRUCTURE OF HUMAN ARGINASE I FROM TWINNED CRYSTAL | 3.5.3.1 |
1WVB | CRYSTAL STRUCTURE OF HUMAN ARGINASE I: THE MUTANT E256Q | 3.5.3.1 |
1WVM | CRYSTAL STRUCTURE OF PSYCHROPHILIC SUBTILISIN-LIKE SERINE PROTEASE APA1 FROM ANTARCTIC PSYCHROTROPH PSEUDOALEROMONAS SP. AS-11, COMPLEXED WITH INHIBITOR CHYMOSTATIN | 3.4.21 |
1WVU | CRYSTAL STRUCTURE OF CHITINASE C FROM STREPTOMYCES GRISEUS HUT6037 | 3.2.1.14 |
1WVV | CRYSTAL STRUCTURE OF CHITINASE C MUTANT E147Q | 3.2.1.14 |
1WW1 | CRYSTAL STRUCTURE OF TRNASE Z FROM THERMOTOGA MARITIMA | 3.1.26.11 |
1WW4 | AGROCYBE CYLINDRACEA GALECTIN COMPLEXED WITH NEUACA2-3LACTOSE | 3.1.21 |
1WW5 | AGROCYBE CYLINDRACEA GALECTIN COMPLEXED WITH 3'-SULFONYL LACTOSE | 3.1.21 |
1WW6 | AGROCYBE CYLINDRACEA GALECTIN COMPLEXED WITH LACTOSE | 3.1.21 |
1WW7 | AGROCYBE CYLINDRACEA GALECTIN (LIGAND-FREE) | 3.1.21 |
1WWR | CRYSTAL STRUCTURE OF TRNA ADENOSINE DEAMINASE TADA FROM AQUIFEX AEOLICUS | 3.5.4 3.5.4.33 |
1WXR | CRYSTAL STRUCTURE OF HEME BINDING PROTEIN, AN AUTOTRANSPORTER HEMOGLOBINE PROTEASE FROM PATHOGENIC ESCHERICHIA COLI | 3.4.21 |
1WXY | CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE LIGATED WITH A POTENT INHIBITOR | 3.5.4.4 |
1WXZ | CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE LIGATED WITH A POTENT INHIBITOR | 3.5.4.4 |
1WY2 | CRYSTAL STRUCTURE OF THE PROLIDASE FROM PYROCOCCUS HORIKOSHII OT3 | 3.4.13.9 |
1WYB | STRUCTURE OF 6-AMINOHEXANOATE-DIMER HYDROLASE | 3.5.1.46 |
1WYC | STRUCTURE OF 6-AMINOHEXANOATE-DIMER HYDROLASE, DN MUTANT | 3.5.1.46 |
1WYK | SINDBIS VIRUS CAPSID PROTEIN (114-264) | 3.4.21 3.4.21.90 |
1WYW | CRYSTAL STRUCTURE OF SUMO1-CONJUGATED THYMINE DNA GLYCOSYLASE | 3.2.2 3.2.2.29 |
1WZA | CRYSTAL STRUCTURE OF ALPHA-AMYLASE FROM H.ORENII | 3.2.1.1 |
1WZC | CRYSTAL STRUCTURE OF PYROCOCCUS HORIKOSHII MANNOSYL-3-PHOSPHOGLYCERATE PHOSPHATASE COMPLEXED WITH MG2+ AND PHOSPHATE | 3.1.3.70 |
1WZK | THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT D465N | 3.2.1.135 |
1WZL | THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469L | 3.2.1.135 |
1WZM | THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469K | 3.2.1.135 |
1WZZ | STRUCTURE OF ENDO-BETA-1,4-GLUCANASE CMCAX FROM ACETOBACTER XYLINUM | 3.2.1.4 |
1X0C | IMPROVED CRYSTAL STRUCTURE OF ISOPULLULANASE FROM ASPERGILLUS NIGER ATCC 9642 | 3.2.1.57 |
1X0T | CRYSTAL STRUCTURE OF RIBONUCLEASE P PROTEIN PH1601P FROM PYROCOCCUS HORIKOSHII OT3 | 3.1.26.5 |
1X10 | STRUCTURE OF MUTANT PYRROLIDONE CARBOXYL PEPTIDASE (E192A) FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS | 3.4.19.3 |
1X12 | STRUCTURE OF MUTANT PYRROLIDONE CARBOXYL PEPTIDASE (E192D) FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS | 3.4.19.3 |
1X1P | CRYSTAL STRUCTURE OF TK-RNASE HII(1-197)-A(28-42) | 3.1.26.4 |
1X1R | CRYSTAL STRUCTURE OF M-RAS IN COMPLEX WITH GDP | 3.6.5.2 |
1X1S | CRYSTAL STRUCTURE OF M-RAS IN COMPLEX WITH GPPNHP | 3.6.5.2 |
1X1U | WATER-MEDIATE INTERACTION AT APROTEIN-PROTEIN INTERFACE | 3.1.27 |
1X1W | WATER-MEDIATE INTERACTION AT APROTEIN-PROTEIN INTERFACE | 3.1.27 |
1X1X | WATER-MEDIATE INTERACTION AT APROTEIN-PROTEIN INTERFACE | 3.1.27 |
1X1Y | WATER-MEDIATE INTERACTION AT APROTEIN-PROTEIN INTERFACE | 3.1.27 |
1X2B | THE CRYSTAL STRUCTURE OF PROLYL AMINOPEPTIDASE COMPLEXED WITH SAR-TBODA | 3.4.11.5 |
1X2E | THE CRYSTAL STRUCTURE OF PROLYL AMINOPEPTIDASE COMPLEXED WITH ALA-TBODA | 3.4.11.5 |
1X37 | STRUCTURE OF BACILLUS SUBTILIS LON PROTEASE SSD DOMAIN | 3.4.21.53 |
1X38 | CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE | 3.2.1.58 |
1X39 | CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE | 3.2.1.58 |
1X3W | STRUCTURE OF A PEPTIDE:N-GLYCANASE-RAD23 COMPLEX | 3.5.1.52 |
1X3Z | STRUCTURE OF A PEPTIDE:N-GLYCANASE-RAD23 COMPLEX | 3.5.1.52 |
1X42 | CRYSTAL STRUCTURE OF A HALOACID DEHALOGENASE FAMILY PROTEIN (PH0459) FROM PYROCOCCUS HORIKOSHII OT3 | 3.8.1 |
1X51 | SOLUTION STRUCTURE OF THE NUDIX DOMAIN FROM HUMAN A/G-SPECIFIC ADENINE DNA GLYCOSYLASE ALPHA-3 SPLICE ISOFORM | 3.2.2 3.2.2.31 |
1X52 | SOLUTION STRUCTURES OF THE C-TERMINAL DOMAIN OF THE HUMAN PELOTA HOMOLOG (CGI-17) | 3.1 |
1X5Z | SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE-III DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, D ISOFORM 4 VARIANT | 3.1.3.48 |
1X60 | SOLUTION STRUCTURE OF THE PEPTIDOGLYCAN BINDING DOMAIN OF B. SUBTILIS CELL WALL LYTIC ENZYME CWLC | 3.5.1.28 |
1X6C | SOLUTION STRUCTURES OF THE SH2 DOMAIN OF HUMAN PROTEIN-TYROSINE PHOSPHATASE SHP-1 | 3.1.3.48 |
1X6L | CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE A MUTANT W167A | 3.2.1.14 |
1X6N | CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE A MUTANT W167A IN COMPLEX WITH ALLOSAMIDIN | 3.2.1.14 |
1X70 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A BETA AMINO ACID INHIBITOR | 3.4.14.5 |
1X7A | PORCINE FACTOR IXA COMPLEXED TO 1-{3-[AMINO(IMINO)METHYL]PHENYL}-N-[4-(1H-BENZIMIDAZOL-1-YL)-2-FLUOROPHENYL]-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE | 3.4.21.22 |
1X8G | CRYSTAL STRUCTURE OF THE MONO-ZINC CARBAPENEMASE CPHA FROM AEROMONAS HYDROPHYLA | 3.5.2.6 |
1X8H | THE MONO-ZINC CARBAPENEMASE CPHA (N220G MUTANT) SHOWS A ZN(II)- NH2 ARG COORDINATION | 3.5.2.6 |
1X8I | CRYSTAL STRUCTURE OF THE ZINC CARBAPENEMASE CPHA IN COMPLEX WITH THE ANTIBIOTIC BIAPENEM | 3.5.2.6 |
1X9D | CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA-1,2-MANNOSIDASE IN COMPLEX WITH THIO-DISACCHARIDE SUBSTRATE ANALOGUE | 3.2.1.113 |
1X9M | T7 DNA POLYMERASE IN COMPLEX WITH AN N-2-ACETYLAMINOFLUORENE-ADDUCTED DNA | 2.7.7.7 3.1.11 |
1X9S | T7 DNA POLYMERASE IN COMPLEX WITH A PRIMER/TEMPLATE DNA CONTAINING A DISORDERED N-2 AMINOFLUORENE ON THE TEMPLATE, CRYSTALLIZED WITH DIDEOXY-CTP AS THE INCOMING NUCLEOTIDE. | 2.7.7.7 3.1.11 |
1X9W | T7 DNA POLYMERASE IN COMPLEX WITH A PRIMER/TEMPLATE DNA CONTAINING A DISORDERED N-2 AMINOFLUORENE ON THE TEMPLATE, CRYSTALLIZED WITH DIDEOXY-ATP AS THE INCOMING NUCLEOTIDE. | 2.7.7.7 3.1.11 |
1X9Y | THE PROSTAPHOPAIN B STRUCTURE | 3.4.22 |
1XAF | CRYSTAL STRUCTURE OF PROTEIN OF UNKNOWN FUNCTION YFIH FROM SHIGELLA FLEXNERI 2A STR. 2457T | 2.4.2.1 3.5.4.4 2.4.2.28 |
1XAX | NMR STRUCTURE OF HI0004, A PUTATIVE ESSENTIAL GENE PRODUCT FROM HAEMOPHILUS INFLUENZAE | 3.1 |
1XBD | INTERNAL XYLAN BINDING DOMAIN FROM CELLULOMONAS FIMI XYLANASE D, NMR, 5 STRUCTURES | 3.2.1.8 3.5.1 |
1XBO | PTP1B COMPLEXED WITH ISOXAZOLE CARBOXYLIC ACID | 3.1.3.48 |
1XBU | STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH P-IODO-D-PHENYLALANINE | 3.4.11 3.4.11.24 |
1XC6 | NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP. IN COMPLEX WITH GALACTOSE | 3.2.1.23 |
1XC8 | CRYSTAL STRUCTURE COMPLEX BETWEEN THE WILD-TYPE LACTOCOCCUS LACTIS FPG (MUTM) AND A FAPY-DG CONTAINING DNA | 3.2.2.23 4.2.99.18 |
1XCM | CRYSTAL STRUCTURE OF THE GPPNHP-BOUND H-RAS G60A MUTANT | 3.6.5.2 |
1XCR | CRYSTAL STRUCTURE OF LONGER SPLICE VARIANT OF PTD012 FROM HOMO SAPIENS REVEALS A NOVEL ZINC-CONTAINING FOLD | 3.1 |
1XCW | ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS | 3.2.1.1 |
1XCX | ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS | 3.2.1.1 |
1XD0 | ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS | 3.2.1.1 |
1XD1 | ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS | 3.2.1.1 |
1XD2 | CRYSTAL STRUCTURE OF A TERNARY RAS:SOS:RAS*GDP COMPLEX | 3.6.5.2 |
1XD3 | CRYSTAL STRUCTURE OF UCHL3-UBVME COMPLEX | 3.4.19.12 |
1XDF | CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR-10.2A FROM YELLOW LUPINE | 3.1.27 |
1XDH | STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH PEPSTATIN A | 3.4.23.39 |
1XE5 | STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE | 3.4.23.39 |
1XE6 | STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE | 3.4.23.39 |
1XEI | THE CRYSTAL STRUCTURES OF LYSOZYME AT VERY LOW LEVELS OF HYDRATION | 3.2.1.17 |
1XEJ | THE CRYSTAL STRUCTURES OF LYSOZYME AT VERY LOW LEVELS OF HYDRATION | 3.2.1.17 |
1XEK | THE CRYSTAL STRUCTURES OF LYSOZYME AT VERY LOW LEVELS OF HYDRATION | 3.2.1.17 |
1XEM | HIGH RESOLUTION CRYSTAL STRUCTURE OF ESCHERICHIA COLI ZINC- PEPTIDE DEFORMYLASE BOUND TO FORMATE | 3.5.1.88 |
1XEN | HIGH RESOLUTION CRYSTAL STRUCTURE OF ESCHERICHIA COLI IRON- PEPTIDE DEFORMYLASE BOUND TO FORMATE | 3.5.1.88 |
1XEO | HIGH RESOLUTION CRYSTALS STRUCTURE OF COBALT- PEPTIDE DEFORMYLASE BOUND TO FORMATE | 3.5.1.88 |
1XEP | CATECHOL IN COMPLEX WITH T4 LYSOZYME L99A/M102Q | 3.2.1.17 |
1XFI | X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT2G17340 | 3.1.3 |
1XFK | 1.8A CRYSTAL STRUCTURE OF FORMIMINOGLUTAMASE FROM VIBRIO CHOLERAE O1 BIOVAR ELTOR STR. N16961 | 3.5.3.8 |
1XFO | CRYSTAL STRUCTURE OF AN ARCHAEAL AMINOPEPTIDASE | 3.4.11 |
1XFT | SYNCHROTRON X-RAY POWDER DIFFRACTION STUDY OF HEXAGONAL TURKEY EGG-WHITE LYSOZYME | 3.2.1.17 |
1XG2 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PECTIN METHYLESTERASE AND ITS INHIBITOR PROTEIN | 3.1.1.11 |
1XG7 | CONSERVED HYPOTHETICAL PROTEIN PFU-877259-001 FROM PYROCOCCUS FURIOSUS | 3.2.2 4.2.99.18 |
1XGE | DIHYDROOROTASE FROM ESCHERICHIA COLI: LOOP MOVEMENT AND COOPERATIVITY BETWEEN SUBUNITS | 3.5.2.3 |
1XGI | AMPC BETA-LACTAMASE IN COMPLEX WITH 3-(3-NITRO-PHENYLSULFAMOYL)-THIOPHENE-2-CARBOXYLIC ACID | 3.5.2.6 |
1XGJ | AMPC BETA-LACTAMASE IN COMPLEX WITH 3-(4-CARBOXY-2-HYDROXY-PHENYLSULFAMOYL)-THIOPHENE-2-CARBOXYLIC ACID | 3.5.2.6 |
1XGM | METHIONINE AMINOPEPTIDASE FROM HYPERTHERMOPHILE PYROCOCCUS FURIOSUS | 3.4.11.18 |
1XGN | METHIONINE AMINOPEPTIDASE FROM HYPERTHERMOPHILE PYROCOCCUS FURIOSUS | 3.4.11.18 |
1XGO | METHIONINE AMINOPEPTIDASE FROM HYPERTHERMOPHILE PYROCOCCUS FURIOSUS | 3.4.11.18 |
1XGS | METHIONINE AMINOPEPTIDASE FROM HYPERTHERMOPHILE PYROCOCCUS FURIOSUS | 3.4.11.18 |
1XGZ | STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE | 3.2.1.1 |
1XH0 | STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH ACARBOSE | 3.2.1.1 |
1XH1 | STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH CHLORIDE | 3.2.1.1 |
1XH2 | STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH CHLORIDE AND ACARBOSE | 3.2.1.1 |
1XHK | CRYSTAL STRUCTURE OF M. JANNASCHII LON PROTEOLYTIC DOMAIN | 3.4.21 |
1XHU | HINCII BOUND TO CLEAVED, COGNATE DNA CONTAINING GTCGAC | 3.1.21.4 |
1XHV | HINCII BOUND TO CLEAVED COGNATE DNA GTCGAC AND MN2+ | 3.1.21.4 |
1XHX | PHI29 DNA POLYMERASE, ORTHORHOMBIC CRYSTAL FORM | 2.7.7.7 3.1.11 |
1XHZ | PHI29 DNA POLYMERASE, ORTHORHOMBIC CRYSTAL FORM, SSDNA COMPLEX | 2.7.7.7 3.1.11 |
1XI1 | PHI29 DNA POLYMERASE SSDNA COMPLEX, MONOCLINIC CRYSTAL FORM | 2.7.7.7 3.1.11 |
1XI6 | EXTRAGENIC SUPPRESSOR FROM PYROCOCCUS FURIOSUS PFU-1862794-001 | 3.1.3.11 |
1XJ0 | CRYSTAL STRUCTURE OF THE GDP-BOUND FORM OF THE RASG60A MUTANT | 3.6.5.2 |
1XJO | STRUCTURE OF AMINOPEPTIDASE | 3.4.11 3.4.11.24 |
1XJT | CRYSTAL STRUCTURE OF ACTIVE FORM OF P1 PHAGE ENDOLYSIN LYZ | 3.2.1.17 |
1XJU | CRYSTAL STRUCTURE OF SECRETED INACTIVE FORM OF P1 PHAGE ENDOLYSIN LYZ | 3.2.1.17 |
1XKA | FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID | 3.4.21.6 |
1XKB | FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID | 3.4.21.6 |
1XKG | CRYSTAL STRUCTURE OF THE MAJOR HOUSE DUST MITE ALLERGEN DER P 1 IN ITS PRO FORM AT 1.61 A RESOLUTION | 3.4.22 3.4.22.65 |
1XKL | CRYSTAL STRUCTURE OF SALICYLIC ACID-BINDING PROTEIN 2 (SABP2) FROM NICOTIANA TABACUM, NESG TARGET AR2241 | 3.1.1 |
1XKO | STRUCTURE OF THERMOTOGA MARITIMA CHEX | 3 |
1XKR | X-RAY STRUCTURE OF THERMOTOGA MARITIMA CHEC | 3 |
1XKT | HUMAN FATTY ACID SYNTHASE: STRUCTURE AND SUBSTRATE SELECTIVITY OF THE THIOESTERASE DOMAIN | 2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 1.1.1.100 4.2.1.59 1.3.1.39 3.1.2.14 |
1XL2 | HIV-1 PROTEASE IN COMPLEX WITH PYRROLIDINMETHANAMINE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1XL5 | HIV-1 PROTEASE IN COMPLEX WITH AMIDHYROXYSULFONE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1XLU | X-RAY STRUCTURE OF DI-ISOPROPYL-PHOSPHORO-FLUORIDATE (DFP) INHIBITED BUTYRYLCHOLINESTERASE AFTER AGING | 3.1.1.8 |
1XLV | ETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH ECHOTHIOPHATE | 3.1.1.8 |
1XLW | DIETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (NONAGED) OBTAINED BY REACTION WITH ECHOTHIOPHATE | 3.1.1.8 |
1XLX | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH CILOMILAST | 3.1.4.17 3.1.4.53 |
1XLZ | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH FILAMINAST | 3.1.4.17 3.1.4.53 |
1XM1 | NONBASIC THROMBIN INHIBITOR COMPLEX | 3.4.21.5 |
1XM2 | CRYSTAL STRUCTURE OF HUMAN PRL-1 | 3.1.3.48 |
1XM4 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH PICLAMILAST | 3.1.4.17 3.1.4.53 |
1XM5 | CRYSTAL STRUCTURE OF METAL-DEPENDENT HYDROLASE YBEY FROM E. COLI, PFAM UPF0054 | 3.1 |
1XM6 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R)-MESOPRAM | 3.1.4.17 3.1.4.53 |
1XM8 | X-RAY STRUCTURE OF GLYOXALASE II FROM ARABIDOPSIS THALIANA GENE AT2G31350 | 3.1.2.6 |
1XMB | X-RAY STRUCTURE OF IAA-AMINOACID HYDROLASE FROM ARABIDOPSIS THALIANA GENE AT5G56660 | 3.5.1 |
1XMI | CRYSTAL STRUCTURE OF HUMAN F508A NBD1 DOMAIN WITH ATP | 3.6.3.49 5.6.1.6 |
1XMJ | CRYSTAL STRUCTURE OF HUMAN DELTAF508 HUMAN NBD1 DOMAIN WITH ATP | 3.6.3.49 5.6.1.6 |
1XMK | THE CRYSTAL STRUCTURE OF THE ZB DOMAIN FROM THE RNA EDITING ENZYME ADAR1 | 3.5.4 3.5.4.37 |
1XML | STRUCTURE OF HUMAN DCPS | 3.6.1.59 |
1XMM | STRUCTURE OF HUMAN DCPS BOUND TO M7GDP | 3.6.1.59 |
1XMN | CRYSTAL STRUCTURE OF THROMBIN BOUND TO HEPARIN | 3.4.21.5 |
1XMU | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH ROFLUMILAST | 3.1.4.17 3.1.4.53 |
1XMY | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R)-ROLIPRAM | 3.1.4.17 3.1.4.53 |
1XN0 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R,S)-ROLIPRAM | 3.1.4.17 3.1.4.53 |
1XN2 | NEW SUBSTRATE BINDING POCKETS FOR BETA-SECRETASE. | 3.4.23.46 |
1XN3 | CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A LONG INHIBITOR WITH ADDITIONAL UPSTREAM RESIDUES. | 3.4.23.46 |
1XNB | HIGH-RESOLUTION STRUCTURES OF XYLANASES FROM B. CIRCULANS AND T. HARZIANUM IDENTIFY A NEW FOLDING PATTERN AND IMPLICATIONS FOR THE ATOMIC BASIS OF THE CATALYSIS | 3.2.1.8 |
1XNC | THERMOSTABILIZATION OF THE BACILLUS CIRCULANS XYLANASE, BY THE INTRODUCTION OF DISULFIDE BONDS | 3.2.1.8 |
1XND | HIGH-RESOLUTION STRUCTURES OF XYLANASES FROM B. CIRCULANS AND T. HARZIANUM IDENTIFY A NEW FOLDING PATTERN AND IMPLICATIONS FOR THE ATOMIC BASIS OF THE CATALYSIS | 3.2.1.8 |
1XNK | BETA-1,4-XYLANASE FROM CHAETOMIUM THERMOPHILUM COMPLEXED WITH METHYL THIOXYLOPENTOSIDE | 3.2.1.8 |
1XNZ | CRYSTAL STRUCTURE OF MN(II) FORM OF E. COLI. METHIONINE AMINOPEPTIDASE IN COMPLEX WITH 5-(2-CHLOROPHENYL)FURAN-2-CARBOXYLIC ACID | 3.4.11.18 |
1XO1 | T5 5'-EXONUCLEASE MUTANT K83A | 3.1.11.3 3.1.11 |
1XOE | N9 TERN INFLUENZA NEURAMINIDASE COMPLEXED WITH (2R,4R,5R)-5-(1-ACETYLAMINO-3-METHYL-BUTYL-PYRROLIDINE-2, 4-DICAROBYXYLIC ACID 4-METHYL ESTERDASE COMPLEXED WITH | 3.2.1.18 |
1XOG | N9 TERN INFLUENZA NEURAMINIDASE COMPLEXED WITH A 2,5-DISUBSTITUTED TETRAHYDROFURAN-5-CARBOXYLIC ACID | 3.2.1.18 |
1XOM | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH CILOMILAST | 3.1.4.17 3.1.4.53 |
1XON | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH PICLAMILAST | 3.1.4.17 3.1.4.53 |
1XOQ | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ROFLUMILAST | 3.1.4.17 3.1.4.53 |
1XOR | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ZARDAVERINE | 3.1.4.17 3.1.4.53 |
1XOS | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH SILDENAFIL | 3.1.4.17 3.1.4.53 |
1XOT | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH VARDENAFIL | 3.1.4.17 3.1.4.53 |
1XOV | THE CRYSTAL STRUCTURE OF THE LISTERIA MONOCYTOGENES BACTERIOPHAGE PSA ENDOLYSIN PLYPSA | 3.5.1.28 |
1XOZ | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH TADALAFIL | 3.1.4.17 3.1.4.35 |
1XP0 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH VARDENAFIL | 3.1.4.17 3.1.4.35 |
1XP3 | CRYSTAL STRUCTURE OF ENDONUCLEASE IV (BA4508) FROM BACILLUS ANTHRACIS AT 2.57A RESOLUTION. | 3.1.21.2 |
1XP4 | CRYSTAL STRUCTURE OF A PEPTIDOGLYCAN SYNTHESIS REGULATORY FACTOR (PBP3) FROM STREPTOCOCCUS PNEUMONIAE | 3.4.16.4 |
1XPB | STRUCTURE OF BETA-LACTAMASE TEM1 | 3.5.2.6 |
1XPS | BOVINE RIBONUCLEASE A (PHOSPHATE-FREE) (93 % HUMIDITY) | 3.1.27.5 4.6.1.18 |
1XPT | BOVINE RIBONUCLEASE A (PHOSPHATE-FREE) | 3.1.27.5 4.6.1.18 |
1XQO | CRYSTAL STRUCTURE OF NATIVE PA-AGOG, 8-OXOGUANINE DNA GLYCOSYLASE FROM PYROBACULUM AEROPHILUM | 3.2.2 4.2.99.18 |
1XQP | CRYSTAL STRUCTURE OF 8-OXOGUANOSINE COMPLEXED PA-AGOG, 8-OXOGUANINE DNA GLYCOSYLASE FROM PYROBACULUM AEROPHILUM | 3.2.2 4.2.99.18 |
1XQV | CRYSTAL STRUCTURE OF INACTIVE F1-MUTANT G37A | 3.4.11.5 |
1XQW | CRYSTAL STRUCTURE OF F1-MUTANT S105A COMPLEX WITH PHE-LEU | 3.4.11.5 |
1XQX | CRYSTAL STRUCTURE OF F1-MUTANT S105A COMPLEX WITH PCK | 3.4.11.5 |
1XQY | CRYSTAL STRUCTURE OF F1-MUTANT S105A COMPLEX WITH PRO-LEU-GLY-GLY | 3.4.11.5 |
1XR5 | CRYSTAL STRUCTURE OF THE RNA-DEPENDENT RNA POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 14 | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
1XR6 | CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 1B | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
1XR7 | CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 16 | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
1XRF | THE CRYSTAL STRUCTURE OF A NOVEL, LATENT DIHYDROOROTASE FROM AQUIFEX AEOLICUS AT 1.7 A RESOLUTION | 3.5.2.3 |
1XRI | X-RAY STRUCTURE OF A PUTATIVE PHOSPHOPROTEIN PHOSPHATASE FROM ARABIDOPSIS THALIANA GENE AT1G05000 | 3.1.3.48 |
1XRL | CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT Y205F COMPLEX WITH INHIBITOR PCK | 3.4.11.5 |
1XRM | CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E213Q SOAKED WITH PEPTIDE ALA-PHE | 3.4.11.5 |
1XRN | CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E213Q SOAKED WITH PEPTIDE PHE-ALA | 3.4.11.5 |
1XRO | CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E213Q SOAKED WITH PEPTIDE PHE-LEU | 3.4.11.5 |
1XRP | CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E213Q SOAKED WITH PEPTIDE PRO-LEU-GLY-GLY | 3.4.11.5 |
1XRQ | CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E245Q SOAKED WITH PEPTIDE PHE-LEU | 3.4.11.5 |
1XRR | CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E245Q SOAKED WITH PEPTIDE PRO-PRO | 3.4.11.5 |
1XRT | THE CRYSTAL STRUCTURE OF A NOVEL, LATENT DIHYDROOROTASE FROM AQUIFEX AEOLICUS AT 1.7 A RESOLUTION | 3.5.2.3 |
1XRY | CRYSTAL STRUCTURE OF AEROMONAS PROTEOLYTICA AMINOPEPTIDASE IN COMPLEX WITH BESTATIN | 3.4.11.10 |
1XS1 | DCTP DEAMINASE FROM ESCHERICHIA COLI IN COMPLEX WITH DUTP | 3.5.4.13 |
1XS4 | DCTP DEAMINASE FROM ESCHERICHIA COLI- E138A MUTANT ENZYME IN COMPLEX WITH DCTP | 3.5.4.13 |
1XS6 | DCTP DEAMINASE FROM ESCHERICHIA COLI. E138A MUTANT ENZYME IN COMPLEX WITH DUTP | 3.5.4.13 |
1XS7 | CRYSTAL STRUCTURE OF A CYCLOAMIDE-URETHANE-DERIVED NOVEL INHIBITOR BOUND TO HUMAN BRAIN MEMAPSIN 2 (BETA-SECRETASE). | 3.4.23.46 |
1XSA | STRUCTURE OF THE NUDIX ENZYME AP4A HYDROLASE FROM HOMO SAPIENS (E63A MUTANT) | 3.6.1.17 |
1XSB | STRUCTURE OF THE NUDIX ENZYME AP4A HYDROLASE FROM HOMO SAPIENS (E63A MUTANT) IN COMPLEX WITH ATP. NO ATP RESTRAINTS INCLUDED | 3.6.1.17 |
1XSC | STRUCTURE OF THE NUDIX ENZYME AP4A HYDROLASE FROM HOMO SAPIENS (E63A MUTANT) IN COMPLEX WITH ATP | 3.6.1.17 |
1XSF | SOLUTION STRUCTURE OF A RESUSCITATION PROMOTING FACTOR DOMAIN FROM MYCOBACTERIUM TUBERCULOSIS | 3 |
1XSQ | CRYSTAL STRUCTURE OF UREIDOGLYCOLATE HYDROLASE FROM E.COLI. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET81. | 3.5.3.19 4.3.2.3 |
1XSR | X-RAY STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SFR7 | 3.5.3.19 4.3.2.3 |
1XT5 | CRYSTAL STRUCTURE OF VCBP3, DOMAIN 1, FROM BRANCHIOSTOMA FLORIDAE | 3.2.1.14 |
1XT9 | CRYSTAL STRUCTURE OF DEN1 IN COMPLEX WITH NEDD8 | 3.4.22 |
1XTF | NEUROTOXIN BONT/A E224Q Y366F MUTANT | 3.4.24.69 |
1XTI | STRUCTURE OF WILDTYPE HUMAN UAP56 | 3.6.4.13 |
1XTJ | STRUCTURE OF HUMAN UAP56 IN COMPLEX WITH ADP | 3.6.4.13 |
1XTK | STRUCTURE OF DECD TO DEAD MUTATION OF HUMAN UAP56 | 3.6.4.13 |
1XTY | CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS PEPTIDYL-TRNA HYDROLASE | 3.1.1.29 |
1XUC | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR | 3.4.24 |
1XUD | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR | 3.4.24 |
1XUF | TRYPSIN-BABIM-ZN+2, PH 8.2 | 3.4.21.4 |
1XUG | TRYPSIN-BABIM-ZN+2, PH 8.2 | 3.4.21.4 |
1XUH | TRYPSIN-KETO-BABIM-CO+2, PH 8.2 | 3.4.21.4 |
1XUI | TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2 | 3.4.21.4 |
1XUJ | TRYPSIN-KETO-BABIM-ZN+2, PH 8.2 | 3.4.21.4 |
1XUK | TRYPSIN-BABIM-SULFATE, PH 5.9 | 3.4.21.4 |
1XUR | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR | 3.4.24 |
1XV8 | CRYSTAL STRUCTURE OF HUMAN SALIVARY ALPHA-AMYLASE DIMER | 3.2.1.1 |
1XVI | CRYSTAL STRUCTURE OF YEDP, PHOSPHATASE-LIKE DOMAIN PROTEIN FROM ESCHERICHIA COLI K12 | 3.1.3.70 |
1XVM | TRYPSIN FROM FUSARIUM OXYSPORUM- ROOM TEMPERATURE TO ATOMIC RESOLUTION | 3.4.21.4 |
1XVO | TRYPSIN FROM FUSARIUM OXYSPORUM AT PH 6 | 3.4.21.4 |
1XW2 | STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE | 3.2.1.8 3.2.1.4 |
1XW8 | X-RAY STRUCTURE OF PUTATIVE LACTAM UTILIZATION PROTEIN YBGL. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET90. | 3.5.2.9 |
1XWF | K185N MUTATED S-ADENOSYLHOMOCYSTEINE HYDROLASE | 3.3.1.1 |
1XWI | CRYSTAL STRUCTURE OF VPS4B | 3.6.4.6 |
1XWQ | STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE | 3.2.1.8 3.2.1.4 |
1XWT | STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE | 3.2.1.8 3.2.1.4 |
1XWW | CRYSTAL STRUCTURE OF HUMAN B-FORM LOW MOLECULAR WEIGHT PHOSPHOTYROSYL PHOSPHATASE AT 1.6 ANGSTROM RESOLUTION | 3.1.3.48 3.1.3.2 |
1XWY | CRYSTAL STRUCTURE OF TATD DEOXYRIBONUCLEASE FROM ESCHERICHIA COLI K12 AT 2.0 A RESOLUTION | 3.1.21 3.1.11 3.1.13 |
1XX2 | REFINEMENT OF P99 BETA-LACTAMASE FROM ENTEROBACTER CLOACAE | 3.5.2.6 |
1XX7 | CONSERVED HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU-403030-001 | 3.1.3.89 |
1XX9 | CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEX WITH ECOTINM84R | 3.4.21.27 |
1XXD | CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEX WITH MUTATED ECOTIN | 3.4.21.27 |
1XXE | RDC REFINED SOLUTION STRUCTURE OF THE AALPXC/TU-514 COMPLEX | 3.5.1 3.5.1.108 |
1XXF | CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEX WITH ECOTIN MUTANT (ECOTINP) | 3.4.21.27 |
1XXM | THE MODULAR ARCHITECTURE OF PROTEIN-PROTEIN BINDING SITE | 3.5.2.6 |
1XXN | CRYSTAL STRUCTURE OF A MESOPHILIC XYLANASE A FROM BACILLUS SUBTILIS 1A1 | 3.2.1.8 |
1XXP | YERSINIA YOPH (RESIDUES 163-468) C403S BINDS PHOSPHOTYROSYL PEPTIDE AT TWO SITES | 3.1.3.48 |
1XXS | STRUCTURAL INSIGHTS FOR FATTY ACID BINDING IN A LYS49 PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF MYOTOXIN II FROM BOTHROPS MOOJENI COMPLEXED WITH STEARIC ACID | 3.1.1.4 |
1XXV | YERSINIA YOPH (RESIDUES 163-468) BINDS PHOSPHONODIFLUOROMETHYL-PHE CONTAINING HEXAPEPTIDE AT TWO SITES | 3.1.3.48 |
1XXW | STRUCTURE OF ZINC INDUCED HETERODIMER OF TWO CALCIUM FREE ISOFORMS OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 2.7A RESOLUTION | 3.1.1.4 |
1XYF | ENDO-1,4-BETA-XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS | 3.2.1.8 |
1XYN | STRUCTURAL COMPARISON OF TWO MAJOR ENDO-1,4-BETA-XYLANASES FROM TRICHODREMA REESEI | 3.2.1.8 |
1XYO | STRUCTURAL COMPARISON OF TWO MAJOR ENDO-1,4-BETA-XYLANASES FROM TRICHODREMA REESEI | 3.2.1.8 |
1XYP | STRUCTURAL COMPARISON OF TWO MAJOR ENDO-1,4-BETA-XYLANASES FROM TRICHODREMA REESEI | 3.2.1.8 |
1XYR | POLIOVIRUS 135S CELL ENTRY INTERMEDIATE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1XYZ | A COMMON PROTEIN FOLD AND SIMILAR ACTIVE SITE IN TWO DISTINCT FAMILIES OF BETA-GLYCANASES | 3.2.1.8 |
1XZA | FUSARIUM SOLANI CUTINASE MUTANT WITH SER 129 REPLACED BY CYS | 3.1.1 3.1.1.74 |
1XZB | FUSARIUM SOLANI CUTINASE MUTANT WITH SER 129 REPLACED BY CYS COMPLEX WITH MERCURY ACETATE | 3.1.1 3.1.1.74 |
1XZC | FUSARIUM SOLANI CUTINASE MUTANT WITH SER 129 REPLACED BY CYS COMPLEX WITH PARA-SULFUROUSPHENYL MERCURY | 3.1.1 3.1.1.74 |
1XZD | FUSARIUM SOLANI CUTINASE MUTANT WITH SER 213 REPLACED BY CYS | 3.1.1 3.1.1.74 |
1XZE | FUSARIUM SOLANI CUTINASE MUTANT WITH SER 92 REPLACED BY CYS | 3.1.1 3.1.1.74 |
1XZF | FUSARIUM SOLANI CUTINASE MUTANT WITH THR 144 REPLACED BY CYS | 3.1.1 3.1.1.74 |
1XZG | FUSARIUM SOLANI CUTINASE MUTANT WITH THR 45 REPLACED BY ALA | 3.1.1 3.1.1.74 |
1XZH | FUSARIUM SOLANI CUTINASE MUTANT WITH THR 80 REPLACED BY PRO | 3.1.1 3.1.1.74 |
1XZI | FUSARIUM SOLANI CUTINASE MUTANT WITH THR 119 REPLACED BY HIS | 3.1.1 3.1.1.74 |
1XZJ | FUSARIUM SOLANI CUTINASE MUTANT WITH THR 38 REPLACED BY PHE | 3.1.1 3.1.1.74 |
1XZK | FUSARIUM SOLANI CUTINASE COMPLEX WITH DI(ISOPROPYL)PHOSPHATE | 3.1.1 3.1.1.74 |
1XZL | FUSARIUM SOLANI CUTINASE COMPLEX WITH N-HEXYLPHOSPHONATE ETHYL ESTER | 3.1.1 3.1.1.74 |
1XZM | FUSARIUM SOLANI CUTINASE COMPLEX WITH N-UNDECYL O-METHYL CHLORO PHOSPHONATE ESTER | 3.1.1 3.1.1.74 |
1XZP | STRUCTURE OF THE GTP-BINDING PROTEIN TRME FROM THERMOTOGA MARITIMA | 3.6.5 |
1XZQ | STRUCTURE OF THE GTP-BINDING PROTEIN TRME FROM THERMOTOGA MARITIMA COMPLEXED WITH 5-FORMYL-THF | 3.6.5 |
1XZW | SWEET POTATO PURPLE ACID PHOSPHATASE/PHOSPHATE COMPLEX | 3.1.3.2 |
1Y0M | CRYSTAL STRUCTURE OF OF THE SH3 DOMAIN OF PHOSPHOLIPASE C GAMMA-1 | 3.1.4.11 |
1Y0R | CRYSTAL STRUCTURE OF THE TETRAHEDRAL AMINOPEPTIDASE FROM P. HORIKOSHII | 3.4.11 |
1Y0Y | CRYSTAL STRUCTURE OF TETRAHEDRAL AMINOPEPTIDASE FROM P. HORIKOSHII IN COMPLEX WITH AMASTATIN | 3.4.11 |
1Y1K | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 T58A MUTANT | 3.4.21.62 |
1Y1N | IDENTIFICATION OF SH3 MOTIF IN M. TUBERCULOSIS METHIONINE AMINOPEPTIDASE SUGGESTS A MODE OF INTERACTION WITH THE RIBOSOME | 3.4.11.18 |
1Y1O | X-RAY CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN-RELATED FACTOR A FROM BACILLUS STEAROTHERMOPHILUS | 3.1.22.4 |
1Y2B | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER | 3.1.4.17 3.1.4.53 |
1Y2C | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER | 3.1.4.17 3.1.4.53 |
1Y2D | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 1-(4-METHOXY-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER | 3.1.4.17 3.1.4.53 |
1Y2E | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 1-(4-AMINO-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER | 3.1.4.17 3.1.4.53 |
1Y2H | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH 1-(2-CHLORO-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER | 3.1.4.17 3.1.4.53 |
1Y2J | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH 3,5-DIMETHYL-1-(3-NITRO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER | 3.1.4.17 3.1.4.53 |
1Y2K | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1-(3-NITRO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER | 3.1.4.17 3.1.4.53 |
1Y33 | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 T58P MUTANT | 3.4.21.62 |
1Y34 | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 E60A MUTANT | 3.4.21.62 |
1Y37 | STRUCTURE OF FLUOROACETATE DEHALOGENASE FROM BURKHOLDERIA SP. FA1 | 3.8.1.3 |
1Y38 | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 DIMER AND GLYCEROPHOSPHATE AT 2.4 A RESOLUTION | 3.1.1.4 |
1Y3B | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 E60S MUTANT | 3.4.21.62 |
1Y3C | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 R62A MUTANT | 3.4.21.62 |
1Y3D | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 R67A MUTANT | 3.4.21.62 |
1Y3F | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 F69A MUTANT | 3.4.21.62 |
1Y3G | CRYSTAL STRUCTURE OF A SILANEDIOL PROTEASE INHIBITOR BOUND TO THERMOLYSIN | 3.4.24.27 |
1Y3J | SOLUTION STRUCTURE OF THE COPPER(I) FORM OF THE FIFTH DOMAIN OF MENKES PROTEIN | 3.6.3.4 7.2.2.8 |
1Y3K | SOLUTION STRUCTURE OF THE APO FORM OF THE FIFTH DOMAIN OF MENKES PROTEIN | 3.6.3.4 7.2.2.8 |
1Y3U | TRYPSIN INHIBITOR COMPLEX | 3.4.21.4 |
1Y3V | TRYPSIN INHIBITOR COMPLEX | 3.4.21.4 |
1Y3W | TRYPSIN INHIBITOR COMPLEX | 3.4.21.4 |
1Y3X | TRYPSIN INHIBITOR COMPLEX | 3.4.21.4 |
1Y3Y | TRYPSIN INHIBITOR COMPLEX | 3.4.21.4 |
1Y43 | CRYSTAL STRUCTURE OF ASPERGILLOGLUTAMIC PEPTIDASE FROM ASPERGILLUS NIGER | 3.4.23.19 |
1Y44 | CRYSTAL STRUCTURE OF RNASE Z | 3.1.26.11 |
1Y48 | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 R65A MUTANT | 3.4.21.62 |
1Y4A | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59R/E60S MUTANT | 3.4.21.62 |
1Y4D | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59R/E60S MUTANT | 3.4.21.62 |
1Y4H | WILD TYPE STAPHOPAIN-STAPHOSTATIN COMPLEX | 3.4.22 |
1Y4L | CRYSTAL STRUCTURE OF BOTHROPS ASPER MYOTOXIN II COMPLEXED WITH THE ANTI-TRYPANOSOMAL DRUG SURAMIN | 3.1.1.4 |
1Y4W | CRYSTAL STRUCTURE OF EXO-INULINASE FROM ASPERGILLUS AWAMORI IN SPACEGROUP P21 | 3.2.1.80 |
1Y54 | CRYSTAL STRUCTURE OF THE NATIVE CLASS C BETA-LACTAMASE FROM ENTEROBACTER CLOACAE 908R COMPLEXED WITH BRL42715 | 3.5.2.6 |
1Y59 | DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT | 3.4.21.4 |
1Y5A | DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT | 3.4.21.4 |
1Y5B | DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT | 3.4.21.4 |
1Y5U | DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT | 3.4.21.4 |
1Y65 | CRYSTAL STRUCTURE OF BETA-HEXOSAMINIDASE FROM VIBRIO CHOLERAE IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE TO A RESOLUTION OF 1.85 | 3.2.1.52 |
1Y6H | CRYSTAL STRUCTURE OF LIPDF | 3.5.1.88 |
1Y6O | CRYSTAL STRUCTURE OF DISULFIDE ENGINEERED PORCINE PANCREATIC PHOSPHOLIPASE A2 TO GROUP-X ISOZYME IN COMPLEX WITH INHIBITOR MJ33 AND PHOSPHATE IONS | 3.1.1.4 |
1Y6P | CRYSTAL STRUCTURE OF DISULFIDE ENGINEERED PORCINE PANCRATIC PHOSPHOLIPASE A2 TO GROUP-X ISOZYME | 3.1.1.4 |
1Y6Q | CYRSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE COMPLEXED WITH MT-DADME-IMMA | 3.2.2.16 3.2.2.9 |
1Y6R | CRYSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE COMPLEXED WITH MT-IMMA. | 3.2.2.16 3.2.2.9 |
1Y6V | STRUCTURE OF E. COLI ALKALINE PHOSPHATASE IN PRESENCE OF COBALT AT 1.60 A RESOLUTION | 3.1.3.1 |
1Y6X | THE 1.25 A RESOLUTION STRUCTURE OF PHOSPHORIBOSYL-ATP PYROPHOSPHOHYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS | 3.6.1.31 |
1Y75 | A NEW FORM OF CATALYTICALLY INACTIVE PHOSPHOLIPASE A2 WITH AN UNUSUAL DISULPHIDE BRIDGE CYS 32- CYS 49 REVEALS RECOGNITION FOR N-ACETYLGLUCOSMINE | 3.1.1.4 |
1Y79 | CRYSTAL STRUCTURE OF THE E.COLI DIPEPTIDYL CARBOXYPEPTIDASE DCP IN COMPLEX WITH A PEPTIDIC INHIBITOR | 3.4.15.5 |
1Y7A | STRUCTURE OF D153H/K328W E. COLI ALKALINE PHOSPHATASE IN PRESENCE OF COBALT AT 1.77 A RESOLUTION | 3.1.3.1 |
1Y7B | BETA-D-XYLOSIDASE, A FAMILY 43 GLYCOSIDE HYDROLASE | 3.2.1.37 |
1Y7E | THE CRYSTAL STRUCTURE OF AMINOPEPTIDASE I FROM BORRELIA BURGDORFERI B31 | 3.4.11 |
1Y7H | STRUCTURAL AND BIOCHEMICAL STUDIES IDENTIFY TOBACCO SABP2 AS A METHYLSALICYLATE ESTERASE AND FURTHER IMPLICATE IT IN PLANT INNATE IMMUNITY, NORTHEAST STRUCTURAL GENOMICS TARGET AR2241 | 3.1.1 |
1Y7I | STRUCTURAL AND BIOCHEMICAL STUDIES IDENTIFY TOBACCO SABP2 AS A METHYLSALICYLATE ESTERASE AND FURTHER IMPLICATE IT IN PLANT INNATE IMMUNITY, NORTHEAST STRUCTURAL GENOMICS TARGET AR2241 | 3.1.1 |
1Y7O | THE STRUCTURE OF STREPTOCOCCUS PNEUMONIAE A153P CLPP | 3.4.21.92 |
1Y7U | CRYSTAL STRUCTURE OF ACYL-COA HYDROLASE FROM BACILLUS CEREUS | 3.1.2.20 |
1Y7V | X-RAY STRUCTURE OF HUMAN ACID-BETA-GLUCOSIDASE COVALENTLY BOUND TO CONDURITOL B EPOXIDE | 3.2.1.45 2.4.1 3.2.1 |
1Y82 | CONSERVED HYPOTHETICAL PROTEIN PFU-367848-001 FROM PYROCOCCUS FURIOSUS | 3.1 |
1Y89 | CRYSTAL STRUCTURE OF DEVB PROTEIN | 3.1.1.31 |
1Y8J | CRYSTAL STRUCTURE OF HUMAN NEP COMPLEXED WITH AN IMIDAZO[4,5-C]PYRIDINE INHIBITOR | 3.4.24.11 |
1Y8T | CRYSTAL STRUCTURE OF RV0983 FROM MYCOBACTERIUM TUBERCULOSIS- PROTEOLYTICALLY ACTIVE FORM | 3.4.21.107 |
1Y92 | CRYSTAL STRUCTURE OF THE P19A/N67D VARIANT OF BOVINE SEMINAL RIBONUCLEASE | 3.1.27.5 4.6.1.18 |
1Y93 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH ACETOHYDROXAMIC ACID AT ATOMIC RESOLUTION | 3.4.24.65 |
1Y94 | CRYSTAL STRUCTURE OF THE G16S/N17T/P19A/S20A/N67D VARIANT OF BOVINE SEMINAL RIBONUCLEASE | 3.1.27.5 4.6.1.18 |
1Y97 | THE HUMAN TREX2 3' EXONUCLEASE STRUCTURE SUGGESTS A MECHANISM FOR EFFICIENT NON-PROCESSIVE DNA CATALYSIS | 3.1.11.2 |
1Y9G | CRYSTAL STRUCTURE OF EXO-INULINASE FROM ASPERGILLUS AWAMORI COMPLEXED WITH FRUCTOSE | 3.2.1.80 |
1Y9M | CRYSTAL STRUCTURE OF EXO-INULINASE FROM ASPERGILLUS AWAMORI IN SPACEGROUP P212121 | 3.2.1.80 |
1Y9O | 1H NMR STRUCTURE OF ACYLPHOSPHATASE FROM THE HYPERTHERMOPHILE SULFOLOBUS SOLFATARICUS | 3.6.1.7 |
1Y9Z | CRYSTAL STRUCTURE OF PSYCHROPHILIC SUBTILISIN-LIKE SERINE PROTEASE FROM ANTARCTIC PSYCHROTROPH PSEUDOALTEROMONAS SP. AS-11 AT 0.14 NM RESOLUTION | 3.4.21 |
1YA4 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE 1 IN COMPLEX WITH TAMOXIFEN | 3.1.1.1 3.1.1.13 3.1.1.56 |
1YA8 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEX WITH CLEAVAGE PRODUCTS OF MEVASTATIN | 3.1.1.1 3.1.1.13 3.1.1.56 |
1YAF | STRUCTURE OF TENA FROM BACILLUS SUBTILIS | 3.5.99.2 |
1YAH | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE COMPLEXED TO ETYL ACETATE; A FATTY ACID ETHYL ESTER ANALOGUE | 3.1.1.1 3.1.1.13 3.1.1.56 |
1YAK | COMPLEX OF BACILLUS SUBTILIS TENA WITH 4-AMINO-2-METHYL-5-HYDROXYMETHYLPYRIMIDINE | 3.5.99.2 |
1YAL | CARICA PAPAYA CHYMOPAPAIN AT 1.7 ANGSTROMS RESOLUTION | 3.4.22.6 |
1YAM | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: CALORIMETRIC STUDIES AND X-RAY STRUCTURAL ANALYSIS OF THE FIVE ISOLEUCINE TO VALINE MUTANTS | 3.2.1.17 |
1YAN | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: CALORIMETRIC STUDIES AND X-RAY STRUCTURAL ANALYSIS OF THE FIVE ISOLEUCINE TO VALINE MUTANTS | 3.2.1.17 |
1YAO | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: CALORIMETRIC STUDIES AND X-RAY STRUCTURAL ANALYSIS OF THE FIVE ISOLEUCINE TO VALINE MUTANTS | 3.2.1.17 |
1YAP | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: CALORIMETRIC STUDIES AND X-RAY STRUCTURAL ANALYSIS OF THE FIVE ISOLEUCINE TO VALINE MUTANTS | 3.2.1.17 |
1YAQ | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: CALORIMETRIC STUDIES AND X-RAY STRUCTURAL ANALYSIS OF THE FIVE ISOLEUCINE TO VALINE MUTANTS | 3.2.1.17 |
1YAX | CYSTAL STRUCTURE ANALYSIS OF S.TYPHIMURIUM PHOQ SENSOR DOMAIN WITH CALCIUM | 2.7.3 2.7.13.3 3.1.3 |
1YBQ | CRYSTAL STRUCTURE OF ESCHERICHIA COLI ISOASPARTYL DIPEPTIDASE MUTANT D285N COMPLEXED WITH BETA-ASPARTYLHISTIDINE | 3.4.19 |
1YBW | PROTEASE DOMAIN OF HGFA WITH NO INHIBITOR | 3.4.21 |
1YC0 | SHORT FORM HGFA WITH FIRST KUNITZ DOMAIN FROM HAI-1 | 3.4.21 |
1YC2 | SIR2AF2-NAD-ADPRIBOSE-NICOTINAMIDE | 3.5.1 2.3.1.286 |
1YC5 | SIR2-P53 PEPTIDE-NICOTINAMIDE | 3.5.1 2.3.1.286 |
1YCD | CRYSTAL STRUCTURE OF YEAST FSH1/YHR049W, A MEMBER OF THE SERINE HYDROLASE FAMILY | 3.1 |
1YCL | CRYSTAL STRUCTURE OF B. SUBTILIS LUXS IN COMPLEX WITH A CATALYTIC 2-KETONE INTERMEDIATE | 3.13.1 4.4.1.21 |
1YCM | SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 12 (MMP12) IN THE PRESENCE OF N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH) | 3.4.24.65 |
1YDH | X-RAY STRUCTURE OF A LYSINE DECARBOXYLASE-LIKE PROTEIN FROM ARABIDOPSIS THALIANA GENE AT5G11950 | 3.2.2 |
1YDY | CRYSTAL STRUCTURE OF PERIPLASMIC GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE FROM ESCHERICHIA COLI | 3.1.4.46 |
1YE5 | CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN OF UNKNOWN FUNCTION FROM PYROCOCCUS HORIKOSHII OT3 | 3.1 |
1YE8 | CRYSTAL STRUCTURE OF THEP1 FROM THE HYPERTHERMOPHILE AQUIFEX AEOLICUS | 3.6.1.15 |
1YF4 | CRYSTAL STRUCTURE OF TRYPSIN-VASOPRESSIN COMPLEX | 3.4.21.4 |
1YF8 | CRYSTAL STRUCTURE OF HIMALAYAN MISTLETOE RIP REVEALS THE PRESENCE OF A NATURAL INHIBITOR AND A NEW FUNCTIONALLY ACTIVE SUGAR-BINDING SITE | 3.2.2.22 |
1YFI | CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE MSPI IN COMPLEX WITH ITS COGNATE DNA IN P212121 SPACE GROUP | 3.1.21.4 |
1YFK | CRYSTAL STRUCTURE OF HUMAN B TYPE PHOSPHOGLYCERATE MUTASE | 5.4.2.1 5.4.2.4 3.1.3.13 5.4.2.11 |
1YFO | RECEPTOR PROTEIN TYROSINE PHOSPHATASE ALPHA, DOMAIN 1 FROM MOUSE | 3.1.3.48 |
1YG9 | THE STRUCTURE OF MUTANT (N93Q) OF BLA G 2 | 3.4.23 |
1YGC | SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR | 3.4.21.21 |
1YGR | CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAIN OF RPTP CD45 | 3.1.3.48 |
1YGU | CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP CD45 WITH A PTYR PEPTIDE | 3.1.3.48 |
1YGW | NMR STRUCTURE OF RIBONUCLEASE T1, 34 STRUCTURES | 3.1.27.3 4.6.1.24 |
1YGZ | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM HELICOBACTER PYLORI | 3.6.1.1 |
1YH3 | CRYSTAL STRUCTURE OF HUMAN CD38 EXTRACELLULAR DOMAIN | 3.2.2.5 3.2.2.6 2.4.99.20 |
1YH8 | CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS LPXC DEACETYLASE COMPLEXED WITH PALMITATE | 3.5.1 3.5.1.108 |
1YHC | CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS LPXC DEACETYLASE COMPLEXED WITH CACODYLATE | 3.5.1 3.5.1.108 |
1YHT | CRYSTAL STRUCTURE ANALYSIS OF DISPERSIN B | 3.2.1.52 |
1YI7 | BETA-D-XYLOSIDASE (SELENOMETHIONINE) XYND FROM CLOSTRIDIUM ACETOBUTYLICUM | 3.2.1.37 |
1YIF | CRYSTAL STRUCTURE OF BETA-1,4-XYLOSIDASE FROM BACILLUS SUBTILIS, NEW YORK STRUCTURAL GENOMICS CONSORTIUM | 3.2.1.37 |
1YIK | STRUCTURE OF HEN EGG WHITE LYSOZYME SOAKED WITH CU-CYCLAM | 3.2.1.17 |
1YIL | STRUCTURE OF HEN EGG WHITE LYSOZYME SOAKED WITH CU2-XYLYLBICYCLAM | 3.2.1.17 |
1YIX | CRYSTAL STRUCTURE OF YCFH, TATD HOMOLOG FROM ESCHERICHIA COLI K12, AT 1.9 A RESOLUTION | 3.1.21 3.1 |
1YJ3 | CRYSTAL STRUCTURE ANALYSIS OF PRODUCT BOUND METHIONINE AMINOPEPTIDASE TYPE 1C FROM MYCOBACTERIUM TUBERCULOSIS | 3.4.11.18 |
1YJ5 | MOLECULAR ARCHITECTURE OF MAMMALIAN POLYNUCLEOTIDE KINASE, A DNA REPAIR ENZYME | 2.7.1.78 3.1.3.32 |
1YJA | SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 20% DIMETHYLFORMAMIDE | 3.4.21.14 3.4.21.62 |
1YJB | SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 35% DIMETHYLFORMAMIDE | 3.4.21.14 3.4.21.62 |
1YJC | SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 50% DIMETHYLFORMAMIDE | 3.4.21.14 3.4.21.62 |
1YJM | CRYSTAL STRUCTURE OF THE FHA DOMAIN OF MOUSE POLYNUCLEOTIDE KINASE IN COMPLEX WITH AN XRCC4-DERIVED PHOSPHOPEPTIDE. | 2.7.1.78 3.1.3.32 |
1YJR | SOLUTION STRUCTURE OF THE APO FORM OF THE SIXTH SOLUBLE DOMAIN A69P MUTANT OF MENKES PROTEIN | 3.6.3.4 7.2.2.8 |
1YJT | SOLUTION STRUCTURE OF THE CU(I) FORM OF THE SIXTH SOLUBLE DOMAIN A69P MUTANT OF MENKES PROTEIN | 3.6.3.4 7.2.2.8 |
1YJU | SOLUTION STRUCTURE OF THE APO FORM OF THE SIXTH SOLUBLE DOMAIN OF MENKES PROTEIN | 3.6.3.4 7.2.2.8 |
1YJV | SOLUTION STRUCTURE OF THE CU(I) FORM OF THE SIXTH SOLUBLE DOMAIN OF MENKES PROTEIN | 3.6.3.4 7.2.2.8 |
1YK8 | CATHEPSIN K COMPLEXED WITH A CYANAMIDE-BASED INHIBITOR | 3.4.22.38 |
1YKS | CRYSTAL STRUCTURE OF YELLOW FEVER VIRUS NS3 HELICASE | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1YKX | EFFECT OF ALCOHOLS ON PROTEIN HYDRATION | 3.2.1.17 |
1YKY | EFFECT OF ALCOHOLS ON PROTEIN HYDRATION | 3.2.1.17 |
1YKZ | EFFECT OF ALCOHOLS ON PROTEIN HYDRATION | 3.2.1.17 |
1YL0 | EFFECT OF ALCOHOLS ON PROTEIN HYDRATION | 3.2.1.17 |
1YL1 | EFFECT OF ALCOHOLS ON PROTEIN HYDRATION | 3.2.1.17 |
1YLI | CRYSTAL STRUCTURE OF HI0827, A HEXAMERIC BROAD SPECIFICITY ACYL-COENZYME A THIOESTERASE | 3.1.2 |
1YLJ | ATOMIC RESOLUTION STRUCTURE OF CTX-M-9 BETA-LACTAMASE | 3.5.2.6 |
1YLP | ATOMIC RESOLUTION STRUCTURE OF CTX-M-27 BETA-LACTAMASE | 3.5.2.6 |
1YLT | ATOMIC RESOLUTION STRUCTURE OF CTX-M-14 BETA-LACTAMASE | 3.5.2.6 |
1YLW | X-RAY STRUCTURE OF CTX-M-16 BETA-LACTAMASE | 3.5.2.6 |
1YLY | X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-9 BETA-LACTAMASE COMPLEXED WITH CEFTAZIDIME-LIKE BORONIC ACID | 3.5.2.6 |
1YLZ | X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-14 BETA-LACTAMASE COMPLEXED WITH CEFTAZIDIME-LIKE BORONIC ACID | 3.5.2.6 |
1YM0 | CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT B: A NOVEL, GLYCOSYLATED TWO-CHAINED TRYPSIN | 3.4.21 |
1YM1 | X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-9 BETA-LACTAMASE COMPLEXED WITH A BORONIC ACID INHIBITOR (SM2) | 3.5.2.6 |
1YM2 | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH NVP-AUR200 | 3.4.23.46 |
1YM4 | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH NVP-AMK640 | 3.4.23.46 |
1YM9 | CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE SULFINIC FORM | 3.1.3.48 |
1YMD | CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE SULFONIC FORM | 3.1.3.48 |
1YME | STRUCTURE OF CARBOXYPEPTIDASE | 3.4.17.1 |
1YMK | CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN IN THE APO FORM | 3.1.3.48 |
1YML | CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE SULFENIC FORM | 3.1.3.48 |
1YMN | THE STUDY OF REDUCTIVE UNFOLDING PATHWAYS OF RNASE A (Y92L MUTANT) | 3.1.27.5 4.6.1.18 |
1YMR | THE STUDY OF REDUCTIVE UNFOLDING PATHWAYS OF RNASE A (Y92A MUTANT) | 3.1.27.5 4.6.1.18 |
1YMS | X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-9 BETA-LACTAMASE COMPLEXED WITH NAFCININ-LIKE BORONIC ACID INHIBITOR | 3.5.2.6 |
1YMW | THE STUDY OF REDUCTIVE UNFOLDING PATHWAYS OF RNASE A (Y92G MUTANT) | 3.1.27.5 4.6.1.18 |
1YMX | X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-9 BETA-LACTAMASE COVALENTLY LINKED TO CEFOXITIN | 3.5.2.6 |
1YMY | CRYSTAL STRUCTURE OF THE N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE FROM ESCHERICHIA COLI K12 | 3.5.1.25 |
1YN9 | CRYSTAL STRUCTURE OF BACULOVIRUS RNA 5'-PHOSPHATASE COMPLEXED WITH PHOSPHATE | 3.1.3.33 3.1.3.48 |
1YNA | ENDO-1,4-BETA-XYLANASE, ROOM TEMPERATURE, PH 4.0 | 3.2.1.8 |
1YNB | CRYSTAL STRUCTURE OF GENOMICS APC5600 | 3.1.3.89 |
1YNH | CRYSTAL STRUCTURE OF N-SUCCINYLARGININE DIHYDROLASE, ASTB, BOUND TO SUBSTRATE AND PRODUCT, AN ENZYME FROM THE ARGININE CATABOLIC PATHWAY OF ESCHERICHIA COLI | 3 3.5.3.23 |
1YNI | CRYSTAL STRUCTURE OF N-SUCCINYLARGININE DIHYDROLASE, ASTB, BOUND TO SUBSTRATE AND PRODUCT, AN ENZYME FROM THE ARGININE CATABOLIC PATHWAY OF ESCHERICHIA COLI | 3 3.5.3.23 |
1YNM | CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE HINP1I | 3.1.21.4 |
1YNS | CRYSTAL STRUCTURE OF HUMAN ENOLASE-PHOSPHATASE E1 AND ITS COMPLEX WITH A SUBSTRATE ANALOG | 3.1.3.77 |
1YNV | ASP79 MAKES A LARGE, UNFAVORABLE CONTRIBUTION TO THE STABILITY OF RNASE SA | 3.1.27.3 4.6.1.24 |
1YNY | MOLECULAR STRUCTURE OF D-HYDANTOINASE FROM A BACILLUS SP. AR9: EVIDENCE FOR MERCURY INHIBITION | 3.5.2.2 |
1YOE | CRYSTAL STRUCTURE OF A THE E. COLI PYRIMIDINE NUCLEOSIDE HYDROLASE YBEK WITH BOUND RIBOSE | 3.2.2.8 3.2 |
1YOU | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH A POTENT PYRIMIDINETRIONE INHIBITOR | 3.4.24 |
1YOY | PREDICTED CODING REGION AF1432 FROM ARCHAEOGLOBUS FULGIDUS | 3.1.3.89 |
1YP9 | TRYPSIN INHIBITOR COMPLEX | 3.4.21.4 |
1YPE | THROMBIN INHIBITOR COMPLEX | 3.4.21.5 |
1YPG | THROMBIN INHIBITOR COMPLEX | 3.4.21.5 |
1YPH | HIGH RESOLUTION STRUCTURE OF BOVINE ALPHA-CHYMOTRYPSIN | 3.4.21.1 |
1YPJ | THROMBIN INHIBITOR COMPLEX | 3.4.21.5 |
1YPK | THROMBIN INHIBITOR COMPLEX | 3.4.21.5 |
1YPL | X-RAY CRYSTAL STRUCTURE OF THROMBIN INHIBITED BY SYNTHETIC CYANOPEPTIDE ANALOGUE RA-1008 | 3.4.21.5 |
1YPM | X-RAY CRYSTAL STRUCTURE OF THROMBIN INHIBITED BY SYNTHETIC CYANOPEPTIDE ANALOGUE RA-1014 | 3.4.21.5 |
1YPP | ACID ANHYDRIDE HYDROLASE | 3.6.1.1 |
1YPT | CRYSTAL STRUCTURE OF YERSINIA PROTEIN TYROSINE PHOSPHATASE AT 2.5 ANGSTROMS AND THE COMPLEX WITH TUNGSTATE | 3.1.3.48 |
1YQC | CRYSTAL STRUCTURE OF UREIDOGLYCOLATE HYDROLASE (ALLA) FROM ESCHERICHIA COLI O157:H7 | 3.5.3.19 4.3.2.3 |
1YQE | CRYSTAL STRUCTURE OF CONSERVED PROTEIN OF UNKNOWN FUNCTION AF0625 | 3.1.1.96 |
1YQK | HUMAN 8-OXOGUANINE GLYCOSYLASE CROSSLINKED WITH GUANINE CONTAINING DNA | 3.2.2 4.2.99.18 |
1YQL | CATALYTICALLY INACTIVE HOGG1 CROSSLINKED WITH 7-DEAZA-8-AZAGUANINE CONTAINING DNA | 3.2.2 4.2.99.18 |
1YQM | CATALYTICALLY INACTIVE HUMAN 8-OXOGUANINE GLYCOSYLASE CROSSLINKED TO 7-DEAZAGUANINE CONTAINING DNA | 3.2.2 4.2.99.18 |
1YQR | CATALYTICALLY INACTIVE HUMAN 8-OXOGUANINE GLYCOSYLASE CROSSLINKED TO OXOG CONTAINING DNA | 3.2.2 4.2.99.18 |
1YQS | INHIBITION OF THE R61 DD-PEPTIDASE BY N-BENZOYL-BETA-SULTAM | 3.4.16.4 |
1YQY | STRUCTURE OF B. ANTHRAX LETHAL FACTOR IN COMPLEX WITH A HYDROXAMATE INHIBITOR | 3.4.24.83 |
1YR2 | STRUCTURAL AND MECHANISTIC ANALYSIS OF TWO PROLYL ENDOPEPTIDASES: ROLE OF INTER-DOMAIN DYNAMICS IN CATALYSIS AND SPECIFICITY | 3.4.21.26 |
1YR6 | PAB0955 CRYSTAL STRUCTURE : A GTPASE IN APO FORM FROM PYROCOCCUS ABYSSI | 3.6.5 |
1YR7 | PAB0955 CRYSTAL STRUCTURE : A GTPASE IN GTP-GAMMA-S BOUND FORM FROM PYROCOCCUS ABYSSI | 3.6.5 |
1YR8 | PAB0955 CRYSTAL STRUCTURE : A GTPASE IN GTP BOUND FORM FROM PYROCOCCUS ABYSSI | 3.6.5 |
1YR9 | PAB0955 CRYSTAL STRUCTURE : A GTPASE IN GDP AND PO4 BOUND FORM FROM PYROCOCCUS ABYSSI | 3.6.5 |
1YRA | PAB0955 CRYSTAL STRUCTURE : A GTPASE IN GDP BOUND FORM FROM PYROCOCCUS ABYSSI | 3.6.5 |
1YRB | PAB0955 CRYSTAL STRUCTURE : A GTPASE IN GDP AND MG BOUND FORM FROM PYROCOCCUS ABYSSI | 3.6.5 |
1YRR | CRYSTAL STRUCTURE OF THE N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE FROM ESCHERICHIA COLI K12 AT 2.0 A RESOLUTION | 3.5.1.25 |
1YRZ | CRYSTAL STRUCTURE OF XYLAN BETA-1,4-XYLOSIDASE FROM BACILLUS HALODURANS C-125 | 3.2.1.37 |
1YS0 | CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE DISULFIDE FORM | 3.1.3.48 |
1YS1 | BURKHOLDERIA CEPACIA LIPASE COMPLEXED WITH HEXYLPHOSPHONIC ACID (R)-2-METHYL-3-PHENYLPROPYL ESTER | 3.1.1.3 |
1YS2 | BURKHOLDERIA CEPACIA LIPASE COMPLEXED WITH HEXYLPHOSPHONIC ACID (S) 2-METHYL-3-PHENYLPROPYL ESTER | 3.1.1.3 |
1YSB | YEAST CYTOSINE DEAMINASE TRIPLE MUTANT | 3.5.4.1 |
1YSC | 2.8 ANGSTROMS STRUCTURE OF YEAST SERINE CARBOXYPEPTIDASE | 3.4.16.5 |
1YSD | YEAST CYTOSINE DEAMINASE DOUBLE MUTANT | 3.5.4.1 |
1YSJ | CRYSTAL STRUCTURE OF BACILLUS SUBTILIS YXEP PROTEIN (APC1829), A DINUCLEAR METAL BINDING PEPTIDASE FROM M20 FAMILY | 3.5.1.14 3.5.1 |
1YSY | NMR STRUCTURE OF THE NONSTRUCTURAL PROTEIN 7 (NSP7) FROM THE SARS CORONAVIRUS | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
1YT3 | CRYSTAL STRUCTURE OF ESCHERICHIA COLI RNASE D, AN EXORIBONUCLEASE INVOLVED IN STRUCTURED RNA PROCESSING | 3.1.26.3 3.1.13.5 |
1YT4 | CRYSTAL STRUCTURE OF TEM-76 BETA-LACTAMASE AT 1.4 ANGSTROM RESOLUTION | 3.5.2.6 |
1YT7 | CATHEPSIN K COMPLEXED WITH A CONSTRAINED KETOAMIDE INHIBITOR | 3.4.22.38 |
1YT9 | HIV PROTEASE WITH OXIMINOARYLSULFONAMIDE BOUND | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1YTA | CRYSTAL STRUCTURE OF OLIGORIBONUCLEASE, THE LONE ESSENTIAL EXORIBONUCLEASE IN ESCHERICHIA COLI | 3.1 |
1YTG | SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1YTH | SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1YTI | SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1YTJ | SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1YTN | HYDROLASE | 3.1.3.48 |
1YTS | A LIGAND-INDUCED CONFORMATIONAL CHANGE IN THE YERSINIA PROTEIN TYROSINE PHOSPHATASE | 3.1.3.48 |
1YTW | YERSINIA PTPASE COMPLEXED WITH TUNGSTATE | 3.1.3.48 |
1YU6 | CRYSTAL STRUCTURE OF THE SUBTILISIN CARLSBERG:OMTKY3 COMPLEX | 3.4.21.62 |
1YUO | OPTIMISATION OF THE SURFACE ELECTROSTATICS AS A STRATEGY FOR COLD ADAPTATION OF URACIL-DNA N-GLYCOSYLASE (UNG)FROM ATLANTIC COD (GADUS MORHUA) | 3.2.2.3 3.2.2.27 |
1YUY | HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE GENOTYPE 2A | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
1YV2 | HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE GENOTYPE 2A | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
1YV4 | X-RAY STRUCTURE OF M23L ONCONASE AT 100K | 3.1.27 |
1YV6 | X-RAY STRUCTURE OF M23L ONCONASE AT 298K | 3.1.27 |
1YV7 | X-RAY STRUCTURE OF (C87S,DES103-104) ONCONASE | 3.1.27 |
1YV9 | CRYSTAL STRUCTURE OF A HAD-LIKE PHOSPHATASE FROM ENTEROCOCCUS FAECALIS V583 | 3.1.3 |
1YVF | HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH INHIBITOR PHA-00729145 | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
1YVG | STRUCTURAL ANALYSIS OF THE CATALYTIC DOMAIN OF TETANUS NEUROTOXIN | 3.4.24.68 |
1YVM | E. COLI METHIONINE AMINOPEPTIDASE IN COMPLEX WITH THIABENDAZOLE | 3.4.11.18 |
1YVS | TRIMERIC DOMAIN SWAPPED BARNASE | 3.1.27 |
1YVW | CRYSTAL STRUCTURE OF PHOSPHORIBOSYL-ATP PYROPHOSPHOHYDROLASE FROM BACILLUS CEREUS. NESGC TARGET BCR13. | 3.6.1.31 |
1YVX | HEPATITIS C VIRUS RNA POLYMERASE GENOTYPE 2A IN COMPLEX WITH NON- NUCLEOSIDE ANALOGUE INHIBITOR | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
1YVZ | HEPATITIS C VIRUS RNA POLYMERASE GENOTYPE 2A IN COMPLEX WITH NON- NUCLEOSIDE ANALOGUE INHIBITOR | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
1YW4 | CRYSTAL STRUCTURE OF THE SUCCINYLGLUTAMATE DESUCCINYLASE FROM CHROMOBACTERIUM VIOLACEUM, NORTHEAST STRUCTURAL GENOMICS TARGET CVR22. | 3.1 3.5.1.96 |
1YW6 | CRYSTAL STRUCTURE OF SUCCINYLGLUTAMATE DESUCCINYLASE FROM ESCHERICHIA COLI, NORTHEAST STRUCTURAL GENOMICS TARGET ET72. | 3.1 3.5.1.96 |
1YW7 | H-METAP2 COMPLEXED WITH A444148 | 3.4.11.18 |
1YW8 | H-METAP2 COMPLEXED WITH A751277 | 3.4.11.18 |
1YW9 | H-METAP2 COMPLEXED WITH A849519 | 3.4.11.18 |
1YWO | PHOSPHOLIPASE CGAMMA1 SH3 IN COMPLEX WITH A SLP-76 MOTIF | 3.1.4.11 |
1YWP | PHOSPHOLIPASE CGAMMA1 SH3 | 3.1.4.11 |
1YX9 | EFFECT OF DIMETHYL SULPHOXIDE ON THE CRYSTAL STRUCTURE OF PORCINE PEPSIN | 3.4.23.1 |
1YXB | CRYSTAL STRUCTURE OF PHOSPHORIBOSYL-ATP PYROPHOSPHATASE FROM STREPTOMYCES COELICOLOR. NESG TARGET RR8. | 3.6.1.31 |
1YXH | CRYSTAL STRUCTURE OF A NOVEL PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA WITH A STRONG ANTICOAGULANT ACTIVITY | 3.1.1.4 |
1YXI | R-STATE AMP COMPLEX REVEALS INITIAL STEPS OF THE QUATERNARY TRANSITION OF FRUCTOSE-1,6-BISPHOSPHATASE | 3.1.3.11 |
1YXL | CRYSTAL STRUCTURE OF A NOVEL PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 1.5 A RESOLUTION | 3.1.1.4 |
1YXR | NMR STRUCTURE OF VPS4A MIT DOMAIN | 3.6.4.6 |
1YXW | A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN | 3.4.24.68 |
1YY6 | THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HAUSP/USP7 COMPLEXED WITH AN EBNA1 PEPTIDE | 3.1.2.15 3.4.19.12 |
1YYK | CRYSTAL STRUCTURE OF RNASE III FROM AQUIFEX AEOLICUS COMPLEXED WITH DOUBLE-STRANDED RNA AT 2.5-ANGSTROM RESOLUTION | 3.1.26.3 |
1YYN | A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN | 3.4.24.68 |
1YYO | CRYSTAL STRUCTURE OF RNASE III MUTANT E110K FROM AQUIFEX AEOLICUS COMPLEXED WITH DOUBLE-STRANDED RNA AT 2.9-ANGSTROM RESOLUTION | 3.1.26.3 |
1YYW | CRYSTAL STRUCTURE OF RNASE III FROM AQUIFEX AEOLICUS COMPLEXED WITH DOUBLE STRANDED RNA AT 2.8-ANGSTROM RESOLUTION | 3.1.26.3 |
1YYY | TRYPSIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES | 3.4.21.4 |
1YYZ | R-STATE AMP COMPLEX REVEALS INITIAL STEPS OF THE QUATERNARY TRANSITION OF FRUCTOSE-1,6-BISPHOSPHATASE | 3.1.3.11 |
1YZ0 | R-STATE AMP COMPLEX REVEALS INITIAL STEPS OF THE QUATERNARY TRANSITION OF FRUCTOSE-1,6-BISPHOSPHATASE | 3.1.3.11 |
1YZ4 | CRYSTAL STRUCTURE OF DUSP15 | 3.1.3.48 3.1.3.16 |
1YZ9 | CRYSTAL STRUCTURE OF RNASE III MUTANT E110Q FROM AQUIFEX AEOLICUS COMPLEXED WITH DOUBLE STRANDED RNA AT 2.1-ANGSTROM RESOLUTION | 3.1.26.3 |
1YZB | SOLUTION STRUCTURE OF THE JOSEPHIN DOMAIN OF ATAXIN-3 | 3.4.19.12 |
1YZE | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF USP7/HAUSP. | 3.1.2.15 3.4.19.12 |
1Z0B | CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN E506A MUTANT | 3.4.21.53 3.4.21 |
1Z0C | CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN D508A MUTANT | 3.4.21.53 3.4.21 |
1Z0E | CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN | 3.4.21.53 3.4.21 |
1Z0G | CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN | 3.4.21.53 3.4.21 |
1Z0H | N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B | 3.4.24.69 |
1Z0T | CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN | 3.4.21.53 3.4.21 |
1Z0V | CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN | 3.4.21.53 3.4.21 |
1Z0W | CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN AT 1.2A RESOLUTION | 3.4.21.53 3.4.21 |
1Z12 | CRYSTAL STRUCTURE OF BOVINE LOW MOLECULAR WEIGHT PTPASE COMPLEXED WITH VANADATE | 3.1.3.48 3.1.3.2 |
1Z13 | CRYSTAL STRUCTURE OF BOVINE LOW MOLECULAR WEIGHT PTPASE COMPLEXED WITH MOLYBDATE | 3.1.3.48 3.1.3.2 |
1Z19 | CRYSTAL STRUCTURE OF A LAMBDA INTEGRASE(75-356) DIMER BOUND TO A COC' CORE SITE | 2.7.7 3.1 |
1Z1B | CRYSTAL STRUCTURE OF A LAMBDA INTEGRASE DIMER BOUND TO A COC' CORE SITE | 2.7.7 3.1 |
1Z1G | CRYSTAL STRUCTURE OF A LAMBDA INTEGRASE TETRAMER BOUND TO A HOLLIDAY JUNCTION | 2.7.7 3.1 |
1Z1H | HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 3 | 3.4.23.16 |
1Z1I | CRYSTAL STRUCTURE OF NATIVE SARS CLPRO | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
1Z1J | CRYSTAL STRUCTURE OF SARS 3CLPRO C145A MUTANT | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
1Z1L | THE CRYSTAL STRUCTURE OF THE PHOSPHODIESTERASE 2A CATALYTIC DOMAIN | 3.1.4.17 |
1Z1R | HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 2 | 3.4.23.16 |
1Z1W | CRYSTAL STRUCTURES OF THE TRICORN INTERACTING FACOR F3 FROM THERMOPLASMA ACIDOPHILUM, A ZINC AMINOPEPTIDASE IN THREE DIFFERENT CONFORMATIONS | 3.4.11 |
1Z2L | CRYSTAL STRUCTURE OF ALLANTOATE-AMIDOHYDROLASE FROM E.COLI K12 IN COMPLEX WITH SUBSTRATE ALLANTOATE | 3.5.3 3.5.3.9 |
1Z32 | STRUCTURE-FUNCTION RELATIONSHIPS IN HUMAN SALIVARY ALPHA-AMYLASE: ROLE OF AROMATIC RESIDUES | 3.2.1.1 |
1Z3A | CRYSTAL STRUCTURE OF TRNA ADENOSINE DEAMINASE TADA FROM ESCHERICHIA COLI | 3.5.4 3.5.4.33 |
1Z3I | STRUCTURE OF THE SWI2/SNF2 CHROMATIN REMODELING DOMAIN OF EUKARYOTIC RAD54 | 3.6.4.12 |
1Z3J | SOLUTION STRUCTURE OF MMP12 IN THE PRESENCE OF N-ISOBUTYL-N-4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH) | 3.4.24.65 |
1Z3L | X-RAY CRYSTAL STRUCTURE OF A MUTANT RIBONUCLEASE S (F8ANB) | 3.1.27.5 4.6.1.18 |
1Z3M | CRYSTAL STRUCTURE OF MUTANT RIBONUCLEASE S (F8NVA) | 3.1.27.5 4.6.1.18 |
1Z3P | X-RAY CRYSTAL STRUCTURE OF A MUTANT RIBONUCLEASE S (M13NVA) | 3.1.27.5 4.6.1.18 |
1Z3T | STRUCTURE OF PHANEROCHAETE CHRYSOSPORIUM CELLOBIOHYDROLASE CEL7D (CBH58) IN COMPLEX WITH CELLOBIOSE | 3.2.1.91 3.2.1 |
1Z3V | STRUCTURE OF PHANEROCHAETE CHRYSOSPORIUM CELLOBIOHYDROLASE CEL7D (CBH58) IN COMPLEX WITH LACTOSE | 3.2.1.91 3.2.1 |
1Z3W | STRUCTURE OF PHANEROCHAETE CHRYSOSPORIUM CELLOBIOHYDROLASE CEL7D (CBH58) IN COMPLEX WITH CELLOBIOIMIDAZOLE | 3.2.1.91 3.2.1 |
1Z4I | STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH DEOXYRIBOURIDINE 5'-MONOPHOSPHATE | 3.1.3 |
1Z4J | STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH URIDINE 2'-MONOPHOSPHATE | 3.1.3 |
1Z4K | STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THYMIDINE 3'-MONOPHOSPHATE | 3.1.3 |
1Z4L | STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THYMIDINE 5'-MONOPHOSPHATE | 3.1.3 |
1Z4M | STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH URIDINE 5'-MONOPHOSPHATE | 3.1.3 |
1Z4P | STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH DEOXYRIBOGUANOSINE 5'-MONOPHOSPHATE | 3.1.3 |
1Z4Q | STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH 2',3'-DIDEOXY-2',3-DIDEHYDROTHYMIDINE 5'-MONOPHOSPHATE (D4T-MP) | 3.1.3 |
1Z4U | HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH INHIBITOR PHA-00799585 | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
1Z55 | EFFECT OF ALCOHOLS ON PROTEIN HYDRATION | 3.2.1.17 |
1Z5G | CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM APHA PROTEIN | 3.1.3.2 |
1Z5N | CRYSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE GLU12GLN MUTANT COMPLEXED WITH 5-METHYLTHIORIBOSE AND ADENINE | 3.2.2.9 |
1Z5O | CRYSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE ASP197ASN MUTANT COMPLEXED WITH 5'-METHYLTHIOADENOSINE | 3.2.2.9 |
1Z5P | CRYSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE WITH A LIGAND-FREE PURINE BINDING SITE | 3.2.2.9 |
1Z5R | CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B | 3.4.17.2 |
1Z5U | CRYSTAL STRUCTURE OF S. TYPHIMURIUM APHA COMPLEXED WITH CYCLIC-AMP | 3.1.3.2 |
1Z66 | NMR SOLUTION STRUCTURE OF DOMAIN III OF E-PROTEIN OF TICK-BORNE LANGAT FLAVIVIRUS (NO RDC RESTRAINTS) | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
1Z68 | CRYSTAL STRUCTURE OF HUMAN FIBROBLAST ACTIVATION PROTEIN ALPHA | 3.4.21 3.4.21.26 3.4.14.5 |
1Z6D | RIBONUCLEASE A- IMP COMPLEX | 3.1.27.5 4.6.1.18 |
1Z6E | FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3'-AMINO-1,2-BENZISOXAZOL-5'-YL)-N-(4-(2'-((DIMETHYLAMINO)METHYL)-1H-IMIDAZOL-1-YL)-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE (RAZAXABAN; DPC906; BMS-561389) | 3.4.21.6 |
1Z6F | CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 5 FROM E. COLI IN COMPLEX WITH A BORONIC ACID INHIBITOR | 3.4.16.4 3.5.2.6 |
1Z6J | CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR/PYRAZINONE INHIBITOR | 3.4.21.21 |
1Z6S | RIBONUCLEASE A- AMP COMPLEX | 3.1.27.5 4.6.1.18 |
1Z6V | HUMAN LACTOFERRICIN | 3.4.21 |
1Z6W | HUMAN LACTOFERRICIN | 3.4.21 |
1Z71 | THROMBIN AND P2 PYRIDINE N-OXIDE INHIBITOR COMPLEX STRUCTURE | 3.4.21.5 |
1Z72 | STRUCTURE OF A PUTATIVE TRANSCRIPTIONAL REGULATOR FROM STREPTOCOCCUS PNEUMONIAE | 3.5.99.2 |
1Z76 | CRYSTAL STRUCTURE OF AN ACIDIC PHOSPHOLIPASE A2 (BTHA-I) FROM BOTHROPS JARARACUSSU VENOM COMPLEXED WITH P-BROMOPHENACYL BROMIDE | 3.1.1.4 |
1Z7H | 2.3 ANGSTROM CRYSTAL STRUCTURE OF TETANUS NEUROTOXIN LIGHT CHAIN | 3.4.24.68 |
1Z7K | CRYSTAL STRUCTURE OF TRYPSIN- OVOMUCOID TURKEY EGG WHITE INHIBITOR COMPLEX | 3.4.21.4 |
1Z7S | THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A21 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1Z7Z | CRYO-EM STRUCTURE OF HUMAN COXSACKIEVIRUS A21 COMPLEXED WITH FIVE DOMAIN ICAM-1KILIFI | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1Z88 | CRYSTAL STRUCTURE OF LYS154ARG MUTANT OF MATURE APHA OF S. TYPHIMURIUM | 3.1.3.2 |
1Z8C | CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (L63P, A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1Z8G | CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE TRANSMEMBRANE SERINE PROTEASE HEPSIN WITH COVALENTLY BOUND PREFERRED SUBSTRATE. | 3.4.21 3.4.21.106 |
1Z8I | CRYSTAL STRUCTURE OF THE THROMBIN MUTANT G193A BOUND TO PPACK | 3.4.21.5 |
1Z8J | CRYSTAL STRUCTURE OF THE THROMBIN MUTANT G193P BOUND TO PPACK | 3.4.21.5 |
1Z8R | 2A CYSTEINE PROTEINASE FROM HUMAN COXSACKIEVIRUS B4 (STRAIN JVB / BENSCHOTEN / NEW YORK / 51) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
1Z8T | STRUCTURE OF MUTANT PYRROLIDONE CARBOXYL PEPTIDASE (E192Q) FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS | 3.4.19.3 |
1Z8W | STRUCTURE OF MUTANT PYRROLIDONE CARBOXYL PEPTIDASE (E192I) FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS | 3.4.19.3 |
1Z8X | STRUCTURE OF MUTANT PYRROLIDONE CARBOXYL PEPTIDASE (E192V) FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS | 3.4.19.3 |
1Z96 | CRYSTAL STRUCTURE OF THE MUD1 UBA DOMAIN | 3.4.23 |
1Z9G | CRYSTAL STRUCTURE ANALYSIS OF THERMOLYSIN COMPLEXED WITH THE INHIBITOR (R)-RETRO-THIORPHAN | 3.4.24.27 |
1Z9T | CRYSTAL STRUCTURE OF A PUTATIVE LACCASE (YFIH) FROM ESCHERICHIA COLI AT 1.54 A RESOLUTION | 2.4.2.1 3.5.4.4 1.10.3 2.4.2.28 |
1ZAB | CRYSTAL STRUCTURE OF MOUSE CYTIDINE DEAMINASE COMPLEXED WITH 3-DEAZAURIDINE | 3.5.4.5 |
1ZAP | SECRETED ASPARTIC PROTEASE FROM C. ALBICANS | 3.4.23.24 |
1ZB7 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE G LIGHT CHAIN | 3.4.24.69 |
1ZBA | FOOT-AND-MOUTH DISEASE VIRUS SEROTYPE A1061 COMPLEXED WITH OLIGOSACCHARIDE RECEPTOR. | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
1ZBE | FOOT-AND MOUTH DISEASE VIRUS SEROTYPE A1061 | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
1ZBF | CRYSTAL STRUCTURE OF B. HALODURANS RNASE H CATALYTIC DOMAIN MUTANT D132N | 3.1.26.4 |
1ZBG | CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ZBH | 3'-END SPECIFIC RECOGNITION OF HISTONE MRNA STEM-LOOP BY 3'-EXONUCLEASE | 3.1 |
1ZBI | BACILLUS HALODURANS RNASE H CATALYTIC DOMAIN MUTANT D132N IN COMPLEX WITH 12-MER RNA/DNA HYBRID | 3.1.26.4 |
1ZBL | BACILLUS HALODURANS RNASE H CATALYTIC DOMAIN MUTANT D192N IN COMPLEX WITH 12-MER RNA/DNA HYBRID | 3.1.26.4 |
1ZC0 | CRYSTAL STRUCTURE OF HUMAN HEMATOPOIETIC TYROSINE PHOSPHATASE (HEPTP) CATALYTIC DOMAIN | 3.1.3.48 |
1ZC2 | CRYSTAL STRUCTURE OF PLASMID-ENCODED CLASS C BETA-LACTAMASE CMY-2 COMPLEXED WITH CITRATE MOLECULE | 3.5.2.6 |
1ZC3 | CRYSTAL STRUCTURE OF THE RAL-BINDING DOMAIN OF EXO84 IN COMPLEX WITH THE ACTIVE RALA | 3.6.5.2 |
1ZC4 | CRYSTAL STRUCTURE OF THE RAL-BINDING DOMAIN OF EXO84 IN COMPLEX WITH THE ACTIVE RALA | 3.6.5.2 |
1ZCF | L-ASPARAGINASE FROM ERWINIA CAROTOVORA | 3.5.1.1 |
1ZCK | NATIVE STRUCTURE PRL-1 (PTP4A1) | 3.1.3.48 |
1ZCM | HUMAN CALPAIN PROTEASE CORE INHIBITED BY ZLLYCH2F | 3.4.22.52 |
1ZCZ | CRYSTAL STRUCTURE OF PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE / IMP CYCLOHYDROLASE (TM1249) FROM THERMOTOGA MARITIMA AT 1.88 A RESOLUTION | 2.1.2.3 3.5.4.10 |
1ZD2 | HUMAN SOLUBLE EPOXIDE HYDROLASE 4-(3-CYCLOHEXYLURIEDO)-ETHANOIC ACID COMPLEX | 3.3.2.3 3.3.2.10 3.1.3.76 |
1ZD3 | HUMAN SOLUBLE EPOXIDE HYDROLASE 4-(3-CYCLOHEXYLURIEDO)-BUTYRIC ACID COMPLEX | 3.3.2.3 3.3.2.10 3.1.3.76 |
1ZD4 | HUMAN SOLUBLE EPOXIDE HYDROLASE 4-(3-CYCLOHEXYLURIEDO)-HEXANOIC ACID COMPLEX | 3.3.2.3 3.3.2.10 3.1.3.76 |
1ZD5 | HUMAN SOLUBLE EPOXIDE HYDROLASE 4-(3-CYCLOHEXYLURIEDO)-HEPTANOIC ACID COMPLEX | 3.3.2.3 3.3.2.10 3.1.3.76 |
1ZDP | CRYSTAL STRUCTURE ANALYSIS OF THERMOLYSIN COMPLEXED WITH THE INHIBITOR (S)-THIORPHAN | 3.4.24.27 |
1ZEB | X-RAY STRUCTURE OF ALKALINE PHOSPHATASE FROM HUMAN PLACENTA IN COMPLEX WITH 5'-AMP | 3.1.3.1 |
1ZED | ALKALINE PHOSPHATASE FROM HUMAN PLACENTA IN COMPLEX WITH P-NITROPHENYL-PHOSPHONATE | 3.1.3.1 |
1ZEF | STRUCTURE OF ALKALINE PHOSPHATASE FROM HUMAN PLACENTA IN COMPLEX WITH ITS UNCOMPETITIVE INHIBITOR L-PHE | 3.1.3.1 |
1ZG4 | TEM1 BETA LACTAMASE | 3.5.2.6 |
1ZG6 | TEM1 BETA LACTAMASE MUTANT S70G | 3.5.2.6 |
1ZG7 | CRYSTAL STRUCTURE OF 2-(5-{[AMINO(IMINO)METHYL]AMINO}-2-CHLOROPHENYL)-3-SULFANYLPROPANOIC ACID BOUND TO ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B | 3.4.17.2 |
1ZG8 | CRYSTAL STRUCTURE OF (R)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-SULFANYLPROPANOIC ACID BOUND TO ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B | 3.4.17.2 |
1ZG9 | CRYSTAL STRUCTURE OF 5-{[AMINO(IMINO)METHYL]AMINO}-2-(SULFANYLMETHYL)PENTANOIC ACID BOUND TO ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B | 3.4.17.2 |
1ZGB | CRYSTAL STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH AN (R)-TACRINE(10)-HUPYRIDONE INHIBITOR. | 3.1.1.7 |
1ZGC | CRYSTAL STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH AN (RS)-TACRINE(10)-HUPYRIDONE INHIBITOR. | 3.1.1.7 |
1ZGG | SOLUTION STRUCTURE OF A LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE FROM BACILLUS SUBTILIS | 3.1.3.48 3.9.1.2 |
1ZGI | THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 21 | 3.4.21.5 |
1ZGV | THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 2 | 3.4.21.5 |
1ZGX | CRYSTAL STRUCTURE OF RIBONUCLEASE MUTANT | 3.1.27.3 4.6.1.24 |
1ZH1 | STRUCTURE OF THE ZINC-BINDING DOMAIN OF HCV NS5A | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
1ZHM | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE COAGULATION FACTOR XIA IN COMPLEX WITH BENZAMIDINE (S434A-T475A-K437 MUTANT) | 3.4.21.27 |
1ZHP | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH BENZAMIDINE (S434A-T475A-K505 MUTANT) | 3.4.21.27 |
1ZHQ | CRYSTAL STRUCTURE OF APO MVL | 3.2.1 |
1ZHR | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH BENZAMIDINE (S434A-T475A-C482S-K437A MUTANT) | 3.4.21.27 |
1ZHS | CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2 | 3.2.1 |
1ZI6 | CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE (C123S) MUTANT- 1.7 A | 3.1.1.45 |
1ZI8 | CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE MUTANT(E36D, C123S, A134S, S208G, A229V, K234R)- 1.4 A | 3.1.1.45 |
1ZI9 | CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE (E36D, C123S) MUTANT- 1.5 A | 3.1.1.45 |
1ZIC | CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE (C123S, R206A) MUTANT- 1.7 A | 3.1.1.45 |
1ZIV | CATALYTIC DOMAIN OF HUMAN CALPAIN-9 | 3.4.22 |
1ZIX | CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE MUTANT (E36D, R105H, C123S, G211D, K234N)- 1.8 A | 3.1.1.45 |
1ZIY | CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE MUTANT (C123S) BOUND WITH THE PMS MOIETY OF THE PROTEASE INHIBITOR, PHENYLMETHYLSULFONYL FLUORIDE (PMSF)- 1.9 A | 3.1.1.45 |
1ZJ4 | CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE MUTANT (E36D, C123S) BOUND WITH THE PMS MOIETY OF THE PROTEASE INHIBITOR, PHENYLMETHYLSULFONYL FLUORIDE (PMSF)- 1.7 A | 3.1.1.45 |
1ZJ5 | CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE MUTANT (E36D, C123S, A134S, S208G, A229V, K234R) BOUND WITH THE PMS MOIETY OF THE PROTEASE INHIBITOR, PHENYLMETHYLSULFONYL FLUORIDE (PMSF)- 1.7 A | 3.1.1.45 |
1ZJ7 | CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[S-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ZJC | AMINOPEPTIDASE S FROM S. AUREUS | 3.4.11 |
1ZJD | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH KUNITZ PROTEASE INHIBITOR DOMAIN OF PROTEASE NEXIN II | 3.4.21.27 |
1ZJK | CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC REGION OF HUMAN MASP-2 | 3.4.21 3.4.21.104 |
1ZKJ | STRUCTURAL BASIS FOR THE EXTENDED SUBSTRATE SPECTRUM OF CMY-10, A PLASMID-ENCODED CLASS C BETA-LACTAMASE | 3.5.2.6 |
1ZKL | MULTIPLE DETERMINANTS FOR INHIBITOR SELECTIVITY OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASES | 3.1.4.17 3.1.4.53 |
1ZKN | STRUCTURE OF PDE4D2-IBMX | 3.1.4.17 3.1.4.53 |
1ZKW | CRYSTAL STRUCTURE OF ARG347ALA MUTANT OF BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN | 3.4.24.69 |
1ZKX | CRYSTAL STRUCTURE OF GLU158ALA/THR159ALA/ASN160ALA- A TRIPLE MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN | 3.4.24.69 |
1ZL0 | STRUCTURE OF PROTEIN OF UNKNOWN FUNCTION PA5198 FROM PSEUDOMONAS AERUGINOSA | 3.4.17.13 |
1ZL5 | CRYSTAL STRUCTURE OF GLU335GLN MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN | 3.4.24.69 |
1ZL6 | CRYSTAL STRUCTURE OF TYR350ALA MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN | 3.4.24.69 |
1ZL7 | CRYSTAL STRUCTURE OF CATALYTICALLY-ACTIVE PHOSPHOLIPASE A2 WITH BOUND CALCIUM | 3.1.1.4 |
1ZLB | CRYSTAL STRUCTURE OF CATALYTICALLY-ACTIVE PHOSPHOLIPASE A2 IN THE ABSENCE OF CALCIUM | 3.1.1.4 |
1ZLF | CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ZLH | CRYSTAL STRUCTURE OF THE TICK CARBOXYPEPTIDASE INHIBITOR IN COMPLEX WITH BOVINE CARBOXYPEPTIDASE A | 3.4.17.1 |
1ZLI | CRYSTAL STRUCTURE OF THE TICK CARBOXYPEPTIDASE INHIBITOR IN COMPLEX WITH HUMAN CARBOXYPEPTIDASE B | 3.4.17.2 |
1ZLP | PETAL DEATH PROTEIN PSR132 WITH CYSTEINE-LINKED GLUTARALDEHYDE FORMING A THIOHEMIACETAL ADDUCT | 4.1.3 3.7.1.1 4.1.3.22 |
1ZLQ | CRYSTALLOGRAPHIC AND SPECTROSCOPIC EVIDENCE FOR HIGH AFFINITY BINDING OF FE EDTA (H2O)- TO THE PERIPLASMIC NICKEL TRANSPORTER NIKA | 3.6.3.24 |
1ZLR | FACTOR XI CATALYTIC DOMAIN COMPLEXED WITH 2-GUANIDINO-1-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ETHYL NICOTINATE | 3.4.21.27 |
1ZM1 | CRYSTAL STRUCTURES OF COMPLEX F. SUCCINOGENES 1,3-1,4-BETA-D-GLUCANASE AND BETA-1,3-1,4-CELLOTRIOSE | 3.2.1.73 |
1ZM6 | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BEWEEN A GROUP I PHOSPHOLIPASE A2 AND DESIGNED PENTA PEPTIDE LEU-ALA-ILE-TYR-SER AT 2.6A RESOLUTION | 3.1.1.4 |
1ZM8 | APO CRYSTAL STRUCTURE OF NUCLEASE A FROM ANABAENA SP. | 3.1.30 |
1ZMJ | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FACTOR XI IN COMPLEX WITH 4-(GUANIDINOMETHYL)-PHENYLBORONIC ACID | 3.4.21.27 |
1ZML | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FACTOR XI IN COMPLEX WITH (R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE | 3.4.21.27 |
1ZMN | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH (R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE | 3.4.21.27 |
1ZN3 | CRYSTAL STRUCTURE OF GLU335ALA MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE E | 3.4.24.69 |
1ZN6 | X-RAY CRYSTAL STRUCTURE OF PROTEIN Q7WLM8 FROM BORDETELLA BRONCHISEPTICA. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BOR19. | 3.4 |
1ZNB | METALLO-BETA-LACTAMASE | 3.5.2.6 |
1ZNO | CRYSTAL STRUCTURE OF VC702 FROM VIBRIO CHOLERAE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET: VCP1 | 3.6.1.73 |
1ZNS | CRYSTAL STRUCTURE OF N-COLE7/12-BP DNA/ZN COMPLEX | 3.1 |
1ZOI | CRYSTAL STRUCTURE OF A STEREOSELECTIVE ESTERASE FROM PSEUDOMONAS PUTIDA IFO12996 | 3.1 |
1ZOM | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH A PEPTIDOMIMETIC INHIBITOR | 3.4.21.27 |
1ZOS | STRUCTURE OF 5'-METHYLTHIONADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM S. PNEUMONIAE WITH A TRANSITION-STATE INHIBITOR MT-IMMA | 3.2.2.16 3.2.2.9 |
1ZP5 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A N-HYDROXYUREA INHIBITOR | 3.4.24.34 |
1ZP7 | THE STRUCTURE OF BACILLUS SUBTILIS RECU HOLLIDAY JUNCTION RESOLVASE AND ITS ROLE IN SUBSTRATE SELECTION AND SEQUENCE SPECIFIC CLEAVAGE. | 3.1.22.4 |
1ZP8 | HIV PROTEASE WITH INHIBITOR AB-2 | 3.4.23.16 |
1ZPA | HIV PROTEASE WITH SCRIPPS AB-3 INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ZPB | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH 4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE | 3.4.21.27 |
1ZPC | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH 2-[2-(3-CHLORO-PHENYL)-2-HYDROXY-ACETYLAMINO]-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-3-METHYL-BUTYRAMIDE | 3.4.21.27 |
1ZPE | ARGINASE I COVALENTLY MODIFIED WITH BUTYLAMINE AT Q19C | 3.5.3.1 |
1ZPG | ARGINASE I COVALENTLY MODIFIED WITH PROPYLAMINE AT Q19C | 3.5.3.1 |
1ZPK | CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ZPS | CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM PHOSPHORIBOSYL-AMP CYCLOHYDROLASE HISI | 3.5.4.19 |
1ZPW | CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN TT1823 FROM THERMUS THERMOPHILUS | 3.1 |
1ZPZ | FACTOR XI CATALYTIC DOMAIN COMPLEXED WITH N-((R)-1-(4-BROMOPHENYL)ETHYL)UREA-ASN-VAL-ARG-ALPHA-KETOTHIAZOLE | 3.4.21.27 |
1ZR0 | CRYSTAL STRUCTURE OF KUNITZ DOMAIN 1 OF TISSUE FACTOR PATHWAY INHIBITOR-2 WITH BOVINE TRYPSIN | 3.4.21.4 |
1ZR8 | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 AND A PLANT ALKALOID AJMALINE AT 2.0A RESOLUTION | 3.1.1.4 |
1ZRB | THROMBIN IN COMPLEX WITH AN AZAFLUORENYL INHIBITOR 23B | 3.4.21.5 |
1ZRK | FACTOR XI COMPLEXED WITH 3-HYDROXYPROPYL 3-(7-AMIDINONAPHTHALENE-1-CARBOXAMIDO)BENZENESULFONATE | 3.4.21.27 |
1ZRM | CRYSTAL STRUCTURE OF THE REACTION INTERMEDIATE OF L-2-HALOACID DEHALOGENASE WITH 2-CHLORO-N-BUTYRATE | 3.8.1.2 |
1ZRN | INTERMEDIATE STRUCTURE OF L-2-HALOACID DEHALOGENASE WITH MONOCHLOROACETATE | 3.8.1.2 |
1ZRS | WILD-TYPE LD-CARBOXYPEPTIDASE | 3.4.17.13 |
1ZS0 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A PHOSPHONATE INHIBITOR (S-ENANTIOMER) | 3.4.24.34 |
1ZS9 | CRYSTAL STRUCTURE OF HUMAN ENOLASE-PHOSPHATASE E1 | 3.1.3.77 |
1ZSF | CRYSTAL STRUCTURE OF COMPLEX OF A HYDROXYETHYLAMINE INHIBITOR WITH HIV-1 PROTEASE AT 2.0A RESOLUTION | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ZSJ | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE | 3.4.21.27 |
1ZSK | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH 6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER | 3.4.21.27 |
1ZSL | FACTOR XI COMPLEXED WITH A PYRIMIDINONE INHIBITOR | 3.4.21.27 |
1ZSR | CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE (BRU ISOLATE) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[S-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ZTJ | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH 2-(5-BENZYLAMINO-2-METHYLSULFANYL-6-OXO-6H-PYRIMIDIN-1-YL)-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-ACETAMIDE | 3.4.21.27 |
1ZTK | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH 2-(5-AMINO-6-OXO-2-M-TOLYL-6H-PYRIMIDIN-1-YL)-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-ACETAMIDE | 3.4.21.27 |
1ZTL | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-2-{6-OXO-5-[(QUINOLIN-8-YLMETHYL)-AMINO]-2-M-TOLYL-6H-PYRIMIDIN-1-YL}-ACETAMIDE | 3.4.21.27 |
1ZTQ | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-033 | 3.4.24 |
1ZTT | NETROPSIN BOUND TO D(CTTAATTCGAATTAAG) IN COMPLEX WITH MMLV RT CATALYTIC FRAGMENT | 2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1ZTW | D(CTTAATTCGAATTAAG) COMPLEXED WITH MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE CATALYTIC FRAGMENT | 2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1 |
1ZTZ | CRYSTAL STRUCTURE OF HIV PROTEASE- METALLACARBORANE COMPLEX | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
1ZUR | CRYSTAL STRUCTURE OF SPIN LABELED T4 LYSOZYME (V131R1F) | 3.2.1.17 |
1ZVM | CRYSTAL STRUCTURE OF HUMAN CD38: CYCLIC-ADP-RIBOSYL SYNTHETASE/NAD+ GLYCOHYDROLASE | 3.2.2.5 3.2.2.6 2.4.99.20 |
1ZVQ | STRUCTURE OF THE Q61G MUTANT OF RAS IN THE GDP-BOUND FORM | 3.6.5.2 |
1ZVR | CRYSTAL STRUCTURE OF MTMR2 IN COMPLEX WITH PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE | 3.1.3 3.1.3.95 3.1.3.64 |
1ZVX | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A PHOSPHONATE INHIBITOR (R-ENANTIOMER) | 3.4.24.34 |
1ZW6 | CRYSTAL STRUCTURE OF THE GTP-BOUND FORM OF RASQ61G | 3.6.5.2 |
1ZWN | CRYSTAL STRUCTURE OF SPIN LABELED T4 LYSOZYME (V131R1B) | 3.2.1.17 |
1ZWP | THE ATOMIC RESOLUTION CRYSTAL STRUCTURE OF THE PHOSPHOLIPASE A2 (PLA2) COMPLEX WITH NIMESULIDE REVEALS ITS WEAKER BINDING TO PLA2 | 3.1.1.4 |
1ZWX | CRYSTAL STRUCTURE OF SMCL | 3.1.4.12 |
1ZWY | CRYSTAL STRUCTURE OF PROTEIN VC0702 FROM VIBRIO CHOLERAE | 3.6.1.73 |
1ZXC | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) WITH INHIBITOR | 3.4.24.86 |
1ZXV | X-RAY CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR BOUND TO A SMALL MOLECULE INHIBITOR, BI-MFM3, 3-{5-[5-(4-CHLORO-PHENYL)-FURAN-2-YLMETHYLENE]-4-OXO-2-THIOXO-THIAZOLIDIN-3-YL}-PROPIONIC ACID. | 3.4.24.83 |
1ZXZ | X-RAY STRUCTURE OF PEPTIDE DEFORMYLASE FROM ARABIDOPSIS THALIANA (ATPDF1A); CRYSTALS GROWN IN PEG-5000 MME AS PRECIPITANT | 3.5.1.88 |
1ZY0 | X-RAY STRUCTURE OF PEPTIDE DEFORMYLASE FROM ARABIDOPSIS THALIANA (ATPDF1A); CRYSTALS GROWN IN PEG-6000 | 3.5.1.88 |
1ZY1 | X-RAY STRUCTURE OF PEPTIDE DEFORMYLASE FROM ARABIDOPSIS THALIANA (ATPDF1A) IN COMPLEX WITH MET-ALA-SER | 3.5.1.88 |
1ZY7 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF AN ADENOSINE DEAMINASE THAT ACTS ON RNA (HADAR2) BOUND TO INOSITOL HEXAKISPHOSPHATE (IHP) | 3.5.4.37 |
1ZY9 | CRYSTAL STRUCTURE OF ALPHA-GALACTOSIDASE (EC 3.2.1.22) (MELIBIASE) (TM1192) FROM THERMOTOGA MARITIMA AT 2.34 A RESOLUTION | 3.2.1.22 |
1ZYO | CRYSTAL STRUCTURE OF THE SERINE PROTEASE DOMAIN OF SESBANIA MOSAIC VIRUS POLYPROTEIN | 3.4.21.19 |
1ZYQ | T7 DNA POLYMERASE IN COMPLEX WITH 8OG AND INCOMING DDATP | 2.7.7.7 3.1.11 |
1ZYT | CRYSTAL STRUCTURE OF SPIN LABELED T4 LYSOZYME (A82R1) | 3.2.1.17 |
1ZYX | CRYSTAL STRUCTURE OF THE COMPLEX OF A GROUP IIA PHOSPHOLIPASE A2 WITH A SYNTHETIC ANTI-INFLAMMATORY AGENT LICOFELONE AT 1.9A RESOLUTION | 3.1.1.4 |
1ZZ0 | CRYSTAL STRUCTURE OF A HDAC-LIKE PROTEIN WITH ACETATE BOUND | 3.5.1 |
1ZZ1 | CRYSTAL STRUCTURE OF A HDAC-LIKE PROTEIN WITH SAHA BOUND | 3.5.1 |
1ZZ3 | CRYSTAL STRUCTURE OF A HDAC-LIKE PROTEIN WITH CYPX BOUND | 3.5.1 |
1ZZM | CRYSTAL STRUCTURE OF YJJV, TATD HOMOLOG FROM ESCHERICHIA COLI K12, AT 1.8 A RESOLUTION | 3.1.21 3.1 |
1ZZW | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN MAP KINASE PHOSPHATASE 5 | 3.1.3.48 3.1.3.16 |
1ZZZ | TRYPSIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES | 3.4.21.4 |
200L | THERMODYNAMIC AND STRUCTURAL COMPENSATION IN SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME" | 3.2.1.17 |
201L | HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME | 3.2.1.17 |
205L | HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME | 3.2.1.17 |
206L | PHAGE T4 LYSOZYME | 3.2.1.17 |
207L | MUTANT HUMAN LYSOZYME C77A | 3.2.1.17 |
208L | MUTANT HUMAN LYSOZYME C77A | 3.2.1.17 |
209L | PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | 3.2.1.17 |
210L | PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | 3.2.1.17 |
211L | PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | 3.2.1.17 |
212L | PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | 3.2.1.17 |
213L | PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | 3.2.1.17 |
214L | PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | 3.2.1.17 |
215L | PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | 3.2.1.17 |
216L | STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | 3.2.1.17 |
217L | STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME | 3.2.1.17 |
218L | PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | 3.2.1.17 |
219L | PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME | 3.2.1.17 |
220L | GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | 3.2.1.17 |
221L | THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME | 3.2.1.17 |
221P | THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES | 3.6.5.2 |
222L | GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | 3.2.1.17 |
223L | GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | 3.2.1.17 |
224L | THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME | 3.2.1.17 |
225L | GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | 3.2.1.17 |
226L | GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | 3.2.1.17 |
227L | GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | 3.2.1.17 |
228L | GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | 3.2.1.17 |
229L | GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | 3.2.1.17 |
230L | T4 LYSOZYME MUTANT M6L | 3.2.1.17 |
231L | T4 LYSOZYME MUTANT M106K | 3.2.1.17 |
232L | T4 LYSOZYME MUTANT M120K | 3.2.1.17 |
233L | T4 LYSOZYME MUTANT M120L | 3.2.1.17 |
234L | T4 LYSOZYME MUTANT M106L | 3.2.1.17 |
235L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
236L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
237L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
238L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
239L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
240L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
241L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
242L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
243L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
244L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
245L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
246L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
247L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
248L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
249L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
250L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
251L | THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT | 3.2.1.17 |
252L | GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS | 3.2.1.17 |
253L | LYSOZYME | 3.2.1.17 |
254L | LYSOZYME | 3.2.1.17 |
255L | HYDROLASE | 3.2.1.17 |
256L | BACTERIOPHAGE T4 LYSOZYME | 3.2.1.17 |
257L | AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME | 3.2.1.17 |
258L | AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME | 3.2.1.17 |
259L | AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME | 3.2.1.17 |
260L | AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME | 3.2.1.17 |
261L | STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND SEQUENCE IN PROTEIN FOLDING | 3.2.1.17 |
262L | STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND SEQUENCE IN PROTEIN FOLDING | 3.2.1.17 |
2A00 | THE SOLUTION STRUCTURE OF THE AMP-PNP BOUND NUCLEOTIDE BINDING DOMAIN OF KDPB | 3.6.3.12 7.2.2.6 |
2A0I | F FACTOR TRAI RELAXASE DOMAIN BOUND TO F ORIT SINGLE-STRANDED DNA | 3.6.1 5.6.2.1 3.6.4.12 |
2A0M | ARGINASE SUPERFAMILY PROTEIN FROM TRYPANOSOMA CRUZI | 3.5.3.8 |
2A0Q | STRUCTURE OF THROMBIN IN 400 MM POTASSIUM CHLORIDE | 3.4.21.5 |
2A11 | CRYSTAL STRUCTURE OF NUCLEASE DOMAIN OF RIBONUCLASE III FROM MYCOBACTERIUM TUBERCULOSIS | 3.1.26.3 |
2A1D | STAPHYLOCOAGULASE BOUND TO BOVINE THROMBIN | 3.4.21.5 |
2A1E | HIGH RESOLUTION STRUCTURE OF HIV-1 PR WITH TS-126 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2A1J | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE C-TERMINAL DOMAINS OF HUMAN XPF AND ERCC1 | 3.1 |
2A1R | CRYSTAL STRUCTURE OF PARN NUCLEASE DOMAIN | 3.1.13.4 |
2A1S | CRYSTAL STRUCTURE OF NATIVE PARN NUCLEASE DOMAIN | 3.1.13.4 |
2A29 | THE SOLUTION STRUCTURE OF THE AMP-PNP BOUND NUCLEOTIDE BINDING DOMAIN OF KDPB | 3.6.3.12 7.2.2.6 |
2A2K | CRYSTAL STRUCTURE OF AN ACTIVE SITE MUTANT, C473S, OF CDC25B PHOSPHATASE CATALYTIC DOMAIN | 3.1.3.48 |
2A2Q | COMPLEX OF ACTIVE-SITE INHIBITED HUMAN COAGULATION FACTOR VIIA WITH HUMAN SOLUBLE TISSUE FACTOR IN THE PRESENCE OF CA2+, MG2+, NA+, AND ZN2+ | 3.4.21.21 |
2A2X | ORALLY ACTIVE THROMBIN INHIBITORS IN COMPLEX WITH THROMBIN INH12 | 3.4.21.5 |
2A31 | TRYPSIN IN COMPLEX WITH BORATE | 3.4.21.4 |
2A32 | TRYPSIN IN COMPLEX WITH BENZENE BORONIC ACID | 3.4.21.4 |
2A33 | X-RAY STRUCTURE OF A LYSINE DECARBOXYLASE-LIKE PROTEIN FROM ARABIDOPSIS THALIANA GENE AT2G37210 | 3.2.2 |
2A39 | HUMICOLA INSOLENS ENDOCELLULASE EGI NATIVE STRUCTURE | 3.2.1.4 |
2A3A | CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH THEOPHYLLINE | 3.2.1.14 |
2A3B | CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH CAFFEINE | 3.2.1.14 |
2A3C | CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH PENTOXIFYLLINE | 3.2.1.14 |
2A3E | CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH ALLOSAMIDIN | 3.2.1.14 |
2A3H | CELLOBIOSE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHERANS AT 2.0 A RESOLUTION | 3.2.1.4 |
2A3K | CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE, PTPN7 (HEPTP, HEMATOPOIETIC PROTEIN TYROSINE PHOSPHATASE) | 3.1.3.48 |
2A3L | X-RAY STRUCTURE OF ADENOSINE 5'-MONOPHOSPHATE DEAMINASE FROM ARABIDOPSIS THALIANA IN COMPLEX WITH COFORMYCIN 5'-PHOSPHATE | 3.5.4.6 |
2A3Q | X-RAY STRUCTURE OF PROTEIN FROM MUS MUSCULUS MM.29898 | 3.6.1.12 |
2A3U | CRYSTAL STRUCTURE OF SULBACTAM BOUND TO E166A VARIANT OF SHV-1 BETA-LACTAMASE | 3.5.2.6 |
2A45 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THROMBIN AND THE CENTRAL E" REGION OF FIBRIN" | 3.4.21.5 |
2A49 | CRYSTAL STRUCTURE OF CLAVULANIC ACID BOUND TO E166A VARIANT OF SHV-1 BETA-LACTAMASE | 3.5.2.6 |
2A4F | SYNTHESIS AND ACTIVITY OF N-AXYL AZACYCLIC UREA HIV-1 PROTEASE INHIBITORS WITH HIGH POTENCY AGAINST MULTIPLE DRUG RESISTANT VIRAL STRAINS. | 3.4.23.16 |
2A4G | HEPATITIS C PROTEASE NS3-4A SERINE PROTEASE WITH KETOAMIDE INHIBITOR SCH225724 BOUND | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
2A4O | DUAL MODES OF MODIFICATION OF HEPATITIS A VIRUS 3C PROTEASE BY A SERINE DERIVED BETA-LACTONE: SELECTIVE CRYTSTALLIZATION AND HIGH RESOLUTION STRUCTURE OF THE HIS102 ADDUCT | 3.4.22.28 3.6.1.15 2.7.7.48 |
2A4R | HCV NS3 PROTEASE DOMAIN WITH A KETOAMIDE INHIBITOR COVALENTLY BOUND. | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
2A4T | CRYSTAL STRUCTURE OF SPIN LABELED T4 LYSOZYME (V131R7) | 3.2.1.17 |
2A5A | CRYSTAL STRUCTURE OF UNBOUND SARS CORONAVIRUS MAIN PEPTIDASE IN THE SPACE GROUP C2 | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2A5I | CRYSTAL STRUCTURES OF SARS CORONAVIRUS MAIN PEPTIDASE INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN THE SPACE GROUP C2 | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2A5K | CRYSTAL STRUCTURES OF SARS CORONAVIRUS MAIN PEPTIDASE INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN SPACE GROUP P212121 | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2A6B | CRYSTAL STRUCTURE OF A PUTATIVE TRANSCRIPTIONAL REGULATOR OF THE TENA FAMILY (SPR0628) FROM STREPTOCOCCUS PNEUMONIAE R6 AT 1.70 A RESOLUTION | 3.5.99.2 |
2A6R | CRYSTAL STRUCTURE OF YOEB UNDER PEG CONDITION | 3.1 |
2A6S | CRYSTAL STRUCTURE OF YOEB UNDER ISOPROPANOL CONDITION | 3.1 |
2A6T | CRYSTAL STRUCTURE OF S.POMBE MRNA DECAPPING ENZYME DCP2P | 3 |
2A6U | PH EVOLUTION OF TETRAGONAL HEWL AT 4 DEGREES CELCIUS. | 3.2.1.17 |
2A75 | TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 2,3- DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE) | 3.2.1.18 |
2A78 | CRYSTAL STRUCTURE OF THE C3BOT-RALA COMPLEX REVEALS A NOVEL TYPE OF ACTION OF A BACTERIAL EXOENZYME | 3.6.5.2 |
2A7C | ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH | 3.4.21.36 |
2A7D | ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH | 3.2.1.17 |
2A7F | ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH | 3.2.1.17 |
2A7G | ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH | 2.2.1.2 3.4.24.27 |
2A7H | ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH | 3.4.21.4 |
2A7J | ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH | 3.4.21.36 |
2A7M | 1.6 ANGSTROM RESOLUTION STRUCTURE OF THE QUORUM-QUENCHING N-ACYL HOMOSERINE LACTONE HYDROLASE OF BACILLUS THURINGIENSIS | 3.1.1 3.1.1.81 |
2A7U | NMR SOLUTION STRUCTURE OF THE E.COLI F-ATPASE DELTA SUBUNIT N-TERMINAL DOMAIN IN COMPLEX WITH ALPHA SUBUNIT N-TERMINAL 22 RESIDUES | 3.6.3.14 |
2A7W | CRYSTAL STRUCTURE OF PHOSPHORIBOSYL-ATP PYROPHOSPHATASE FROM CHROMOBACTERIUM VIOLACEUM (ATCC 12472). NESG TARGET CVR7 | 3.6.1.31 |
2A8A | CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F LIGHT CHAIN | 3.4.24.69 |
2A8B | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TYROSINE PHOSPHATASE RECEPTOR, TYPE R | 3.1.3.48 |
2A8H | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THIOMORPHOLINE SULFONAMIDE HYDROXAMATE INHIBITOR | 3.4.24.86 |
2A8I | CRYSTAL STRUCTURE OF HUMAN TASPASE1 | 3.4.25 |
2A8J | CRYSTAL STRUCTURE OF HUMAN TASPASE1 (ACIVATED FORM) | 3.4.25 |
2A8K | STRUCTURAL AND MUTATIONAL STUDIES OF THE CATALYTIC DOMAIN OF COLICIN E5A TRNA-SPECIFIC RIBONUCLEASE | 3.1 |
2A8L | CRYSTAL STRUCTURE OF HUMAN TASPASE1 (T234A MUTANT) | 3.4.25 |
2A8M | CRYSTAL STRUCTURE OF HUMAN TASPASE1 (T234S MUTANT) | 3.4.25 |
2A8N | BIOCHEMICAL AND STRUCTURAL STUDIES OF A-TO-I EDITING BY TRNA:A34 DEAMINASES AT THE WOBBLE POSITION OF TRANSFER RNA | 3.5.4.33 |
2A8P | 2.7 ANGSTROM CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE NUCLEAR SNORNA DECAPPING NUDIX HYDROLASE X29 AND MANGANESE | 3.6.1 3.6.1.62 3.6.1.64 |
2A8Q | 2.6 ANGSTROM CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE NUCLEAR SNORNA DECAPPING NUDIX HYDROLASE X29 AND MANGANESE IN THE PRESENCE OF 7-METHYL-GDP | 3.6.1 3.6.1.62 3.6.1.64 |
2A8R | 2.45 ANGSTROM CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE NUCLEAR SNORNA DECAPPING NUDIX HYDROLASE X29 AND MANGANESE IN THE PRESENCE OF 7-METHYL-GTP | 3.6.1 3.6.1.62 3.6.1.64 |
2A8S | 2.45 ANGSTROM CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE NUCLEAR SNORNA DECAPPING NUDIX HYDROLASE X29, MANGANESE AND GTP | 3.6.1 3.6.1.62 3.6.1.64 |
2A8T | 2.1 ANGSTROM CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE NUCLEAR U8 SNORNA DECAPPING NUDIX HYDROLASE X29, MANGANESE AND M7G-PPP-A | 3.6.1 3.6.1.62 3.6.1.64 |
2A8Z | STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE | 3.2.1.8 3.2.1.4 |
2A96 | CRYSTAL STRUCTURE OF PHOSPHATE TETHERED PHON OF S. TYPHIMURIUM | 3.1.3.2 |
2A97 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F | 3.4.24.69 |
2A9G | STRUCTURE OF C406A ARGININE DEIMINASE IN COMPLEX WITH L-ARGININE | 3.5.3.6 |
2A9K | CRYSTAL STRUCTURE OF THE C3BOT-NAD-RALA COMPLEX REVEALS A NOVEL TYPE OF ACTION OF A BACTERIAL EXOENZYME | 3.6.5.2 |
2A9U | STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 8 (USP8) | 3.1.2.15 3.4.19.12 |
2AAA | CALCIUM BINDING IN ALPHA-AMYLASES: AN X-RAY DIFFRACTION STUDY AT 2.1 ANGSTROMS RESOLUTION OF TWO ENZYMES FROM ASPERGILLUS | 3.2.1.1 |
2AAD | THE ROLE OF HISTIDINE-40 IN RIBONUCLEASE T1 CATALYSIS: THREE-DIMENSIONAL STRUCTURES OF THE PARTIALLY ACTIVE HIS40LYS MUTANT | 3.1.27.3 4.6.1.24 |
2AAE | THE ROLE OF HISTIDINE-40 IN RIBONUCLEASE T1 CATALYSIS: THREE-DIMENSIONAL STRUCTURES OF THE PARTIALLY ACTIVE HIS40LYS MUTANT | 3.1.27.3 4.6.1.24 |
2AAF | STRUCTURE OF H278A ARGININE DEIMINASE WITH L-ARGININE FORMING A S-ALKYLTHIOURONIUM REACTION INTERMEDIATE | 3.5.3.6 |
2AAI | CRYSTALLOGRAPHIC REFINEMENT OF RICIN TO 2.5 ANGSTROMS | 3.2.2.22 |
2AAS | HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF RIBONUCLEASE A IN SOLUTION BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY | 3.1.27.5 4.6.1.18 |
2AB0 | CRYSTAL STRUCTURE OF E. COLI PROTEIN YAJL (THIJ) | 3.1.2 3.5.1 3.5.1.124 |
2ABR | STRUCTURE OF D280A ARGININE DEIMINASE WITH L-ARGININE FORMING A S-ALKYLTHIOURONIUM REACTION INTERMEDIATE | 3.5.3.6 |
2ABW | GLUTAMINASE SUBUNIT OF THE PLASMODIAL PLP SYNTHASE (VITAMIN B6 BIOSYNTHESIS) | 2.6 4.3.3.6 3.5.1.2 |
2ABZ | CRYSTAL STRUCTURE OF C19A/C43A MUTANT OF LEECH CARBOXYPEPTIDASE INHIBITOR IN COMPLEX WITH BOVINE CARBOXYPEPTIDASE A | 3.4.17.1 |
2AC1 | CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE FROM ARABIDOPSIS THALIANA | 3.2.1.26 |
2ACE | NATIVE ACETYLCHOLINESTERASE (E.C. 3.1.1.7) FROM TORPEDO CALIFORNICA | 3.1.1.7 |
2ACF | NMR STRUCTURE OF SARS-COV NON-STRUCTURAL PROTEIN NSP3A (SARS1) FROM SARS CORONAVIRUS | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2ACI | STRUCTURE OF D166A ARGININE DEIMINASE | 3.5.3.6 |
2ACJ | CRYSTAL STRUCTURE OF THE B/Z JUNCTION CONTAINING DNA BOUND TO Z-DNA BINDING PROTEINS | 3.5.4 3.5.4.37 |
2ACK | ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, MONOCHROMATIC DATA | 3.1.1.7 |
2ACT | CRYSTALLOGRAPHIC REFINEMENT OF THE STRUCTURE OF ACTINIDIN AT 1.7 ANGSTROMS RESOLUTION BY FAST FOURIER LEAST-SQUARES METHODS | 3.4.22.14 |
2ACY | ACYL-PHOSPHATASE (COMMON TYPE) FROM BOVINE TESTIS | 3.6.1.7 |
2ADA | ATOMIC STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH A TRANSITION-STATE ANALOG: UNDERSTANDING CATALYSIS AND IMMUNODEFICIENCY MUTATIONS | 3.5.4.4 |
2ADD | CRYSTAL STRUCTURE OF FRUCTAN 1-EXOHYDROLASE IIA FROM CICHORIUM INTYBUS IN COMPLEX WITH SUCROSE | 3.2.1.153 3.2.1.80 |
2ADE | CRYSTAL STRUCTURE OF FRUCTAN 1-EXOHYDROLASE IIA FROM CICHORIUM INTYBUS IN COMPLEX WITH FRUCTOSE | 3.2.1.153 3.2.1.80 |
2ADU | HUMAN METHIONINE AMINOPEPTIDASE COMPLEX WITH 4-ARYL-1,2,3-TRIAZOLE INHIBITOR | 3.4.11.18 |
2AE0 | CRYSTAL STRUCTURE OF MLTA FROM ESCHERICHIA COLI REVEALS A UNIQUE LYTIC TRANSGLYCOSYLASE FOLD | 3.2.1 4.2.2 |
2AE5 | GLUTARYL 7-AMINOCEPHALOSPORANIC ACID ACYLASE: MUTATIONAL STUDY OF ACTIVATION MECHANISM | 3.5.1.11 3.5.1.93 |
2AEB | CRYSTAL STRUCTURE OF HUMAN ARGINASE I AT 1.29 A RESOLUTION AND EXPLORATION OF INHIBITION IN IMMUNE RESPONSE. | 3.5.3.1 |
2AEG | X-RAY CRYSTAL STRUCTURE OF PROTEIN ATU5096 FROM AGROBACTERIUM TUMEFACIENS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ATR63. | 3.4 |
2AEI | CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR AND 2-[[6-[3-(AMINOIMINOMETHYL)PHENOXY]-3,5-DIFLURO-4-[(1-METHYL-3-PHENYLPROPYL)AMINO]-2-PYRIDINYL]OXY]-BENZOIC ACID | 3.4.21.21 |
2AEP | AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX. | 3.2.1.18 |
2AEQ | AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX. | 3.2.1 3.2.1.18 |
2AER | CRYSTAL STRUCTURE OF BENZAMIDINE-FACTOR VIIA/SOLUBLE TISSUE FACTOR COMPLEX. | 3.4.21.21 |
2AEY | CRYSTAL STRUCTURE OF FRUCTAN 1-EXOHYDROLASE IIA FROM CICHORIUM INTYBUS IN COMPLEX WITH 2,5 DIDEOXY-2,5-IMMINO-D-MANNITOL | 3.2.1.153 3.2.1.80 |
2AEZ | CRYSTAL STRUCTURE OF FRUCTAN 1-EXOHYDROLASE IIA (E201Q) FROM CICHORIUM INTYBUS IN COMPLEX WITH 1-KESTOSE | 3.2.1.153 3.2.1.80 |
2AFQ | 1.9 ANGSTROM CRYSTAL STRUCTURE OF WILD-TYPE HUMAN THROMBIN IN THE SODIUM FREE STATE | 3.4.21.5 |
2AGA | DE-UBIQUITINATING FUNCTION OF ATAXIN-3: INSIGHTS FROM THE SOLUTION STRUCTURE OF THE JOSEPHIN DOMAIN | 3.4.19.12 |
2AGS | TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 2-KETO-3-DEOXY-D-GLYCERO-D-GALACTO-2,3-DIFLUORO-NONONIC ACID (2,3-DIFLUORO-KDN) | 3.2.1.18 |
2AGV | CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH BHQ AND TG | 3.6.3.8 7.2.2.10 |
2AH2 | TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 2,3-DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE) | 3.2.1.18 |
2AH4 | GUANIDINOBENZOYL-TRYPSIN ACYL-ENZYME AT 1.13 A RESOLUTION | 3.4.21.4 |
2AHD | THE APO STRUCTURE OF METHANOCOCCUS JANNASCHII PHOSPHODIESTERASE MJ0936 | 3.1.4 |
2AHF | UNSATURATED GLUCURONYL HYDROLASE MUTANT D88N | 3.2.1 3.2.1.179 |
2AHM | CRYSTAL STRUCTURE OF SARS-COV SUPER COMPLEX OF NON-STRUCTURAL PROTEINS: THE HEXADECAMER | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2AHN | HIGH RESOLUTION STRUCTURE OF A CHERRY ALLERGEN PRU AV 2 | 3.2.1.39 |
2AHO | STRUCTURE OF THE ARCHAEAL INITIATION FACTOR EIF2 ALPHA-GAMMA HETERODIMER FROM SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDPNP | 3.6.5.3 |
2AHS | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TYROSINE RECEPTOR PHOSPHATASE BETA | 3.1.3.48 |
2AI6 | SOLUTION STRUCTURE OF HUMAN PHOSPHOHISTIDINE PHOSPHATASE 1 | 3.1.3 3.9.1.3 |
2AI7 | S.PNEUMONIAE POLYPEPTIDE DEFORMYLASE COMPLEXED WITH SB-485345 | 3.5.1.88 |
2AI8 | E.COLI POLYPEPTIDE DEFORMYLASE COMPLEXED WITH SB-485343 | 3.5.1.88 |
2AI9 | S.AUREUS POLYPEPTIDE DEFORMYLASE | 3.5.1.88 |
2AIA | S.PNEUMONIAE PDF COMPLEXED WITH SB-543668 | 3.5.1.88 |
2AID | STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE-BASED DRUG DESIGN | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AIE | S.PNEUMONIAE POLYPEPTIDE DEFORMYLASE COMPLEXED WITH SB-505684 | 3.5.1.88 |
2AIG | ADAMALYSIN II WITH PEPTIDOMIMETIC INHIBITOR POL647 | 3.4.24.46 |
2AIM | CRUZAIN INHIBITED WITH BENZOYL-ARGININE-ALANINE-FLUOROMETHYLKETONE | 3.4.22 3.4.22.51 |
2AIO | METALLO BETA LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA COMPLEXED WITH HYDROLYZED MOXALACTAM | 3.5.2.6 |
2AIP | CRYSTAL STRUCTURE OF NATIVE PROTEIN C ACTIVATOR FROM THE VENOM OF COPPERHEAD SNAKE AGKISTRODON CONTORTRIX CONTORTRIX | 3.4.21.74 3.4.21 |
2AIQ | CRYSTAL STRUCTURE OF BENZAMIDINE-INHIBITED PROTEIN C ACTIVATOR FROM THE VENOM OF COPPERHEAD SNAKE AGKISTRODON CONTORTRIX CONTORTRIX | 3.4.21.74 3.4.21 |
2AJ0 | SOLUTION STRUCTURE OF APOCADA | 3.6.3.3 7.2.2.21 |
2AJ1 | SOLUTION STRUCTURE OF APOCADA | 3.6.3.3 7.2.2.21 |
2AJB | PORCINE DIPEPTIDYL PEPTIDASE IV (CD26) IN COMPLEX WITH THE TRIPEPTIDE TERT-BUTYL-GLY-L-PRO-L-ILE (TBU-GPI) | 3.4.14.5 |
2AJD | PORCINE DIPEPTIDYL PEPTIDASE IV (CD26) IN COMPLEX WITH L-PRO-BORO-L-PRO (BOROPRO) | 3.4.14.5 |
2AJF | STRUCTURE OF SARS CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH ITS RECEPTOR | 3.4.17 3.4.17.23 |
2AJQ | STRUCTURE OF REPLICATIVE DNA POLYMERASE PROVIDES INSIGTS INTO THE MECHANISMS FOR PROCESSIVITY, FRAMESHIFTING AND EDITING | 2.7.7.7 3.1.11 |
2AKC | CRYSTAL STRUCTURE OF TUNGSTATE COMPLEX OF THE PHON PROTEIN FROM S. TYPHIMURIUM | 3.1.3.2 |
2ALA | CRYSTAL STRUCTURE OF THE SEMLIKI FOREST VIRUS ENVELOPE PROTEIN E1 IN ITS MONOMERIC CONFORMATION. | 3.4.21.90 |
2ALP | REFINED STRUCTURE OF ALPHA-LYTIC PROTEASE AT 1.7 ANGSTROMS RESOLUTION. ANALYSIS OF HYDROGEN BONDING AND SOLVENT STRUCTURE | 3.4.21.12 |
2ALU | DETECTION OF NEW BINDING SITE IN THE C-TERMINAL LOBE OF LACTOFERRIN:CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE LACTOFERRIN AND A TETRASACCHARIDE AT 2.1A RESOLUTION | 3.4.21 |
2ALV | X-RAY STRUCTURAL ANALYSIS OF SARS CORONAVIRUS 3CL PROTEINASE IN COMPLEX WITH DESIGNED ANTI-VIRAL INHIBITORS | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2ALW | GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH NOEUROMYCIN | 3.2.1.114 |
2AMD | CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N9 | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2AMG | STRUCTURE OF HYDROLASE (GLYCOSIDASE) | 3.2.1.60 |
2AMP | CRYSTAL STRUCTURE OF PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS MPRO IN COMPLEX WITH AN INHIBITOR N1 | 3.4.22 3.4.19.12 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
2AMQ | CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N3 | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2AMX | CRYSTAL STRUCTURE OF PLASMODIUM YOELII ADENOSINE DEAMINASE (PY02076) | 3.5.4.4 |
2ANE | CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF E.COLI LON PROTEASE | 3.4.21.53 |
2ANG | CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE MET(-1) FORM | 3.1.27 |
2ANH | ALKALINE PHOSPHATASE (D153H) | 3.1.3.1 |
2ANK | ORALLY ACTIVE THROMBIN INHIBITORS IN COMPLEX WITH THROMBIN AND AN EXOSITE DECAPEPTIDE | 3.4.21.5 |
2ANM | TERNARY COMPLEX OF AN ORALLY ACTIVE THROMBIN INHIBITOR WITH HUMAN THROMBIN AND A C-TERMINAL HIRUDIN DERIVED EXO-SIT INHIBITOR | 3.4.21.5 |
2ANP | FUNCTIONAL GLUTAMATE 151 TO HISTIDINE MUTANT OF THE AMINOPEPTIDASE FROM AEROMONAS PROTEOLYTICA. | 3.4.11.10 |
2ANV | CRYSTAL STRUCTURE OF P22 LYSOZYME MUTANT L86M | 3.2.1.17 |
2ANW | EXPRESSION, CRYSTALLIZATION AND THREE-DIMENSIONAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PLASMA KALLIKREIN: IMPLICATIONS FOR STRUCTURE-BASED DESIGN OF PROTEASE INHIBITORS | 3.4.21.34 |
2ANX | CRYSTAL STRUCTURE OF BACTERIOPHAGE P22 LYSOZYME MUTANT L87M | 3.2.1.17 |
2ANY | EXPRESSION, CRYSTALLIZATION AND THE THREE-DIMENSIONAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PLASMA KALLIKREIN: IMPLICATIONS FOR STRUCTURE-BASED DESIGN OF PROTEASE INHIBITORS | 3.4.21.34 |
2AO7 | ADAM10 DISINTEGRIN AND CYSTEINE- RICH DOMAIN | 3.4.24.81 |
2AOC | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A SUBSTRATE ANALOG P2-NC | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AOD | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A SUBSTRATE ANALOG P2-NC | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AOE | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG CA-P2 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AOF | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG P1-P6 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AOG | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG P2-NC | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AOH | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG P6-PR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AOI | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A SUBSTRATE ANALOG P1-P6 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AOJ | CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A SUBSTRATE ANALOG P6-PR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2APJ | X-RAY STRUCTURE OF PROTEIN FROM ARABIDOPSIS THALIANA AT4G34215 AT 1.6 ANGSTROM RESOLUTION | 3.1 |
2APQ | CRYSTAL STRUCTURE OF AN ACTIVE SITE MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A (H119A-RNASE A) WITH A 10-GLUTAMINE EXPANSION IN THE C-TERMINAL HINGE-LOOP. | 3.1.27.5 4.6.1.18 |
2APR | STRUCTURE AND REFINEMENT AT 1.8 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM RHIZOPUS CHINENSIS | 3.4.23.6 3.4.23.21 |
2AQ0 | SOLUTION STRUCTURE OF THE HUMAN HOMODIMERIC DNA REPAIR PROTEIN XPF | 3.1 |
2AQO | CRYSTAL STRUCTURE OF E. COLI ISOASPARTYL DIPEPTIDASE MUTANT E77Q | 3.4.19 |
2AQU | STRUCTURE OF HIV-1 PROTEASE BOUND TO ATAZANAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AQV | CRYSTAL STRUCTURE OF E. COLI ISOASPARTYL DIPEPTIDASE MUTANT Y137F | 3.4.19 |
2AR3 | E90A MUTANT STRUCTURE OF PLYL | 3.5.1.28 |
2AR9 | CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9 | 3.4.22 3.4.22.62 |
2ARF | SOLUTION STRUCTURE OF THE WILSON ATPASE N-DOMAIN IN THE PRESENCE OF ATP | 3.6.3.4 7.2.2.8 |
2ARM | CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH A NATURAL COMPOUND ATROPINE AT 1.2 A RESOLUTION | 3.1.1.4 |
2ARY | CATALYTIC DOMAIN OF HUMAN CALPAIN-1 | 3.4.22.52 |
2AS8 | CRYSTAL STRUCTURE OF MATURE AND FULLY ACTIVE DER P 1 ALLERGEN | 3.4.22 3.4.22.65 |
2AS9 | FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF SPL PROTEASES FROM STAPHYLOCOCCUS AUREUS | 3.4.21 |
2ASE | NMR STRUCTURE OF THE F28L MUTANT OF CDC42HS | 3.6.5.2 |
2ASI | ASPARTIC PROTEINASE | 3.4.23.23 |
2ATM | CRYSTAL STRUCTURE OF THE RECOMBINANT ALLERGEN VES V 2 | 3.2.1.35 |
2ATO | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN K IN COMPLEX WITH MYOCRISIN | 3.4.22.38 |
2ATQ | RB69 SINGLE-STRANDED DNA BINDING PROTEIN-DNA POLYMERASE FUSION | 2.7.7.7 3.1.11 |
2ATV | THE CRYSTAL STRUCTURE OF HUMAN RERG IN THE GDP BOUND STATE | 3.6.5.2 |
2ATX | CRYSTAL STRUCTURE OF THE TC10 GPPNHP COMPLEX | 3.6.5.2 |
2AU6 | CRYSTAL STRUCTURE OF CATALYTIC INTERMEDIATE OF INORGANIC PYROPHOSPHATASE | 3.6.1.1 |
2AU7 | THE R43Q ACTIVE SITE VARIANT OF E.COLI INORGANIC PYROPHOSPHATASE | 3.6.1.1 |
2AU8 | CATALYTIC INTERMEDIATE STRUCTURE OF INORGANIC PYROPHOSPHATASE | 3.6.1.1 |
2AU9 | INORGANIC PYROPHOSPHATASE COMPLEXED WITH SUBSTRATE | 3.6.1.1 |
2AUB | LYSOZYME STRUCTURE DERIVED FROM THIN-FILM-BASED CRYSTALS | 3.2.1.17 |
2AUD | UNLIGANDED HINCII | 3.1.21.4 |
2AUM | ACTIVE SITE SER115ALA MUTANT OF LD-CARBOXYPEPTIDASE | 3.4.17.13 |
2AUN | ACTIVE SITE HIS285ALA MUTANT OF LD-CARBOXYPEPTIDASE | 3.4.17.13 |
2AUT | CRYSTAL STRUCTURE OF LYS154ASN MUTANT OF MATURE APHA OF S. TYPHIMURIUM | 3.1.3.2 |
2AUU | INORGANIC PYROPHOSPHATASE COMPLEXED WITH MAGNESIUM PYROPHOSPHATE AND FLUORIDE | 3.6.1.1 |
2AUX | CATHEPSIN K COMPLEXED WITH A SEMICARBAZONE INHIBITOR | 3.4.22.38 |
2AUZ | CATHEPSIN K COMPLEXED WITH A SEMICARBAZONE INHIBITOR | 3.4.22.38 |
2AV5 | CRYSTAL STRUCTURE OF PYROCOCCUS FURIOSUS POP5, AN ARCHAEAL RIBONUCLEASE P PROTEIN | 3.1.26.5 |
2AVM | KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AVO | KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AVQ | KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AVS | KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AVV | KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AWN | CRYSTAL STRUCTURE OF THE ADP-MG-BOUND E. COLI MALK (CRYSTALLIZED WITH ATP-MG) | 3.6.3.19 7.5.2.1 |
2AWO | CRYSTAL STRUCTURE OF THE ADP-MG-BOUND E. COLI MALK (CRYSTALLIZED WITH ADP-MG) | 3.6.3.19 7.5.2.1 |
2AWZ | HEPATITIS C VIRUS NS5B RNA POLYMERASE IN COMPLEX WITH A COVALENT INHIBITOR (5H) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
2AX0 | HEPATITIS C VIRUS NS5B RNA POLYMERASE IN COMPLEX WITH A COVALENT INHIBITOR (5X) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
2AX1 | HEPATITIS C VIRUS NS5B RNA POLYMERASE IN COMPLEX WITH A COVALENT INHIBITOR (5EE) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
2AXC | CRYSTAL STRUCTURE OF COLE7 TRANSLOCATION DOMAIN | 3.1 |
2AXE | IODINATED COMPLEX OF ACETYL XYLAN ESTERASE AT 1.80 ANGSTROMS | 3.1.1.6 3.1.1.72 |
2AXL | SOLUTION STRUCTURE OF A MULTIFUNCTIONAL DNA- AND PROTEIN-BINDING DOMAIN OF HUMAN WERNER SYNDROME PROTEIN | 3.6.4.12 3.1 |
2AXN | CRYSTAL STRUCTURE OF THE HUMAN INDUCIBLE FORM 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE | 2.7.1.105 3.1.3.46 |
2AYH | CRYSTAL AND MOLECULAR STRUCTURE AT 1.6 ANGSTROMS RESOLUTION OF THE HYBRID BACILLUS ENDO-1,3-1,4-BETA-D-GLUCAN 4-GLUCANOHYDROLASE H(A16-M) | 3.2.1.73 |
2AYI | WILD-TYPE AMPT FROM THERMUS THERMOPHILUS | 3.4.11 |
2AYK | INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE, NMR, MINIMIZED AVERAGE STRUCTURE | 3.4.24.7 |
2AYN | STRUCTURE OF USP14, A PROTEASOME-ASSOCIATED DEUBIQUITINATING ENZYME | 3.1.2.15 3.4.19.12 |
2AYO | STRUCTURE OF USP14 BOUND TO UBQUITIN ALDEHYDE | 3.1.2.15 3.4.19.12 |
2AYS | A CONSERVED NON-METALLIC BINDING SITE IN THE C-TERMINAL LOBE OF LACTOFERRIN: STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH N-ACETYL GALACTOSAMINE AT 1.86 A RESOLUTION | 3.4.21 |
2AYW | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN TRYPSIN AND A DESIGNED SYNTHETIC HIGHLY POTENT INHIBITOR IN THE PRESENCE OF BENZAMIDINE AT 0.97 A RESOLUTION | 3.4.21.4 |
2AZ8 | HIV-1 PROTEASE NL4-3 IN COMPLEX WITH INHIBITOR, TL-3 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AZ9 | HIV-1 PROTEASE NL4-3 1X MUTANT | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AZB | HIV-1 PROTEASE NL4-3 3X MUTANT IN COMPLEX WITH INHIBITOR, TL-3 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AZC | HIV-1 PROTEASE NL4-3 6X MUTANT | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2AZR | CRYSTAL STRUCTURE OF PTP1B WITH BICYCLIC THIOPHENE INHIBITOR | 3.1.3.48 |
2AZY | CRYSTAL STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 IN COMPLEX WITH CHOLATE | 3.1.1.4 |
2AZZ | CRYSTAL STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 IN COMPLEX WITH TAUROCHOLATE | 3.1.1.4 |
2B00 | CRYSTAL STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 IN COMPLEX WITH GLYCOCHOLATE | 3.1.1.4 |
2B01 | CRYSTAL STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 IN COMPLEX WITH TAUROCHENODEOXYCHOLATE | 3.1.1.4 |
2B03 | CRYSTAL STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 IN COMPLEX WITH TAUROCHENODEOXYCHOLATE | 3.1.1.4 |
2B04 | CRYSTAL STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 IN COMPLEX WITH GLYCOCHENODEOXYCHOLATE | 3.1.1.4 |
2B07 | CRYSTAL STRUCTURE OF PTP1B WITH TRICYCLIC THIOPHENE INHIBITOR. | 3.1.3.48 |
2B0C | THE CRYSTAL STRUCTURE OF THE PUTATIVE PHOSPHATASE FROM ESCHERICHIA COLI | 3.1.3.10 |
2B0D | ECORV RESTRICTION ENDONUCLEASE/GAATTC/CA2+ | 3.1.21.4 |
2B0E | ECORV RESTRICTION ENDONUCLEASE/GAAUTC/CA2+ | 3.1.21.4 |
2B0F | NMR STRUCTURE OF THE HUMAN RHINOVIRUS 3C PROTEASE (SEROTYPE 14) WITH COVALENTLY BOUND ACE-LEALFQ-ETHYLPROPIONATE INHIBITOR | 3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48 |
2B0P | TRUNCATED S. AUREUS LYTM, P212121 CRYSTAL FORM | 3.4.24.75 |
2B0V | NUDIX HYDROLASE FROM NITROSOMONAS EUROPAEA. | 3.6.1 |
2B13 | TRUNCATED S. AUREUS LYTM, P41 CRYSTAL FORM | 3.4.24.75 |
2B17 | SPECIFIC BINDING OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) TO PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND DICLOFENAC AT 2.7 A RESOLUTION: | 3.1.1.4 |
2B1G | CRYSTAL STRUCTURES OF TRANSITION STATE ANALOGUE INHIBITORS OF INOSINE MONOPHOSPHATE CYCLOHYDROLASE | 3.5.4.10 2.1.2.3 |
2B1I | CRYSTAL STRUCTURES OF TRANSITION STATE ANALOGUE INHIBITORS OF INOSINE MONOPHOSPHATE CYCLOHYDROLASE | 3.5.4.10 2.1.2.3 |
2B1Q | X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP.PCC6803 IN COMPLEX WITH TREHALOSE | 3.1.3.24 |
2B1R | X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP.PCC6803 IN COMPLEX WITH CELLOBIOSE | 3.1.3.24 |
2B2N | STRUCTURE OF TRANSCRIPTION-REPAIR COUPLING FACTOR | 3.6.4 |
2B2T | TANDEM CHROMODOMAINS OF HUMAN CHD1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING TRIMETHYLLYSINE 4 AND PHOSPHOTHREONINE 3 | 3.6.4.12 |
2B2U | TANDEM CHROMODOMAINS OF HUMAN CHD1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING TRIMETHYLLYSINE 4 AND DIMETHYLARGININE 2 | 3.6.4.12 |
2B2V | CRYSTAL STRUCTURE ANALYSIS OF HUMAN CHD1 CHROMODOMAINS 1 AND 2 BOUND TO HISTONE H3 RESI 1-15 MEK4 | 3.6.4.12 |
2B2W | TANDEM CHROMODOMAINS OF HUMAN CHD1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING TRIMETHYLLYSINE 4 | 3.6.4.12 |
2B2Y | TANDEM CHROMODOMAINS OF HUMAN CHD1 | 3.6.4.12 |
2B3H | CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE TYPE I WITH A THIRD COBALT IN THE ACTIVE SITE | 3.4.11.18 |
2B3J | CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS TRNA ADENOSINE DEAMINASE, TADA, IN COMPLEX WITH RNA | 3.5.4 3.5.4.33 |
2B3K | CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE TYPE I IN THE HOLO FORM | 3.4.11.18 |
2B3L | CRYSTAL STRUCTURE OF TYPE I HUMAN METHIONINE AMINOPEPTIDASE IN THE APO FORM | 3.4.11.18 |
2B3O | CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE SHP-1 | 3.1.3.48 |
2B3W | NMR STRUCTURE OF THE E.COLI PROTEIN YBIA, NORTHEAST STRUCTURAL GENOMICS TARGET ET24. | 3.2.2 |
2B3Z | CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS | 3.5.4.26 1.1.1.193 |
2B43 | CRYSTAL STRUCTURE OF THE NORWALK VIRUS RNA DEPENDENT RNA POLYMERASE FROM STRAIN HU/NLV/DRESDEN174/1997/GE | 2.7.7.48 3.4.22.66 3.6.1.15 |
2B44 | TRUNCATED S. AUREUS LYTM, P 32 2 1 CRYSTAL FORM | 3.4.24.75 |
2B45 | CRYSTAL STRUCTURE OF AN ENGINEERED UNINHIBITED BACILLUS SUBTILIS XYLANASE IN FREE STATE | 3.2.1.8 |
2B46 | CRYSTAL STRUCTURE OF AN ENGINEERED UNINHIBITED BACILLUS SUBTILIS XYLANASE IN SUBSTRATE BOUND STATE | 3.2.1.8 |
2B49 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 3 | 3.1.3.48 |
2B4F | STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE IN COMPLEX WITH SUBSTRATE | 3.2.1.8 3.2.1.4 |
2B4J | STRUCTURAL BASIS FOR THE RECOGNITION BETWEEN HIV-1 INTEGRASE AND LEDGF/P75 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2B4K | ACETOBACTER TURBIDANS ALPHA-AMINO ACID ESTER HYDROLASE COMPLEXED WITH PHENYLGLYCINE | 3.1.1.43 |
2B4O | STRUCTURE OF THE R258K MUTANT OF SELENOMONAS RUMINANTIUM PTP-LIKE PHYTASE | 3.1.3.72 |
2B4P | STRUCTURE OF THE D223N MUTANT OF SELENOMONAS RUMINANTIUM PTP-LIKE PHYTASE | 3.1.3.72 |
2B4S | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE | 3.1.3.48 |
2B4U | STRUCTURE OF THE C252S MUTANT OF SELENOMONAS RUMINANTIUM PTP-LIKE PHYTASE | 3.1.3.72 |
2B4Y | CRYSTAL STRUCTURE OF HUMAN SIRTUIN HOMOLOG 5 | 3.5.1 2.3.1 |
2B5D | CRYSTAL STRUCTURE OF THE NOVEL ALPHA-AMYLASE AMYC FROM THERMOTOGA MARITIMA | 3.2.1.1 |
2B5J | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2B5R | 1B LACTAMASE / B LACTAMASE INHIBITOR | 3.5.2.6 |
2B5T | 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN, SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES | 3.4.21.5 |
2B5U | CRYSTAL STRUCTURE OF COLICIN E3 V206C MUTANT IN COMPLEX WITH ITS IMMUNITY PROTEIN | 3.1 |
2B5Z | HEN LYSOZYME CHEMICALLY GLYCOSYLATED | 3.2.1.17 |
2B65 | CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE OF BOVINE LACTOFERRIN WITH MALTOSE AT 1.5A RESOLUTION | 3.4.21 |
2B6A | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2B6B | CRYO EM STRUCTURE OF DENGUE COMPLEXED WITH CRD OF DC-SIGN | 3.4.21.91 3.6.1.15 3.6.4.13 |
2B6E | X-RAY CRYSTAL STRUCTURE OF PROTEIN HI1161 FROM HAEMOPHILUS INFLUENZAE. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET IR63. | 3.1.2 |
2B6N | THE 1.8 A CRYSTAL STRUCTURE OF A PROTEINASE K LIKE ENZYME FROM A PSYCHROTROPH SERRATIA SPECIES | 3.4.21 |
2B6T | T4 LYSOZYME MUTANT L99A AT 200 MPA | 3.2.1.17 |
2B6W | T4 LYSOZYME MUTANT L99A AT 200 MPA | 3.2.1.17 |
2B6X | T4 LYSOZYME MUTANT L99A AT 200 MPA | 3.2.1.17 |
2B6Y | T4 LYSOZYME MUTANT L99A AT AMBIENT PRESSURE | 3.2.1.17 |
2B6Z | T4 LYSOZYME MUTANT L99A AT AMBIENT PRESSURE | 3.2.1.17 |
2B70 | T4 LYSOZYME MUTANT L99A AT AMBIENT PRESSURE | 3.2.1.17 |
2B72 | T4 LYSOZYME MUTANT L99A AT 100 MPA | 3.2.1.17 |
2B73 | T4 LYSOZYME MUTANT L99A AT 100 MPA | 3.2.1.17 |
2B74 | T4 LYSOZYME MUTANT L99A AT 100 MPA | 3.2.1.17 |
2B75 | T4 LYSOZYME MUTANT L99A AT 150 MPA | 3.2.1.17 |
2B7D | FACTOR VIIA INHIBITORS: CHEMICAL OPTIMIZATION, PRECLINICAL PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY IN A BABOON THROMBOSIS MODEL | 3.4.21.21 |
2B7F | CRYSTAL STRUCTURE OF HUMAN T-CELL LEUKEMIA VIRUS PROTEASE, A NOVEL TARGET FOR ANTI-CANCER DESIGN | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
2B7T | STRUCTURE OF ADAR2 DSRBM1 | 3.5 3.5.4.37 |
2B7U | RIBOSOME INACTIVATING PROTEIN TYPE 1 FROM CHARYBDIS MARITIMA AGG | 3.2.2.22 |
2B7V | STRUCTURE OF ADAR2 DSRBM2 | 3.5 3.5.4.37 |
2B7X | SEQUENTIAL REORGANIZATION OF BETA-SHEET TOPOLOGY BY INSERTION OF A SINGLE STRAND | 3.2.1.17 |
2B7Z | STRUCTURE OF HIV-1 PROTEASE MUTANT BOUND TO INDINAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2B82 | CRYSTAL STRUCTURE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE TERNARY COMPLEX WITH ADENOSINE AND PHOSPHATE BOUND TO THE CATALYTIC METAL AT 1.2 A RESOLUTION | 3.1.3.2 |
2B8H | A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE | 3.2.1.18 |
2B8J | CRYSTAL STRUCTURE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE TERNARY COMPLEX WITH ADENOSINE AND PHOSPHATE AT 2 A RESOLUTION | 3.1.3.2 |
2B8L | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR | 3.4.23.46 |
2B8O | CRYSTAL STRUCTURE OF GLU-GLY-ARG-CHLOROMETHYL KETONE-FACTOR VIIA/SOLUBLE TISSUE FACTOR COMPLEX | 3.4.21.21 |
2B8V | CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH L-L000430,469 | 3.4.23.46 |
2B8W | CRYSTAL-STRUCTURE OF THE N-TERMINAL LARGE GTPASE DOMAIN OF HUMAN GUANYLATE BINDING PROTEIN 1 (HGBP1) IN COMPLEX WITH GMP/ALF4 | 3.6.5 |
2B92 | CRYSTAL-STRUCTURE OF THE N-TERMINAL LARGE GTPASE DOMAIN OF HUMAN GUANYLATE BINDING PROTEIN 1 (HGBP1) IN COMPLEX WITH GDP/ALF3 | 3.6.5 |
2B96 | THIRD CALCIUM ION FOUND IN AN INHIBITOR BOUND PHOSPHOLIPASE A2 | 3.1.1.4 |
2BAA | THE REFINED CRYSTAL STRUCTURE OF AN ENDOCHITINASE FROM HORDEUM VULGARE L. SEEDS TO 1.8 ANGSTROMS RESOLUTION | 3.2.1.14 |
2BAG | 3D STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH GANSTIGMINE | 3.1.1.7 |
2BAM | RESTRICTION ENDONUCLEASE BAMHI COMPLEX WITH DNA AND CALCIUM IONS (PRE-REACTIVE COMPLEX). | 3.1.21.4 |
2BAN | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2BAT | THE STRUCTURE OF THE COMPLEX BETWEEN INFLUENZA VIRUS NEURAMINIDASE AND SIALIC ACID, THE VIRAL RECEPTOR | 3.2.1.18 |
2BAX | ATOMIC RESOLUTION STRUCTURE OF THE DOUBLE MUTANT (K53,56M) OF BOVINE PANCREATIC PHOSPHOLIPASE A2 | 3.1.1.4 |
2BAZ | STRUCTURE OF YOSS, A PUTATIVE DUTPASE FROM BACILLUS SUBTILIS | 3.6.1.23 |
2BB0 | STRUCTURE OF IMIDAZOLONEPROPIONASE FROM BACILLUS SUBTILIS | 3.5.2.7 |
2BB4 | PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ASP-PHE AT PH 5.0 | 3.4.21.36 |
2BB7 | MN FORM OF E. COLI METHIONINE AMINOPEPTIDASE IN COMPLEX WITH A QUINOLINYL SULFONAMIDE INHIBITOR | 3.4.11.18 |
2BB9 | STRUCTURE OF HIV1 PROTEASE AND AKC4P_133A COMPLEX. | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2BBB | STRUCTURE OF HIV1 PROTEASE AND HH1_173_3A COMPLEX. | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2BBV | THE REFINED THREE-DIMENSIONAL STRUCTURE OF AN INSECT VIRUS AT 2.8 ANGSTROMS RESOLUTION | 3.4.23.44 |
2BBY | DNA-BINDING DOMAIN FROM HUMAN RAP30, NMR, 30 STRUCTURES | 3.6.4.12 |
2BC2 | METALLO BETA-LACTAMASE II FROM BACILLUS CEREUS 569/H/9 AT PH 6.0, TRIGONAL CRYSTAL FORM | 3.5.2.6 |
2BC9 | CRYSTAL-STRUCTURE OF THE N-TERMINAL LARGE GTPASE DOMAIN OF HUMAN GUANYLATE BINDING PROTEIN 1 (HGBP1) IN COMPLEX WITH NON-HYDROLYSABLE GTP ANALOGUE GPPNHP | 3.6.5 |
2BCD | X-RAY CRYSTAL STRUCTURE OF PROTEIN PHOSPHATASE-1 WITH THE MARINE TOXIN MOTUPORIN BOUND | 3.1.3.16 |
2BCE | CHOLESTEROL ESTERASE FROM BOS TAURUS | 3.1.1.13 3.1.1.3 3.1.1.6 |
2BCH | A POSSIBLE OF SECOND CALCIUM ION IN INTERFACIAL BINDING: ATOMIC AND MEDIUM RESOLUTION CRYSTAL STRUCTURES OF THE QUADRUPLE MUTANT OF PHOSPHOLIPASE A2 | 3.1.1.4 |
2BCO | X-RAY STRUCTURE OF SUCCINYLGLUTAMATE DESUCCINALASE FROM VIBRIO PARAHAEMOLYTICUS (RIMD 2210633) AT THE RESOLUTION 2.3 A, NORTHEAST STRUCTURAL GENOMICS TARGET VPR14 | 3.1 3.5.1.96 |
2BD1 | A POSSIBLE ROLE OF THE SECOND CALCIUM ION IN INTERFACIAL BINDING: ATOMIC AND MEDIUM RESOLUTION CRYSTAL STRUCTURES OF THE QUADRUPLE MUTANT OF PHOSPHOLIPASE A2 | 3.1.1.4 |
2BD2 | PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG-PHE AT PH 5.0 | 3.4.21.36 |
2BD3 | PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND LYS-ALA-NH2 AT PH 5.0 | 3.4.21.36 |
2BD4 | PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND LYS-SER AT PH 5.0 | 3.4.21.36 |
2BD5 | PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND LYS-SER AT PH 5 AND IMMERSED IN PH 9 BUFFER FOR 30 SECONDS | 3.4.21.36 |
2BD7 | PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG-PHE AT PH 5.0 (50 MIN SOAK) | 3.4.21.36 |
2BD8 | PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG-PHE AT PH 5.0 (50 MIN SOAK) AND IMMERSED IN PH 9 BUFFER FOR 30 SECONDS | 3.4.21.36 |
2BD9 | PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG-PHE AT PH 5.0 (50 MIN SOAK) AND IMMERSED IN PH 9 BUFFER FOR 28 SECONDS (2ND PH JUMP) | 3.4.21.36 |
2BDA | PORCINE PANCREATIC ELASTASE COMPLEXED WITH N-ACETYL-NPI AND ALA-ALA AT PH 5.0 | 3.4.21.36 |
2BDB | PORCINE PANCREATIC ELASTASE COMPLEXED WITH ASN-PRO-ILE AND ALA-ALA AT PH 5.0 | 3.4.21.36 |
2BDC | PORCINE PANCREATIC ELASTASE COMPLEXED WITH ASN-PRO-ILE AT PH 5.0 | 3.4.21.36 |
2BDG | HUMAN KALLIKREIN 4 COMPLEX WITH NICKEL AND P-AMINOBENZAMIDINE | 3.4.21 |
2BDH | HUMAN KALLIKREIN 4 COMPLEX WITH ZINC AND P-AMINOBENZAMIDINE | 3.4.21 |
2BDL | CATHEPSIN K COMPLEXED WITH A PYRROLIDINE KETOAMIDE-BASED INHIBITOR | 3.4.22.38 |
2BDR | CRYSTAL STRUCTURE OF THE PUTATIVE UREIDOGLYCOLATE HYDROLASE PP4288 FROM PSEUDOMONAS PUTIDA, NORTHEAST STRUCTURAL GENOMICS TARGET PPR49 | 3.5.3.19 4.3.2.3 |
2BDU | X-RAY STRUCTURE OF A CYTOSOLIC 5'-NUCLEOTIDASE III FROM MUS MUSCULUS MM.158936 | 3.1.3.5 3.1.3.91 |
2BDV | X-RAY CRYSTAL STRUCTURE OF PHAGE-RELATED PROTEIN BB2244 FROM BORDETELLA BRONCHISEPTICA. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BOR24. | 3.4 |
2BDX | X-RAY CRYSTAL STRUCTURE OF DIHYDROMICROCYSTIN-LA BOUND TO PROTEIN PHOSPHATASE-1 | 3.1.3.16 |
2BDY | THROMBIN IN COMPLEX WITH INHIBITOR | 3.4.21.5 |
2BDZ | MEXICAIN FROM JACARATIA MEXICANA | 3.4.22 |
2BE1 | STRUCTURE OF THE COMPACT LUMENAL DOMAIN OF YEAST IRE1 | 2.7.11.1 3.1.26 |
2BE2 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2BEJ | STRUCTURE OF THE BACTERIAL CHROMOSOME SEGREGATION PROTEIN SOJ | 3.6 |
2BEK | STRUCTURE OF THE BACTERIAL CHROMOSOME SEGREGATION PROTEIN SOJ | 3.6 |
2BER | Y370G ACTIVE SITE MUTANT OF THE SIALIDASE FROM MICROMONOSPORA VIRIDIFACIENS IN COMPLEX WITH BETA-NEU5AC (SIALIC ACID). | 3.2.1.18 |
2BF6 | ATOMIC RESOLUTION STRUCTURE OF THE BACTERIAL SIALIDASE NANI FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH ALPHA-SIALIC ACID (NEU5AC). | 3.2.1.18 |
2BFK | BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH7 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT | 3.5.2.6 |
2BFL | BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH5 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. | 3.5.2.6 |
2BFN | THE CRYSTAL STRUCTURE OF THE COMPLEX OF THE HALOALKANE DEHALOGENASE LINB WITH THE PRODUCT OF DEHALOGENATION REACTION 1,2-DICHLOROPROPANE. | 3.8.1.5 |
2BFQ | MACRO DOMAINS ARE ADP-RIBOSE BINDING MOLECULES | 3.2.2 |
2BFR | THE MACRO DOMAIN IS AN ADP-RIBOSE BINDING MODULE | 3.2.2 |
2BFZ | BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED. | 3.5.2.6 |
2BG1 | ACTIVE SITE RESTRUCTURING REGULATES LIGAND RECOGNITION IN CLASSA PENICILLIN-BINDING PROTEINS (PBPS) | 2.4.1.129 3.4.16.4 |
2BG2 | BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20MM ZNSO4 IN THE BUFFER. 1MM DTT AND 1MM TCEP- HCL WERE USED AS REDUCING AGENTS. CYS221 IS REDUCED. | 3.5.2.6 |
2BG6 | BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED. | 3.5.2.6 |
2BG7 | BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED. | 3.5.2.6 |
2BG8 | BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT AND 1MM TCEP-HCL WERE USED AS REDUCING AGENTS. | 3.5.2.6 |
2BGA | BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH7 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED. | 3.5.2.6 |
2BGD | STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS | 3.1.3.48 |
2BGE | STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS | 3.1.3.48 |
2BGN | HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26) | 3.4.14.5 |
2BGR | CRYSTAL STRUCTURE OF HIV-1 TAT DERIVED NONAPEPTIDES TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26) | 3.4.14.5 |
2BH3 | ZN SUBSTITUTED E. COLI AMINOPEPTIDASE P IN COMPLEX WITH PRODUCT | 3.4.11.9 |
2BH7 | CRYSTAL STRUCTURE OF A SEMET DERIVATIVE OF AMID AT 2.2 ANGSTROMS | 3.5.1.28 |
2BHA | E. COLI AMINOPEPTIDASE P IN COMPLEX WITH SUBSTRATE | 3.4.11.9 |
2BHB | ZN SUBSTITUTED E. COLI AMINOPEPTIDASE P | 3.4.11.9 |
2BHC | NA SUBSTITUTED E. COLI AMINOPEPTIDASE P | 3.4.11.9 |
2BHD | MG SUBSTITUTED E. COLI AMINOPEPTIDASE P IN COMPLEX WITH PRODUCT | 3.4.11.9 |
2BHG | 3C PROTEASE FROM TYPE A10(61) FOOT-AND-MOUTH DISEASE VIRUS | 3.4.22.28 3.4.22.46 3.6.1.15 2.7.7.48 |
2BHR | DENGUE VIRUS RNA HELICASE | 3.4.21.91 3.6.1.15 3.6.4.13 |
2BHU | CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MALTOOLIGOSYLTREHALOSE TREHALOHYDROLASE | 3.2.1.1 3.2.1.141 |
2BHY | CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MALTOOLIGOSYLTREHALOSE TREHALOHYDROLASE IN COMPLEX WITH TREHALOSE | 3.2.1.1 3.2.1.141 |
2BHZ | CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MALTOOLIGOSYLTREHALOSE TREHALOHYDROLASE IN COMPLEX WITH MALTOSE | 3.2.1.1 3.2.1.141 |
2BIF | 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE H256A MUTANT WITH F6P IN PHOSPHATASE ACTIVE SITE | 2.7.1.105 3.1.3.46 |
2BIJ | CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 (STEP, STRIATUM ENRICHED ENRICHED PHOSPHATASE) | 3.1.3.48 |
2BJD | SULFOLOBUS SOLFATARICUS ACYLPHOSPHATASE. TRICLINIC SPACE GROUP | 3.6.1.7 |
2BJE | ACYLPHOSPHATASE FROM SULFOLOBUS SOLFATARICUS. MONCLINIC P21 SPACE GROUP | 3.6.1.7 |
2BJF | CRYSTAL STRUCTURE OF CONJUGATED BILE ACID HYDROLASE FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH REACTION PRODUCTS TAURINE AND DEOXYCHOLATE | 3.5.1.24 3.5.1 |
2BJG | CRYSTAL STRUCTURE OF CONJUGATED BILE ACID HYDROLASE FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH REACTION PRODUCTS TAURINE AND DEOXYCHOLATE | 3.5.1.24 3.5.1 |
2BJH | CRYSTAL STRUCTURE OF S133A ANFAEA-FERULIC ACID COMPLEX | 3.1.1.73 |
2BJI | HIGH RESOLUTION STRUCTURE OF MYO-INOSITOL MONOPHOSPHATASE, THE TARGET OF LITHIUM THERAPY | 3.1.3.25 3.1.3.94 |
2BJJ | STRUCTURE OF RECOMBINANT HUMAN LACTOFERRIN PRODUCED IN THE MILK OF TRANSGENIC COWS | 3.4.21 |
2BJU | PLASMEPSIN II COMPLEXED WITH A HIGHLY ACTIVE ACHIRAL INHIBITOR | 3.4.23.39 |
2BKL | STRUCTURAL AND MECHANISTIC ANALYSIS OF TWO PROLYL ENDOPEPTIDASES: ROLE OF INTER-DOMAIN DYNAMICS IN CATALYSIS AND SPECIFICITY | 3.4.21.26 |
2BKQ | NEDD8 PROTEASE | 3.4.22 |
2BKR | NEDD8 NEDP1 COMPLEX | 3.4.22 |
2BKS | CRYSTAL STRUCTURE OF RENIN-PF00074777 COMPLEX | 3.4.23.15 |
2BKT | CRYSTAL STRUCTURE OF RENIN-PF00257567 COMPLEX | 3.4.23.15 |
2BKV | STRUCTURE AND KINETICS OF A MONOMERIC GLUCOSAMINE-6-PHOSPHATE DEAMINASE: MISSING LINK OF THE NAGB SUPERFAMILY | 3.5.99.6 |
2BKX | STRUCTURE AND KINETICS OF A MONOMERIC GLUCOSAMINE-6-PHOSPHATE DEAMINASE: MISSING LINK OF THE NAGB SUPERFAMILY | 3.5.99.6 |
2BL2 | THE MEMBRANE ROTOR OF THE V-TYPE ATPASE FROM ENTEROCOCCUS HIRAE | 3.6.3.14 |
2BLO | ELASTASE BEFORE A HIGH DOSE X-RAY BURN"" | 3.4.21.36 |
2BLP | RNASE BEFORE UNATTENUATED X-RAY BURN | 3.1.27.5 4.6.1.18 |
2BLQ | ELASTASE AFTER A HIGH DOSE X-RAY BURN"" | 3.4.21.36 |
2BLS | AMPC BETA-LACTAMASE FROM ESCHERICHIA COLI | 3.5.2.6 |
2BLV | TRYPSIN BEFORE A HIGH DOSE X-RAY BURN"" | 3.4.21.4 |
2BLW | TRYPSIN AFTER A HIGH DOSE X-RAY BURN"" | 3.4.21.4 |
2BLX | HEWL BEFORE A HIGH DOSE X-RAY BURN"" | 3.2.1.17 |
2BLY | HEWL AFTER A HIGH DOSE X-RAY BURN"" | 3.2.1.17 |
2BLZ | RNASE AFTER A HIGH DOSE X-RAY BURN"" | 3.1.27.5 4.6.1.18 |
2BM2 | HUMAN BETA-II TRYPTASE IN COMPLEX WITH 4-(3-AMINOMETHYL-PHENYL)- PIPERIDIN-1-YL-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE | 3.4.21.59 |
2BMD | HIGH RESOLUTION STRUCTURE OF GDP-BOUND HUMAN RAB4A | 3.6.5.2 |
2BME | HIGH RESOLUTION STRUCTURE OF GPPNHP-BOUND HUMAN RAB4A | 3.6.5.2 |
2BMF | DENGUE VIRUS RNA HELICASE AT 2.4A | 3.4.21.91 3.6.1.15 3.6.4.13 |
2BMG | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50 | 3.4.21.6 |
2BMI | METALLO-BETA-LACTAMASE | 3.5.2.6 |
2BML | OFLOXACIN-LIKE ANTIBIOTICS INHIBIT PNEUMOCOCCAL CELL WALL DEGRADING VIRULENCE FACTORS | 3.5.1.28 |
2BN7 | MN SUBSTITUTED E. COLI AMINOPEPTIDASE P IN COMPLEX WITH PRODUCT AND ZN | 3.4.11.9 |
2BNG | STRUCTURE OF AN M.TUBERCULOSIS LEH-LIKE EPOXIDE HYDROLASE | 3.3.2.8 3.3.2.10 3.3.2.11 |
2BNJ | THE XYLANASE TA FROM THERMOASCUS AURANTIACUS UTILIZES ARABINOSE DECORATIONS OF XYLAN AS SIGNIFICANT SUBSTRATE SPECIFICITY DETERMINANTS. | 3.2.1.8 |
2BO5 | BOVINE OLIGOMYCIN SENSITIVITY CONFERRAL PROTEIN N-TERMINAL DOMAIN | 3.6.3.14 |
2BO9 | HUMAN CARBOXYPEPTIDASE A4 IN COMPLEX WITH HUMAN LATEXIN. | 3.4.17 |
2BOA | HUMAN PROCARBOXYPEPTIDASE A4. | 3.4.17 |
2BOD | CATALYTIC DOMAIN OF ENDO-1,4-GLUCANASE CEL6A FROM THERMOBIFIDA FUSCA IN COMPLEX WITH METHYL CELLOBIOSYL-4-THIO-BETA-CELLOBIOSIDE | 3.2.1.4 |
2BOE | CATALYTIC DOMAIN OF ENDO-1,4-GLUCANASE CEL6A MUTANT Y73S FROM THERMOBIFIDA FUSCA | 3.2.1.4 |
2BOF | CATALYTIC DOMAIN OF ENDO-1,4-GLUCANASE CEL6A MUTANT Y73S FROM THERMOBIFIDA FUSCA IN COMPLEX WITH CELLOTETROSE | 3.2.1.4 |
2BOG | CATALYTIC DOMAIN OF ENDO-1,4-GLUCANASE CEL6A MUTANT Y73S FROM THERMOBIFIDA FUSCA IN COMPLEX WITH METHYL CELLOBIOSYL-4-THIO-BETA- CELLOBIOSIDE | 3.2.1.4 |
2BOH | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 1"" | 3.4.21.6 |
2BOK | FACTOR XA - CATION | 3.4.21.6 |
2BOO | THE CRYSTAL STRUCTURE OF URACIL-DNA N-GLYCOSYLASE (UNG) FROM DEINOCOCCUS RADIODURANS. | 3.2.2.3 3.2.2.27 |
2BOV | MOLECULAR RECOGNITION OF AN ADP-RIBOSYLATING CLOSTRIDIUM BOTULINUM C3 EXOENZYME BY RALA GTPASE | 3.6.5.2 |
2BP2 | THE STRUCTURE OF BOVINE PANCREATIC PROPHOSPHOLIPASE A2 AT 3.0 ANGSTROMS RESOLUTION | 3.1.1.4 |
2BPP | PHOSPHOLIPASE A2 ENGINEERING. X-RAY STRUCTURAL AND FUNCTIONAL EVIDENCE FOR THE INTERACTION OF LYSINE-56 WITH SUBSTRATES | 3.1.1.4 |
2BPU | THE KEDGE HOLMIUM DERIVATIVE OF HEN EGG-WHITE LYSOZYME AT HIGH RESOLUTION FROM SINGLE WAVELENGTH ANOMALOUS DIFFRACTION | 3.2.1.17 |
2BPV | HIV-1 PROTEASE-INHIBITOR COMPLEX | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2BPW | HIV-1 PROTEASE-INHIBITOR COMPLEX | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2BPX | HIV-1 PROTEASE-INHIBITOR COMPLEX | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2BPY | HIV-1 PROTEASE-INHIBITOR COMPLEX | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2BPZ | HIV-1 PROTEASE-INHIBITOR COMPLEX | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
2BQ6 | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21 | 3.4.21.6 |
2BQ7 | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43 | 3.4.21.6 |
2BQ8 | CRYSTAL STRUCTURE OF HUMAN PURPLE ACID PHOSPHATASE WITH AN INHIBITORY CONFORMATION OF THE REPRESSION LOOP | 3.1.3.2 |
2BQA | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQB | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQC | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQD | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQE | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQF | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQG | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQH | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQI | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQJ | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQK | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQL | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQM | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQN | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQO | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME | 3.2.1.17 |
2BQV | HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR AHA455 | 3.4.23.16 |
2BQW | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45 | 3.4.21.6 |
2BQX | INORGANIC PYROPHOSPHATASE FROM THE PATHOGENIC BACTERIUM HELICOBACTER PYLORI-KINETIC AND STRUCTURAL PROPERTIES | 3.6.1.1 |
2BQY | INORGANIC PYROPHOSPHATASE FROM THE PATHOGENIC BACTERIUM HELICOBACTER PYLORI-KINETIC AND STRUCTURAL PROPERTIES | 3.6.1.1 |
2BR6 | CRYSTAL STRUCTURE OF QUORUM-QUENCHING N-ACYL HOMOSERINE LACTONE LACTONASE | 3.1.1.81 |
2BRF | CRYSTAL STRUCTURE OF THE FHA DOMAIN OF HUMAN POLYNUCLEOTIDE KINASE 3' PHOSPHATASE | 3.1.3.32 2.7.1.78 |
2BRK | CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH AN ALLOSTERIC INHIBITOR (COMPOUND 1) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
2BRL | CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH AN ALLOSTERIC INHIBITOR (COMPOUND 2) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
2BSQ | FITAB BOUND TO DNA | 3.1 |
2BSY | EPSTEIN BARR VIRUS DUTPASE | 3.6.1.23 |
2BT1 | EPSTEIN BARR VIRUS DUTPASE IN COMPLEX WITH A,B-IMINO DUTP | 3.6.1.23 |
2BTC | BOVINE TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II) | 3.4.21.4 |
2BTN | CRYSTAL STRUCTURE AND CATALYTIC MECHANISM OF THE QUORUM-QUENCHING N- ACYL HOMOSERINE LACTONE HYDROLASE | 3.1.1.81 |
2BU4 | RIBONUCLEASE T1 COMPLEX WITH 2'GMP | 3.1.27.3 4.6.1.24 |
2BUB | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (CD26) IN COMPLEX WITH A REVERSED AMIDE INHIBITOR | 3.4.14.5 |
2BUG | SOLUTION STRUCTURE OF THE TPR DOMAIN FROM PROTEIN PHOSPHATASE 5 IN COMPLEX WITH HSP90 DERIVED PEPTIDE | 3.1.3.16 |
2BV5 | CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 AT 1.8A RESOLUTION | 3.1.3.48 |
2BV9 | HOW FAMILY 26 GLYCOSIDE HYDROLASES ORCHESTRATE CATALYSIS ON DIFFERENT POLYSACCHARIDES. STRUCTURE AND ACTIVITY OF A CLOSTRIDIUM THERMOCELLUM LICHENASE, CTLIC26A | 3.2.1.4 |
2BVD | HOW FAMILY 26 GLYCOSIDE HYDROLASES ORCHESTRATE CATALYSIS ON DIFFERENT POLYSACCHARIDES. STRUCTURE AND ACTIVITY OF A CLOSTRIDIUM THERMOCELLUM LICHENASE, CTLIC26A | 3.2.1.4 |
2BVL | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TOXIN B FROM CLOSTRIDIUM DIFFICILE IN COMPLEX WITH UDP, GLC AND MANGANESE ION | 2.4.1 3.4.22 |
2BVM | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TOXIN B FROM CLOSTRIDIUM DIFFICILE IN COMPLEX WITH UDP, GLC AND MANGANESE ION | 2.4.1 3.4.22 |
2BVN | E. COLI EF-TU:GDPNP IN COMPLEX WITH THE ANTIBIOTIC ENACYLOXIN IIA | 3.6.1.48 |
2BVR | HUMAN THROMBIN COMPLEXED WITH FRAGMENT-BASED SMALL MOLECULES OCCUPYING THE S1 POCKET | 3.4.21.5 |
2BVS | HUMAN THROMBIN COMPLEXED WITH FRAGMENT-BASED SMALL MOLECULES OCCUPYING THE S1 POCKET | 3.4.21.5 |
2BVT | THE STRUCTURE OF A MODULAR ENDO-BETA-1,4-MANNANASE FROM CELLULOMONAS FIMI EXPLAINS THE PRODUCT SPECIFICITY OF GLYCOSIDE HYDROLASE FAMILY 26 MANNANASES. | 3.2.1.78 |
2BVV | SUGAR RING DISTORTION IN THE GLYCOSYL-ENZYME INTERMEDIATE OF A FAMILY G/11 XYLANASE. | 3.2.1.8 |
2BVW | CELLOBIOHYDROLASE II (CEL6A) FROM HUMICOLA INSOLENS IN COMPLEX WITH GLUCOSE AND CELLOTETRAOSE | 3.2.1.91 |
2BVX | DESIGN AND DISCOVERY OF NOVEL, POTENT THROMBIN INHIBITORS WITH A SOLUBILIZING CATIONIC P1-P2-LINKER | 3.4.21.5 |
2BVY | THE STRUCTURE AND CHARACTERIZATION OF A MODULAR ENDO-BETA-1,4-MANNANASE FROM CELLULOMONAS FIMI | 3.2.1.78 |
2BW8 | NATIVE STRUCTURE OF ENDOGLUCANASE 12A (CEL12A) FROM RHODOTHERMUS MARINUS | 3.2.1.4 |
2BWA | STRUCTURE OF ENDOGLUCANASE 12A (CEL12A) FROM RHODOTHERMUS MARINUS IN COMPLEX WITH CELLOPENTAOSE, 20 MINUTE SOAK. | 3.2.1.4 |
2BWC | STRUCTURE OF ENDOGLUCANASE 12A (CEL12A) FROM RHODOTHERMUS MARINUS IN COMPLEX WITH CELLOPENTAOSE (5 MINUTE SOAK) | 3.2.1.4 |
2BWK | MURINE ANGIOGENIN, SULPHATE COMPLEX | 3.1.27.5 3.1.27 |
2BWL | MURINE ANGIOGENIN, PHOSPHATE COMPLEX | 3.1.27.5 3.1.27 |
2BWS | HIS243ALA ESCHERICHIA COLI AMINOPEPTIDASE P | 3.4.11.9 |
2BWT | ASP260ALA ESCHERICHIA COLI AMINOPEPTIDASE P | 3.4.11.9 |
2BWU | ASP271ALA ESCHERICHIA COLI AMINOPEPTIDASE P | 3.4.11.9 |
2BWV | HIS361ALA ESCHERICHIA COLI AMINOPEPTIDASE P | 3.4.11.9 |
2BWW | HIS350ALA ESCHERICHIA COLI AMINOPEPTIDASE P | 3.4.11.9 |
2BWX | HIS354ALA ESCHERICHIA COLI AMINOPEPTIDASE P | 3.4.11.9 |
2BWY | GLU383ALA ESCHERICHIA COLI AMINOPEPTIDASE P | 3.4.11.9 |
2BX2 | CATALYTIC DOMAIN OF E. COLI RNASE E | 3.1.4 3.1.26.12 |
2BX3 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (P43212) | 3.4.24 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2BX4 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (P21212) | 3.4.22 3.4.24 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2BXT | DESIGN AND DISCOVERY OF NOVEL, POTENT THROMBIN INHIBITORS WITH A SOLUBILIZING CATIONIC P1-P2-LINKER | 3.4.21.5 |
2BXU | DESIGN AND DISCOVERY OF NOVEL, POTENT THROMBIN INHIBITORS WITH A SOLUBILIZING CATIONIC P1-P2-LINKER | 3.4.21.5 |
2BXY | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.2.1.1 3.2.1.141 |
2BXZ | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.2.1.1 3.2.1.141 |
2BY0 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.2.1.1 3.2.1.141 |
2BY1 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.2.1.1 3.2.1.141 |
2BY2 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.2.1.1 3.2.1.141 |
2BY3 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.2.1.1 3.2.1.141 |
2BY4 | SR CA(2+)-ATPASE IN THE HNE2 STATE COMPLEXED WITH THE THAPSIGARGIN DERIVATIVE BOC-12ADT. | 3.6.3.8 7.2.2.10 |
2BY5 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.4.21.4 |
2BY6 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.4.21.4 |
2BY7 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.4.21.4 |
2BY8 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.4.21.4 |
2BY9 | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.4.21.4 |
2BYA | IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION | 3.4.21.4 |
2BYE | NMR SOLUTION STRUCTURE OF PHOSPHOLIPASE C EPSILON RA 1 DOMAIN | 3.1.4.11 |
2BYF | NMR SOLUTION STRUCTURE OF PHOSPHOLIPASE C EPSILON RA 2 DOMAIN | 3.1.4.11 |
2BZ1 | CRYSTAL STRUCTURE OF APO E. COLI GTP CYCLOHYDROLASE II | 3.5.4.25 |
2BZ6 | ORALLY AVAILABLE FACTOR7A INHIBITOR | 3.4.21.21 |
2BZA | BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZYLAMINE | 3.4.21.4 |
2BZD | GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE. | 3.2.1.18 |
2BZL | CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE N14 AT 1. 65 A RESOLUTION | 3.1.3.48 |
2BZZ | CRYSTAL STRUCTURES OF EOSINOPHIL-DERIVED NEUROTOXIN IN COMPLEX WITH THE INHIBITORS 5'-ATP, AP3A, AP4A AND AP5A | 3.1.27.5 4.6.1.18 |
2C01 | CRYSTAL STRUCTURES OF EOSINOPHIL-DERIVED NEUROTOXIN IN COMPLEX WITH THE INHIBITORS 5'-ATP, AP3A, AP4A AND AP5A | 3.1.27.5 4.6.1.18 |
2C02 | CRYSTAL STRUCTURES OF EOSINOPHIL-DERIVED NEUROTOXIN IN COMPLEX WITH THE INHIBITORS 5'-ATP, AP3A, AP4A AND AP5A | 3.1.27.5 4.6.1.18 |
2C05 | CRYSTAL STRUCTURES OF EOSINOPHIL-DERIVED NEUROTOXIN IN COMPLEX WITH THE INHIBITORS 5'-ATP, AP3A, AP4A AND AP5A | 3.1.27.5 4.6.1.18 |
2C06 | NMR-BASED MODEL OF THE COMPLEX OF THE TOXIN KID AND A 5-NUCLEOTIDE SUBSTRATE RNA FRAGMENT (AUACA) | 3.1 |
2C0B | CATALYTIC DOMAIN OF E. COLI RNASE E IN COMPLEX WITH 13-MER RNA | 3.1.4 3.1.26.12 |
2C0H | X-RAY STRUCTURE OF BETA-MANNANASE FROM BLUE MUSSEL MYTILUS EDULIS | 3.2.1.78 |
2C0P | AGED FORM OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY TABUN | 3.1.1.7 |
2C0Q | NON-AGED FORM OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY TABUN | 3.1.1.7 |
2C0Y | THE CRYSTAL STRUCTURE OF A CYS25ALA MUTANT OF HUMAN PROCATHEPSIN S | 3.4.22.27 |
2C1C | STRUCTURAL BASIS OF THE RESISTANCE OF AN INSECT CARBOXYPEPTIDASE TO PLANT PROTEASE INHIBITORS | 3.4.17.2 |
2C1E | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS. | 3.4.22 3.4.22.56 |
2C1F | THE STRUCTURE OF THE FAMILY 11 XYLANASE FROM NEOCALLIMASTIX PATRICIARUM | 3.2.1.8 |
2C1G | STRUCTURE OF STREPTOCOCCUS PNEUMONIAE PEPTIDOGLYCAN DEACETYLASE (SPPGDA) | 3.5.1.33 3.5.1.104 |
2C1I | STRUCTURE OF STREPTOCOCCUS PNEUMONIAE PEPTIDOGLYCAN DEACETYLASE (SPPGDA) D 275 N MUTANT. | 3.5.1.33 3.5.1.104 |
2C1L | STRUCTURE OF THE BFII RESTRICTION ENDONUCLEASE | 3.1.21.4 |
2C1W | THE STRUCTURE OF XENDOU: A SPLICING INDEPENDENT SNORNA PROCESSING ENDORIBONUCLEASE | 3.1 |
2C2H | CRYSTAL STRUCTURE OF THE HUMAN RAC3 IN COMPLEX WITH GDP | 3.6.5.2 |
2C2K | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS. | 3.4.22 3.4.22.56 |
2C2M | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS. | 3.4.22 3.4.22.56 |
2C2O | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS. | 3.4.22 3.4.22.56 |
2C2P | THE CRYSTAL STRUCTURE OF MISMATCH SPECIFIC URACIL-DNA GLYCOSYLASE (MUG) FROM DEINOCOCCUS RADIODURANS | 3.2.2 |
2C2Q | THE CRYSTAL STRUCTURE OF MISMATCH SPECIFIC URACIL-DNA GLYCOSYLASE (MUG) FROM DEINOCOCCUS RADIODURANS. INACTIVE MUTANT ASP93ALA. | 3.2.2 |
2C2X | THREE DIMENSIONAL STRUCTURE OF BIFUNCTIONAL METHYLENETETRAHYDROFOLATE DEHYDROGENASE-CYCLOHYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS | 1.5.1.5 3.5.4.9 |
2C2Y | THREE DIMENSIONAL STRUCTURE OF BIFUNCTIONAL METHYLENETETRAHYDROFOLATE DEHYDROGENASE-CYCLOHYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS | 1.5.1.5 3.5.4.9 |
2C2Z | CRYSTAL STRUCTURE OF CASPASE-8 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITOR | 3.4.22 3.4.22.61 |
2C3S | STRUCTURE OF SARS COV MAIN PROTEINASE AT 1.9 A (PH6.5) | 3.4.24 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2C40 | CRYSTAL STRUCTURE OF INOSINE-URIDINE PREFERRING NUCLEOSIDE HYDROLASE FROM BACILLUS ANTHRACIS AT 2.2A RESOLUTION | 3.2.2.1 |
2C46 | CRYSTAL STRUCTURE OF THE HUMAN RNA GUANYLYLTRANSFERASE AND 5'- PHOSPHATASE | 2.7.7.50 3.1.3.33 |
2C4A | STRUCTURE OF NEURAMINIDASE SUBTYPE N9 COMPLEXED WITH 30 MM SIALIC ACID (NANA, NEU5AC), CRYSTAL SOAKED FOR 3 HOURS AT 291 K. | 3.2.1.18 |
2C4B | INHIBITOR CYSTINE KNOT PROTEIN MCOEETI FUSED TO THE CATALYTICALLY INACTIVE BARNASE MUTANT H102A | 3.1.27.3 3.1.27 |
2C4F | CRYSTAL STRUCTURE OF FACTOR VII.STF COMPLEXED WITH PD0297121 | 3.4.21.21 |
2C4H | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH 500MM ACETYLTHIOCHOLINE | 3.1.1.7 |
2C4L | STRUCTURE OF NEURAMINIDASE SUBTYPE N9 COMPLEXED WITH 30 MM SIALIC ACID (NANA, NEU5AC), CRYSTAL SOAKED FOR 24 HOURS AT 291 K AND FINALLY BACKSOAKED FOR 30 MIN IN A CRYOPROTECTANT SOLUTION WHICH DID NOT CONTAIN NEU5AC | 3.2.1.18 |
2C4N | NAGD FROM E.COLI K-12 STRAIN | 3.1.3.5 |
2C4R | CATALYTIC DOMAIN OF E. COLI RNASE E | 3.1.4 3.1.26.12 |
2C53 | A COMPARATIVE STUDY OF URACIL DNA GLYCOSYLASES FROM HUMAN AND HERPES SIMPLEX VIRUS TYPE 1 | 3.2.2.3 3.2.2.27 |
2C56 | A COMPARATIVE STUDY OF URACIL DNA GLYCOSYLASES FROM HUMAN AND HERPES SIMPLEX VIRUS TYPE 1 | 3.2.2.3 3.2.2.27 |
2C58 | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH 20MM ACETYLTHIOCHOLINE | 3.1.1.7 |
2C5F | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON HYDROLYSABLE SUBSTRATE ANALOGUE, 4-OXO-N,N,N-TRIMETHYLPENTANAMINIUM | 3.1.1.7 |
2C5G | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH 20MM THIOCHOLINE | 3.1.1.7 |
2C5L | STRUCTURE OF PLC EPSILON RAS ASSOCIATION DOMAIN WITH HRAS | 3.6.5.2 |
2C5W | PENICILLIN-BINDING PROTEIN 1A (PBP-1A) ACYL-ENZYME COMPLEX (CEFOTAXIME) FROM STREPTOCOCCUS PNEUMONIAE | 2.4.1.129 3.4.16.4 |
2C61 | CRYSTAL STRUCTURE OF THE NON-CATALYTIC B SUBUNIT OF A-TYPE ATPASE FROM M. MAZEI GO1 | 3.6.3.14 |
2C6C | MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH GPI-18431 (S)-2-(4-IODOBENZYLPHOSPHONOMETHYL)-PENTANEDIOIC ACID | 3.4.17.21 |
2C6G | MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) WITH BOUND GLUTAMATE | 3.4.17.21 |
2C6P | MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH PHOSPHATE ANION | 3.4.17.21 |
2C6W | PENICILLIN-BINDING PROTEIN 1A (PBP-1A) FROM STREPTOCOCCUS PNEUMONIAE | 2.4.1.129 3.4.16.4 |
2C6Z | CRYSTAL STRUCTURE OF DIMETHYLARGININE DIMETHYLAMINOHYDROLASE I IN COMPLEX WITH CITRULLINE | 3.5.3.18 |
2C71 | THE STRUCTURE OF A FAMILY 4 ACETYL XYLAN ESTERASE FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH A MAGNESIUM ION. | 3.1.1.72 3.2.1.8 |
2C77 | EF-TU COMPLEXED WITH A GTP ANALOG AND THE ANTIBIOTIC GE2270 A | 3.1.5.1 |
2C78 | EF-TU COMPLEXED WITH A GTP ANALOG AND THE ANTIBIOTIC PULVOMYCIN | 3.1.5.1 |
2C79 | THE STRUCTURE OF A FAMILY 4 ACETYL XYLAN ESTERASE FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH A COLBALT ION. | 3.1.1.72 3.2.1.8 |
2C7B | THE CRYSTAL STRUCTURE OF ESTE1, A NEW THERMOPHILIC AND THERMOSTABLE CARBOXYLESTERASE CLONED FROM A METAGENOMIC LIBRARY | 3.1.1.1 |
2C7S | CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE KAPPA AT 1.95A RESOLUTION | 3.1.3.48 |
2C88 | CRYSTAL STRUCTURE OF (SR) CALCIUM-ATPASE E2(TG):AMPPCP FORM | 3.6.3.8 7.2.2.10 |
2C8I | COMPLEX OF ECHOVIRUS TYPE 12 WITH DOMAINS 1, 2, 3 AND 4 OF ITS RECEPTOR DECAY ACCELERATING FACTOR (CD55) BY CRYO ELECTRON MICROSCOPY AT 16 A | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
2C8K | CRYSTAL STRUCTURE OF (SR) CALCIUM-ATPASE E2(TG) WITH PARTIALLY OCCUPIED AMPPCP SITE | 3.6.3.8 7.2.2.10 |
2C8L | CRYSTAL STRUCTURE OF (SR) CALCIUM-ATPASE E2(TG) FORM | 3.6.3.8 7.2.2.10 |
2C8O | LYSOZYME (1SEC) AND UV LASR EXCITED FLUORESCENCE | 3.2.1.17 |
2C8P | LYSOZYME (60SEC) AND UV LASER EXCITED FLUORESCENCE | 3.2.1.17 |
2C8T | THE 3.0 A RESOLUTION STRUCTURE OF CASEINOLYTIC CLP PROTEASE 1 FROM MYCOBACTERIUM TUBERCULOSIS | 3.4.21.92 |
2C8W | THROMBIN INHIBITORS | 3.4.21.5 |
2C8X | THROMBIN INHIBITORS | 3.4.21.5 |
2C8Y | THROMBIN INHIBITORS | 3.4.21.5 |
2C8Z | THROMBIN INHIBITORS | 3.4.21.5 |
2C90 | THROMBIN INHIBITORS | 3.4.21.5 |
2C93 | THROMBIN INHIBITORS | 3.4.21.5 |
2C9A | CRYSTAL STRUCTURE OF THE MAM-IG MODULE OF RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU | 3.1.3.48 |
2C9M | STRUCTURE OF (SR) CALCIUM-ATPASE IN THE CA2E1 STATE SOLVED IN A P1 CRYSTAL FORM. | 3.6.3.8 7.2.2.10 |
2C9O | 3D STRUCTURE OF THE HUMAN RUVB-LIKE HELICASE RUVBL1 | 3.6.1 3.6.4.12 |
2CAR | CRYSTAL STRUCTURE OF HUMAN INOSINE TRIPHOSPHATASE | 3.6.1.19 3.6.1.9 |
2CB5 | HUMAN BLEOMYCIN HYDROLASE, C73S/DELE455 MUTANT | 3.4.22 3.4.22.40 |
2CBH | DETERMINATION OF THE THREE-DIMENSIONAL STRUCTURE OF THE C-TERMINAL DOMAIN OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI. A STUDY USING NUCLEAR MAGNETIC RESONANCE AND HYBRID DISTANCE GEOMETRY-DYNAMICAL SIMULATED ANNEALING | 3.2.1.91 |
2CBI | STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NAGJ FAMILY 84 GLYCOSIDE HYDROLASE, A HOMOLOGUE OF HUMAN O-GLCNACASE | 3.2.1.35 3.2.1.169 |
2CBJ | STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS NAGJ FAMILY 84 GLYCOSIDE HYDROLASE, A HOMOLOGUE OF HUMAN O-GLCNACASE IN COMPLEX WITH PUGNAC | 3.2.1.35 3.2.1.169 |
2CBN | CRYSTAL STRUCTURE OF ZIPD FROM ESCHERICHIA COLI | 3.1.26.11 3.1 |
2CBU | BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH CASTANOSPERMINE | 3.2.1.21 |
2CBV | BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH CALYSTEGINE B2 | 3.2.1.21 |
2CBY | CRYSTAL STRUCTURE OF THE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 (CLPP1) FROM MYCOBACTERIUM TUBERCULOSIS | 3.4.21.92 |
2CC0 | FAMILY 4 CARBOHYDRATE ESTERASE FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH ACETATE | 3.1.1.72 |
2CC1 | CRYSTAL STRUCTURE OF THE CLASS A BETA-LACTAMASE FROM MYCOBACTERIUM FORTUITUM | 3.5.2.6 |
2CCQ | THE PUB DOMAIN FUNCTIONS AS A P97 BINDING MODULE IN HUMAN PEPTIDE N-GLYCANASE. | 3.5.1.52 |
2CCR | STRUCTURE OF BETA-1,4-GALACTANASE | 3.2.1.89 |
2CDR | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS. | 3.4.22 3.4.22.56 |
2CDS | LYSOZYME | 3.2.1.17 |
2CE2 | CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GDP | 3.6.5.2 |
2CE3 | CRYSTAL STRUCTURE OF THE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 (CLPP1) FROM MYCOBACTERIUM TUBERCULOSIS | 3.4.21.92 |
2CE7 | EDTA TREATED | 3.4.24 |
2CEJ | P1' EXTENDED HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMICKING SCAFFOLD | 3.4.23.16 |
2CEK | CONFORMATIONAL FLEXIBILITY IN THE PERIPHERAL SITE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE REVEALED BY THE COMPLEX STRUCTURE WITH A BIFUNCTIONAL INHIBITOR | 3.1.1.7 |
2CEL | ACTIVE-SITE MUTANT E212Q DETERMINED AT PH 6.0 WITH NO LIGAND BOUND IN THE ACTIVE SITE | 3.2.1.91 |
2CEM | P1' EXTENDED HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMICKING SCAFFOLD | 3.4.23.16 |
2CEN | P1' EXTENDED HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMICKING SCAFFOLD | 3.4.23.16 |
2CEQ | BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH GLUCOIMIDAZOLE | 3.2.1.23 |
2CER | BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH PHENETHYL-SUBSTITUTED GLUCOIMIDAZOLE | 3.2.1.21 3.2.1.23 |
2CES | BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH GLUCOIMIDAZOLE | 3.2.1.21 |
2CET | BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH PHENETHYL- SUBSTITUTED GLUCOIMIDAZOLE | 3.2.1.21 |
2CEV | ARGINASE FROM BACILLUS CALDEVELOX, NATIVE STRUCTURE AT PH 8.5 | 3.5.3.1 |
2CF4 | PYROCOCCUS HORIKOSHII TET1 PEPTIDASE CAN ASSEMBLE INTO A TETRAHEDRON OR A LARGE OCTAHEDRAL SHELL | 3.4.11 |
2CF8 | COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH AN INHIBITOR | 3.4.21.5 |
2CF9 | COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH AN INHIBITOR | 3.4.21.5 |
2CFR | CRYSTAL STRUCTURE OF HUMAN PYRIDOXAL 5'-PHOSPHATE PHOSPHATASE | 3.1.3.74 3.1.3.3 |
2CFS | CRYSTAL STRUCTURE OF HUMAN PYRIDOXAL 5'-PHOSPHATE PHOSPHATASE | 3.1.3.74 3.1.3.3 |
2CFT | CRYSTAL STRUCTURE OF HUMAN PYRIDOXAL 5'-PHOSPHATE PHOSPHATASE WITH ITS SUBSTRATE | 3.1.3.74 3.1.3.3 |
2CFV | CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE J | 3.1.3.48 |
2CGA | BOVINE CHYMOTRYPSINOGEN A. X-RAY CRYSTAL STRUCTURE ANALYSIS AND REFINEMENT OF A NEW CRYSTAL FORM AT 1.8 ANGSTROMS RESOLUTION | 3.4.21.1 |
2CGI | SIRAS STRUCTURE OF TETRAGONAL LYSOZYME USING DERIVATIVE DATA COLLECTED AT THE HIGH ENERGY REMOTE HOLMIUM KEDGE | 3.2.1.17 |
2CHA | THE STRUCTURE OF CRYSTALLINE ALPHA-CHYMOTRYPSIN, $V.THE ATOMIC STRUCTURE OF TOSYL-ALPHA-CHYMOTRYPSIN AT 2 ANGSTROMS RESOLUTION | 3.4.21.1 |
2CHM | CRYSTAL STRUCTURE OF N2 SUBSTITUTED PYRAZOLO PYRIMIDINONES - A FLIPPED BINDING MODE IN PDE5 | 3.1.4.17 3.1.4.35 3.1.4.53 |
2CHN | BACTEROIDES THETAIOTAOMICRON HEXOSAMINIDASE WITH O-GLCNACASE ACTIVITY- NAG-THIAZOLINE COMPLEX | 3.2.1.52 3.2.1.169 |
2CHO | BACTEROIDES THETAIOTAOMICRON HEXOSAMINIDASE WITH O-GLCNACASE ACTIVITY | 3.2.1.52 3.2.1.169 |
2CI1 | CRYSTAL STRUCTURE OF DIMETHYLARGININE DIMETHYLAMINOHYDROLASE I IN COMPLEX WITH S-NITROSO-LHOMOCYSTEINE | 3.5.3.18 |
2CI3 | CRYSTAL STRUCTURE OF DIMETHYLARGININE DIMETHYLAMINOHYDROLASE CRYSTAL FORM I | 3.5.3.18 |
2CI4 | CRYSTAL STRUCTURE OF DIMETHYLARGININE DIMETHYLAMINOHYDROLASE I CRYSTAL FORM II | 3.5.3.18 |
2CI5 | CRYSTAL STRUCTURE OF DIMETHYLARGININE DIMETHYLAMINOHYDROLASE I IN COMPLEX WITH L-HOMOCYSTEINE | 3.5.3.18 |
2CI6 | CRYSTAL STRUCTURE OF DIMETHYLARGININE DIMETHYLAMINOHYDROLASE I BOUND WITH ZINC LOW PH | 3.5.3.18 |
2CI7 | CRYSTAL STRUCTURE OF DIMETHYLARGININE DIMETHYLAMINOHYDROLASE I IN COMPLEX WITH ZINC, HIGH PH | 3.5.3.18 |
2CIC | THE CRYSTAL STRUCTURE OF A COMPLEX OF CAMPYLOBACTER JEJUNI DUTPASE WITH SUBSTRATE ANALOGUE DUPNHPP | 3.6.1.23 |
2CIJ | MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) WITH BOUND METHIONINE | 3.4.17.21 |
2CIO | THE HIGH RESOLUTION X-RAY STRUCTURE OF PAPAIN COMPLEXED WITH FRAGMENTS OF THE TRYPANOSOMA BRUCEI CYSTEINE PROTEASE INHIBITOR ICP. | 3.4.22.2 |
2CIP | STRUCTURE OF THE MICHAELIS COMPLEX OF A FAMILY 26 LICHENASE | 3.2.1.4 |
2CIT | STRUCTURE OF THE COVALENT INTERMEDIATE OF A FAMILY 26 LICHENASE | 3.2.1.4 |
2CJE | THE CRYSTAL STRUCTURE OF A COMPLEX OF LEISHMANIA MAJOR DUTPASE WITH SUBSTRATE ANALOGUE DUPNHP | 3.6.1.23 |
2CJI | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX | 3.4.21.6 |
2CJL | CRYSTAL STRUCTURE AND ENZYMATIC PROPERTIES OF A BACTERIAL FAMILY 19 CHITINASE REVEAL DIFFERENCES WITH PLANT ENZYMES | 3.2.1.14 |
2CJP | STRUCTURE OF POTATO (SOLANUM TUBEROSUM) EPOXIDE HYDROLASE I (STEH1) | 3.3.2.3 |
2CJQ | BOVINE VIRAL DIARRHEA VIRUS CP7-R12 RNA-DEPENDENT RNA POLYMERASE | 2.7.7.48 3.4.22 3.4.21.113 3.6.1.15 3.6.4.13 |
2CJX | EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS | 3.4.22.56 |
2CJY | EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS | 3.4.22.56 |
2CJZ | CRYSTAL STRUCTURE OF THE C472S MUTANT OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 (STEP, STRIATUM ENRICHED PHOSPHATASE) IN COMPLEX WITH PHOSPHOTYROSINE | 3.1.3.48 |
2CK3 | AZIDE INHIBITED BOVINE F1-ATPASE | 3.6.3.14 |
2CKA | SOLUTION STRUCTURES OF THE BRK DOMAINS OF THE HUMAN CHROMO HELICASE DOMAIN 7 AND 8, REVEALS STRUCTURAL SIMILARITY WITH GYF DOMAIN SUGGESTING A ROLE IN PROTEIN INTERACTION | 3.6.1 3.6.4.12 |
2CKC | SOLUTION STRUCTURES OF THE BRK DOMAINS OF THE HUMAN CHROMO HELICASE DOMAIN 7 AND 8, REVEALS STRUCTURAL SIMILARITY WITH GYF DOMAIN SUGGESTING A ROLE IN PROTEIN INTERACTION | 3.6.4.12 |
2CKG | THE STRUCTURE OF SENP1 SUMO-2 CO-COMPLEX SUGGESTS A STRUCTURAL BASIS FOR DISCRIMINATION BETWEEN SUMO PARALOGUES DURING PROCESSING | 3.4.22 |
2CKH | SENP1-SUMO2 COMPLEX | 3.4.22 |
2CKI | STRUCTURE OF ULILYSIN, A MEMBER OF THE PAPPALYSIN FAMILY OF METZINCIN METALLOENDOPEPTIDASES. | 3.4.24 |
2CKM | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH ALKYLENE- LINKED BIS-TACRINE DIMER (7 CARBON LINKER) | 3.1.1.7 |
2CKR | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THERMOBIFIDA FUSCA ENDOGLUCANASE CEL5A (E5) E355Q IN COMPLEX WITH CELLOTETRAOSE | 3.2.1.4 |
2CKS | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THERMOBIFIDA FUSCA ENDOGLUCANASE CEL5A (E5) | 3.2.1.4 |
2CKW | THE 2.3 A RESOLUTION STRUCTURE OF THE SAPPORO VIRUS RNA DEPENDANT RNA POLYMERASE. | 2.7.7.48 3.6.1.15 3.4.22.66 |
2CL0 | CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GPPNHP | 3.6.5.2 |
2CL2 | ENDO-1,3(4)-BETA-GLUCANASE FROM PHANEROCHAETE CHRYSOSPORIUM, SOLVED USING NATIVE SULFUR SAD, EXHIBITING INTACT HEPTASACCHARIDE GLYCOSYLATION | 3.2.1.6 |
2CL6 | CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH S-CAGED GTP | 3.6.5.2 |
2CL7 | CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GTP | 3.6.5.2 |
2CLC | CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GTP (2) | 3.6.5.2 |
2CLD | CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GDP (2) | 3.6.5.2 |
2CLT | CRYSTAL STRUCTURE OF THE ACTIVE FORM (FULL-LENGTH) OF HUMAN FIBROBLAST COLLAGENASE. | 3.4.24.7 |
2CLY | SUBCOMPLEX OF THE STATOR OF BOVINE MITOCHONDRIAL ATP SYNTHASE | 3.6.3.14 |
2CM0 | THE PUB DOMAIN FUNCTIONS AS A P97 BINDING MODULE IN HUMAN PEPTIDE N-GLYCANASE. | 3.5.1.52 |
2CM1 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF SERINE THREONINE PROTEIN PHOSPHATASE PSTP IN COMPLEX WITH 2 MANGANESE IONS. | 3.1.3.16 |
2CM2 | STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (P212121) | 3.1.3.48 |
2CM3 | STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (C2) | 3.1.3.48 |
2CM7 | STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS | 3.1.3.48 |
2CM8 | STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS | 3.1.3.48 |
2CMA | STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS | 3.1.3.48 |
2CMB | STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS | 3.1.3.48 |
2CMC | STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS | 3.1.3.48 |
2CMF | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH ALKYLENE- LINKED BIS-TACRINE DIMER (5 CARBON LINKER) | 3.1.1.7 |
2CML | STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM ZANAMIVIR, CRYSTAL SOAKED FOR 3 HOURS AT 291 K. | 3.2.1.18 |
2CMU | CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDYL-ARGININE DEIMINASE | 3.5.3.6 |
2CMY | CRYSTAL COMPLEX BETWEEN BOVINE TRYPSIN AND VERONICA HEDERIFOLIA TRYPSIN INHIBITOR | 3.4.21.4 |
2CN0 | COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED INHIBITOR | 3.4.21.5 |
2CN1 | CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'-NUCLEOTIDASE III (NT5C3)(CASP TARGET) | 3.1.3.5 3.1.3.91 |
2CN3 | CRYSTAL STRUCTURES OF CLOSTRIDIUM THERMOCELLUM XYLOGLUCANASE | 3.2.1.151 3.2.1 |
2CNC | FAMILY 10 XYLANASE | 3.2.1.8 |
2CNE | STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
2CNF | STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
2CNG | STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
2CNH | STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
2CNI | STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B | 3.1.3.48 |
2CNK | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS. | 3.4.22 3.4.22.56 |
2CNL | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS. | 3.4.22 3.4.22.56 |
2CNN | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS. | 3.4.22 3.4.22.56 |
2CNO | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS. | 3.4.22 3.4.22.56 |
2CON | SOLUTION STRUCTURE OF RSGI RUH-035, A ZN-RIBBON MODULE IN MOUSE CDNA | 3.1 |
2COV | CRYSTAL STRUCTURE OF CBM31 FROM BETA-1,3-XYLANASE | 3.2.1.32 |
2CPR | SOLUTION STRUCTURE OF THE HRDC DOMAIN OF HUMAN EXOSOME COMPONENT 10 | 3.1.13 |
2CPT | SOLUTION STRUCTURE OF MIT DOMAIN FROM HUMAN SKD1 | 3.6.4.6 |
2CPU | SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT | 3.2.1.1 |
2CPW | SOLUTION STRUCTURE OF RSGI RUH-031, A UBA DOMAIN FROM HUMAN CDNA | 3.1.3.48 |
2CQA | SOLUTION STRUCTURE OF RSGI RUH-039, A FRAGMENT OF C-TERMINAL DOMAIN OF RUVB-LIKE 2 FROM HUMAN CDNA | 3.6.1 3.6.4.12 |
2CQZ | CRYSTAL STRUCTURE OF PH0347 PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 | 3.1.3.89 |
2CS5 | SOLUTION STRUCTURE OF PDZ DOMAIN OF PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 4 | 3.1.3.48 |
2CTB | THE HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CARBOXYPEPTIDASE A AND L-PHENYL LACTATE | 3.4.17.1 |
2CTC | THE HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CARBOXYPEPTIDASE A AND L-PHENYL LACTATE | 3.4.17.1 |
2CU7 | SOLUTION STRUCTURE OF THE SANT DOMAIN OF HUMAN KIAA1915 PROTEIN | 3.4.19 |
2CUT | CUTINASE, A LIPOLYTIC ENZYME WITH A PREFORMED OXYANION HOLE | 3.1.1 3.1.1.74 |
2CUU | CRYSTAL STRUCTURE OF SPIN LABELED T4 LYSOZYME (V131R1) | 3.2.1.17 |
2CV3 | CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH A MACROCLYCLIC PEPTIDE INHIBITOR | 3.4.21.36 |
2CV8 | CRYSTAL STRUCTURE OF TRNA-INTRON ENDONUCLEASE FROM SULFOLOBUS TOKODAII | 3.1.27.9 4.6.1.16 |
2CVR | NMR SOLUTION STRUCTURE OF SSO7D MUTANT, K12L, 12 CONFORMERS | 3.1.27 |
2CW7 | CRYSTAL STRUCTURE OF INTEIN HOMING ENDONUCLEASE II | 3.1 2.7.7.7 |
2CW8 | CRYSTAL STRUCTURE OF INTEIN HOMING ENDONUCLEASE II | 3.1 2.7.7.7 |
2CWI | X-RAY CRYSTAL STRUCTURE ANALYSIS OF RECOMBINANT WILD-TYPE CANINE MILK LYSOZYME (APO-TYPE) | 3.2.1.17 |
2CWJ | CRYSTAL STRUCTURE OF APE1501, A PUTATIVE ENDONUCLEASE FROM AEROPYRUM PERNIX | 3.1 |
2CWR | CRYSTAL STRUCTURE OF CHITIN BIDING DOMAIN OF CHITINASE FROM PYROCOCCUS FURIOSUS | 3.2.1.14 |
2CXV | DUAL MODES OF MODIFICATION OF HEPATITIS A VIRUS 3C PROTEASE BY A SERINE-DERIVED BETALACTONE: SELECTIVE CRYSTALLIZATION AND HIGH-RESOLUTION STRUCTURE OF THE HIS-102 ADDUCT | 3.4.22.28 3.6.1.15 2.7.7.48 |
2CY7 | THE CRYSTAL STRUCTURE OF HUMAN ATG4B | 3.4.22 |
2CY9 | CRYSTAL STRUCTURE OF THIOESTERASE SUPERFAMILY MEMBER2 FROM MUS MUSCULUS | 3.1.2 3.1.2.2 |
2CYD | CRYSTAL STRUCTURE OF LITHIUM BOUND ROTOR RING OF THE V-ATPASE FROM ENTEROCOCCUS HIRAE | 3.6.3.14 |
2CYE | CRYSTAL STRUCTURE OF THIOESTERASE COMPLEXED WITH COENZYME A AND ZN FROM THERMUS THERMOPHILUS HB8 | 3.1.2 |
2CYG | CRYSTAL STRUCTURE AT 1.45- RESOLUTION OF THE MAJOR ALLERGEN ENDO-BETA-1,3-GLUCANASE OF BANANA AS A MOLECULAR BASIS FOR THE LATEX-FRUIT SYNDROME | 3.2.1.39 |
2CZH | CRYSTAL STRUCTURE OF HUMAN MYO-INOSITOL MONOPHOSPHATASE 2 (IMPA2) WITH PHOSPHATE ION (ORTHORHOMBIC FORM) | 3.1.3.25 |
2CZI | CRYSTAL STRUCTURE OF HUMAN MYO-INOSITOL MONOPHOSPHATASE 2 (IMPA2) WITH CALCIUM AND PHOSPHATE IONS | 3.1.3.25 |
2CZK | CRYSTAL STRUCTURE OF HUMAN MYO-INOSITOL MONOPHOSPHATASE 2 (IMPA2) (TRIGONAL FORM) | 3.1.3.25 |
2CZN | SOLUTION STRUCTURE OF THE CHITIN-BINDING DOMAIN OF HYPERTHERMOPHILIC CHITINASE FROM PYROCOCCUS FURIOSUS | 3.2.1.14 |
2CZQ | A NOVEL CUTINASE-LIKE PROTEIN FROM CRYPTOCOCCUS SP. | 3.1.1 |
2CZV | CRYSTAL STRUCTURE OF ARCHEAL RNASE P PROTEIN PH1481P IN COMPLEX WITH PH1877P | 3.1.26.5 |
2D00 | SUBUNIT F OF V-TYPE ATPASE/SYNTHASE | 3.6.3.14 |
2D05 | CHITOSANASE FROM BACILLUS CIRCULANS MUTANT K218P | 3.2.1.132 |
2D07 | CRYSTAL STRUCTURE OF SUMO-3-MODIFIED THYMINE-DNA GLYCOSYLASE | 3.2.2 3.2.2.29 |
2D0A | CRYSTAL STRUCTURE OF BST-RNASE HIII | 3.1.26.4 |
2D0B | CRYSTAL STRUCTURE OF BST-RNASE HIII IN COMPLEX WITH MG2+ | 3.1.26.4 |
2D0C | CRYSTAL STRUCTURE OF BST-RNASE HIII IN COMPLEX WITH MN2+ | 3.1.26.4 |
2D0D | CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) A129V MUTANT | 3.7.1.9 |
2D0F | CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 (TVAI) MUTANT D356N COMPLEXED WITH P2, A PULLULAN MODEL OLIGOSACCHARIDE | 3.2.1.1 3.2.1.135 |
2D0G | CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 (TVAI) MUTANT D356N/E396Q COMPLEXED WITH P5, A PULLULAN MODEL OLIGOSACCHARIDE | 3.2.1.1 3.2.1.135 |
2D0H | CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 (TVAI) MUTANT D356N/E396Q COMPLEXED WITH P2, A PULLULAN MODEL OLIGOSACCHARIDE | 3.2.1.1 3.2.1.135 |
2D1G | STRUCTURE OF FRANCISELLA TULARENSIS ACID PHOSPHATASE A (ACPA) BOUND TO ORTHOVANADATE | 3.1.3.2 |
2D1I | STRUCTURE OF HUMAN ATG4B | 3.4.22 |
2D1J | FACTOR XA IN COMPLEX WITH THE INHIBITOR 2-[[4-[(5-CHLOROINDOL-2-YL)SULFONYL]PIPERAZIN-1-YL] CARBONYL]THIENO[3,2-B]PYRIDINE N-OXIDE | 3.4.21.6 |
2D1N | COLLAGENASE-3 (MMP-13) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR | 3.4.24 |
2D1O | STROMELYSIN-1 (MMP-3) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR | 3.4.24.17 |
2D1Z | CRYSTAL STRUCTURE OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 | 3.2.1.8 |
2D20 | CRYSTAL STRUCTURE OF MICHAELIS COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 | 3.2.1.8 |
2D22 | CRYSTAL STRUCTURE OF COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 | 3.2.1.8 |
2D23 | CRYSTAL STRUCTURE OF EP COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 | 3.2.1.8 |
2D24 | CRYSTAL STRUCTURE OF ES COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 | 3.2.1.8 |
2D2D | CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR I2 | 3.4.24 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
2D2G | OPDA FROM AGROBACTERIUM RADIOBACTER WITH BOUND PRODUCT DIMETHYLTHIOPHOSPHATE | 3.1.8.1 |
2D2H | OPDA FROM AGROBACTERIUM RADIOBACTER WITH BOUND INHIBITOR TRIMETHYL PHOSPHATE AT 1.8 A RESOLUTION | 3.1.8.1 |
2D2J | OPDA FROM AGROBACTERIUM RADIOBACTER WITHOUT INHIBITOR/PRODUCT PRESENT AT 1.75 A RESOLUTION | 3.1.8.1 |
2D2O | STRUCTURE OF A COMPLEX OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2 WITH MALTOHEXAOSE DEMONSTRATES THE IMPORTANT ROLE OF AROMATIC RESIDUES AT THE REDUCING END OF THE SUBSTRATE BINDING CLEFT | 3.2.1.135 |
2D2V | X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP.PCC6803 IN COMPLEX WITH MALTOSE | 3.1.3.24 |
2D30 | CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE CDD-2 (BA4525) FROM BACILLUS ANTHRACIS AT 2.40A RESOLUTION | 3.5.4.5 |
2D3K | STRUCTURAL STUDY ON PROJECT ID PH1539 FROM PYROCOCCUS HORIKOSHII OT3 | 3.1.1.29 |
2D3L | CRYSTAL STRUCTURE OF MALTOHEXAOSE-PRODUCING AMYLASE FROM BACILLUS SP.707 COMPLEXED WITH MALTOPENTAOSE. | 3.2.1.98 |
2D3N | CRYSTAL STRUCTURE OF MALTOHEXAOSE-PRODUCING AMYLASE FROM BACILLUS SP.707 COMPLEXED WITH MALTOHEXAOSE | 3.2.1.98 |
2D3U | X-RAY CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA DEPENDENT RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE ANALOGUE INHIBITOR | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
2D3Y | CRYSTAL STRUCTURE OF URACIL-DNA GLYCOSYLASE FROM THERMUS THERMOPHILUS HB8 | 3.2.2 |
2D3Z | X-RAY CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE ANALOGUE INHIBITOR | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
2D41 | X-RAY CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
2D43 | CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH ARABINOTRIOSE | 3.2.1.55 |
2D44 | CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH ARABINOFURANOSYL-ALPHA-1,2-XYLOBIOSE | 3.2.1.55 |
2D49 | SOLUTION STRUCTURE OF THE CHITIN-BINDING DOMAIN OF STREPTOMYCES GRISEUS CHITINASE C | 3.2.1.14 |
2D4G | STRUCTURE OF YJCG PROTEIN, A PUTATIVE 2'-5' RNA LIGASE FROM BACILLUS SUBTILIS | 3.1 |
2D4H | CRYSTAL-STRUCTURE OF THE N-TERMINAL LARGE GTPASE DOMAIN OF HUMAN GUANYLATE BINDING PROTEIN 1 (HGBP1) IN COMPLEX WITH GMP | 3.6.5 |
2D4I | MONOCLINIC HEN EGG-WHITE LYSOZYME CRYSTALLIZED AT PH4.5 FORM HEAVY WATER SOLUTION | 3.2.1.17 |
2D4J | TRANSFORMED MONOCLINIC CRYSTAL OF HEN EGG-WHITE LYSOZYME FROM A HEAVY WATER SOLUTION | 3.2.1.17 |
2D4K | MONOCLINIC HEN EGG-WHITE LYSOZYME CRYSTALLIZED AT 313K | 3.2.1.17 |
2D4L | CRYSTAL STRUCTURE OF TRUNCATED IN C-TERMINAL M-PMV DUTPASE | 3.6.1.23 3.4.23 |
2D4M | CRYSTAL STRUCTURE OF APO M-PMV DUTPASE | 3.6.1.23 3.4.23 |
2D4N | CRYSTAL STRUCTURE OF M-PMV DUTPASE COMPLEXED WITH DUPNPP, SUBSTRATE ANALOGUE | 3.6.1.23 3.4.23 |
2D5J | UNSATURATED GLUCURONYL HYDROLASE TRIGGERS HYDRATION OF VINYL ETHER GROUP BUT NOT OF GLYCOSIDIC BOND | 3.2.1 3.2.1.179 |
2D5L | CRYSTAL STRUCTURE OF PROLYL TRIPEPTIDYL AMINOPEPTIDASE FROM PORPHYROMONAS GINGIVALIS | 3.4.14 3.4.14.12 |
2D5N | CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS | 3.5.4.26 1.1.1.193 |
2D5R | CRYSTAL STRUCTURE OF A TOB-HCAF1 COMPLEX | 3.1.13.4 |
2D5U | SOLUTION STRUCTURE OF THE N-TERMINAL PORTION OF THE PUB DOMAIN OF MOUSE PEPTIDE:N-GLYCANASE | 3.5.1.52 |
2D6B | NOVEL BROMATE SPECIES TRAPPED WITHIN A PROTEIN CRYSTAL | 3.2.1.17 |
2D73 | CRYSTAL STRUCTURE ANALYSIS OF SUSB | 3.2.1.20 3.2.1.3 |
2D74 | CRYSTAL STRUCTURE OF TRANSLATION INITIATION FACTOR AIF2BETAGAMMA HETERODIMER | 3.6.5.3 |
2D7D | STRUCTURAL INSIGHTS INTO THE CRYPTIC DNA DEPENDENT ATP-ASE ACTIVITY OF UVRB | 3.1 |
2D7E | CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF PRIA FROM E.COLI | 3.6.1 3.6.4 |
2D7G | CRYSTAL STRUCTURE OF THE AA COMPLEX OF THE N-TERMINAL DOMAIN OF PRIA | 3.6.4 |
2D7H | CRYSTAL STRUCTURE OF THE CCC COMPLEX OF THE N-TERMINAL DOMAIN OF PRIA | 3.6.4 |
2D7S | FOOT AND MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH VPG PROTEIN | 2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15 |
2D80 | CRYSTAL STRUCTURE OF PHB DEPOLYMERASE FROM PENICILLIUM FUNICULOSUM | 3.1.1.75 |
2D81 | PHB DEPOLYMERASE (S39A) COMPLEXED WITH R3HB TRIMER | 3.1.1.75 |
2D8L | CRYSTAL STRUCTURE OF UNSATURATED RHAMNOGALACTURONYL HYDROLASE IN COMPLEX WITH DGLCA-GALNAC | 3.2.1 3.2.1.172 |
2D8W | STRUCTURE OF HYPER-VIL-TRYPSIN | 3.4.21.4 |
2D91 | STRUCTURE OF HYPER-VIL-LYSOZYME | 3.2.1.17 |
2D97 | STRUCTURE OF VIL-XYLANASE | 3.2.1.8 |
2D98 | STRUCTURE OF VIL (EXTRA KI/I2 ADDED)-XYLANASE | 3.2.1.8 |
2D9I | SOLUTION STRUCTURE OF THE SMR DOMAIN OF NEDD4-BINDING PROTEIN 2 | 3 |
2DAG | SOLUTION STRUCTURE OF THE FIRST UBA DOMAIN IN THE HUMAN UBIQUITIN SPECIFIC PROTEASE 5 (ISOPEPTIDASE 5) | 3.1.2.15 3.4.19.12 |
2DAK | SOLUTION STRUCTURE OF THE SECOND UBA DOMAIN IN THE HUMAN UBIQUITIN SPECIFIC PROTEASE 5 (ISOPEPTIDASE 5) | 3.1.2.15 3.4.19.12 |
2DAT | SOLUTION STRUCTURE OF THE BROMODOMAIN OF HUMAN SWI/SNF RELATED MATRIX ASSOCIATED ACTIN DEPENDENT REGULATOR OF CROMATIN SUBFAMILY A MEMBER 2 | 3.6.4 |
2DB2 | SOLUTION STRUCTURE OF THE DOUBLE-STRANDED RNA BINDING DOMAIN IN KIAA0890 PROTEIN | 3.6.4.13 |
2DB3 | STRUCTURAL BASIS FOR RNA UNWINDING BY THE DEAD-BOX PROTEIN DROSOPHILA VASA | 3.6.1.3 3.6.4.13 |
2DB4 | CRYSTAL STRUCTURE OF ROTOR RING WITH DCCD OF THE V- ATPASE FROM ENTEROCOCCUS HIRAE | 3.6.3.14 |
2DBO | CRYSTAL STRUCTURE OF D-TYR-TRNA(TYR) DEACYLASE FROM AQUIFEX AEOLICUS | 3.1 3.1.1.96 |
2DBT | CRYSTAL STRUCTURE OF CHITINASE C FROM STREPTOMYCES GRISEUS HUT6037 | 3.2.1.14 |
2DBU | CRYSTAL STRUCTURE OF GAMMA-GLUTAMYLTRANSPEPTIDASE FROM ESCHERICHIA COLI | 2.3.2.2 3.4.19.13 |
2DBW | CRYSTAL STRUCTURE OF GAMMA-GLUTAMYLTRANSPEPTIDASE FROM ESCHERICHIA COLI ACYL-ENZYME INTERMEDIATE | 2.3.2.2 3.4.19.13 |
2DBX | CRYSTAL STRUCTURE OF GAMMA-GLUTAMYLTRANSPEPTIDASE FROM ESCHERICHIA COLI COMPLEXED WITH L-GLUTAMATE | 2.3.2.2 3.4.19.13 |
2DC6 | X-RAY CRYSTAL STRUCTURE ANALYSIS OF BOVINE SPLEEN CATHEPSIN B-CA073 COMPLEX | 3.4.22.1 |
2DC7 | X-RAY CRYSTAL STRUCTURE ANALYSIS OF BOVINE SPLEEN CATHEPSIN B-CA042 COMPLEX | 3.4.22.1 |
2DC8 | X-RAY CRYSTAL STRUCTURE ANALYSIS OF BOVINE SPLEEN CATHEPSIN B-CA059 COMPLEX | 3.4.22.1 |
2DC9 | X-RAY CRYSTAL STRUCTURE ANALYSIS OF BOVINE SPLEEN CATHEPSIN B-CA074ME COMPLEX | 3.4.22.1 |
2DCA | X-RAY CRYSTAL STRUCTURE ANALYSIS OF BOVINE SPLEEN CATHEPSIN B-CA075 COMPLEX | 3.4.22.1 |
2DCB | X-RAY CRYSTAL STRUCTURE ANALYSIS OF BOVINE SPLEEN CATHEPSIN B-CA076 COMPLEX | 3.4.22.1 |
2DCC | X-RAY CRYSTAL STRUCTURE ANALYSIS OF BOVINE SPLEEN CATHEPSIN B-CA077 COMPLEX | 3.4.22.1 |
2DCD | X-RAY CRYSTAL STRUCTURE ANALYSIS OF BOVINE SPLEEN CATHEPSIN B-CA078 COMPLEX | 3.4.22.1 |
2DCE | SOLUTION STRUCTURE OF THE SWIRM DOMAIN OF HUMAN KIAA1915 PROTEIN | 3.4.19 |
2DCF | CRYSTAL STRUCTURE OF 6-AMINOHEXANOATE-DIMER HYDROLASE S112A/G181D/H266N MUTANT WITH SUBSTRATE | 3.5.1.46 |
2DCH | CRYSTAL STRUCTURE OF ARCHAEAL INTRON-ENCODED HOMING ENDONUCLEASE I-TSP061I | 3.1 |
2DCJ | A TWO-DOMAIN STRUCTURE OF ALKALIPHILIC XYNJ FROM BACILLUS SP. 41M-1 | 3.2.1.8 |
2DCK | A TETRAGONAL-LATTICE STRUCTURE OF ALKALIPHILIC XYNJ FROM BACILLUS SP. 41M-1 | 3.2.1.8 |
2DCM | THE CRYSTAL STRUCTURE OF S603A MUTATED PROLYL TRIPEPTIDYL AMINOPEPTIDASE COMPLEXED WITH SUBSTRATE | 3.4.14 3.4.14.12 |
2DCU | CRYSTAL STRUCTURE OF TRANSLATION INITIATION FACTOR AIF2BETAGAMMA HETERODIMER WITH GDP | 3.6.5.3 |
2DCY | CRYSTAL STRUCTURE OF BACILLUS SUBTILIS FAMILY-11 XYLANASE | 3.2.1.8 |
2DCZ | THERMAL STABILIZATION OF BACILLUS SUBTILIS FAMILY-11 XYLANASE BY DIRECTED EVOLUTION | 3.2.1.8 |
2DD4 | THIOCYANATE HYDROLASE (SCNASE) FROM THIOBACILLUS THIOPARUS RECOMBINANT APO-ENZYME | 3.5.5.8 |
2DD5 | THIOCYANATE HYDROLASE (SCNASE) FROM THIOBACILLUS THIOPARUS NATIVE HOLO-ENZYME | 3.5.5.8 |
2DDF | CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH TAPI-2 | 3.4.24.86 |
2DDG | CRYSTAL STRUCTURE OF URACIL-DNA GLYCOSYLASE IN COMPLEX WITH AP:G CONTAINING DNA | 3.2.2 |
2DDK | CRYSTAL STRUCTURE OF HUMAN MYO-INOSITOL MONOPHOSPHATASE 2 (IMPA2) (ORTHORHOMBIC FORM) | 3.1.3.25 |
2DDR | CRYSTAL STRUCTURE OF SPHINGOMYELINASE FROM BACILLUS CEREUS WITH CALCIUM ION | 3.1.4.12 |
2DDS | CRYSTAL STRUCTURE OF SPHINGOMYELINASE FROM BACILLUS CEREUS WITH COBALT ION | 3.1.4.12 |
2DDT | CRYSTAL STRUCTURE OF SPHINGOMYELINASE FROM BACILLUS CEREUS WITH MAGNESIUM ION | 3.1.4.12 |
2DDU | CRYSTAL STRUCTURE OF THE THIRD REPEAT DOMAIN OF REELIN | 3.4.21 |
2DDX | CRYSTAL STRUCTURE OF BETA-1,3-XYLANASE FROM VIBRIO SP. AX-4 | 3.2.1 3.2.1.32 |
2DDY | SOLUTION STRUCTURE OF MATRILYSIN (MMP-7) COMPLEXED TO CONSTRAINT CONFORMATIONAL SULFONAMIDE INHIBITOR | 3.4.24.23 |
2DE2 | CRYSTAL STRUCTURE OF DESULFURIZATION ENZYME DSZB | 3.13.1.3 |
2DE3 | CRYSTAL STRUCTURE OF DSZB C27S MUTANT IN COMPLEX WITH 2'-HYDROXYBIPHENYL-2-SULFINIC ACID | 3.13.1.3 |
2DE4 | CRYSTAL STRUCTURE OF DSZB C27S MUTANT IN COMPLEX WITH BIPHENYL-2-SULFINIC ACID | 3.13.1.3 |
2DE8 | CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE WITH A UNIQUE CONFORMATION INDUCED BY TRIS | 3.4.21.36 |
2DE9 | CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH TRIS AFTER SOAKING A TRIS-FREE SOLUTION | 3.4.21.36 |
2DEA | CRYSTAL STRUCTURE OF THE AMINOPEPTIDASE OF AEROMONAS PROTEOLYTICA AT PH 4.7 | 3.4.11.10 |
2DEF | PEPTIDE DEFORMYLASE CATALYTIC CORE (RESIDUES 1-147), NMR, 20 STRUCTURES | 3.5.1.31 3.5.1.88 |
2DEM | CRYSTAL STRUCTURE OF URACIL-DNA GLYCOSYLASE IN COMPLEX WITH AP:A CONTAINING DNA | 3.2.2 |
2DEO | 1510-N MEMBRANE PROTEASE SPECIFIC FOR A STOMATIN HOMOLOG FROM PYROCOCCUS HORIKOSHII | 3.4.21 |
2DEP | CRYSTAL STRUCTURE OF XYLANASE B FROM CLOSTRIDIUM STERCORARIUM F9 | 3.2.1.4 3.2.1.8 |
2DF5 | CRYSTAL STRUCTURE OF PF-PCP(1-204)-C | 3.4.19.3 |
2DFA | CRYSTAL STRUCTURE OF LACTAM UTILIZATION PROTEIN FROM THERMUS THERMOPHILUS HB8 | 3.5.2.9 |
2DFB | XYLANASE II FROM TRICODERMA REESEI AT 100K | 3.2.1.8 |
2DFC | XYLANASE II FROM TRICODERMA REESEI AT 293K | 3.2.1.8 |
2DFE | CRYSTAL STRUCTURE OF TK-RNASE HII(1-200)-C | 3.1.26.4 |
2DFF | CRYSTAL STRUCTURE OF TK-RNASE HII(1-204)-C | 3.1.26.4 |
2DFH | CRYSTAL STRUCTURE OF TK-RNASE HII(1-212)-C | 3.1.26.4 |
2DFI | CRYSTAL STRUCTURE OF PF-MAP(1-292)-C | 3.4.11.18 |
2DFJ | CRYSTAL STRUCTURE OF THE DIADENOSINE TETRAPHOSPHATE HYDROLASE FROM SHIGELLA FLEXNERI 2A | 3.6.1.41 |
2DFP | X-RAY STRUCTURE OF AGED DI-ISOPROPYL-PHOSPHORO-FLUORIDATE (DFP) BOUND TO ACETYLCHOLINESTERASE | 3.1.1.7 |
2DFX | CRYSTAL STRUCTURE OF THE CARBOXY TERMINAL DOMAIN OF COLICIN E5 COMPLEXED WITH ITS INHIBITOR | 3.1 |
2DG0 | CRYSTAL STRUCTURE OF DRP35, A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS | 3.1.1.25 3.1.1 |
2DG1 | CRYSTAL STRUCTURE OF DRP35, A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS, COMPLEXED WITH CA2+ | 3.1.1.25 3.1.1 |
2DG5 | CRYSTAL STRUCTURE OF GAMMA-GLUTAMYL TRANSPEPTIDASE FROM ESCHERICHIA COLI IN COMPLEX WITH HYDROLYZED GLUTATHIONE | 2.3.2.2 3.4.19.13 |
2DGA | CRYSTAL STRUCTURE OF HEXAMERIC BETA-GLUCOSIDASE IN WHEAT | 3.2.1.21 3.2.1.182 |
2DGZ | SOLUTION STRUCTURE OF THE HELICASE AND RNASE D C-TERMINAL DOMAIN IN WERNER SYNDROME ATP-DEPENDENT HELICASE | 3.6.1 3.6.4.12 3.1 |
2DHC | CRYSTALLOGRAPHIC ANALYSIS OF THE CATALYTIC MECHANISM OF HALOALKANE DEHALOGENASE | 3.8.1.5 |
2DHD | CRYSTALLOGRAPHIC ANALYSIS OF THE CATALYTIC MECHANISM OF HALOALKANE DEHALOGENASE | 3.8.1.5 |
2DHE | CRYSTALLOGRAPHIC ANALYSIS OF THE CATALYTIC MECHANISM OF HALOALKANE DEHALOGENASE | 3.8.1.5 |
2DHR | WHOLE CYTOSOLIC REGION OF ATP-DEPENDENT METALLOPROTEASE FTSH (G399L) | 3.4.24 |
2DI4 | CRYSTAL STRUCTURE OF THE FTSH PROTEASE DOMAIN | 3.4.24 |
2DIE | ALKALINE ALPHA-AMYLASE AMYK FROM BACILLUS SP. KSM-1378 | 3.2.1.1 |
2DJF | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C) IN COMPLEX WITH THE INHIBITOR GLY-PHE-CHN2 | 3.4.14.1 |
2DJG | RE-DETERMINATION OF THE NATIVE STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C) | 3.4.14.1 |
2DJH | CRYSTAL STRUCTURE OF THE CARBOXY-TERMINAL RIBONUCLEASE DOMAIN OF COLICIN E5 | 3.1 |
2DJM | SOLUTION STRUCTURE OF N-TERMINAL STARCH-BINDING DOMAIN OF GLUCOAMYLASE FROM RHIZOPUS ORYZAE | 3.2.1.3 |
2DJU | SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE F | 3.1.3.48 |
2DKF | CRYSTAL STRUCTURE OF TTHA0252 FROM THERMUS THERMOPHILUS HB8, A RNA DEGRADATION PROTEIN OF THE METALLO-BETA-LACTAMASE SUPERFAMILY | 3.1 |
2DKO | EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS | 3.4.22 3.4.22.56 |
2DKQ | SOLUTION STRUCTURE OF THE PTB DOMAIN OF KIAA1075 PROTEIN FROM HUMAN | 3.1.3.48 |
2DKV | CRYSTAL STRUCTURE OF CLASS I CHITINASE FROM ORYZA SATIVA L. JAPONICA | 3.2.1.14 |
2DL6 | SOLUTION STRUCTURE OF THE FIRST BRK DOMAIN FROM HUMAN CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 8 | 3.6.4.12 |
2DLE | SOLUTION STRUCTURE OF THE FOURTH FN3 DOMAIN OF HUMAN RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE ETA | 3.1.3.48 |